data_2cpe_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2cpe _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.929 0.395 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -112.75 160.81 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 31.3 pt -131.89 144.48 37.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -103.44 111.47 23.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.492 ' CG2' ' CZ ' ' A' ' 381' ' ' PHE . 8.2 t -96.42 140.12 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.098 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -145.91 122.44 11.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.26 17.97 1.72 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.489 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 87.0 mt -78.2 153.09 32.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.873 0.368 . . . . 0.0 110.861 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -76.17 -179.52 5.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.85 3.54 50.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 12.5 m -119.27 15.81 13.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.61 134.02 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.152 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 70.2 p -117.87 160.22 21.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.158 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.449 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 12.3 tp -53.11 -64.17 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.95 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -46.1 -38.75 8.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.55 -32.69 74.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 381' ' ' PHE . 75.7 mt -87.09 -28.08 22.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.8 -39.56 66.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.015 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.415 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 40.0 t0 -76.51 -20.82 56.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.497 ' CE1' ' NE2' ' A' ' 383' ' ' GLN . 40.6 t80 -91.6 -53.84 4.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.551 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 16.6 m-85 -57.56 -23.67 51.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . 0.415 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 13.9 ptmt -74.44 -12.16 60.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.925 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . 0.497 ' NE2' ' CE1' ' A' ' 380' ' ' PHE . 6.8 mt-30 -48.68 -53.4 18.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 2.3 t -59.74 -65.17 0.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -136.82 -124.3 2.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.459 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 95.1 t -125.51 128.82 72.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.841 0.353 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 58.2 t -82.53 124.79 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.101 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -45.85 107.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.975 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' MET . . . . . 0.471 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 20.4 mtp -102.91 127.28 50.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.894 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -53.7 146.01 14.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.75 -13.69 25.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -102.52 -42.09 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 66.8 p -96.93 -19.57 18.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.157 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . 0.471 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 66.04 18.44 66.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.442 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -107.14 152.75 41.2 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.554 0.692 . . . . 0.0 110.934 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 147.62 63.2 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.684 2.256 . . . . 0.0 112.349 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' MET . . . . . 0.422 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 11.3 mmt -81.61 40.76 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.846 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.449 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 97.7 mt -99.33 137.68 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.171 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -118.5 143.56 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.808 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 58.6 mt -134.59 93.9 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -59.77 125.23 22.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.844 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 36.5 mt -109.38 134.57 51.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.9 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 407' ' ' GLY . 11.1 t0 -55.67 121.25 8.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -69.23 -1.29 7.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -88.5 -38.5 14.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 70.1 p -124.74 -35.05 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.85 -1.47 35.96 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.475 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 12.0 pttp -84.37 152.62 61.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.8 Cg_endo -69.75 94.69 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.68 2.253 . . . . 0.0 112.341 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -33.55 -52.75 0.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 153.19 -15.85 0.67 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.487 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . 0.404 ' CG ' ' HE3' ' A' ' 410' ' ' LYS . 49.5 p-10 -87.74 157.24 19.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -170.15 171.67 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.096 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.4 142.91 37.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.183 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.522 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 57.0 t -130.13 111.94 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' SER . . . . . 0.422 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 9.1 m -87.35 114.39 23.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.432 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 47.3 m-85 -88.07 164.41 15.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.77 -63.29 1.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.499 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.4 m-20 -115.9 156.05 47.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.604 0.716 . . . . 0.0 110.84 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.602 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.39 -43.01 55.77 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.644 2.23 . . . . 0.0 112.356 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.7 Cg_exo -50.06 -29.57 22.3 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.686 2.257 . . . . 0.0 112.286 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 70.0 m -85.8 -40.07 16.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.159 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.432 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -61.93 -51.5 67.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.131 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -58.93 -35.58 73.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.849 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.29 -31.69 54.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.041 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.23 68.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.147 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 92.6 t -54.68 -60.83 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -66.7 -14.65 62.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.55 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -77.85 -52.04 9.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.975 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.551 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 91.2 m-85 -90.37 -17.37 27.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 3.8 t70 -57.12 100.28 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 101.5 13.78 31.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.445 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 18.7 mmtp -71.7 -178.75 2.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.748 0.309 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.79 102.87 6.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . 0.437 ' HB2' ' CD1' ' A' ' 440' ' ' LEU . 5.0 t80 -102.76 113.1 26.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 59.01 27.16 15.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 96.02 -16.66 60.72 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.431 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 24.3 m -90.62 150.46 21.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.965 0.412 . . . . 0.0 110.819 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -87.61 133.74 33.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.437 ' CD1' ' HB2' ' A' ' 435' ' ' PHE . 6.0 mt -102.66 143.09 32.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.932 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.03 101.42 7.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.983 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.416 ' CG1' ' HA ' ' A' ' 427' ' ' VAL . 20.5 t -96.98 132.6 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.079 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.5 m -154.24 128.73 9.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 22.4 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.849 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.804 0.335 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -141.82 156.15 45.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . 0.457 HD11 ' CG1' ' A' ' 442' ' ' VAL . 18.8 pt -128.8 141.88 45.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.121 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -103.5 112.02 24.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.518 ' CG2' ' CZ ' ' A' ' 381' ' ' PHE . 9.1 t -97.96 138.99 21.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -145.03 120.66 10.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.64 16.51 1.83 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.503 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 97.7 mt -74.51 155.39 38.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.821 0.343 . . . . 0.0 110.861 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -75.12 -178.88 4.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.55 3.69 53.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.2 t -121.05 16.58 11.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 8.5 p -76.89 133.99 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 81.8 p -118.28 154.8 31.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.451 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 11.1 tp -50.75 -62.82 1.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -46.72 -38.15 9.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.864 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.26 -29.59 68.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.402 HD23 ' CE2' ' A' ' 381' ' ' PHE . 45.5 mt -87.08 -28.52 22.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.16 62.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.146 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -75.11 -18.48 60.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -92.63 -47.17 7.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.555 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 15.7 m-85 -66.98 -26.44 66.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -9.13 57.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -51.58 -51.75 52.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 42.4 t -61.02 -65.45 0.69 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -134.55 -126.74 2.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.508 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . 0.441 ' CG1' ' OE2' ' A' ' 418' ' ' GLU . 91.0 t -123.53 128.47 74.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.83 0.347 . . . . 0.0 111.127 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 84.5 t -83.64 123.1 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.076 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -47.55 108.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 23.8 mtp -105.41 124.18 49.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.896 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -50.9 143.94 9.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -94.72 -8.41 37.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -102.47 -45.55 5.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.967 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 20.5 p -95.82 -22.16 17.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.157 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 71.1 23.29 78.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.503 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -112.09 152.49 44.39 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.523 0.678 . . . . 0.0 110.929 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.426 ' HG2' ' CD1' ' A' ' 374' ' ' LEU . 54.9 Cg_endo -69.67 149.41 67.4 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.693 2.262 . . . . 0.0 112.352 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 11.1 mmt -82.19 40.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.794 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.451 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 93.6 mt -97.52 137.4 25.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.148 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -116.78 138.75 51.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 58.0 mt -132.41 94.99 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -62.47 127.6 32.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 409' ' ' PRO . 36.2 mt -112.06 135.48 52.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 407' ' ' GLY . 6.6 t70 -56.14 122.25 11.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -1.05 9.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -89.04 -38.46 14.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.809 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 59.0 p -123.65 -34.73 3.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.3 -3.28 37.51 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.481 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -83.61 152.69 63.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.505 0.669 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.4 Cg_endo -69.74 95.17 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.673 2.248 . . . . 0.0 112.356 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 409' ' ' PRO . 9.2 ptmt -33.33 -52.01 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.882 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 152.2 -15.61 0.77 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.519 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -87.68 154.51 20.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 110.825 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -167.68 170.51 10.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.23 142.4 37.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.107 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.536 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 39.2 t -128.23 112.88 28.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.123 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 9.6 m -87.82 114.03 24.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.556 ' CE2' ' CB ' ' A' ' 426' ' ' ALA . 38.5 m-85 -87.06 167.21 14.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.965 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . 0.441 ' OE2' ' CG1' ' A' ' 386' ' ' VAL . 4.0 mt-10 -65.5 -61.96 1.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.502 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.8 m-20 -116.43 156.28 47.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.552 0.692 . . . . 0.0 110.884 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.3 -43.01 56.27 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.773 2.316 . . . . 0.0 112.335 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.8 Cg_exo -50.7 -27.36 19.62 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.7 2.267 . . . . 0.0 112.354 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 55.4 m -87.35 -40.72 14.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.154 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.512 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -60.17 -54.66 43.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 37.5 mtpt -55.63 -35.39 65.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.29 -33.09 55.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.159 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . 0.556 ' CB ' ' CE2' ' A' ' 417' ' ' TYR . . . -70.51 -31.83 69.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.101 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 72.9 t -58.16 -64.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.151 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -65.11 -10.92 34.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.546 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.2 t-105 -80.3 -56.22 4.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.985 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.555 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 91.2 m-85 -88.09 -18.19 29.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.485 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.2 t70 -54.66 96.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.38 17.3 13.95 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.515 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.417 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 17.1 mmtm -76.87 170.7 16.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.721 0.296 . . . . 0.0 110.913 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 434' ' ' ASP . 2.8 p-10 -115.83 110.49 19.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -113.42 106.87 15.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 62.15 25.91 15.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.919 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 93.29 -5.92 75.09 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.51 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.4 m -104.87 129.39 53.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.877 0.37 . . . . 0.0 110.878 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -70.83 137.83 49.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 12.4 mt -103.66 150.89 23.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -123.81 100.04 6.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.466 ' CG1' ' HA ' ' A' ' 427' ' ' VAL . 17.8 t -95.13 128.22 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.103 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 89.7 p -146.42 125.44 12.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 19.8 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.915 0.388 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -129.65 162.67 27.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.138 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . 0.458 ' CG2' HG23 ' A' ' 427' ' ' VAL . 34.3 pt -133.34 144.55 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -102.15 115.09 29.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.497 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 13.5 t -100.31 136.34 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.142 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -143.64 120.74 11.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 128.96 20.18 1.5 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.441 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 88.0 mt -79.25 155.34 28.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 110.944 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . 0.487 ' OD1' ' NE2' ' A' ' 436' ' ' GLN . 4.2 p30 -75.07 178.07 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.844 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -91.31 13.4 17.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.857 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.1 m -130.13 13.22 5.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.69 141.93 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 72.2 p -121.59 160.42 24.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.126 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.464 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 10.6 tp -56.22 -58.1 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -50.61 -38.17 44.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.823 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -66.71 -27.77 67.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.492 HD21 ' CE2' ' A' ' 381' ' ' PHE . 51.6 mt -89.03 -32.02 17.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.12 -33.78 65.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.408 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 15.8 t0 -82.93 -20.24 35.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -92.69 -48.43 6.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 18.7 m-85 -63.75 -19.08 64.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . 0.408 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -76.27 -6.69 52.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.916 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -54.31 -56.86 14.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.6 t -56.56 -65.54 0.59 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -135.67 -126.01 2.55 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.448 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 44.5 t -125.06 132.59 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 111.111 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 60.3 t -87.25 128.62 39.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.206 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 49.6 tttt -50.31 108.32 0.22 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 396' ' ' PRO . 73.6 mmm -104.05 122.79 45.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -47.66 143.18 4.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -93.38 -18.64 22.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 37.5 ttt85 -99.01 -46.6 5.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 30.1 p -89.72 -24.96 21.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.047 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . 0.413 ' C ' ' HE2' ' A' ' 389' ' ' MET . . . 69.24 31.92 72.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.513 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -121.85 153.62 60.4 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.619 0.723 . . . . 0.0 110.899 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.415 ' N ' ' SD ' ' A' ' 389' ' ' MET . 54.6 Cg_endo -69.55 146.17 60.67 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.736 2.29 . . . . 0.0 112.432 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 9.1 mmt -82.12 40.32 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.825 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.464 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 94.3 mt -96.53 145.84 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -126.04 136.11 52.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 59.5 mt -131.04 94.79 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -61.6 127.78 33.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.898 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.44 HD21 ' N ' ' A' ' 409' ' ' PRO . 33.5 mt -112.24 135.56 52.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.953 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 407' ' ' GLY . 8.1 t0 -55.44 122.78 11.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -1.18 12.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -90.03 -36.03 15.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 37.7 p -125.21 -35.63 2.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.73 -3.66 36.42 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.487 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -83.33 152.59 64.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.679 0.752 . . . . 0.0 110.814 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.2 Cg_endo -69.74 94.99 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.726 2.284 . . . . 0.0 112.281 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -33.37 -50.56 0.32 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.955 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 150.6 -16.4 0.96 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.489 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -87.79 156.09 19.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 110.856 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.48 173.14 6.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.081 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.06 142.13 32.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.168 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.472 HG22 ' CD2' ' A' ' 381' ' ' PHE . 57.4 t -128.74 117.68 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 24.0 m -92.73 112.86 24.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.496 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 51.9 m-85 -87.17 163.29 17.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.947 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -58.01 -65.3 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.502 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.5 m-20 -114.11 155.89 44.88 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.603 0.716 . . . . 0.0 110.903 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.42 -42.84 57.36 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.677 2.251 . . . . 0.0 112.334 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 54.3 Cg_exo -49.58 -28.81 17.47 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.719 2.279 . . . . 0.0 112.373 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 48.6 m -86.94 -42.98 12.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.496 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -59.7 -48.34 82.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.188 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -61.5 -39.62 91.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.45 -32.84 62.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.094 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.29 -32.91 70.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.458 HG23 ' CG2' ' A' ' 363' ' ' ILE . 84.1 t -55.85 -60.85 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.164 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.12 -13.0 61.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.561 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.0 OUTLIER -79.49 -52.27 8.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.558 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 89.5 m-85 -88.5 -16.68 32.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.871 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.5 OUTLIER -60.4 93.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.22 16.79 7.55 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -82.37 163.91 21.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 110.862 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -110.24 108.54 18.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.931 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -109.12 108.65 19.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . 0.487 ' NE2' ' OD1' ' A' ' 369' ' ' ASN . 62.2 mt-30 61.32 26.56 16.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.972 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 94.38 -13.71 66.74 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.526 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.6 m -100.67 128.9 46.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 110.864 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -70.41 138.77 51.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.05 152.95 21.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -126.26 106.08 9.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 14.2 t -99.41 138.56 23.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 3.6 p -161.12 130.17 4.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.825 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 45.7 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.83 0.347 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -131.85 166.18 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.065 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . 0.404 ' CG2' HG23 ' A' ' 427' ' ' VAL . 27.4 pt -140.38 144.47 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -100.05 124.53 45.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.98 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.4 ' CG2' ' CZ ' ' A' ' 381' ' ' PHE . 21.8 t -108.68 143.33 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -149.73 121.11 7.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.48 19.86 1.46 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.506 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 97.4 mt -78.76 154.35 30.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.885 0.374 . . . . 0.0 110.926 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . 0.432 ' ND2' ' CD ' ' A' ' 436' ' ' GLN . 9.4 p30 -76.37 179.32 5.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.4 1.87 53.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.2 m -119.85 18.73 12.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . 0.426 ' N ' ' OD1' ' A' ' 369' ' ' ASN . 8.1 p -82.38 133.05 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.131 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 69.4 p -115.99 163.46 15.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.06 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.466 ' CD1' ' HG2' ' A' ' 396' ' ' PRO . 12.2 tp -54.64 -59.92 4.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.17 -47.38 23.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -53.15 -38.48 62.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 381' ' ' PHE . 81.5 mt -82.82 -30.04 29.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.957 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -71.99 -25.64 61.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.074 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -93.27 -19.96 20.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -91.9 -52.34 4.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 21.2 m-85 -59.83 -23.47 63.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -72.35 -10.98 60.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -49.9 -58.03 6.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 37.7 t -56.45 -69.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -130.56 -124.24 2.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 71.0 t -126.87 131.41 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.104 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 85.7 t -83.81 123.42 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.146 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -46.72 105.05 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.917 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' MET . . . . . 0.445 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 26.7 mtp -102.85 128.17 49.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -53.97 147.09 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -94.61 -16.13 23.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 15.8 ttm105 -96.43 -49.65 5.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 46.9 p -90.45 -22.11 21.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . 0.445 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 69.49 23.66 76.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.438 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -110.93 153.02 43.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.571 0.7 . . . . 0.0 110.951 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.466 ' HG2' ' CD1' ' A' ' 374' ' ' LEU . 53.7 Cg_endo -69.82 148.13 64.0 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.652 2.235 . . . . 0.0 112.3 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' MET . . . . . 0.407 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 7.6 mmt -81.74 40.68 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.42 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.3 mt -98.53 138.86 21.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.204 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -116.97 141.78 47.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 75.0 mt -134.7 95.4 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.222 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -62.69 124.94 22.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 409' ' ' PRO . 44.1 mt -110.67 135.37 51.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 407' ' ' GLY . 9.0 t70 -55.49 126.36 24.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -75.16 -1.07 21.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -93.47 -30.29 15.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 43.4 p -127.97 -36.09 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 104.3 -5.89 45.6 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.474 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 8.8 pttm -82.94 152.8 66.38 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.569 0.699 . . . . 0.0 110.845 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.47 ' N ' HD23 ' A' ' 402' ' ' LEU . 54.1 Cg_endo -69.73 95.29 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.66 2.24 . . . . 0.0 112.343 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 409' ' ' PRO . 9.4 ptmt -32.88 -51.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.866 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.15 -12.34 0.8 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.491 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -90.93 157.95 17.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.777 0.322 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.53 172.65 6.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.079 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.88 136.59 30.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.174 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.479 HG22 ' CD2' ' A' ' 381' ' ' PHE . 40.6 t -120.89 127.69 75.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.133 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' SER . . . . . 0.407 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 3.3 m -102.46 111.17 23.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.514 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 62.9 m-85 -87.4 157.68 19.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.944 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -53.46 -65.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.506 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.9 m-20 -113.31 155.81 44.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.644 0.735 . . . . 0.0 110.838 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.589 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.1 -42.96 58.0 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.689 2.259 . . . . 0.0 112.32 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.0 Cg_exo -50.34 -27.37 17.98 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.377 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 44.9 m -88.89 -34.3 17.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.514 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -64.76 -50.61 66.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.116 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . 0.436 ' HG2' ' CD1' ' A' ' 444' ' ' LEU . 23.1 mttp -61.05 -40.01 92.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -69.56 -35.27 75.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.087 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.41 -34.68 76.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.043 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.492 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 72.6 t -54.75 -61.73 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.74 -12.89 60.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.551 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.82 -54.21 6.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.543 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 84.5 m-85 -87.63 -20.12 26.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.2 t70 -54.74 99.93 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 104.42 11.72 30.6 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.539 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -74.44 176.16 7.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.757 0.313 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -122.27 112.59 18.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.926 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . 0.407 ' HB2' ' CD1' ' A' ' 440' ' ' LEU . 4.3 t80 -113.4 112.59 23.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . 0.432 ' CD ' ' ND2' ' A' ' 369' ' ' ASN . 53.6 mt-30 58.44 36.89 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 85.9 -15.76 46.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.1 t -92.69 165.8 12.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.845 0.355 . . . . 0.0 110.901 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -102.95 134.09 46.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.921 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.407 ' CD1' ' HB2' ' A' ' 435' ' ' PHE . 11.7 mt -102.05 143.97 31.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -119.75 104.57 10.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 6.2 t -99.95 140.91 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.146 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 20.0 m -162.47 125.73 2.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.808 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.436 ' CD1' ' HG2' ' A' ' 424' ' ' LYS . 17.4 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.864 0.364 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -135.02 165.07 26.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.089 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . 0.423 ' HB ' ' CG1' ' A' ' 442' ' ' VAL . 41.6 pt -135.26 145.79 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -103.89 112.94 26.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.531 HG21 ' CE1' ' A' ' 381' ' ' PHE . 20.5 t -97.04 142.34 14.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.133 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -148.16 122.78 9.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.59 17.05 1.77 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.47 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 87.5 mt -76.23 155.97 33.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.842 0.353 . . . . 0.0 110.907 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -79.37 -174.99 4.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.82 1.57 56.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.7 m -118.74 20.56 12.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 6.2 p -87.15 137.29 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.083 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 59.2 p -120.22 163.46 17.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.197 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.455 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 10.0 tp -57.35 -63.35 1.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -44.87 -30.78 1.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.838 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -74.21 -34.19 63.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.828 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 374' ' ' LEU . 61.0 mt -86.26 -23.53 26.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -75.86 -32.53 59.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.111 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.413 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 19.6 t0 -87.47 -18.01 30.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.825 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -92.07 -50.72 5.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.618 ' CD2' ' CG2' ' A' ' 415' ' ' VAL . 16.3 m-85 -62.03 -22.13 65.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.826 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . 0.413 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 12.7 ptmt -75.55 -10.62 59.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -51.14 -53.96 29.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 34.4 t -58.93 -66.0 0.57 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.24 -124.76 2.55 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.454 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.32 130.71 71.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.878 0.371 . . . . 0.0 111.103 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.56 129.27 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.188 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -54.41 108.14 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' MET . . . . . 0.443 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 67.4 mmm -103.75 122.04 44.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.436 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 17.6 t-20 -48.51 149.06 1.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.839 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -94.87 -18.86 20.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.875 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -97.77 -47.32 5.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.436 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 49.0 p -90.68 -18.95 24.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.181 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . 0.443 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 62.13 27.53 69.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.448 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -114.77 153.5 46.88 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.611 0.719 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.416 ' CA ' ' SD ' ' A' ' 389' ' ' MET . 53.5 Cg_endo -69.75 146.07 59.15 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.69 2.26 . . . . 0.0 112.282 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' MET . . . . . 0.433 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 16.6 mmt -81.17 41.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.455 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 95.7 mt -99.44 135.87 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.094 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -116.39 141.55 48.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 71.4 mt -133.65 93.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -60.69 124.41 20.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.98 136.71 48.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.94 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 407' ' ' GLY . 3.1 t70 -55.42 127.23 28.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.837 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.0 pttm -74.29 -1.03 18.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -97.18 -34.89 10.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 37.5 p -121.09 -34.97 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.154 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 99.59 -1.06 56.87 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.533 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -86.94 155.95 55.3 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.512 0.673 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.7 Cg_endo -69.82 91.36 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.697 2.265 . . . . 0.0 112.307 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.482 ' C ' ' O ' ' A' ' 409' ' ' PRO . 10.2 ptmt -31.75 -53.14 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.892 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.9 -14.78 0.51 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.501 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -88.45 156.81 18.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.868 0.366 . . . . 0.0 110.803 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.99 167.75 10.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.106 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.9 p -136.76 140.17 42.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.618 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 37.0 t -127.1 112.26 28.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.121 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' SER . . . . . 0.433 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 6.0 m -89.39 113.75 25.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.479 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 69.1 m-85 -88.8 164.97 14.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -57.27 -68.86 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.508 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 4.0 m-20 -112.68 156.97 41.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.605 0.717 . . . . 0.0 110.886 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.32 -43.06 55.79 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.704 2.269 . . . . 0.0 112.329 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.2 Cg_exo -50.25 -26.64 15.87 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.651 2.234 . . . . 0.0 112.326 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 35.2 m -90.0 -39.87 12.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.479 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -60.37 -51.31 70.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.065 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -57.52 -39.31 76.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.09 70.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.046 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.68 71.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.08 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.457 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 85.6 t -56.89 -64.15 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.58 -11.44 24.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.537 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -82.09 -55.29 4.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.551 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 89.1 m-85 -88.3 -13.88 39.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.831 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.8 t0 -58.64 96.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 112.26 -16.07 24.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.529 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -49.7 165.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.737 0.303 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -122.33 110.37 15.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -97.78 105.43 17.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 62.98 34.37 14.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 83.58 19.66 61.51 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.503 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 22.2 p -125.19 128.66 48.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.952 0.406 . . . . 0.0 110.828 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.65 133.1 45.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 8.6 mt -107.2 160.59 15.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -133.41 101.04 5.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.423 ' CG1' ' HB ' ' A' ' 363' ' ' ILE . 13.8 t -98.26 131.99 44.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.17 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.3 m -153.2 128.98 10.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 39.5 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.909 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 417' ' ' TYR . 3.3 p . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.896 0.379 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -144.25 166.98 23.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.084 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . 0.4 ' CG2' HG21 ' A' ' 427' ' ' VAL . 37.7 pt -142.49 142.73 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -100.79 114.36 28.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.981 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.431 ' CG2' ' CZ ' ' A' ' 381' ' ' PHE . 9.4 t -97.52 142.19 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.176 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -147.79 120.06 8.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.43 20.55 1.39 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.48 154.43 28.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.865 0.364 . . . . 0.0 110.85 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . 0.402 HD22 ' NE2' ' A' ' 436' ' ' GLN . 5.7 p30 -74.04 -177.95 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.24 0.42 57.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 20.1 m -118.68 16.9 13.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.837 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.48 135.18 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.131 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 75.5 p -117.26 158.82 23.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.195 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.45 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 10.7 tp -56.99 -60.03 4.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.871 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -48.13 -40.12 22.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -28.8 68.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.425 HD12 ' CD1' ' A' ' 400' ' ' ILE . 47.6 mt -86.44 -31.44 21.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.38 -33.73 67.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.101 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.421 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 9.3 t70 -81.79 -20.16 39.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -92.45 -46.55 7.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.563 ' CD2' HG22 ' A' ' 415' ' ' VAL . 17.4 m-85 -65.76 -19.11 65.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -78.65 -4.28 48.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.914 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -56.74 -54.0 51.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.5 t -59.44 -65.92 0.59 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -134.41 -125.6 2.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.48 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 50.9 t -124.21 136.61 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.946 0.403 . . . . 0.0 111.105 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.22 132.26 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.089 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -57.18 106.87 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' MET . . . . . 0.49 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 73.4 mmm -102.44 121.08 41.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.78 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -46.79 150.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.72 -23.06 17.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.931 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -96.37 -47.11 6.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 61.9 p -89.46 -16.34 31.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . 0.49 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 58.59 24.09 56.07 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.478 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -111.45 153.34 44.2 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.638 0.733 . . . . 0.0 110.883 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 146.67 60.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.667 2.245 . . . . 0.0 112.362 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' MET . . . . . 0.404 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.6 mmt -81.79 40.83 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.45 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 95.6 mt -98.8 136.22 30.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.122 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -116.3 141.09 48.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . 0.425 ' CD1' HD12 ' A' ' 377' ' ' LEU . 76.9 mt -134.67 94.13 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -60.65 124.41 20.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.412 HD21 ' N ' ' A' ' 409' ' ' PRO . 36.3 mt -109.82 135.17 51.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 407' ' ' GLY . 7.7 t0 -55.57 123.42 13.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.819 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -70.75 -2.03 13.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -89.28 -38.93 13.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 27.4 p -122.7 -34.74 3.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.177 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 104.79 -1.45 41.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.537 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -84.55 152.69 60.8 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.523 0.678 . . . . 0.0 110.915 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.467 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.2 Cg_endo -69.8 94.0 0.53 Allowed 'Trans proline' 0 N--CA 1.466 -0.132 0 C-N-CA 122.689 2.259 . . . . 0.0 112.354 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 409' ' ' PRO . 7.9 ptmt -32.94 -49.57 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 149.72 -13.58 1.02 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -90.53 155.83 18.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.84 0.353 . . . . 0.0 110.876 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.46 170.51 9.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.1 p -139.73 132.83 29.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.563 HG22 ' CD2' ' A' ' 381' ' ' PHE . 99.7 t -118.25 122.8 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' SER . . . . . 0.404 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 1.8 m -98.42 113.12 24.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.49 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 58.4 m-85 -86.74 169.85 12.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -63.44 -66.28 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.504 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.9 m-20 -114.53 156.25 44.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.708 . . . . 0.0 110.895 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.15 -43.01 57.2 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.706 2.271 . . . . 0.0 112.381 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.0 Cg_exo -50.42 -27.03 17.42 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.769 2.312 . . . . 0.0 112.348 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 90.2 m -90.4 -41.17 11.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.196 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -59.34 -49.6 77.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.077 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -59.34 -40.24 85.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.94 -33.98 71.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.037 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.5 -33.94 75.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.48 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 97.6 t -55.38 -60.88 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.97 -12.7 60.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.942 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.549 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -80.16 -55.19 5.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.918 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 91.2 m-85 -86.73 -17.68 33.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.6 OUTLIER -54.16 94.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.861 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.2 20.26 9.89 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.464 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.442 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 15.2 mmtm -78.16 170.4 16.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.877 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -114.36 112.93 23.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -120.96 105.21 10.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . 0.402 ' NE2' HD22 ' A' ' 369' ' ' ASN . 60.9 mt-30 62.25 38.08 13.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.937 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 73.97 23.38 76.41 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 71.3 m -132.38 131.05 41.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 0.0 110.868 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -72.51 136.06 45.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 8.5 mt -104.15 143.27 33.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -117.45 104.23 10.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 7.5 t -101.11 133.86 43.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.128 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 3.8 m -156.07 132.09 9.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 7.6 m . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.888 0.375 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -136.95 166.04 24.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.071 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . 0.443 ' CG2' HG21 ' A' ' 427' ' ' VAL . 12.5 pt -137.69 142.14 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.139 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -100.44 117.91 35.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.45 ' CG2' ' CZ ' ' A' ' 381' ' ' PHE . 40.4 t -101.78 144.41 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.033 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -150.31 118.06 6.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.38 23.11 1.03 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.447 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 93.9 mt -81.36 156.37 25.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.817 0.341 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' A' ' 436' ' ' GLN . 8.5 p30 -79.9 179.94 7.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.87 1.5 53.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.844 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.9 m -117.31 16.0 14.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.83 136.59 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.098 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 73.4 p -123.05 156.21 35.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.136 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.463 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 10.6 tp -52.56 -65.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -46.61 -36.94 7.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -69.15 -31.56 70.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.402 ' CD1' HD12 ' A' ' 400' ' ' ILE . 43.4 mt -84.93 -28.45 25.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.93 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.8 -40.38 63.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.421 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 23.2 t0 -73.14 -21.39 60.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -92.58 -49.42 6.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 14.8 m-85 -62.51 -22.65 66.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -74.67 -12.77 60.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.881 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -48.47 -56.11 9.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 32.6 t -55.74 -69.58 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -132.46 -123.4 2.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.439 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 55.8 t -125.5 133.52 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 111.165 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.38 131.21 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.167 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -54.95 109.28 0.5 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' MET . . . . . 0.402 ' SD ' ' CA ' ' A' ' 396' ' ' PRO . 65.0 mmm -104.29 123.16 46.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -50.51 145.51 6.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.867 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -94.85 -8.81 36.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 392' ' ' ARG . 3.8 ptp180 -102.98 -49.46 3.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.887 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 41.1 p -94.11 -14.92 25.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.179 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 62.53 30.19 75.8 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.469 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -116.52 153.28 48.91 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.6 0.714 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.461 ' HG2' ' CD1' ' A' ' 374' ' ' LEU . 53.6 Cg_endo -69.82 147.61 62.87 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 12.5 mmt -81.36 41.23 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.463 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.0 mt -97.79 135.67 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.074 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -116.09 139.99 49.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . 0.402 HD12 ' CD1' ' A' ' 377' ' ' LEU . 60.7 mt -133.34 94.29 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.187 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -59.83 129.83 43.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.458 HD21 ' N ' ' A' ' 409' ' ' PRO . 27.0 mt -114.09 137.12 52.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 407' ' ' GLY . 5.0 t70 -55.43 128.95 36.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -76.15 -1.62 27.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -97.46 -30.18 13.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.883 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 52.5 p -124.38 -36.17 2.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 97.62 7.84 56.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.452 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.8 156.66 37.06 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.584 0.707 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.484 ' O ' ' C ' ' A' ' 410' ' ' LYS . 54.0 Cg_endo -69.68 89.08 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.644 2.229 . . . . 0.0 112.382 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 409' ' ' PRO . 6.7 ptmt -31.22 -55.45 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 157.67 -15.93 0.31 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.484 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -88.76 158.0 18.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.349 . . . . 0.0 110.842 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -170.55 173.57 5.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.139 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.4 p -141.91 137.63 31.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.157 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.555 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 45.9 t -123.55 111.63 30.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.127 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 3.6 m -87.67 113.9 23.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.523 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 55.5 m-85 -87.72 166.91 14.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.859 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -61.33 -66.24 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.3 m-20 -110.73 156.63 40.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.636 0.731 . . . . 0.0 110.831 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.04 -42.91 58.88 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.674 2.249 . . . . 0.0 112.38 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.0 Cg_exo -50.86 -46.0 32.87 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.713 2.276 . . . . 0.0 112.394 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 86.2 m -68.36 -39.22 81.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.166 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.523 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -61.82 -48.13 81.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.116 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -61.33 -39.38 90.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.59 -34.93 72.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.152 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -67.7 -34.16 76.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.053 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 94.3 t -54.93 -62.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -66.48 -10.83 48.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.548 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.2 t-105 -82.01 -55.63 4.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.918 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 90.7 m-85 -86.14 -21.43 27.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.5 t70 -52.62 97.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 103.42 21.37 9.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.494 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.411 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 19.5 mmtt -81.46 176.02 10.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.853 0.358 . . . . 0.0 110.845 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 1.6 p-10 -119.9 114.91 22.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -121.69 104.08 9.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . 0.417 ' HB2' ' ND2' ' A' ' 369' ' ' ASN . 41.9 mt-30 62.69 40.61 9.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.829 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 71.79 25.56 74.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.5 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 67.8 m -134.79 127.69 31.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.902 0.382 . . . . 0.0 110.891 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -68.95 136.77 53.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.9 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 12.4 mt -106.37 140.05 39.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -116.06 106.26 13.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.6 135.77 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.093 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 12.6 p -156.13 127.41 7.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 25.0 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.978 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.83 0.348 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -115.29 163.1 16.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.066 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . 0.453 ' CG2' HG23 ' A' ' 427' ' ' VAL . 37.7 pt -137.06 141.99 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -100.93 114.67 28.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.935 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.512 HG22 ' CZ ' ' A' ' 381' ' ' PHE . 5.1 t -101.2 141.9 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.105 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -147.4 123.67 10.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 128.66 14.26 2.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.521 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.09 152.61 41.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 372' ' ' VAL . 6.1 p30 -72.94 -176.41 2.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.95 -0.15 57.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.827 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.0 t -117.02 17.8 14.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . 0.4 ' N ' ' OD1' ' A' ' 369' ' ' ASN . 9.0 p -79.04 139.71 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.089 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 72.7 p -122.81 160.21 26.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.462 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 9.1 tp -56.55 -60.33 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -48.0 -37.1 13.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -30.12 68.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.495 HD22 ' CE2' ' A' ' 381' ' ' PHE . 63.2 mt -85.39 -31.34 22.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.95 -35.14 66.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.421 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 23.3 t0 -80.63 -20.56 42.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.828 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -92.65 -51.61 5.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 16.3 m-85 -61.11 -21.48 63.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 8.4 ptpt -75.79 -13.34 60.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -47.21 -54.53 10.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 21.6 t -57.34 -70.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -131.84 -124.22 2.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.508 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 96.3 t -124.55 136.67 59.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.392 . . . . 0.0 111.08 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 96.3 t -92.17 129.26 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.143 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -51.05 107.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 62.7 mmm -103.89 124.64 49.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.791 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.405 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 11.4 t-20 -47.44 145.48 2.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -94.69 -18.32 21.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 19.2 tpp85 -99.74 -45.26 5.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.863 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.405 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 23.6 p -91.85 -24.28 19.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.216 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 68.55 29.0 72.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.537 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.76 153.07 47.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.536 0.684 . . . . 0.0 110.961 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 144.95 55.28 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.625 2.216 . . . . 0.0 112.326 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' MET . . . . . 0.433 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 12.5 mmt -81.37 41.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.462 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.5 mt -97.81 142.79 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.151 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -122.22 139.62 53.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 64.3 mt -133.31 94.6 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.191 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -61.23 122.32 14.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 33.3 mt -107.12 135.06 49.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 407' ' ' GLY . 9.9 t0 -55.51 121.54 9.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -1.16 8.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -89.08 -37.64 14.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 43.1 p -125.19 -35.67 2.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.109 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.36 1.7 38.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.467 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -87.12 152.58 53.27 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.561 0.696 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.472 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.6 Cg_endo -69.72 93.06 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.701 2.267 . . . . 0.0 112.317 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 409' ' ' PRO . 6.5 ptmt -32.76 -52.93 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.884 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 153.95 -16.08 0.61 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.494 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -87.68 155.49 19.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.848 0.356 . . . . 0.0 110.84 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.46 168.59 11.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.9 p -136.7 139.85 42.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.54 HG23 ' CD2' ' A' ' 381' ' ' PHE . 31.9 t -124.81 116.62 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' SER . . . . . 0.433 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 22.9 m -92.06 110.76 22.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.869 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 51.9 m-85 -86.79 161.89 18.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -57.94 -63.54 1.22 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.502 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 1.2 m-20 -118.59 157.13 50.51 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.576 0.703 . . . . 0.0 110.84 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.51 -43.0 55.12 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.648 2.232 . . . . 0.0 112.383 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 56.9 Cg_exo -49.48 -26.43 12.23 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.641 2.227 . . . . 0.0 112.397 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 98.8 m -91.33 -41.13 11.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.504 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -59.04 -51.0 71.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -58.63 -39.05 79.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -72.62 -32.18 65.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.104 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.87 72.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.073 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.482 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 94.6 t -54.39 -61.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.187 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -66.25 -13.03 59.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.533 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -80.46 -50.84 9.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 82.3 m-85 -92.88 -13.09 29.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.0 OUTLIER -59.51 92.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.97 -13.64 19.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.421 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 9.8 mmtm -45.68 166.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.749 0.309 . . . . 0.0 110.916 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 4.4 p-10 -115.1 112.24 22.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -111.76 108.6 18.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 61.64 31.06 18.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 91.49 -15.96 60.16 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.563 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.2 t -91.11 159.05 16.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.382 . . . . 0.0 110.898 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -96.23 134.52 39.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 8.6 mt -100.01 140.05 34.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -117.36 100.13 7.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 12.5 t -97.67 133.08 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 6.1 p -156.49 128.43 7.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.825 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.973 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.829 0.347 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -139.05 166.98 23.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.069 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 33.7 pt -137.71 143.78 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -102.32 114.31 28.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.527 HG23 ' CZ ' ' A' ' 381' ' ' PHE . 15.6 t -97.72 141.31 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.177 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -147.89 121.05 8.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.49 20.72 1.36 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.438 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 65.8 mt -81.28 153.4 27.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.766 0.317 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -75.71 -177.21 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.25 7.59 40.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.8 t -123.2 14.11 9.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 10.8 p -75.57 132.9 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 58.6 p -114.53 159.68 20.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.203 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.464 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 13.1 tp -58.95 -61.29 2.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -48.74 -32.74 9.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.97 -31.09 65.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.418 ' HB3' ' CE2' ' A' ' 381' ' ' PHE . 38.6 mt -86.21 -30.03 22.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.87 -33.26 65.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.67 -20.97 35.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.428 ' CE2' ' CD1' ' A' ' 430' ' ' PHE . 63.6 t80 -92.32 -49.5 6.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.56 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 16.1 m-85 -59.9 -26.38 65.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -75.89 -4.39 40.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -55.43 -48.88 73.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 39.3 t -63.71 -57.87 8.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -142.22 -123.19 1.83 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.488 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 71.9 t -124.84 135.98 62.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 85.9 t -92.04 128.35 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -53.18 108.96 0.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 40.1 mmm -105.87 127.53 53.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.431 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 14.4 t-20 -50.23 146.17 5.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -94.86 -13.39 25.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -100.47 -48.27 4.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.431 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 30.4 p -92.49 -19.62 21.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . 0.473 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 66.12 26.65 72.49 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.472 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -112.59 153.28 45.03 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.654 0.74 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.407 ' CA ' ' SD ' ' A' ' 389' ' ' MET . 53.9 Cg_endo -69.67 146.61 61.32 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.722 2.281 . . . . 0.0 112.379 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' MET . . . . . 0.425 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.2 mmt -81.49 40.69 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.464 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 97.1 mt -98.05 138.76 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -118.3 137.16 53.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 73.6 mt -130.8 95.54 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.157 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -63.16 126.15 26.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.438 HD21 ' N ' ' A' ' 409' ' ' PRO . 35.8 mt -110.96 135.49 51.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.913 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.7 t0 -56.58 121.46 9.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.422 ' C ' ' HD3' ' A' ' 404' ' ' LYS . 0.0 OUTLIER -70.12 -1.05 8.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -89.04 -37.27 15.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.0 p -124.18 -36.01 2.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.098 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 107.56 -2.87 34.39 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.45 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -85.15 152.82 59.09 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.6 Cg_endo -69.76 95.79 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.707 2.271 . . . . 0.0 112.292 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 409' ' ' PRO . 6.4 ptmt -33.39 -52.37 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.99 -12.8 0.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.51 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -91.39 152.03 20.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -165.26 170.6 14.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.4 p -139.1 142.12 38.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.555 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 48.1 t -128.99 116.28 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' SER . . . . . 0.425 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 14.5 m -90.76 115.54 27.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.541 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 56.6 m-85 -88.36 163.98 15.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -62.17 -63.61 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.5 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 1.6 m-20 -116.01 156.29 46.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.634 0.731 . . . . 0.0 110.87 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.26 -43.02 56.44 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.745 2.297 . . . . 0.0 112.36 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 56.7 Cg_exo -49.31 -26.71 11.99 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.658 2.238 . . . . 0.0 112.373 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 93.4 m -91.89 -41.46 10.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.541 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -59.28 -47.36 85.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.126 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -63.26 -37.41 87.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.86 -32.33 61.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.041 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . 0.424 ' CB ' ' CZ ' ' A' ' 417' ' ' TYR . . . -69.36 -33.85 73.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.027 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 85.2 t -56.15 -64.42 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.127 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.59 -13.67 44.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.53 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -79.21 -54.39 6.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.56 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 79.8 m-85 -90.61 -11.67 39.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 3.0 t70 -61.4 98.38 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 106.38 -7.93 40.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.511 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.431 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 30.8 mmtt -53.82 165.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 110.876 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -112.67 116.18 29.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -113.82 109.71 18.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 61.13 28.77 18.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 94.1 -14.83 64.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.512 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 19.7 m -91.81 160.59 15.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 0.0 110.834 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -97.39 134.46 40.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.937 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 9.6 mt -102.84 144.9 30.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -122.77 99.51 6.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 16.9 t -96.2 131.37 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 5.4 m -151.8 129.43 11.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 21.5 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.938 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 6.8 m . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.871 0.367 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -141.52 165.65 26.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.146 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . 0.463 ' HB ' ' CG1' ' A' ' 442' ' ' VAL . 17.1 pt -137.66 139.29 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.081 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -99.45 113.49 25.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.512 ' CG2' ' CZ ' ' A' ' 381' ' ' PHE . 23.2 t -96.93 143.31 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.132 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -149.95 120.57 7.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.82 20.76 1.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.498 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 44.2 mt -83.58 156.01 22.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 110.88 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . 0.543 HD22 ' NE2' ' A' ' 436' ' ' GLN . 18.4 p30 -78.62 -176.3 4.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.58 10.06 29.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.5 t -122.91 10.04 9.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.79 128.95 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 74.8 p -111.35 162.86 14.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.122 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.458 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 13.8 tp -58.74 -63.77 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -46.69 -38.24 9.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.869 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -67.09 -29.99 69.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.465 HD13 ' CD1' ' A' ' 400' ' ' ILE . 47.6 mt -87.33 -29.81 21.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.934 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.92 -41.04 64.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.411 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 30.7 t0 -76.17 -19.39 58.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -92.61 -45.58 8.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.943 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.595 ' CD2' ' CG2' ' A' ' 415' ' ' VAL . 15.0 m-85 -67.46 -19.36 65.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.838 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . 0.411 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 5.7 ptmm? -77.14 -6.04 51.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -53.24 -53.08 55.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 13.2 t -59.2 -68.18 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.07 -122.39 2.31 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.483 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 71.7 t -126.98 135.22 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.882 0.372 . . . . 0.0 111.16 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.48 130.93 36.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.158 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -55.09 104.51 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' MET . . . . . 0.499 ' SD ' ' N ' ' A' ' 396' ' ' PRO . 59.4 mmm -101.5 118.71 37.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -46.82 150.38 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -95.09 -23.6 17.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.64 -46.51 7.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.821 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 41.4 p -90.93 -14.1 32.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.16 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . 0.45 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 55.32 30.41 55.12 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.529 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -118.67 153.18 52.14 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.556 0.693 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.499 ' N ' ' SD ' ' A' ' 389' ' ' MET . 54.1 Cg_endo -69.8 147.95 63.76 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.682 2.255 . . . . 0.0 112.345 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' MET . . . . . 0.443 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 19.7 mmt -81.84 40.58 0.61 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.829 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.458 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.2 mt -96.71 143.66 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.144 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -123.66 138.11 54.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . 0.465 ' CD1' HD13 ' A' ' 377' ' ' LEU . 60.3 mt -131.73 96.23 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.136 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -63.75 124.46 21.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.461 HD22 ' N ' ' A' ' 409' ' ' PRO . 24.7 mt -109.84 136.16 49.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.935 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.5 t70 -56.72 134.67 55.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.806 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -5.82 55.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -97.31 -26.37 14.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.43 ' OG1' ' CG ' ' A' ' 408' ' ' LYS . 65.2 p -123.1 -36.16 2.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.074 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 95.17 -6.61 68.99 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.461 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . 0.43 ' CG ' ' OG1' ' A' ' 406' ' ' THR . 3.7 ptpt -86.97 159.42 51.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.592 0.711 . . . . 0.0 110.858 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.473 ' O ' ' C ' ' A' ' 410' ' ' LYS . 54.0 Cg_endo -69.76 92.57 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.61 2.207 . . . . 0.0 112.404 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -32.39 -51.98 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 153.77 -13.96 0.59 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -90.43 157.08 17.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.903 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -170.17 169.63 7.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.056 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.6 p -140.05 139.15 35.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.138 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.595 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 60.5 t -125.66 120.85 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' SER . . . . . 0.443 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 4.8 m -95.46 116.42 28.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.827 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.441 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 60.4 m-85 -89.29 163.6 15.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.898 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -58.49 -66.35 0.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.831 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.505 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.5 m-20 -112.31 156.44 42.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.663 0.744 . . . . 0.0 110.793 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.37 -42.99 56.12 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.7 2.267 . . . . 0.0 112.349 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.3 Cg_exo -50.21 -32.63 33.17 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.638 2.225 . . . . 0.0 112.345 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 89.1 m -81.75 -38.57 25.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.441 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -62.33 -50.64 70.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.181 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -58.94 -35.61 73.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.64 -32.05 57.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.25 -33.38 71.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.069 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 97.2 t -55.91 -63.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.13 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -65.73 -9.74 30.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.534 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.2 t-105 -83.77 -55.09 4.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.555 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 93.2 m-85 -87.29 -18.52 30.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.856 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.8 t70 -55.81 98.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 103.92 12.22 30.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.518 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.431 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 16.2 mmtm -71.05 175.03 5.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.766 0.317 . . . . 0.0 110.894 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -121.72 127.94 51.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -123.92 100.74 6.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . 0.543 ' NE2' HD22 ' A' ' 369' ' ' ASN . 56.9 mt-30 62.17 36.85 14.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 93.3 -21.36 40.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.47 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 24.4 p -85.53 166.84 15.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.96 0.41 . . . . 0.0 110.842 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -112.43 137.02 51.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.4 mt -108.71 151.19 26.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -125.31 106.78 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.463 ' CG1' ' HB ' ' A' ' 363' ' ' ILE . 15.0 t -96.74 138.95 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 47.7 m -157.51 126.1 5.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.909 179.984 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.913 0.387 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -126.52 158.96 34.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.112 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . 0.443 ' CG2' HG23 ' A' ' 427' ' ' VAL . 38.2 pt -130.76 143.3 41.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.154 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -102.57 110.9 22.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.521 HG23 ' CZ ' ' A' ' 381' ' ' PHE . 12.0 t -95.13 142.23 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.149 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -146.66 121.09 9.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.88 14.49 2.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.519 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.47 154.85 39.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -77.11 178.79 6.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.99 6.25 40.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.9 t -121.91 13.57 10.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.858 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.7 p -74.31 138.02 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.156 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 35.4 p -122.45 158.7 29.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.447 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 17.6 tp -54.81 -60.4 3.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -50.9 -29.74 12.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -75.8 -34.24 60.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 53.0 mt -82.63 -27.96 31.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -74.26 -37.87 63.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.074 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.42 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 13.5 t70 -76.08 -21.58 56.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.848 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -92.53 -49.32 6.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.935 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.577 ' CD2' ' CG2' ' A' ' 415' ' ' VAL . 16.6 m-85 -63.82 -11.6 28.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . 0.42 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 13.5 ptmt -88.63 -5.13 58.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -54.54 -54.04 46.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.51 -67.36 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -130.71 -127.43 2.89 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.514 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 78.3 t -125.86 130.78 72.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 111.195 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 56.0 t -82.0 128.58 38.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -50.03 105.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 82.7 mmm -100.57 124.08 45.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.404 ' CB ' ' OG1' ' A' ' 393' ' ' THR . 8.0 t-20 -50.38 144.78 7.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -94.46 -18.83 21.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -99.93 -44.1 6.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.404 ' OG1' ' CB ' ' A' ' 390' ' ' ASN . 25.6 p -92.18 -22.14 19.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.185 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 65.89 29.95 76.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -120.03 153.11 55.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.86 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.83 145.72 57.6 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.721 2.281 . . . . 0.0 112.298 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' MET . . . . . 0.4 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 11.8 mmt -81.33 41.21 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.447 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 98.6 mt -98.76 140.86 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -121.05 140.25 52.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 61.3 mt -132.64 99.86 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -68.12 131.61 45.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 409' ' ' PRO . 26.0 mt -115.51 138.28 51.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.921 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 407' ' ' GLY . 6.0 t0 -59.53 124.52 20.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -71.34 -1.17 12.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -89.5 -39.66 13.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 82.8 p -121.72 -33.42 3.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 103.9 -4.49 45.84 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.523 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -82.54 152.86 67.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.6 0.714 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.468 ' N ' HD23 ' A' ' 402' ' ' LEU . 54.1 Cg_endo -69.76 95.64 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.689 2.26 . . . . 0.0 112.336 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 409' ' ' PRO . 8.7 ptmt -32.76 -54.62 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.51 -13.87 0.52 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.2 p-10 -87.73 157.21 19.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.743 0.306 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.38 169.4 9.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.052 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 2.3 p -137.84 139.69 40.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.192 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.577 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 48.6 t -127.15 114.78 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' SER . . . . . 0.4 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 2.8 m -91.11 112.17 23.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.841 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.515 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 68.8 m-85 -86.84 160.93 18.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.88 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -55.18 -67.44 0.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.83 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.506 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.4 m-20 -107.41 156.21 38.15 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.517 0.675 . . . . 0.0 110.942 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.34 -42.94 56.76 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.712 2.275 . . . . 0.0 112.324 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 53.0 Cg_exo -50.03 -46.82 26.35 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.733 2.289 . . . . 0.0 112.253 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 28.6 m -64.45 -43.77 93.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.17 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.515 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -58.85 -45.8 89.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.093 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -64.49 -35.33 80.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.03 -33.53 57.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.078 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -69.38 -33.87 73.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.075 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.474 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 77.1 t -54.71 -61.43 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.55 -15.03 63.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.535 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -78.14 -52.39 8.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.903 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.555 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 89.1 m-85 -88.92 -16.68 31.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.869 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.0 t70 -59.9 97.04 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 111.57 1.26 27.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.547 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 19.5 mmtm -67.36 168.34 10.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.803 0.335 . . . . 0.0 110.956 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 434' ' ' ASP . 1.4 p-10 -115.78 111.55 20.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -111.27 106.55 15.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 61.42 37.73 16.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 74.6 23.61 74.79 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.415 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 36.5 m -132.35 128.78 38.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.919 0.39 . . . . 0.0 110.832 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.17 133.75 48.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.925 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 17.1 mt -101.05 156.81 17.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.96 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -129.74 100.58 5.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.886 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 14.2 t -100.58 131.89 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.171 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 444' ' ' LEU . 13.3 m -157.37 124.27 5.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 443' ' ' SER . 34.9 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.858 0.361 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -142.85 161.65 37.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.091 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . 0.413 ' CG2' HG23 ' A' ' 427' ' ' VAL . 38.9 pt -135.52 141.14 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.113 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -100.03 122.04 42.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 8.1 t -107.5 141.75 21.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.076 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -145.62 123.59 12.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 126.54 16.33 2.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.458 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 93.9 mt -73.84 152.89 40.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 372' ' ' VAL . 6.1 p30 -73.96 -176.53 2.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.96 3.6 54.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.8 m -120.79 17.7 11.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . 0.423 ' N ' ' OD1' ' A' ' 369' ' ' ASN . 11.5 p -79.31 143.23 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.181 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 82.2 p -126.82 155.51 42.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.183 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.466 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 16.5 tp -49.64 -62.05 1.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -48.74 -37.85 20.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.83 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -66.53 -27.43 67.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 89.6 mt -91.09 -30.06 16.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.66 -37.53 67.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.089 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.418 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 27.7 t70 -78.39 -19.63 52.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.895 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -92.61 -51.9 4.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 19.1 m-85 -60.34 -24.87 65.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . 0.418 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 8.8 ptmt -70.87 -10.48 59.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.934 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -51.71 -57.4 9.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.3 t -53.93 -66.82 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -136.59 -122.67 2.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 75.4 t -126.01 130.66 72.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.92 0.39 . . . . 0.0 111.115 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.61 131.15 34.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -54.54 107.76 0.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' MET . . . . . 0.467 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 64.0 mmm -104.35 122.76 46.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.449 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 14.4 t-20 -48.8 148.98 1.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -94.91 -22.38 18.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.85 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -93.98 -48.39 6.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.842 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.449 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 41.1 p -88.42 -24.07 23.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.098 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . 0.467 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 68.0 25.88 74.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.433 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -114.94 153.22 47.05 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.571 0.7 . . . . 0.0 110.965 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.433 ' CA ' ' SD ' ' A' ' 389' ' ' MET . 53.4 Cg_endo -69.78 147.03 61.86 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.7 2.267 . . . . 0.0 112.339 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' MET . . . . . 0.45 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 15.0 mmt -81.27 41.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.466 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.2 mt -98.04 136.52 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.182 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -117.47 142.19 47.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 61.4 mt -134.81 94.08 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -61.17 121.84 13.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.465 HD21 ' N ' ' A' ' 409' ' ' PRO . 31.3 mt -108.88 135.37 50.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.931 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 407' ' ' GLY . 11.7 t0 -55.33 122.36 10.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -69.89 -0.9 8.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.772 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -91.35 -41.21 11.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.6 p -118.78 -34.39 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 101.7 5.06 51.71 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.46 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -91.09 153.15 44.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.552 0.692 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.484 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.4 Cg_endo -69.76 91.89 0.51 Allowed 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.652 2.235 . . . . 0.0 112.372 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 409' ' ' PRO . 9.2 ptmt -31.67 -52.41 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.33 -17.13 0.59 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -87.63 157.22 19.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.856 0.36 . . . . 0.0 110.872 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.4 174.17 6.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 2.2 p -143.61 141.32 30.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.113 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.534 HG21 ' CD2' ' A' ' 381' ' ' PHE . 95.8 t -129.41 115.23 34.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' SER . . . . . 0.45 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 1.9 m -90.67 114.76 27.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.494 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 51.8 m-85 -87.94 161.1 17.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -54.34 -66.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.835 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.507 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 7.1 m-20 -116.34 158.35 43.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.632 0.729 . . . . 0.0 110.878 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.8 Cg_exo -57.44 -43.23 53.44 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.71 2.273 . . . . 0.0 112.332 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 53.1 Cg_exo -49.99 -27.44 16.48 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.65 2.234 . . . . 0.0 112.374 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 40.4 m -89.61 -41.78 11.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.117 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.494 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -59.84 -48.89 79.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -59.7 -38.96 83.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.82 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -72.84 -32.99 65.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -69.09 -35.07 76.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 94.7 t -55.27 -62.52 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -66.9 -11.11 55.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.551 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -81.02 -55.39 4.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.925 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 91.0 m-85 -87.34 -19.65 27.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.859 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.1 t70 -51.65 96.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.854 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 103.93 20.8 10.19 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.485 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.441 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 16.1 mmtm -76.81 170.99 15.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.769 0.319 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . 0.426 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 1.7 p30 -115.04 109.29 17.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.841 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -112.79 108.07 16.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 62.08 33.72 16.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 89.2 -16.38 55.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.448 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 3.1 m -92.66 164.04 13.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.964 0.411 . . . . 0.0 110.836 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -101.62 138.38 38.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 12.4 mt -106.89 144.86 32.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -118.94 107.93 14.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.408 ' CG1' HD11 ' A' ' 363' ' ' ILE . 9.1 t -100.85 131.99 47.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.12 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 10.3 p -152.12 128.81 10.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.885 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.972 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.896 0.379 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -108.86 158.71 17.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . 0.461 ' CG1' ' HB ' ' A' ' 415' ' ' VAL . 28.9 pt -125.84 142.33 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -103.09 116.32 32.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.418 ' CG2' ' CZ ' ' A' ' 381' ' ' PHE . 9.3 t -101.73 144.21 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.123 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -149.06 120.13 7.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.01 20.25 1.33 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.454 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 90.9 mt -79.94 154.53 28.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.808 0.337 . . . . 0.0 110.965 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -77.61 -178.53 5.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.69 3.5 52.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.0 t -118.83 15.72 13.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.859 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.13 136.15 25.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 34.0 p -121.48 157.16 31.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.14 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.47 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 21.8 tp -53.75 -65.99 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -45.47 -32.75 2.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.21 -32.34 64.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 374' ' ' LEU . 27.8 mt -82.59 -31.11 29.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.918 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -71.03 -44.93 64.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.107 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -72.57 -18.63 61.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -92.62 -41.6 10.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 16.3 m-85 -73.6 -25.01 60.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -67.06 -6.84 18.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.982 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -56.04 -60.19 3.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 35.2 t -49.46 -64.45 0.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.907 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -143.98 -122.55 1.64 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.451 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 69.0 t -121.79 122.04 65.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 0.0 111.131 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 81.8 t -77.53 127.75 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.226 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.462 ' CD ' ' HA ' ' A' ' 418' ' ' GLU . 33.2 tptt -46.09 103.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 73.0 mmm -103.32 126.33 50.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -51.43 145.7 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.92 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -94.59 -20.81 19.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -97.38 -45.47 6.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 25.0 p -90.72 -25.26 20.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 68.98 29.47 72.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -117.9 153.76 51.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.644 0.735 . . . . 0.0 110.927 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 144.11 53.17 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.68 2.253 . . . . 0.0 112.379 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' MET . . . . . 0.414 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 15.2 mmt -82.1 40.26 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.47 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.4 mt -96.06 141.42 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.158 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -122.03 139.48 53.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 61.2 mt -132.08 94.48 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.126 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -61.29 130.11 44.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 409' ' ' PRO . 35.8 mt -114.36 136.82 52.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.861 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 407' ' ' GLY . 6.4 t0 -56.83 126.52 27.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.812 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.57 -1.15 17.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -92.02 -36.74 13.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 31.2 p -123.57 -33.6 3.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 101.64 -1.52 52.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.524 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -84.27 152.93 62.15 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.612 0.72 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.48 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.2 Cg_endo -69.76 92.42 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.306 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.48 ' C ' ' O ' ' A' ' 409' ' ' PRO . 8.1 ptmt -31.82 -51.99 0.23 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.86 -15.6 0.8 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.531 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -88.23 151.64 22.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -164.29 172.04 14.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.1 p -140.21 141.3 35.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.12 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.461 ' HB ' ' CG1' ' A' ' 363' ' ' ILE . 58.0 t -128.29 113.63 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.076 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' SER . . . . . 0.414 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 2.1 m -87.48 119.25 27.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.559 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 37.2 m-85 -91.55 159.02 16.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.959 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . 0.462 ' HA ' ' CD ' ' A' ' 388' ' ' LYS . 15.9 mm-40 -58.2 -60.88 3.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.512 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.2 m-20 -113.69 156.9 42.96 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.568 0.699 . . . . 0.0 110.899 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.4 Cg_exo -57.01 -42.89 59.36 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.626 2.217 . . . . 0.0 112.323 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.5 Cg_exo -52.46 -41.99 64.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.727 2.285 . . . . 0.0 112.351 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 39.3 m -67.36 -40.82 85.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.167 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.559 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -62.18 -49.8 74.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.06 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -60.15 -36.14 76.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.55 -33.05 58.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.115 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 417' ' ' TYR . . . -72.43 -33.24 66.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.476 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 86.1 t -57.33 -62.06 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.179 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -68.12 -11.35 58.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.549 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.62 -54.81 5.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 91.7 m-85 -87.76 -19.6 27.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.4 t0 -54.15 89.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 116.46 13.99 7.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.533 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.459 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 2.4 mmmp? -79.44 176.2 9.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 0.0 110.903 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -121.36 126.9 50.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -126.24 105.53 8.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 62.58 31.01 17.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.889 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 83.94 18.38 63.38 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.527 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 19.4 m -128.6 126.67 40.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.969 0.414 . . . . 0.0 110.862 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.9 138.07 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 10.0 mt -108.89 147.49 32.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -119.37 108.5 14.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.433 ' CG1' ' HA ' ' A' ' 427' ' ' VAL . 13.0 t -100.85 132.2 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 9.5 p -151.7 127.54 10.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.806 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 16.4 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.891 179.96 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 417' ' ' TYR . 8.5 p . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.866 0.365 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -146.99 169.24 19.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.068 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . 0.429 ' CG2' HG23 ' A' ' 427' ' ' VAL . 37.0 pt -144.96 142.68 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -101.1 113.11 25.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.488 HG22 ' CZ ' ' A' ' 381' ' ' PHE . 19.3 t -96.19 144.22 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.123 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -150.23 119.55 6.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.4 23.38 1.01 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.574 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 71.6 mt -83.72 152.71 24.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 0.0 110.887 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . 0.505 ' ND2' ' CD ' ' A' ' 436' ' ' GLN . 5.0 p30 -74.61 179.34 4.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.41 1.08 52.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 14.3 m -117.29 13.65 14.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.845 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.37 133.59 31.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.129 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 81.6 p -117.56 163.98 15.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.149 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.458 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 16.3 tp -58.9 -62.77 1.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.08 -38.37 7.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.92 -31.8 73.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 84.5 mt -86.97 -30.32 21.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.959 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.17 -33.76 65.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.081 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.405 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 8.4 t70 -84.6 -19.4 33.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.493 ' CE1' ' NE2' ' A' ' 383' ' ' GLN . 47.0 t80 -91.92 -50.89 5.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.56 ' CD2' HG23 ' A' ' 415' ' ' VAL . 20.0 m-85 -61.72 -23.6 66.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.876 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . 0.405 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 30.3 pttt -72.65 -6.95 47.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.865 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . 0.493 ' NE2' ' CE1' ' A' ' 380' ' ' PHE . 12.5 mt-30 -55.11 -51.91 64.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 7.3 t -62.79 -64.75 0.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -134.82 -129.87 2.93 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.49 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 50.3 t -122.07 129.11 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.808 0.337 . . . . 0.0 111.178 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.85 128.43 38.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -52.42 105.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.845 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 73.9 mmm -101.22 123.75 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.409 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 11.5 t-20 -50.1 147.27 4.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.844 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -94.71 -18.28 21.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -99.71 -44.22 6.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.409 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 67.0 p -93.53 -17.12 23.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 60.69 26.67 65.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.514 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -115.37 153.04 47.53 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.581 0.705 . . . . 0.0 110.942 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 146.66 61.21 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.696 2.264 . . . . 0.0 112.362 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 6.8 mmt -81.37 41.15 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.926 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.458 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 90.6 mt -98.96 135.02 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.137 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -114.77 138.08 51.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 60.7 mt -130.79 94.2 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.163 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -61.78 123.82 19.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 409' ' ' PRO . 45.3 mt -110.19 135.93 50.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 407' ' ' GLY . 11.1 t70 -55.42 124.37 16.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.932 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -73.09 -1.05 15.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -95.08 -35.12 12.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 37.2 p -121.24 -36.13 3.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.079 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 103.21 -6.99 51.21 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.551 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -82.55 153.04 67.87 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.592 0.71 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.473 ' N ' HD23 ' A' ' 402' ' ' LEU . 53.8 Cg_endo -69.69 94.51 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.7 2.267 . . . . 0.0 112.372 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -32.58 -50.15 0.24 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.817 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 150.14 -15.3 1.01 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.468 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -88.15 154.99 20.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.777 0.322 . . . . 0.0 110.927 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.05 170.93 10.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.121 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 2.5 p -137.91 142.04 40.62 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.167 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.56 HG23 ' CD2' ' A' ' 381' ' ' PHE . 47.3 t -127.81 115.25 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 1.9 m -92.65 114.97 27.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.498 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 54.2 m-85 -89.05 163.39 15.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.974 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -56.24 -65.49 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.505 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 4.7 m-20 -115.78 156.56 46.24 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.731 . . . . 0.0 110.842 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.2 Cg_exo -57.37 -42.89 57.11 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.636 2.224 . . . . 0.0 112.366 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.0 Cg_exo -50.69 -26.98 18.49 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.625 2.217 . . . . 0.0 112.361 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 52.9 m -89.05 -43.17 11.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.498 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -58.87 -48.13 82.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -59.86 -38.47 82.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.888 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.0 -32.83 63.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.079 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.73 -31.95 68.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.464 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 90.5 t -56.32 -60.69 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.082 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -67.06 -12.45 59.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.554 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.53 -54.6 5.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.551 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 88.9 m-85 -88.26 -14.56 38.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.88 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.7 OUTLIER -58.49 93.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 108.1 14.72 16.06 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.466 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.402 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 15.7 mmtm -73.92 169.67 16.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.76 0.315 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -112.28 112.92 24.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -115.47 106.48 14.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . 0.505 ' CD ' ' ND2' ' A' ' 369' ' ' ASN . 69.1 mt-30 61.59 38.56 15.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.968 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 84.49 -14.53 45.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.5 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 6.1 m -94.25 168.92 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.815 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -106.62 135.95 47.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 9.4 mt -102.69 145.05 30.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -119.78 107.39 13.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.832 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.412 ' CG1' ' HB ' ' A' ' 363' ' ' ILE . 6.3 t -103.08 136.26 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.1 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 444' ' ' LEU . 22.0 m -157.3 126.38 5.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 443' ' ' SER . 19.4 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.866 0.365 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -145.68 156.73 43.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.105 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . 0.453 ' HB ' ' CG1' ' A' ' 442' ' ' VAL . 44.8 pt -128.67 140.12 50.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -98.75 111.36 23.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.461 HG23 ' CZ ' ' A' ' 381' ' ' PHE . 13.0 t -95.19 140.09 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.148 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -147.39 122.4 10.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 131.81 6.07 3.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.517 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 19.8 mt -71.99 156.42 39.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.871 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . 0.519 ' H ' ' ND2' ' A' ' 369' ' ' ASN . 0.3 OUTLIER -83.88 175.37 9.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -83.61 7.45 17.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.5 t -116.92 3.51 12.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 5.0 p -75.05 134.61 29.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.083 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 41.1 p -113.59 170.69 8.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.155 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.467 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 12.0 tp -65.93 -65.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -45.59 -26.58 0.62 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -73.41 -36.39 65.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.828 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 374' ' ' LEU . 81.1 mt -87.32 -25.48 23.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.6 -35.3 72.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -89.15 -15.04 34.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -92.53 -42.58 9.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 20.3 m-85 -72.49 -22.19 61.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 2.7 ptmm? -68.87 -5.05 18.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -56.13 -59.99 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 4.1 t -52.8 -64.26 0.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -139.05 -123.43 2.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.445 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 92.8 t -125.53 131.41 72.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 111.099 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 64.7 t -82.52 122.36 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -47.06 110.39 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' MET . . . . . 0.478 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 27.9 mtp -107.94 128.75 54.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.879 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -54.83 147.6 14.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.63 -14.25 25.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -101.09 -46.5 5.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.836 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 67.3 p -91.76 -19.28 22.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.118 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . 0.478 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 64.89 19.9 66.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.464 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -107.64 152.65 41.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 0.0 110.917 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 147.41 62.47 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.66 2.24 . . . . 0.0 112.38 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 11.0 mmt -81.36 41.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.467 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 91.8 mt -98.63 135.97 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -115.59 138.07 51.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.827 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 67.0 mt -134.41 94.0 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.095 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -59.63 122.34 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.931 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.439 HD21 ' N ' ' A' ' 409' ' ' PRO . 49.0 mt -106.76 136.35 46.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.939 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 407' ' ' GLY . 1.5 t70 -55.14 125.93 22.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -73.1 -1.24 16.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.441 ' CG ' ' OD1' ' A' ' 403' ' ' ASP . 3.4 mm-40 -96.48 -36.59 10.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 34.6 p -119.74 -35.22 3.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 100.25 -1.02 56.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.507 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -86.8 155.95 55.7 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.597 0.713 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.9 Cg_endo -69.75 91.3 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.72 2.28 . . . . 0.0 112.272 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.482 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -31.49 -48.45 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.864 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 148.95 -10.63 1.03 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -95.35 154.53 17.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 0.0 110.828 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.39 171.47 9.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.13 128.63 20.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.512 HG21 ' CE2' ' A' ' 381' ' ' PHE . 62.5 t -112.3 118.38 57.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 3.2 m -92.59 116.08 28.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.849 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 52.9 m-85 -89.74 160.3 16.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -57.5 -63.97 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.501 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.7 m-20 -115.59 156.66 45.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.625 0.726 . . . . 0.0 110.845 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.8 Cg_exo -57.4 -43.02 55.66 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.705 2.27 . . . . 0.0 112.3 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 61.7 Cg_exo -48.68 -29.43 14.44 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 90.7 m -88.58 -39.45 14.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.133 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -61.5 -50.23 73.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -60.08 -38.5 83.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.98 -31.29 61.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.104 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . 0.421 ' CB ' ' CE2' ' A' ' 417' ' ' TYR . . . -70.04 -33.81 72.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.156 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.486 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 76.3 t -55.85 -64.11 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.157 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -64.99 -12.58 51.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.534 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -80.16 -54.64 5.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 90.9 m-85 -89.47 -14.1 36.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.7 t0 -58.15 99.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.768 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 99.79 22.85 11.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.53 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.435 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 19.9 mmtt -78.72 167.92 20.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.794 0.33 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 4.3 p-10 -110.7 108.29 18.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.792 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -115.42 108.33 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.82 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 61.28 36.94 17.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 75.2 21.17 78.44 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.555 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 72.1 m -130.85 129.69 42.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.908 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -70.27 136.56 49.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 8.0 mt -104.66 157.41 17.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.894 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -130.39 106.01 8.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 363' ' ' ILE . 10.2 t -103.1 133.06 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.106 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 84.7 p -150.04 132.21 15.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.902 -179.967 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.913 0.387 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -140.25 155.83 46.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.102 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . 0.425 HD12 ' CG1' ' A' ' 442' ' ' VAL . 31.4 pt -128.85 143.48 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.102 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.69 123.35 44.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.479 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 11.3 t -107.45 139.34 29.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.135 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -145.79 122.87 11.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 128.63 11.11 3.06 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.518 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 30.6 mt -70.98 155.84 40.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.798 0.332 . . . . 0.0 110.921 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . 0.478 ' OD1' ' NE2' ' A' ' 436' ' ' GLN . 6.6 p30 -78.2 174.46 11.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.68 14.53 5.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.4 t -131.71 19.57 4.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.831 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 8.2 p -82.69 130.15 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.133 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 58.8 p -110.44 156.69 20.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.141 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.463 ' CD1' ' HG2' ' A' ' 396' ' ' PRO . 9.1 tp -54.46 -54.16 44.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -54.57 -35.13 62.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -69.88 -28.49 65.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 60.2 mt -89.42 -29.06 19.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -71.67 -38.48 70.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.417 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 8.9 t70 -82.56 -17.37 45.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -92.67 -41.73 10.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.616 ' CD2' ' CG2' ' A' ' 415' ' ' VAL . 15.2 m-85 -71.95 -16.91 62.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . 0.417 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 9.5 ptpt -77.79 -6.59 54.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -55.74 -50.28 70.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.0 t -62.14 -60.84 3.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.91 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -142.65 -126.46 2.08 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.82 128.81 75.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 0.0 111.195 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 84.2 t -84.9 130.05 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.099 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -54.8 113.29 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' MET . . . . . 0.501 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 43.7 mmm -109.74 123.63 49.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -49.55 144.15 6.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -94.75 -8.39 37.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -101.9 -46.82 4.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 35.0 p -97.42 -16.63 20.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.101 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . 0.501 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 65.6 26.66 72.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.568 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -112.43 152.95 44.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.557 0.694 . . . . 0.0 110.967 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.463 ' HG2' ' CD1' ' A' ' 374' ' ' LEU . 54.6 Cg_endo -69.69 149.12 66.91 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.74 2.293 . . . . 0.0 112.333 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 7.0 mmt -82.69 38.09 0.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.463 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 91.8 mt -95.98 140.97 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.158 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -121.5 138.01 54.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 61.6 mt -131.1 93.83 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.076 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -59.44 124.4 19.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.965 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.426 HD22 ' N ' ' A' ' 409' ' ' PRO . 35.1 mt -107.9 137.16 46.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.891 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 407' ' ' GLY . 8.1 t0 -55.46 123.92 15.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -71.2 -1.12 11.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -96.08 -39.1 9.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 33.0 p -117.31 -35.43 4.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 101.23 -1.65 54.35 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.446 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -85.94 155.55 58.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.646 0.736 . . . . 0.0 110.856 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.1 Cg_endo -69.76 90.95 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.702 2.268 . . . . 0.0 112.279 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.482 ' C ' ' O ' ' A' ' 409' ' ' PRO . 2.3 ptmt -31.73 -53.89 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 155.01 -15.96 0.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.507 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -88.9 156.99 18.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.769 0.319 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.93 175.23 5.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.14 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.56 132.71 23.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.147 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.616 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 38.8 t -118.87 113.3 41.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.168 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 2.6 m -89.54 116.78 27.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.49 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 57.7 m-85 -93.04 164.18 13.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -56.84 -66.46 0.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.939 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.509 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.4 m-20 -114.54 156.97 43.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.614 0.721 . . . . 0.0 110.83 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.34 -42.97 56.48 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.634 2.223 . . . . 0.0 112.355 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.1 Cg_exo -50.53 -27.19 18.35 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.652 2.235 . . . . 0.0 112.412 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 29.4 m -87.91 -42.36 12.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -60.44 -41.42 93.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.113 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -65.77 -38.36 88.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.887 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.38 -30.89 62.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.138 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -72.1 -30.78 65.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.438 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 64.0 t -58.74 -63.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.144 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -64.23 -13.21 47.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.523 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -80.08 -54.65 5.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.552 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 79.3 m-85 -87.56 -14.06 41.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.4 t70 -61.51 95.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 117.8 -19.05 11.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.496 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.409 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 2.5 mmmp? -47.88 176.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.764 0.316 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -124.53 130.4 52.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.811 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -129.75 107.27 9.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . 0.478 ' NE2' ' OD1' ' A' ' 369' ' ' ASN . 63.7 mt-30 61.8 32.53 18.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 81.12 19.53 66.89 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.465 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 12.2 m -128.11 129.31 46.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.911 0.386 . . . . 0.0 110.844 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -68.67 134.52 49.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 22.1 mt -100.81 143.07 31.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -119.37 101.81 8.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.425 ' CG1' HD12 ' A' ' 363' ' ' ILE . 14.0 t -99.27 129.8 49.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.143 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.5 m -154.21 128.46 9.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.866 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 28.6 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.967 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.867 0.365 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -137.39 164.78 27.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . 0.449 ' CG2' HG22 ' A' ' 427' ' ' VAL . 36.7 pt -138.32 142.22 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.11 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -102.52 115.25 30.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.977 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.419 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 12.1 t -101.35 142.59 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -150.55 122.29 8.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 133.16 6.82 2.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.455 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 28.2 mt -72.82 156.4 38.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.812 0.339 . . . . 0.0 110.954 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.62 179.86 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.81 6.1 33.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.78 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 10.9 t -114.23 4.21 15.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.839 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 6.2 p -76.1 139.06 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.107 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 68.9 p -122.21 173.88 7.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.448 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 14.9 tp -67.29 -63.3 1.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -47.64 -28.63 2.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.909 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.07 -32.6 56.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 381' ' ' PHE . 48.4 mt -84.78 -27.94 26.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.872 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.77 -37.29 65.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.413 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 21.7 t0 -78.75 -20.25 50.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -92.69 -51.31 5.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.555 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 15.9 m-85 -60.01 -24.64 64.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . 0.413 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -71.27 -15.08 62.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.894 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -45.35 -53.58 8.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 38.3 t -59.23 -69.0 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.14 -124.99 2.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.47 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 67.1 t -124.73 135.25 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.921 0.391 . . . . 0.0 111.113 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.16 131.57 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -55.8 111.74 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.955 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' MET . . . . . 0.434 ' SD ' ' CA ' ' A' ' 396' ' ' PRO . 64.7 mmm -106.8 121.72 44.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -48.3 148.15 2.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -94.77 -19.16 20.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -96.78 -46.67 6.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.816 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 37.1 p -91.09 -21.7 21.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 65.6 27.93 73.1 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.507 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -117.18 153.24 49.77 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.532 0.682 . . . . 0.0 110.932 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.434 ' CA ' ' SD ' ' A' ' 389' ' ' MET . 53.2 Cg_endo -69.79 146.99 61.64 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.694 2.262 . . . . 0.0 112.293 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' MET . . . . . 0.4 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.5 mmt -81.17 41.47 0.6 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.448 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.7 mt -99.27 135.93 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.18 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -115.5 141.03 48.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 67.6 mt -134.12 93.72 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -59.71 122.35 13.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.467 HD22 ' N ' ' A' ' 409' ' ' PRO . 45.0 mt -107.57 136.4 47.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.889 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 407' ' ' GLY . 2.0 t70 -55.19 133.63 49.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.09 -6.54 57.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -97.46 -22.88 16.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 69.5 p -128.17 -36.06 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 94.8 0.54 64.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.507 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -90.7 156.93 44.6 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.615 0.721 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.489 ' O ' ' C ' ' A' ' 410' ' ' LYS . 54.3 Cg_endo -69.73 89.38 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 0.0 112.392 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.489 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.1 OUTLIER -30.54 -54.74 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 156.77 -15.27 0.36 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.482 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -91.22 153.53 19.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.909 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -166.87 174.85 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.083 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 3.0 p -141.78 143.37 33.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.154 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.456 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 45.3 t -130.69 119.87 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' SER . . . . . 0.4 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 2.1 m -94.66 114.01 25.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.508 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 50.4 m-85 -86.8 162.32 17.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.41 -65.5 0.6 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.51 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 4.5 m-20 -115.5 157.72 43.44 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.669 0.747 . . . . 0.0 110.843 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.2 Cg_exo -57.16 -43.11 56.2 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.617 2.212 . . . . 0.0 112.371 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.4 Cg_exo -50.81 -29.37 26.13 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.648 2.232 . . . . 0.0 112.369 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 40.9 m -86.26 -39.27 16.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.185 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.508 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -62.3 -53.95 47.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.093 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -56.51 -33.94 66.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.81 -32.07 52.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.063 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -72.1 -33.81 68.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.084 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.486 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 77.8 t -55.17 -61.58 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -66.59 -12.79 59.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.548 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.76 -54.31 5.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.555 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 91.3 m-85 -88.75 -18.01 28.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.835 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.6 t70 -52.93 97.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 100.95 23.56 9.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.503 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.44 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 25.0 mmtt -76.5 175.87 8.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.32 . . . . 0.0 110.906 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.39 112.33 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -108.12 98.61 8.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.886 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 61.04 35.25 18.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 96.37 -21.55 44.87 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.45 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.2 p -82.55 152.77 25.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.976 0.417 . . . . 0.0 110.834 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -99.72 130.75 45.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.81 144.39 32.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.954 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -122.02 107.7 12.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 7.1 t -100.23 135.52 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 10.0 p -155.99 130.72 9.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.816 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.887 -179.964 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.78 0.324 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -123.39 156.7 34.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.153 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . 0.421 ' CG1' ' HB ' ' A' ' 415' ' ' VAL . 29.4 pt -126.08 142.74 41.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.085 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -104.5 111.68 24.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.994 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.501 ' CG2' ' CZ ' ' A' ' 381' ' ' PHE . 8.5 t -95.7 141.09 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.148 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -145.67 120.3 9.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.1 19.95 1.51 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.68 151.74 32.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.768 0.318 . . . . 0.0 110.955 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -74.68 -176.36 2.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.23 4.62 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.5 t -120.32 17.67 12.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.3 p -80.64 136.72 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.178 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 77.5 p -121.3 162.47 20.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.134 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.463 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 17.8 tp -57.28 -66.1 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -45.98 -30.19 1.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.95 -34.04 66.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.83 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.423 ' HB3' ' CE2' ' A' ' 381' ' ' PHE . 54.1 mt -85.5 -28.99 24.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.853 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.64 -28.88 62.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.408 ' HA ' ' NZ ' ' A' ' 382' ' ' LYS . 10.4 t70 -84.99 -22.34 29.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.437 ' CE2' ' CD1' ' A' ' 430' ' ' PHE . 68.0 t80 -92.63 -48.14 6.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.554 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 17.7 m-85 -62.57 -21.02 65.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . 0.408 ' NZ ' ' HA ' ' A' ' 379' ' ' ASP . 2.0 ptpp? -78.19 -4.57 48.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -56.05 -57.92 10.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.947 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . 0.568 ' SG ' ' CE3' ' A' ' 429' ' ' TRP . 1.9 t -56.38 -64.63 0.8 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.68 -127.22 2.74 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.409 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 77.3 t -125.87 131.51 71.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.897 0.38 . . . . 0.0 111.183 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 57.3 t -84.55 128.44 38.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -51.04 105.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' A' ' 396' ' ' PRO . 64.1 mmm -101.55 122.13 43.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -46.52 145.65 1.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -94.39 -21.58 18.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -96.25 -46.93 6.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 30.2 p -88.94 -26.63 21.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 70.25 32.08 68.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.477 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -121.07 153.66 57.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.586 0.707 . . . . 0.0 110.95 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.43 ' N ' ' SD ' ' A' ' 389' ' ' MET . 53.3 Cg_endo -69.8 145.15 56.05 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.677 2.251 . . . . 0.0 112.276 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' MET . . . . . 0.433 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 7.0 mmt -81.52 41.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.827 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.463 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 94.4 mt -97.97 142.75 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.156 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -120.98 141.34 50.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 60.1 mt -134.91 94.73 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.189 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -62.44 127.41 31.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.409 HD23 ' N ' ' A' ' 409' ' ' PRO . 37.0 mt -112.11 134.56 53.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.878 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 407' ' ' GLY . 13.1 t0 -55.43 120.21 6.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.856 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -1.98 8.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -88.0 -39.67 14.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 33.4 p -121.88 -35.92 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 107.27 -0.87 35.07 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.47 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -86.53 152.56 54.87 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.53 0.681 . . . . 0.0 110.935 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.461 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.8 Cg_endo -69.71 94.82 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.748 2.299 . . . . 0.0 112.321 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 409' ' ' PRO . 8.4 ptmt -33.19 -52.02 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.883 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.65 -14.39 0.8 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -89.88 149.01 22.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.785 0.326 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -162.09 170.17 19.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.067 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.4 p -138.96 143.29 38.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.184 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.487 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 59.4 t -129.01 118.58 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.17 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' SER . . . . . 0.433 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 17.3 m -92.67 114.03 26.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.554 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 43.6 m-85 -86.82 165.68 15.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -61.4 -64.28 1.0 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.846 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.509 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.9 m-20 -112.63 156.68 42.04 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.672 0.749 . . . . 0.0 110.789 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.3 Cg_exo -57.11 -43.0 57.48 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.654 2.236 . . . . 0.0 112.339 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.5 Cg_exo -50.96 -43.15 49.2 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.708 2.272 . . . . 0.0 112.361 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 52.3 m -67.8 -43.22 80.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.111 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.554 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -57.2 -57.61 11.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.1 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -51.89 -36.96 50.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.85 64.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . 0.482 ' CB ' ' CE2' ' A' ' 417' ' ' TYR . . . -69.51 -30.8 68.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.052 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.491 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 85.0 t -58.66 -62.14 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.159 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -67.5 -9.71 44.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.568 ' CE3' ' SG ' ' A' ' 384' ' ' CYS . 1.2 t-105 -82.44 -54.16 5.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.972 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.554 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 91.2 m-85 -89.05 -20.96 23.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.491 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.0 OUTLIER -49.7 94.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.823 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.15 20.29 9.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.535 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.457 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 14.3 mmtm -78.11 161.47 27.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.842 0.353 . . . . 0.0 110.851 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -107.08 106.45 16.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . 0.44 ' HB2' ' CD1' ' A' ' 440' ' ' LEU . 4.3 t80 -107.17 110.11 22.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 58.22 35.26 24.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 89.76 -18.94 44.18 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.519 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.4 m -90.35 164.21 14.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.4 . . . . 0.0 110.886 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.86 140.53 33.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.44 ' CD1' ' HB2' ' A' ' 435' ' ' PHE . 11.4 mt -108.06 139.66 42.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -115.82 103.93 11.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 19.2 t -99.34 132.37 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.077 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 9.5 p -151.6 132.35 14.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.824 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.868 -179.933 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.458 -0.047 0 CA-C-O 120.905 0.383 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -130.92 166.68 20.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.077 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 39.8 pt -134.7 142.49 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -99.31 115.02 28.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.553 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 4.5 t -103.06 142.31 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.128 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -149.12 124.84 10.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.27 12.59 2.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.489 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 30.2 mt -77.84 156.38 30.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.72 -179.32 7.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.945 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.92 -2.02 58.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 39.4 t -106.14 3.14 27.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.782 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 12.2 p -69.46 144.77 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 80.7 p -127.85 170.6 12.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.16 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.461 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 12.1 tp -68.26 -49.69 58.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -59.74 -34.46 72.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.841 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.37 -31.41 68.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.443 ' HB3' ' CE2' ' A' ' 381' ' ' PHE . 60.0 mt -87.96 -28.09 21.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.932 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.41 -35.83 68.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.413 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 12.5 t70 -85.36 -17.92 35.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -92.31 -43.94 9.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.575 ' CD2' ' CG2' ' A' ' 415' ' ' VAL . 15.8 m-85 -69.9 -21.85 63.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.861 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . 0.413 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -72.9 -9.49 58.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.947 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -50.08 -54.65 19.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 3.5 t -58.88 -65.9 0.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -135.19 -126.34 2.6 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.462 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 93.2 t -124.44 131.29 72.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.837 0.351 . . . . 0.0 111.177 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 57.0 t -82.44 126.03 39.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -49.22 107.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' MET . . . . . 0.468 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 19.5 mtp -104.47 122.3 45.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -50.73 147.07 5.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -94.59 -18.41 21.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -95.22 -47.89 6.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 37.8 p -90.36 -26.85 19.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.202 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . 0.468 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 73.39 20.32 79.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -108.97 152.81 42.63 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.546 0.688 . . . . 0.0 110.978 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 147.73 63.18 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.636 2.224 . . . . 0.0 112.345 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 9.5 mmt -81.52 40.96 0.6 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.461 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.1 mt -98.82 136.36 30.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -115.71 136.17 53.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 67.7 mt -132.33 93.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -59.17 124.54 20.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.465 HD21 ' N ' ' A' ' 409' ' ' PRO . 35.1 mt -109.34 135.14 50.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.9 t0 -55.37 128.1 32.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -75.11 -1.0 21.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -93.66 -31.24 14.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.9 p -128.32 -35.89 1.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.089 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 100.57 9.92 45.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.501 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -95.7 155.62 38.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.533 0.682 . . . . 0.0 110.944 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.6 Cg_endo -69.78 89.47 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.629 2.219 . . . . 0.0 112.381 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 409' ' ' PRO . 5.1 ptmt -31.58 -53.23 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 155.64 -14.68 0.44 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -90.64 155.07 19.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.5 169.47 10.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.3 p -141.79 124.16 15.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.173 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.575 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 59.3 t -109.33 121.35 62.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 2.2 m -95.96 114.08 25.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.914 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.532 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 67.2 m-85 -87.1 162.85 17.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -57.63 -67.12 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.51 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 5.7 m-20 -111.6 157.55 38.99 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.626 0.727 . . . . 0.0 110.858 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.16 -43.0 57.28 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.696 2.264 . . . . 0.0 112.319 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.3 Cg_exo -50.81 -31.24 32.5 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.672 2.248 . . . . 0.0 112.299 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 23.6 m -84.26 -37.72 21.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.105 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.532 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -64.55 -47.86 77.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.074 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -62.4 -36.56 82.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.01 -31.24 58.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . 0.407 ' CB ' ' CZ ' ' A' ' 417' ' ' TYR . . . -70.39 -31.88 69.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.465 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 94.2 t -57.18 -64.02 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.196 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.0 -11.55 29.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.526 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -81.3 -54.33 5.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 89.7 m-85 -89.79 -13.39 36.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.2 t0 -60.23 95.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 108.29 -0.03 33.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.465 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.441 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 18.7 mmtt -61.13 173.75 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.773 0.32 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -121.18 120.61 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.909 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . 0.415 ' HB2' ' CD1' ' A' ' 440' ' ' LEU . 5.4 t80 -117.85 105.12 11.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 62.36 26.09 15.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.903 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 97.27 -16.47 60.69 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.539 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 75.5 m -96.8 127.02 42.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.949 0.404 . . . . 0.0 110.817 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -71.12 140.22 50.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.415 ' CD1' ' HB2' ' A' ' 435' ' ' PHE . 10.6 mt -108.87 151.65 25.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.953 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -122.63 108.16 12.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.912 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 10.4 t -104.36 135.49 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.197 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.4 m -154.86 127.49 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.891 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.912 -179.961 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.827 0.346 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.99 159.13 22.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.074 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . 0.434 ' CG2' HG23 ' A' ' 427' ' ' VAL . 38.6 pt -131.8 142.28 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -98.72 117.38 33.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.422 HG22 ' CZ ' ' A' ' 381' ' ' PHE . 15.7 t -102.34 141.94 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.137 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -148.83 122.58 9.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.43 18.82 1.59 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.418 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 64.6 mt -80.87 154.4 27.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -81.44 171.01 15.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.84 6.59 10.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 31.7 m -119.67 14.43 12.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 6.5 p -79.58 137.33 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 74.8 p -119.93 156.82 30.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.174 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.465 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 11.6 tp -53.24 -60.69 2.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -51.76 -33.58 35.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.796 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.47 -29.74 68.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 49.1 mt -89.9 -29.5 18.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.78 72.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.086 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' ASP . . . . . 0.412 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 21.1 t70 -80.38 -18.91 47.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -92.47 -52.93 4.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.56 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 28.3 m-85 -59.58 -21.66 60.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . 0.412 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 2.6 ptmm? -75.38 -6.1 48.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -58.62 -56.25 24.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 28.3 t -57.57 -63.09 1.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.839 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -136.02 -126.54 2.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.463 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 76.2 t -125.46 133.92 68.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 111.124 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 68.4 t -87.14 129.97 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.163 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -56.62 106.85 0.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' MET . . . . . 0.5 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 47.6 mmm -103.34 125.94 50.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.869 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' ASN . . . . . 0.402 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 15.5 t-20 -51.14 148.88 4.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -94.88 -17.99 21.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.944 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -97.28 -48.32 5.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.402 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 38.2 p -90.63 -17.95 25.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.173 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . 0.5 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 62.16 27.47 69.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.436 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -114.63 153.19 46.78 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.608 0.718 . . . . 0.0 110.922 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.461 ' N ' ' SD ' ' A' ' 389' ' ' MET . 53.7 Cg_endo -69.68 146.64 61.28 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.67 2.247 . . . . 0.0 112.366 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' MET . . . . . 0.434 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.8 mmt -81.25 41.26 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.846 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.465 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.1 mt -98.64 136.4 29.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.124 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -115.64 142.24 47.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 66.9 mt -134.86 94.03 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.084 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -59.7 125.28 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' LEU . . . . . 0.446 HD23 ' N ' ' A' ' 409' ' ' PRO . 50.0 mt -109.13 136.7 48.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.971 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.4 t0 -55.24 132.33 47.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -79.74 -5.58 55.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -97.3 -24.05 15.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 70.4 p -128.15 -36.09 1.97 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.135 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 97.4 -4.49 62.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.565 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -85.69 156.05 58.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.56 0.695 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.48 ' O ' ' C ' ' A' ' 410' ' ' LYS . 54.2 Cg_endo -69.78 91.37 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.738 2.292 . . . . 0.0 112.305 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.48 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.1 OUTLIER -31.67 -51.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.873 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.46 -12.0 0.76 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -93.68 152.79 18.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.83 0.348 . . . . 0.0 110.846 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -165.68 173.4 10.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 p -138.81 140.63 38.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.172 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . 0.431 HG22 ' CE2' ' A' ' 381' ' ' PHE . 46.0 t -124.77 116.93 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.144 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' SER . . . . . 0.434 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 13.4 m -92.85 112.16 24.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 59.0 m-85 -86.84 161.41 18.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.897 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.86 -66.51 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.953 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.504 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.4 m-20 -115.17 156.72 45.12 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.617 0.723 . . . . 0.0 110.848 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.591 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.31 -42.97 56.64 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.659 2.239 . . . . 0.0 112.373 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.8 Cg_exo -50.42 -26.85 17.05 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.743 2.295 . . . . 0.0 112.323 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 56.0 m -89.09 -41.07 12.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.513 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -60.23 -47.31 86.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.077 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -60.92 -38.11 84.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.24 -34.59 63.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.029 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.99 -32.62 72.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 70.1 t -56.04 -60.02 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.061 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -67.62 -13.89 62.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' TRP . . . . . 0.551 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -78.75 -55.14 5.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . 0.56 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 82.8 m-85 -87.41 -14.81 39.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.6 OUTLIER -55.74 93.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.875 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.8 21.54 8.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.505 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' LYS . . . . . 0.448 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 15.5 mmtm -77.3 176.78 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.7 124.82 44.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.803 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -128.16 100.44 5.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 62.52 34.52 15.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.902 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 82.4 19.96 63.25 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.468 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 19.7 p -126.36 130.09 50.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 110.868 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -75.95 131.37 39.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.861 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 5.8 mt -105.49 133.83 49.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.59 113.71 27.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 9.2 t -107.8 131.19 58.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.096 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 2.7 m -156.89 130.98 8.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.772 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 26.5 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.946 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 8.3 t -105.55 153.25 22.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.876 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 34.9 t -86.6 132.76 33.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.934 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 87.43 127.61 2.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 23.3 m -88.03 94.78 9.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.937 0.398 . . . . 0.0 110.834 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 47.7 t -98.29 82.77 2.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.819 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 68.21 132.17 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.51 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -107.18 147.2 34.72 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.618 0.723 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 154.29 68.05 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.705 2.27 . . . . 0.0 112.33 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -170.69 167.72 7.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -65.98 112.81 4.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -99.82 44.7 1.01 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.947 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 359' ' ' ASP . 20.1 m -79.4 70.41 5.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.854 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 358' ' ' SER . 3.9 m-20 -37.3 -37.75 0.2 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 446' ' ' ARG . 10.0 t30 -45.36 112.13 0.41 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.949 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 6.3 p -107.35 15.8 24.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -112.75 160.81 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 31.3 pt -131.89 144.48 37.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -103.44 111.47 23.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.492 ' CG2' ' CZ ' ' A' ' 381' ' ' PHE . 8.2 t -96.42 140.12 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.098 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -145.91 122.44 11.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.26 17.97 1.72 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.489 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 87.0 mt -78.2 153.09 32.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.873 0.368 . . . . 0.0 110.861 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -76.17 -179.52 5.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.85 3.54 50.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 12.5 m -119.27 15.81 13.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.61 134.02 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.152 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 70.2 p -117.87 160.22 21.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.158 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.449 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 12.3 tp -53.11 -64.17 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.95 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -46.1 -38.75 8.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.55 -32.69 74.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 381' ' ' PHE . 75.7 mt -87.09 -28.08 22.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.8 -39.56 66.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.015 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.415 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 40.0 t0 -76.51 -20.82 56.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.497 ' CE1' ' NE2' ' A' ' 383' ' ' GLN . 40.6 t80 -91.6 -53.84 4.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.551 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 16.6 m-85 -57.56 -23.67 51.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . 0.415 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 13.9 ptmt -74.44 -12.16 60.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.925 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . 0.497 ' NE2' ' CE1' ' A' ' 380' ' ' PHE . 6.8 mt-30 -48.68 -53.4 18.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 2.3 t -59.74 -65.17 0.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -136.82 -124.3 2.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.459 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 95.1 t -125.51 128.82 72.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.841 0.353 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 58.2 t -82.53 124.79 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.101 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -45.85 107.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.975 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' MET . . . . . 0.471 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 20.4 mtp -102.91 127.28 50.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.894 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -53.7 146.01 14.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.75 -13.69 25.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -102.52 -42.09 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 66.8 p -96.93 -19.57 18.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.157 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.471 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 66.04 18.44 66.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.442 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -107.14 152.75 41.2 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.554 0.692 . . . . 0.0 110.934 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 147.62 63.2 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.684 2.256 . . . . 0.0 112.349 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' MET . . . . . 0.422 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 11.3 mmt -81.61 40.76 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.846 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.449 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 97.7 mt -99.33 137.68 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.171 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -118.5 143.56 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.808 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 58.6 mt -134.59 93.9 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -59.77 125.23 22.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.844 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 36.5 mt -109.38 134.57 51.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.9 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 407' ' ' GLY . 11.1 t0 -55.67 121.25 8.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -69.23 -1.29 7.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -88.5 -38.5 14.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 70.1 p -124.74 -35.05 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.85 -1.47 35.96 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.475 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 12.0 pttp -84.37 152.62 61.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.8 Cg_endo -69.75 94.69 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.68 2.253 . . . . 0.0 112.341 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -33.55 -52.75 0.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 153.19 -15.85 0.67 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.487 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . 0.404 ' CG ' ' HE3' ' A' ' 410' ' ' LYS . 49.5 p-10 -87.74 157.24 19.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -170.15 171.67 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.096 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.4 142.91 37.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.183 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.522 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 57.0 t -130.13 111.94 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' SER . . . . . 0.422 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 9.1 m -87.35 114.39 23.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.432 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 47.3 m-85 -88.07 164.41 15.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.77 -63.29 1.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.499 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.4 m-20 -115.9 156.05 47.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.604 0.716 . . . . 0.0 110.84 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.602 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.39 -43.01 55.77 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.644 2.23 . . . . 0.0 112.356 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.7 Cg_exo -50.06 -29.57 22.3 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.686 2.257 . . . . 0.0 112.286 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 70.0 m -85.8 -40.07 16.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.159 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.432 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -61.93 -51.5 67.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.131 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -58.93 -35.58 73.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.849 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.29 -31.69 54.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.041 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.23 68.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.147 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 92.6 t -54.68 -60.83 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -66.7 -14.65 62.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.55 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -77.85 -52.04 9.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.975 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.551 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 91.2 m-85 -90.37 -17.37 27.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 3.8 t70 -57.12 100.28 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 101.5 13.78 31.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.445 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 18.7 mmtp -71.7 -178.75 2.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.748 0.309 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.79 102.87 6.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . 0.437 ' HB2' ' CD1' ' A' ' 440' ' ' LEU . 5.0 t80 -102.76 113.1 26.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 59.01 27.16 15.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 96.02 -16.66 60.72 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.431 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 24.3 m -90.62 150.46 21.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.965 0.412 . . . . 0.0 110.819 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -87.61 133.74 33.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.437 ' CD1' ' HB2' ' A' ' 435' ' ' PHE . 6.0 mt -102.66 143.09 32.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.932 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.03 101.42 7.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.983 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.416 ' CG1' ' HA ' ' A' ' 427' ' ' VAL . 20.5 t -96.98 132.6 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.079 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.5 m -154.24 128.73 9.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 445' ' ' ALA . 22.4 mt -43.76 109.8 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.849 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 444' ' ' LEU . . . -35.71 -55.96 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.415 ' H ' ' ND2' ' A' ' 360' ' ' ASN . 26.8 ttt180 -92.43 92.98 8.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -131.22 128.68 40.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . 0.445 ' CD ' ' HD2' ' A' ' 449' ' ' PRO . 35.7 tptt -162.68 137.06 4.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.535 0.683 . . . . 0.0 110.93 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . 0.445 ' HD2' ' CD ' ' A' ' 448' ' ' LYS . 53.5 Cg_endo -69.8 149.54 66.78 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.638 2.226 . . . . 0.0 112.359 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -173.93 0.81 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.765 2.31 . . . . 0.0 112.307 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -94.07 -47.85 6.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.857 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -57.72 115.42 2.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 15.4 m 61.82 27.8 16.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -71.69 -79.8 0.39 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.515 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 145.08 56.28 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.705 2.27 . . . . 0.0 112.388 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 39.0 m -113.93 -50.32 2.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 57.9 p -158.78 178.38 10.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.844 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.46 -179.945 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 68.2 m -85.6 87.09 7.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.875 0.369 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 10.8 t -117.26 135.32 53.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 149.13 -51.83 0.54 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 3.7 t -101.24 -61.19 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 0.0 110.893 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 23.1 t -126.69 111.1 13.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.919 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -162.37 169.1 37.59 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.469 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.75 143.1 39.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.661 0.744 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 162.59 41.51 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.771 2.314 . . . . 0.0 112.327 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -141.36 162.38 35.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -132.22 141.93 49.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.86 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 357' ' ' ASP . 0.0 OUTLIER -104.08 -45.17 4.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 5.3 t -165.21 148.91 8.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -74.83 89.7 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.815 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -139.53 116.19 10.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.4 m -106.28 40.03 1.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.858 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -141.82 156.15 45.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . 0.457 HD11 ' CG1' ' A' ' 442' ' ' VAL . 18.8 pt -128.8 141.88 45.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.121 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -103.5 112.02 24.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.518 ' CG2' ' CZ ' ' A' ' 381' ' ' PHE . 9.1 t -97.96 138.99 21.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -145.03 120.66 10.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.64 16.51 1.83 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.503 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 97.7 mt -74.51 155.39 38.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.821 0.343 . . . . 0.0 110.861 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -75.12 -178.88 4.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.55 3.69 53.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.2 t -121.05 16.58 11.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 8.5 p -76.89 133.99 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 81.8 p -118.28 154.8 31.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.451 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 11.1 tp -50.75 -62.82 1.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -46.72 -38.15 9.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.864 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.26 -29.59 68.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.402 HD23 ' CE2' ' A' ' 381' ' ' PHE . 45.5 mt -87.08 -28.52 22.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.16 62.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.146 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -75.11 -18.48 60.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -92.63 -47.17 7.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.555 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 15.7 m-85 -66.98 -26.44 66.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -9.13 57.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -51.58 -51.75 52.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 42.4 t -61.02 -65.45 0.69 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -134.55 -126.74 2.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.508 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . 0.441 ' CG1' ' OE2' ' A' ' 418' ' ' GLU . 91.0 t -123.53 128.47 74.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.83 0.347 . . . . 0.0 111.127 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 84.5 t -83.64 123.1 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.076 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -47.55 108.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 23.8 mtp -105.41 124.18 49.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.896 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -50.9 143.94 9.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -94.72 -8.41 37.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -102.47 -45.55 5.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.967 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 20.5 p -95.82 -22.16 17.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.157 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 71.1 23.29 78.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.503 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -112.09 152.49 44.39 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.523 0.678 . . . . 0.0 110.929 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.426 ' HG2' ' CD1' ' A' ' 374' ' ' LEU . 54.9 Cg_endo -69.67 149.41 67.4 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.693 2.262 . . . . 0.0 112.352 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 11.1 mmt -82.19 40.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.794 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.451 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 93.6 mt -97.52 137.4 25.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.148 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -116.78 138.75 51.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 58.0 mt -132.41 94.99 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -62.47 127.6 32.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 409' ' ' PRO . 36.2 mt -112.06 135.48 52.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 407' ' ' GLY . 6.6 t70 -56.14 122.25 11.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -1.05 9.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -89.04 -38.46 14.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.809 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 59.0 p -123.65 -34.73 3.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.3 -3.28 37.51 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.481 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -83.61 152.69 63.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.505 0.669 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.4 Cg_endo -69.74 95.17 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.673 2.248 . . . . 0.0 112.356 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 409' ' ' PRO . 9.2 ptmt -33.33 -52.01 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.882 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 152.2 -15.61 0.77 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.519 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -87.68 154.51 20.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 110.825 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -167.68 170.51 10.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.23 142.4 37.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.107 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.536 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 39.2 t -128.23 112.88 28.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.123 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 9.6 m -87.82 114.03 24.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.556 ' CE2' ' CB ' ' A' ' 426' ' ' ALA . 38.5 m-85 -87.06 167.21 14.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.965 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . 0.441 ' OE2' ' CG1' ' A' ' 386' ' ' VAL . 4.0 mt-10 -65.5 -61.96 1.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.502 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.8 m-20 -116.43 156.28 47.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.552 0.692 . . . . 0.0 110.884 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.3 -43.01 56.27 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.773 2.316 . . . . 0.0 112.335 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.8 Cg_exo -50.7 -27.36 19.62 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.7 2.267 . . . . 0.0 112.354 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 55.4 m -87.35 -40.72 14.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.154 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.512 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -60.17 -54.66 43.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 37.5 mtpt -55.63 -35.39 65.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.29 -33.09 55.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.159 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . 0.556 ' CB ' ' CE2' ' A' ' 417' ' ' TYR . . . -70.51 -31.83 69.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.101 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 72.9 t -58.16 -64.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.151 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -65.11 -10.92 34.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.546 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.2 t-105 -80.3 -56.22 4.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.985 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.555 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 91.2 m-85 -88.09 -18.19 29.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.485 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.2 t70 -54.66 96.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.38 17.3 13.95 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.515 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.417 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 17.1 mmtm -76.87 170.7 16.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.721 0.296 . . . . 0.0 110.913 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 434' ' ' ASP . 2.8 p-10 -115.83 110.49 19.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -113.42 106.87 15.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 62.15 25.91 15.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.919 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 93.29 -5.92 75.09 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.51 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.4 m -104.87 129.39 53.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.877 0.37 . . . . 0.0 110.878 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -70.83 137.83 49.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 12.4 mt -103.66 150.89 23.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -123.81 100.04 6.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.466 ' CG1' ' HA ' ' A' ' 427' ' ' VAL . 17.8 t -95.13 128.22 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.103 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 89.7 p -146.42 125.44 12.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 19.8 mt -38.58 102.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -45.3 127.84 7.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.143 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -118.32 121.58 40.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.864 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.0 -175.77 3.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.7 152.21 79.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.587 0.708 . . . . 0.0 110.871 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 149.22 66.39 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.676 2.25 . . . . 0.0 112.292 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -3.01 11.15 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.694 2.262 . . . . 0.0 112.339 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 62.9 mmm -133.19 147.26 52.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -65.4 136.66 56.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.934 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 29.2 t -112.03 85.29 2.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 143.13 82.68 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.505 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 136.6 33.33 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.605 2.203 . . . . 0.0 112.334 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 2.0 t -37.38 133.89 0.67 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 51.8 m -114.57 167.26 10.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.478 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 4.2 m -152.79 139.78 19.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.894 0.378 . . . . 0.0 110.804 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 96.4 p -57.92 -15.94 10.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.856 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 178.27 83.29 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.58 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 71.4 p -99.06 114.92 27.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 0.0 110.905 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 31.8 p -70.56 -43.71 68.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 130.93 -55.04 0.78 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.461 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.415 ' CG ' ' HD2' ' A' ' 354' ' ' PRO . 8.4 t70 -143.27 140.77 18.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.591 0.71 . . . . 0.0 110.818 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' A' ' 353' ' ' ASP . 53.5 Cg_endo -69.76 79.68 0.93 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.684 2.256 . . . . 0.0 112.297 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -85.33 92.77 8.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.19 172.4 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.882 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.87 121.29 42.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 82.5 p -42.49 -41.42 2.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -95.95 155.84 16.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.863 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.76 82.68 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.3 m -99.44 28.26 4.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.875 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -129.65 162.67 27.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.138 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . 0.458 ' CG2' HG23 ' A' ' 427' ' ' VAL . 34.3 pt -133.34 144.55 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -102.15 115.09 29.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.497 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 13.5 t -100.31 136.34 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.142 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -143.64 120.74 11.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 128.96 20.18 1.5 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.441 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 88.0 mt -79.25 155.34 28.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 110.944 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . 0.487 ' OD1' ' NE2' ' A' ' 436' ' ' GLN . 4.2 p30 -75.07 178.07 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.844 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -91.31 13.4 17.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.857 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.1 m -130.13 13.22 5.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.69 141.93 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 72.2 p -121.59 160.42 24.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.126 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.464 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 10.6 tp -56.22 -58.1 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -50.61 -38.17 44.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.823 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -66.71 -27.77 67.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.492 HD21 ' CE2' ' A' ' 381' ' ' PHE . 51.6 mt -89.03 -32.02 17.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.12 -33.78 65.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.408 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 15.8 t0 -82.93 -20.24 35.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -92.69 -48.43 6.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 18.7 m-85 -63.75 -19.08 64.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . 0.408 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -76.27 -6.69 52.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.916 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -54.31 -56.86 14.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.6 t -56.56 -65.54 0.59 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -135.67 -126.01 2.55 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.448 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 44.5 t -125.06 132.59 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 111.111 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 60.3 t -87.25 128.62 39.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.206 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 49.6 tttt -50.31 108.32 0.22 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 396' ' ' PRO . 73.6 mmm -104.05 122.79 45.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -47.66 143.18 4.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -93.38 -18.64 22.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 37.5 ttt85 -99.01 -46.6 5.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 30.1 p -89.72 -24.96 21.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.047 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.413 ' C ' ' HE2' ' A' ' 389' ' ' MET . . . 69.24 31.92 72.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.513 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -121.85 153.62 60.4 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.619 0.723 . . . . 0.0 110.899 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.415 ' N ' ' SD ' ' A' ' 389' ' ' MET . 54.6 Cg_endo -69.55 146.17 60.67 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.736 2.29 . . . . 0.0 112.432 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 9.1 mmt -82.12 40.32 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.825 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.464 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 94.3 mt -96.53 145.84 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -126.04 136.11 52.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 59.5 mt -131.04 94.79 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -61.6 127.78 33.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.898 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.44 HD21 ' N ' ' A' ' 409' ' ' PRO . 33.5 mt -112.24 135.56 52.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.953 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 407' ' ' GLY . 8.1 t0 -55.44 122.78 11.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -1.18 12.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -90.03 -36.03 15.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 37.7 p -125.21 -35.63 2.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.73 -3.66 36.42 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.487 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -83.33 152.59 64.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.679 0.752 . . . . 0.0 110.814 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.2 Cg_endo -69.74 94.99 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.726 2.284 . . . . 0.0 112.281 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -33.37 -50.56 0.32 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.955 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 150.6 -16.4 0.96 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.489 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -87.79 156.09 19.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 110.856 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.48 173.14 6.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.081 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.06 142.13 32.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.168 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.472 HG22 ' CD2' ' A' ' 381' ' ' PHE . 57.4 t -128.74 117.68 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 24.0 m -92.73 112.86 24.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.496 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 51.9 m-85 -87.17 163.29 17.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.947 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -58.01 -65.3 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.502 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.5 m-20 -114.11 155.89 44.88 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.603 0.716 . . . . 0.0 110.903 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.42 -42.84 57.36 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.677 2.251 . . . . 0.0 112.334 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 54.3 Cg_exo -49.58 -28.81 17.47 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.719 2.279 . . . . 0.0 112.373 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 48.6 m -86.94 -42.98 12.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.496 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -59.7 -48.34 82.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.188 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -61.5 -39.62 91.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.45 -32.84 62.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.094 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.29 -32.91 70.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.458 HG23 ' CG2' ' A' ' 363' ' ' ILE . 84.1 t -55.85 -60.85 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.164 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.12 -13.0 61.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.561 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.0 OUTLIER -79.49 -52.27 8.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.558 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 89.5 m-85 -88.5 -16.68 32.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.871 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.5 OUTLIER -60.4 93.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.22 16.79 7.55 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -82.37 163.91 21.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 110.862 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -110.24 108.54 18.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.931 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -109.12 108.65 19.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . 0.487 ' NE2' ' OD1' ' A' ' 369' ' ' ASN . 62.2 mt-30 61.32 26.56 16.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.972 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 94.38 -13.71 66.74 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.526 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.6 m -100.67 128.9 46.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 110.864 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -70.41 138.77 51.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.05 152.95 21.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -126.26 106.08 9.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 14.2 t -99.41 138.56 23.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 3.6 p -161.12 130.17 4.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.825 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 45.7 mt -43.38 121.78 2.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.79 156.77 13.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.116 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? 66.03 29.68 9.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm -149.63 155.29 40.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.09 152.63 1.4 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.605 0.717 . . . . 0.0 110.889 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 162.03 43.68 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.713 2.275 . . . . 0.0 112.376 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 147.53 63.79 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.76 2.306 . . . . 0.0 112.333 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 9.7 ttt -123.3 160.09 27.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -83.99 104.59 14.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 14.1 m -144.06 122.84 12.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 147.17 -158.26 27.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.503 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 2.8 3.22 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.6 2.2 . . . . 0.0 112.359 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 88.4 p -136.57 130.23 32.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 43.5 t -104.56 95.48 5.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.515 179.986 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 30.6 t -106.87 122.05 45.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 0.0 110.859 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 35.3 m -111.31 42.04 1.74 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 132.15 -61.15 0.66 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.459 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 9.1 t -62.42 119.83 9.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.892 0.377 . . . . 0.0 110.807 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 17.5 t -81.39 -57.56 3.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.869 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 178.55 80.12 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.467 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.79 159.69 29.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.565 0.698 . . . . 0.0 110.813 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 175.71 7.69 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.691 2.261 . . . . 0.0 112.36 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -153.49 148.62 26.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -83.08 168.42 16.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -78.0 135.48 37.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.848 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 58.7 p -132.07 171.11 14.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.8 t0 66.34 38.01 4.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.824 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -96.05 76.19 3.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.944 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.2 m -88.73 29.59 1.0 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -131.85 166.18 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.065 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . 0.404 ' CG2' HG23 ' A' ' 427' ' ' VAL . 27.4 pt -140.38 144.47 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -100.05 124.53 45.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.98 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.4 ' CG2' ' CZ ' ' A' ' 381' ' ' PHE . 21.8 t -108.68 143.33 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -149.73 121.11 7.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.48 19.86 1.46 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.506 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 97.4 mt -78.76 154.35 30.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.885 0.374 . . . . 0.0 110.926 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . 0.432 ' ND2' ' CD ' ' A' ' 436' ' ' GLN . 9.4 p30 -76.37 179.32 5.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.4 1.87 53.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.2 m -119.85 18.73 12.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . 0.426 ' N ' ' OD1' ' A' ' 369' ' ' ASN . 8.1 p -82.38 133.05 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.131 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 69.4 p -115.99 163.46 15.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.06 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.466 ' CD1' ' HG2' ' A' ' 396' ' ' PRO . 12.2 tp -54.64 -59.92 4.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.17 -47.38 23.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -53.15 -38.48 62.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 381' ' ' PHE . 81.5 mt -82.82 -30.04 29.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.957 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -71.99 -25.64 61.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.074 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -93.27 -19.96 20.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -91.9 -52.34 4.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 21.2 m-85 -59.83 -23.47 63.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -72.35 -10.98 60.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -49.9 -58.03 6.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 37.7 t -56.45 -69.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -130.56 -124.24 2.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 71.0 t -126.87 131.41 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.104 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 85.7 t -83.81 123.42 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.146 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -46.72 105.05 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.917 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' MET . . . . . 0.445 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 26.7 mtp -102.85 128.17 49.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -53.97 147.09 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -94.61 -16.13 23.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 15.8 ttm105 -96.43 -49.65 5.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 46.9 p -90.45 -22.11 21.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.445 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 69.49 23.66 76.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.438 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -110.93 153.02 43.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.571 0.7 . . . . 0.0 110.951 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.466 ' HG2' ' CD1' ' A' ' 374' ' ' LEU . 53.7 Cg_endo -69.82 148.13 64.0 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.652 2.235 . . . . 0.0 112.3 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' MET . . . . . 0.407 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 7.6 mmt -81.74 40.68 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.42 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.3 mt -98.53 138.86 21.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.204 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -116.97 141.78 47.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 75.0 mt -134.7 95.4 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.222 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -62.69 124.94 22.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 409' ' ' PRO . 44.1 mt -110.67 135.37 51.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 407' ' ' GLY . 9.0 t70 -55.49 126.36 24.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -75.16 -1.07 21.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -93.47 -30.29 15.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 43.4 p -127.97 -36.09 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 104.3 -5.89 45.6 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.474 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 8.8 pttm -82.94 152.8 66.38 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.569 0.699 . . . . 0.0 110.845 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.47 ' N ' HD23 ' A' ' 402' ' ' LEU . 54.1 Cg_endo -69.73 95.29 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.66 2.24 . . . . 0.0 112.343 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 409' ' ' PRO . 9.4 ptmt -32.88 -51.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.866 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.15 -12.34 0.8 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.491 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -90.93 157.95 17.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.777 0.322 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.53 172.65 6.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.079 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.88 136.59 30.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.174 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.479 HG22 ' CD2' ' A' ' 381' ' ' PHE . 40.6 t -120.89 127.69 75.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.133 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' SER . . . . . 0.407 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 3.3 m -102.46 111.17 23.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.514 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 62.9 m-85 -87.4 157.68 19.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.944 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -53.46 -65.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.506 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.9 m-20 -113.31 155.81 44.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.644 0.735 . . . . 0.0 110.838 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.589 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.1 -42.96 58.0 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.689 2.259 . . . . 0.0 112.32 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.0 Cg_exo -50.34 -27.37 17.98 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.377 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 44.9 m -88.89 -34.3 17.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.514 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -64.76 -50.61 66.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.116 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . 0.436 ' HG2' ' CD1' ' A' ' 444' ' ' LEU . 23.1 mttp -61.05 -40.01 92.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -69.56 -35.27 75.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.087 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.41 -34.68 76.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.043 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.492 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 72.6 t -54.75 -61.73 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.74 -12.89 60.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.551 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.82 -54.21 6.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.543 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 84.5 m-85 -87.63 -20.12 26.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.2 t70 -54.74 99.93 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 104.42 11.72 30.6 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.539 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -74.44 176.16 7.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.757 0.313 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -122.27 112.59 18.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.926 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . 0.407 ' HB2' ' CD1' ' A' ' 440' ' ' LEU . 4.3 t80 -113.4 112.59 23.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . 0.432 ' CD ' ' ND2' ' A' ' 369' ' ' ASN . 53.6 mt-30 58.44 36.89 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 85.9 -15.76 46.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.1 t -92.69 165.8 12.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.845 0.355 . . . . 0.0 110.901 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -102.95 134.09 46.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.921 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.407 ' CD1' ' HB2' ' A' ' 435' ' ' PHE . 11.7 mt -102.05 143.97 31.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -119.75 104.57 10.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 6.2 t -99.95 140.91 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.146 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 20.0 m -162.47 125.73 2.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.808 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.436 ' CD1' ' HG2' ' A' ' 424' ' ' LYS . 17.4 mt -36.99 118.72 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.29 96.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.079 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -106.15 91.41 3.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.872 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.82 146.6 26.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . 0.43 ' CG ' ' HD2' ' A' ' 449' ' ' PRO . 38.5 tttp -141.76 140.16 19.59 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.544 0.688 . . . . 0.0 110.942 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . 0.43 ' HD2' ' CG ' ' A' ' 448' ' ' LYS . 53.5 Cg_endo -69.83 157.79 59.06 Favored 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.728 2.285 . . . . 0.0 112.281 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 114.86 3.84 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.66 2.24 . . . . 0.0 112.359 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 12.2 mmt -118.14 -45.56 2.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.88 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 56.06 39.96 30.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 35.7 p -83.35 99.45 10.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -159.17 84.04 0.13 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.491 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 2.78 3.28 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.706 2.271 . . . . 0.0 112.305 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 77.3 p -104.55 -43.76 5.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 80.1 p -73.03 140.77 47.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.46 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 24.3 m -46.4 121.99 3.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.35 . . . . 0.0 110.913 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 78.4 p -65.75 -45.72 81.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 98.56 115.14 3.51 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.544 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 9.5 m -60.57 128.69 37.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.764 0.316 . . . . 0.0 110.87 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 83.8 p -154.61 158.53 39.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -100.16 117.72 5.96 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.505 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.7 147.38 34.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.599 0.714 . . . . 0.0 110.872 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 0.22 5.99 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.679 2.252 . . . . 0.0 112.337 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -151.98 150.5 30.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.851 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -53.09 -30.9 38.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -145.35 135.18 23.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 3.6 m -100.75 42.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -45.28 97.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.87 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -156.83 107.09 2.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.939 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.4 m -89.56 30.45 1.02 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -135.02 165.07 26.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.089 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . 0.423 ' HB ' ' CG1' ' A' ' 442' ' ' VAL . 41.6 pt -135.26 145.79 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -103.89 112.94 26.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.531 HG21 ' CE1' ' A' ' 381' ' ' PHE . 20.5 t -97.04 142.34 14.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.133 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -148.16 122.78 9.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.59 17.05 1.77 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.47 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 87.5 mt -76.23 155.97 33.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.842 0.353 . . . . 0.0 110.907 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -79.37 -174.99 4.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.82 1.57 56.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.7 m -118.74 20.56 12.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 6.2 p -87.15 137.29 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.083 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 59.2 p -120.22 163.46 17.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.197 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.455 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 10.0 tp -57.35 -63.35 1.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -44.87 -30.78 1.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.838 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -74.21 -34.19 63.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.828 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 374' ' ' LEU . 61.0 mt -86.26 -23.53 26.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -75.86 -32.53 59.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.111 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.413 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 19.6 t0 -87.47 -18.01 30.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.825 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -92.07 -50.72 5.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.618 ' CD2' ' CG2' ' A' ' 415' ' ' VAL . 16.3 m-85 -62.03 -22.13 65.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.826 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . 0.413 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 12.7 ptmt -75.55 -10.62 59.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -51.14 -53.96 29.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 34.4 t -58.93 -66.0 0.57 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.24 -124.76 2.55 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.454 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.32 130.71 71.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.878 0.371 . . . . 0.0 111.103 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.56 129.27 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.188 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -54.41 108.14 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' MET . . . . . 0.443 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 67.4 mmm -103.75 122.04 44.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.436 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 17.6 t-20 -48.51 149.06 1.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.839 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -94.87 -18.86 20.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.875 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -97.77 -47.32 5.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.436 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 49.0 p -90.68 -18.95 24.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.181 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.443 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 62.13 27.53 69.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.448 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -114.77 153.5 46.88 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.611 0.719 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.416 ' CA ' ' SD ' ' A' ' 389' ' ' MET . 53.5 Cg_endo -69.75 146.07 59.15 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.69 2.26 . . . . 0.0 112.282 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' MET . . . . . 0.433 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 16.6 mmt -81.17 41.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.455 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 95.7 mt -99.44 135.87 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.094 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -116.39 141.55 48.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 71.4 mt -133.65 93.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -60.69 124.41 20.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.98 136.71 48.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.94 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 407' ' ' GLY . 3.1 t70 -55.42 127.23 28.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.837 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.0 pttm -74.29 -1.03 18.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -97.18 -34.89 10.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 37.5 p -121.09 -34.97 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.154 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 99.59 -1.06 56.87 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.533 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -86.94 155.95 55.3 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.512 0.673 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.7 Cg_endo -69.82 91.36 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.697 2.265 . . . . 0.0 112.307 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.482 ' C ' ' O ' ' A' ' 409' ' ' PRO . 10.2 ptmt -31.75 -53.14 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.892 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.9 -14.78 0.51 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.501 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -88.45 156.81 18.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.868 0.366 . . . . 0.0 110.803 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.99 167.75 10.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.106 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.9 p -136.76 140.17 42.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.618 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 37.0 t -127.1 112.26 28.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.121 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' SER . . . . . 0.433 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 6.0 m -89.39 113.75 25.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.479 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 69.1 m-85 -88.8 164.97 14.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -57.27 -68.86 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.508 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 4.0 m-20 -112.68 156.97 41.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.605 0.717 . . . . 0.0 110.886 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.32 -43.06 55.79 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.704 2.269 . . . . 0.0 112.329 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.2 Cg_exo -50.25 -26.64 15.87 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.651 2.234 . . . . 0.0 112.326 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 35.2 m -90.0 -39.87 12.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.479 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -60.37 -51.31 70.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.065 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -57.52 -39.31 76.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.09 70.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.046 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.68 71.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.08 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.457 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 85.6 t -56.89 -64.15 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.58 -11.44 24.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.537 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -82.09 -55.29 4.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.551 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 89.1 m-85 -88.3 -13.88 39.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.831 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.8 t0 -58.64 96.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 112.26 -16.07 24.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.529 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -49.7 165.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.737 0.303 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -122.33 110.37 15.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -97.78 105.43 17.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 62.98 34.37 14.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 83.58 19.66 61.51 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.503 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 22.2 p -125.19 128.66 48.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.952 0.406 . . . . 0.0 110.828 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.65 133.1 45.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 8.6 mt -107.2 160.59 15.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -133.41 101.04 5.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.423 ' CG1' ' HB ' ' A' ' 363' ' ' ILE . 13.8 t -98.26 131.99 44.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.17 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.3 m -153.2 128.98 10.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 39.5 mt -37.96 136.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.909 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -81.83 162.13 22.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.84 159.07 6.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -139.03 115.49 10.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.42 148.01 62.31 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.574 0.702 . . . . 0.0 110.868 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 159.34 53.77 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.88 158.43 56.83 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.635 2.224 . . . . 0.0 112.304 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -87.53 160.75 18.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.9 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -174.46 137.04 0.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 37.2 p -97.85 175.39 6.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 79.73 84.46 0.64 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.477 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 115.49 4.13 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.64 2.226 . . . . 0.0 112.342 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 54.2 p -153.49 145.48 23.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 3.1 t -77.66 92.46 4.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.477 179.996 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 15.6 t -79.36 154.38 29.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.892 0.377 . . . . 0.0 110.843 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 15.6 t -86.04 125.0 33.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.893 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 40.92 88.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.574 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 15.2 t -142.88 112.9 7.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.84 0.352 . . . . 0.0 110.871 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 7.6 m -72.2 136.0 46.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.811 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 147.32 42.63 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.471 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -120.3 140.43 30.12 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.584 0.707 . . . . 0.0 110.899 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -175.02 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.701 2.267 . . . . 0.0 112.349 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -133.24 171.44 14.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -52.19 115.47 1.74 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -144.96 154.06 42.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.842 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 52.9 p -79.39 165.2 23.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -42.92 118.67 1.31 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -161.19 123.16 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.938 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 417' ' ' TYR . 3.3 p -120.71 37.69 4.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -144.25 166.98 23.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.084 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . 0.4 ' CG2' HG21 ' A' ' 427' ' ' VAL . 37.7 pt -142.49 142.73 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -100.79 114.36 28.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.981 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.431 ' CG2' ' CZ ' ' A' ' 381' ' ' PHE . 9.4 t -97.52 142.19 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.176 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -147.79 120.06 8.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.43 20.55 1.39 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.48 154.43 28.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.865 0.364 . . . . 0.0 110.85 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . 0.402 HD22 ' NE2' ' A' ' 436' ' ' GLN . 5.7 p30 -74.04 -177.95 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.24 0.42 57.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 20.1 m -118.68 16.9 13.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.837 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.48 135.18 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.131 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 75.5 p -117.26 158.82 23.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.195 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.45 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 10.7 tp -56.99 -60.03 4.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.871 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -48.13 -40.12 22.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -28.8 68.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.425 HD12 ' CD1' ' A' ' 400' ' ' ILE . 47.6 mt -86.44 -31.44 21.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.38 -33.73 67.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.101 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.421 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 9.3 t70 -81.79 -20.16 39.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -92.45 -46.55 7.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.563 ' CD2' HG22 ' A' ' 415' ' ' VAL . 17.4 m-85 -65.76 -19.11 65.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -78.65 -4.28 48.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.914 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -56.74 -54.0 51.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.5 t -59.44 -65.92 0.59 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -134.41 -125.6 2.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.48 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 50.9 t -124.21 136.61 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.946 0.403 . . . . 0.0 111.105 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.22 132.26 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.089 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -57.18 106.87 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' MET . . . . . 0.49 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 73.4 mmm -102.44 121.08 41.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.78 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -46.79 150.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.72 -23.06 17.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.931 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -96.37 -47.11 6.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 61.9 p -89.46 -16.34 31.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.49 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 58.59 24.09 56.07 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.478 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -111.45 153.34 44.2 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.638 0.733 . . . . 0.0 110.883 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 146.67 60.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.667 2.245 . . . . 0.0 112.362 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' MET . . . . . 0.404 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.6 mmt -81.79 40.83 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.45 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 95.6 mt -98.8 136.22 30.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.122 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -116.3 141.09 48.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . 0.425 ' CD1' HD12 ' A' ' 377' ' ' LEU . 76.9 mt -134.67 94.13 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -60.65 124.41 20.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.412 HD21 ' N ' ' A' ' 409' ' ' PRO . 36.3 mt -109.82 135.17 51.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 407' ' ' GLY . 7.7 t0 -55.57 123.42 13.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.819 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -70.75 -2.03 13.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -89.28 -38.93 13.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 27.4 p -122.7 -34.74 3.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.177 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 104.79 -1.45 41.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.537 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -84.55 152.69 60.8 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.523 0.678 . . . . 0.0 110.915 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.467 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.2 Cg_endo -69.8 94.0 0.53 Allowed 'Trans proline' 0 N--CA 1.466 -0.132 0 C-N-CA 122.689 2.259 . . . . 0.0 112.354 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 409' ' ' PRO . 7.9 ptmt -32.94 -49.57 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 149.72 -13.58 1.02 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -90.53 155.83 18.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.84 0.353 . . . . 0.0 110.876 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.46 170.51 9.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.1 p -139.73 132.83 29.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.563 HG22 ' CD2' ' A' ' 381' ' ' PHE . 99.7 t -118.25 122.8 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' SER . . . . . 0.404 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 1.8 m -98.42 113.12 24.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.49 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 58.4 m-85 -86.74 169.85 12.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -63.44 -66.28 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.504 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.9 m-20 -114.53 156.25 44.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.708 . . . . 0.0 110.895 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.15 -43.01 57.2 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.706 2.271 . . . . 0.0 112.381 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.0 Cg_exo -50.42 -27.03 17.42 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.769 2.312 . . . . 0.0 112.348 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 90.2 m -90.4 -41.17 11.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.196 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -59.34 -49.6 77.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.077 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -59.34 -40.24 85.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.94 -33.98 71.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.037 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.5 -33.94 75.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.48 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 97.6 t -55.38 -60.88 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.97 -12.7 60.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.942 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.549 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -80.16 -55.19 5.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.918 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 91.2 m-85 -86.73 -17.68 33.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.6 OUTLIER -54.16 94.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.861 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.2 20.26 9.89 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.464 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.442 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 15.2 mmtm -78.16 170.4 16.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.877 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -114.36 112.93 23.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -120.96 105.21 10.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . 0.402 ' NE2' HD22 ' A' ' 369' ' ' ASN . 60.9 mt-30 62.25 38.08 13.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.937 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 73.97 23.38 76.41 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 71.3 m -132.38 131.05 41.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 0.0 110.868 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -72.51 136.06 45.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 8.5 mt -104.15 143.27 33.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -117.45 104.23 10.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 7.5 t -101.11 133.86 43.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.128 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 3.8 m -156.07 132.09 9.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 18.5 mt -40.35 119.82 1.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.57 98.5 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -133.9 126.52 30.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.22 143.24 28.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -110.77 135.09 20.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.563 0.697 . . . . 0.0 110.907 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 162.43 42.09 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.619 2.213 . . . . 0.0 112.387 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -34.47 14.5 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.683 2.255 . . . . 0.0 112.369 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -75.11 148.47 39.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -142.77 111.99 6.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 54.5 p 38.39 35.15 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.798 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -56.0 169.78 2.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.475 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 89.8 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.665 2.243 . . . . 0.0 112.328 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 57.1 m -101.85 106.11 17.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.89 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.1 t -60.45 96.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.489 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 89.2 p -78.69 140.42 38.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.877 0.37 . . . . 0.0 110.858 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 54.4 p -125.58 174.65 8.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -149.35 -82.77 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.47 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 46.5 p -75.05 91.65 2.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.349 . . . . 0.0 110.829 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 8.0 m -109.56 128.43 55.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.897 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 170.52 -135.03 3.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.477 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -140.9 141.28 23.71 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.62 0.724 . . . . 0.0 110.855 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 164.95 32.61 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.768 2.312 . . . . 0.0 112.353 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -69.05 79.05 0.33 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.29 141.3 58.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.13 136.29 57.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.829 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 73.2 m -101.08 44.15 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -110.38 177.52 4.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -97.01 94.02 6.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 7.6 m -90.88 37.06 0.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.806 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -136.95 166.04 24.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.071 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . 0.443 ' CG2' HG21 ' A' ' 427' ' ' VAL . 12.5 pt -137.69 142.14 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.139 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -100.44 117.91 35.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.45 ' CG2' ' CZ ' ' A' ' 381' ' ' PHE . 40.4 t -101.78 144.41 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.033 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -150.31 118.06 6.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.38 23.11 1.03 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.447 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 93.9 mt -81.36 156.37 25.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.817 0.341 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' A' ' 436' ' ' GLN . 8.5 p30 -79.9 179.94 7.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.87 1.5 53.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.844 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.9 m -117.31 16.0 14.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.83 136.59 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.098 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 73.4 p -123.05 156.21 35.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.136 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.463 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 10.6 tp -52.56 -65.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -46.61 -36.94 7.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -69.15 -31.56 70.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.402 ' CD1' HD12 ' A' ' 400' ' ' ILE . 43.4 mt -84.93 -28.45 25.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.93 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.8 -40.38 63.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.421 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 23.2 t0 -73.14 -21.39 60.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -92.58 -49.42 6.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 14.8 m-85 -62.51 -22.65 66.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -74.67 -12.77 60.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.881 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -48.47 -56.11 9.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 32.6 t -55.74 -69.58 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -132.46 -123.4 2.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.439 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 55.8 t -125.5 133.52 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 111.165 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.38 131.21 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.167 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -54.95 109.28 0.5 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' MET . . . . . 0.402 ' SD ' ' CA ' ' A' ' 396' ' ' PRO . 65.0 mmm -104.29 123.16 46.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -50.51 145.51 6.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.867 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -94.85 -8.81 36.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 392' ' ' ARG . 3.8 ptp180 -102.98 -49.46 3.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.887 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 41.1 p -94.11 -14.92 25.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.179 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 62.53 30.19 75.8 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.469 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -116.52 153.28 48.91 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.6 0.714 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.461 ' HG2' ' CD1' ' A' ' 374' ' ' LEU . 53.6 Cg_endo -69.82 147.61 62.87 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 12.5 mmt -81.36 41.23 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.463 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.0 mt -97.79 135.67 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.074 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -116.09 139.99 49.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . 0.402 HD12 ' CD1' ' A' ' 377' ' ' LEU . 60.7 mt -133.34 94.29 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.187 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -59.83 129.83 43.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.458 HD21 ' N ' ' A' ' 409' ' ' PRO . 27.0 mt -114.09 137.12 52.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 407' ' ' GLY . 5.0 t70 -55.43 128.95 36.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -76.15 -1.62 27.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -97.46 -30.18 13.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.883 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 52.5 p -124.38 -36.17 2.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 97.62 7.84 56.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.452 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.8 156.66 37.06 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.584 0.707 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.484 ' O ' ' C ' ' A' ' 410' ' ' LYS . 54.0 Cg_endo -69.68 89.08 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.644 2.229 . . . . 0.0 112.382 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 409' ' ' PRO . 6.7 ptmt -31.22 -55.45 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 157.67 -15.93 0.31 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.484 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -88.76 158.0 18.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.349 . . . . 0.0 110.842 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -170.55 173.57 5.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.139 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.4 p -141.91 137.63 31.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.157 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.555 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 45.9 t -123.55 111.63 30.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.127 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 3.6 m -87.67 113.9 23.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.523 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 55.5 m-85 -87.72 166.91 14.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.859 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -61.33 -66.24 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.3 m-20 -110.73 156.63 40.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.636 0.731 . . . . 0.0 110.831 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.04 -42.91 58.88 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.674 2.249 . . . . 0.0 112.38 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.0 Cg_exo -50.86 -46.0 32.87 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.713 2.276 . . . . 0.0 112.394 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 86.2 m -68.36 -39.22 81.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.166 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.523 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -61.82 -48.13 81.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.116 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -61.33 -39.38 90.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.59 -34.93 72.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.152 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -67.7 -34.16 76.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.053 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 94.3 t -54.93 -62.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -66.48 -10.83 48.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.548 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.2 t-105 -82.01 -55.63 4.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.918 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 90.7 m-85 -86.14 -21.43 27.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.5 t70 -52.62 97.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 103.42 21.37 9.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.494 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.411 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 19.5 mmtt -81.46 176.02 10.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.853 0.358 . . . . 0.0 110.845 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 1.6 p-10 -119.9 114.91 22.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -121.69 104.08 9.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . 0.417 ' HB2' ' ND2' ' A' ' 369' ' ' ASN . 41.9 mt-30 62.69 40.61 9.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.829 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 71.79 25.56 74.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.5 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 67.8 m -134.79 127.69 31.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.902 0.382 . . . . 0.0 110.891 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -68.95 136.77 53.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.9 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 12.4 mt -106.37 140.05 39.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -116.06 106.26 13.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.6 135.77 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.093 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 12.6 p -156.13 127.41 7.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 25.0 mt -38.87 112.63 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.978 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -50.18 132.3 23.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -75.15 142.52 43.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -173.3 135.17 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.79 150.42 39.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.619 0.723 . . . . 0.0 110.929 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 155.64 65.5 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.362 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.73 159.18 54.4 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.704 2.27 . . . . 0.0 112.339 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 34.8 ttm -101.07 118.69 37.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.829 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.56 131.15 52.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.881 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 38.9 t -163.9 116.15 1.4 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.808 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -115.51 171.02 13.51 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.419 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 -178.43 2.36 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.649 2.233 . . . . 0.0 112.397 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 43.6 t -54.7 147.8 13.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.812 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 78.0 p -116.93 -48.75 2.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.464 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 14.2 m -97.42 135.47 39.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.846 0.355 . . . . 0.0 110.89 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 8.2 t -101.34 170.02 8.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 62.94 107.76 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.464 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 6.3 t -113.06 40.9 2.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.871 0.367 . . . . 0.0 110.867 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 4.0 t -129.86 166.78 19.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 93.68 141.5 11.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.443 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 353' ' ' ASP . 0.3 OUTLIER -96.6 158.42 33.71 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 0.0 110.866 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 355' ' ' ASP . 53.5 Cg_endo -69.77 -7.94 22.34 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.61 2.207 . . . . 0.0 112.347 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 354' ' ' PRO . 24.5 t0 -36.24 118.74 0.55 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -102.01 143.92 31.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -103.24 -52.7 2.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 35.5 t -105.04 92.17 4.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.95 130.52 41.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.846 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -113.84 88.85 2.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 32.6 t -86.06 21.63 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -115.29 163.1 16.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.066 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . 0.453 ' CG2' HG23 ' A' ' 427' ' ' VAL . 37.7 pt -137.06 141.99 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -100.93 114.67 28.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.935 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.512 HG22 ' CZ ' ' A' ' 381' ' ' PHE . 5.1 t -101.2 141.9 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.105 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -147.4 123.67 10.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 128.66 14.26 2.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.521 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.09 152.61 41.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 372' ' ' VAL . 6.1 p30 -72.94 -176.41 2.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.95 -0.15 57.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.827 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.0 t -117.02 17.8 14.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . 0.4 ' N ' ' OD1' ' A' ' 369' ' ' ASN . 9.0 p -79.04 139.71 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.089 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 72.7 p -122.81 160.21 26.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.462 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 9.1 tp -56.55 -60.33 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -48.0 -37.1 13.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -30.12 68.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.495 HD22 ' CE2' ' A' ' 381' ' ' PHE . 63.2 mt -85.39 -31.34 22.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.95 -35.14 66.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.421 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 23.3 t0 -80.63 -20.56 42.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.828 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -92.65 -51.61 5.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 16.3 m-85 -61.11 -21.48 63.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 8.4 ptpt -75.79 -13.34 60.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -47.21 -54.53 10.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 21.6 t -57.34 -70.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -131.84 -124.22 2.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.508 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 96.3 t -124.55 136.67 59.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.392 . . . . 0.0 111.08 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 96.3 t -92.17 129.26 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.143 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -51.05 107.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 62.7 mmm -103.89 124.64 49.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.791 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.405 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 11.4 t-20 -47.44 145.48 2.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -94.69 -18.32 21.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 19.2 tpp85 -99.74 -45.26 5.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.863 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.405 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 23.6 p -91.85 -24.28 19.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.216 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 68.55 29.0 72.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.537 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.76 153.07 47.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.536 0.684 . . . . 0.0 110.961 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 144.95 55.28 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.625 2.216 . . . . 0.0 112.326 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' MET . . . . . 0.433 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 12.5 mmt -81.37 41.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.462 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.5 mt -97.81 142.79 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.151 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -122.22 139.62 53.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 64.3 mt -133.31 94.6 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.191 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -61.23 122.32 14.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . . . . . . . . . 33.3 mt -107.12 135.06 49.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 407' ' ' GLY . 9.9 t0 -55.51 121.54 9.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -1.16 8.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -89.08 -37.64 14.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 43.1 p -125.19 -35.67 2.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.109 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.36 1.7 38.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.467 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -87.12 152.58 53.27 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.561 0.696 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.472 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.6 Cg_endo -69.72 93.06 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.701 2.267 . . . . 0.0 112.317 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 409' ' ' PRO . 6.5 ptmt -32.76 -52.93 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.884 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 153.95 -16.08 0.61 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.494 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -87.68 155.49 19.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.848 0.356 . . . . 0.0 110.84 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.46 168.59 11.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.9 p -136.7 139.85 42.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.54 HG23 ' CD2' ' A' ' 381' ' ' PHE . 31.9 t -124.81 116.62 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' SER . . . . . 0.433 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 22.9 m -92.06 110.76 22.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.869 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 51.9 m-85 -86.79 161.89 18.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -57.94 -63.54 1.22 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.502 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 1.2 m-20 -118.59 157.13 50.51 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.576 0.703 . . . . 0.0 110.84 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.51 -43.0 55.12 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.648 2.232 . . . . 0.0 112.383 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 56.9 Cg_exo -49.48 -26.43 12.23 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.641 2.227 . . . . 0.0 112.397 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 98.8 m -91.33 -41.13 11.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.504 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -59.04 -51.0 71.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -58.63 -39.05 79.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -72.62 -32.18 65.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.104 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.87 72.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.073 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.482 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 94.6 t -54.39 -61.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.187 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -66.25 -13.03 59.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.533 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -80.46 -50.84 9.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 82.3 m-85 -92.88 -13.09 29.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.0 OUTLIER -59.51 92.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.97 -13.64 19.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.421 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 9.8 mmtm -45.68 166.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.749 0.309 . . . . 0.0 110.916 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 4.4 p-10 -115.1 112.24 22.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -111.76 108.6 18.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 61.64 31.06 18.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 91.49 -15.96 60.16 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.563 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.2 t -91.11 159.05 16.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.382 . . . . 0.0 110.898 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -96.23 134.52 39.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 8.6 mt -100.01 140.05 34.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -117.36 100.13 7.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 12.5 t -97.67 133.08 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 6.1 p -156.49 128.43 7.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.825 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 18.8 mt -39.76 130.13 1.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -67.23 148.12 52.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 63.16 28.99 16.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.814 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -135.59 168.59 18.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . 0.471 ' CG ' ' HD2' ' A' ' 449' ' ' PRO . 20.5 ttpt -84.11 139.78 39.61 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.55 0.69 . . . . 0.0 110.942 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 448' ' ' LYS . 53.8 Cg_endo -69.75 159.77 52.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.682 2.255 . . . . 0.0 112.351 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 123.31 9.97 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.704 2.269 . . . . 0.0 112.314 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 18.7 ptm -63.72 176.01 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.863 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -57.27 -54.81 42.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 5.7 t -160.33 156.11 25.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.809 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -150.96 81.9 0.18 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.485 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -12.61 33.27 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.707 2.271 . . . . 0.0 112.324 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 2.2 t -104.79 92.07 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 7.1 t -57.47 -51.89 67.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.5 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.388 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 58.7 m -102.55 177.06 4.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.867 0.365 . . . . 0.0 110.844 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 26.6 p -130.98 -53.67 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.889 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 138.5 -153.06 22.31 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.478 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 3.1 t -78.34 91.53 4.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.914 0.387 . . . . 0.0 110.843 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 80.0 p -112.29 93.54 4.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.915 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 54.33 -89.6 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.552 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.18 153.45 46.72 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.631 0.729 . . . . 0.0 110.853 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 156.66 62.9 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.774 2.316 . . . . 0.0 112.375 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.79 43.4 1.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -68.1 100.15 0.97 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.893 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -131.17 126.85 36.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 34.2 t -159.3 149.34 18.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -115.8 152.64 32.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -75.2 80.35 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.887 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.6 m -104.49 36.83 2.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.841 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -139.05 166.98 23.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.069 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 33.7 pt -137.71 143.78 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -102.32 114.31 28.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.527 HG23 ' CZ ' ' A' ' 381' ' ' PHE . 15.6 t -97.72 141.31 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.177 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -147.89 121.05 8.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.49 20.72 1.36 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.438 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 65.8 mt -81.28 153.4 27.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.766 0.317 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -75.71 -177.21 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.25 7.59 40.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.8 t -123.2 14.11 9.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 10.8 p -75.57 132.9 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 58.6 p -114.53 159.68 20.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.203 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.464 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 13.1 tp -58.95 -61.29 2.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -48.74 -32.74 9.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.97 -31.09 65.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.418 ' HB3' ' CE2' ' A' ' 381' ' ' PHE . 38.6 mt -86.21 -30.03 22.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.87 -33.26 65.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.67 -20.97 35.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.428 ' CE2' ' CD1' ' A' ' 430' ' ' PHE . 63.6 t80 -92.32 -49.5 6.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.56 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 16.1 m-85 -59.9 -26.38 65.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -75.89 -4.39 40.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -55.43 -48.88 73.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 39.3 t -63.71 -57.87 8.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -142.22 -123.19 1.83 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.488 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 71.9 t -124.84 135.98 62.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 85.9 t -92.04 128.35 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -53.18 108.96 0.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 40.1 mmm -105.87 127.53 53.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.431 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 14.4 t-20 -50.23 146.17 5.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -94.86 -13.39 25.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -100.47 -48.27 4.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.431 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 30.4 p -92.49 -19.62 21.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.473 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 66.12 26.65 72.49 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.472 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -112.59 153.28 45.03 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.654 0.74 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.407 ' CA ' ' SD ' ' A' ' 389' ' ' MET . 53.9 Cg_endo -69.67 146.61 61.32 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.722 2.281 . . . . 0.0 112.379 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' MET . . . . . 0.425 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.2 mmt -81.49 40.69 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.464 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 97.1 mt -98.05 138.76 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -118.3 137.16 53.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 73.6 mt -130.8 95.54 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.157 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -63.16 126.15 26.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.438 HD21 ' N ' ' A' ' 409' ' ' PRO . 35.8 mt -110.96 135.49 51.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.913 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.7 t0 -56.58 121.46 9.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.422 ' C ' ' HD3' ' A' ' 404' ' ' LYS . 0.0 OUTLIER -70.12 -1.05 8.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -89.04 -37.27 15.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.0 p -124.18 -36.01 2.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.098 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 107.56 -2.87 34.39 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.45 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -85.15 152.82 59.09 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.6 Cg_endo -69.76 95.79 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.707 2.271 . . . . 0.0 112.292 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 409' ' ' PRO . 6.4 ptmt -33.39 -52.37 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.99 -12.8 0.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.51 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -91.39 152.03 20.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -165.26 170.6 14.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.4 p -139.1 142.12 38.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.555 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 48.1 t -128.99 116.28 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' SER . . . . . 0.425 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 14.5 m -90.76 115.54 27.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.541 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 56.6 m-85 -88.36 163.98 15.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -62.17 -63.61 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.5 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 1.6 m-20 -116.01 156.29 46.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.634 0.731 . . . . 0.0 110.87 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.26 -43.02 56.44 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.745 2.297 . . . . 0.0 112.36 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 56.7 Cg_exo -49.31 -26.71 11.99 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.658 2.238 . . . . 0.0 112.373 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 93.4 m -91.89 -41.46 10.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.541 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -59.28 -47.36 85.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.126 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -63.26 -37.41 87.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.86 -32.33 61.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.041 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . 0.424 ' CB ' ' CZ ' ' A' ' 417' ' ' TYR . . . -69.36 -33.85 73.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.027 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 85.2 t -56.15 -64.42 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.127 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.59 -13.67 44.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.53 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -79.21 -54.39 6.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.56 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 79.8 m-85 -90.61 -11.67 39.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 3.0 t70 -61.4 98.38 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 106.38 -7.93 40.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.511 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.431 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 30.8 mmtt -53.82 165.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 110.876 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -112.67 116.18 29.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -113.82 109.71 18.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 61.13 28.77 18.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 94.1 -14.83 64.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.512 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 19.7 m -91.81 160.59 15.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 0.0 110.834 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -97.39 134.46 40.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.937 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 9.6 mt -102.84 144.9 30.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -122.77 99.51 6.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 16.9 t -96.2 131.37 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 5.4 m -151.8 129.43 11.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 21.5 mt -44.33 112.84 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.938 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -50.13 104.28 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.173 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 27.7 ttt-85 -107.09 152.53 23.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.91 158.88 30.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.943 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . 0.448 ' CG ' ' HD2' ' A' ' 449' ' ' PRO . 26.5 tttt -76.7 139.32 66.65 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.642 0.735 . . . . 0.0 110.851 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 448' ' ' LYS . 53.9 Cg_endo -69.77 125.63 12.36 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.711 2.274 . . . . 0.0 112.372 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.69 10.23 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.686 2.257 . . . . 0.0 112.378 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.1 150.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.861 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 454' ' ' GLY . 7.9 t30 -123.96 122.49 38.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.908 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 1.9 m -64.68 85.68 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . 0.418 ' O ' ' ND2' ' A' ' 452' ' ' ASN . . . 69.46 147.54 0.26 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.524 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 456' ' ' SER . 53.3 Cg_endo -69.77 2.68 3.32 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.702 2.268 . . . . 0.0 112.411 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 455' ' ' PRO . 6.1 m -34.76 134.44 0.23 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.3 t -40.43 155.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.848 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.497 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 47.6 t -113.1 140.06 48.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 110.848 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 63.7 m 48.65 42.87 20.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 350' ' ' SER . . . -117.44 72.54 0.29 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.504 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 349' ' ' GLY . 4.2 m -36.05 -50.29 0.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.908 0.385 . . . . 0.0 110.885 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 71.3 p -44.84 118.41 1.61 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -134.41 -90.2 0.36 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.523 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -139.44 153.54 70.79 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.563 0.696 . . . . 0.0 110.906 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.72 163.77 36.98 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.719 2.279 . . . . 0.0 112.367 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -110.19 97.65 7.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.817 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -89.12 39.94 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -86.67 148.91 25.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 4.7 t -134.34 -54.13 0.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.25 46.07 1.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.841 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -130.36 82.37 2.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.938 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 6.8 m -93.63 42.39 1.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -141.52 165.65 26.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.146 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . 0.463 ' HB ' ' CG1' ' A' ' 442' ' ' VAL . 17.1 pt -137.66 139.29 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.081 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -99.45 113.49 25.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.512 ' CG2' ' CZ ' ' A' ' 381' ' ' PHE . 23.2 t -96.93 143.31 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.132 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -149.95 120.57 7.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.82 20.76 1.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.498 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 44.2 mt -83.58 156.01 22.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 110.88 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . 0.543 HD22 ' NE2' ' A' ' 436' ' ' GLN . 18.4 p30 -78.62 -176.3 4.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.58 10.06 29.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.5 t -122.91 10.04 9.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.79 128.95 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 74.8 p -111.35 162.86 14.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.122 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.458 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 13.8 tp -58.74 -63.77 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -46.69 -38.24 9.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.869 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -67.09 -29.99 69.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.465 HD13 ' CD1' ' A' ' 400' ' ' ILE . 47.6 mt -87.33 -29.81 21.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.934 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.92 -41.04 64.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.411 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 30.7 t0 -76.17 -19.39 58.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -92.61 -45.58 8.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.943 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.595 ' CD2' ' CG2' ' A' ' 415' ' ' VAL . 15.0 m-85 -67.46 -19.36 65.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.838 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . 0.411 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 5.7 ptmm? -77.14 -6.04 51.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -53.24 -53.08 55.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 13.2 t -59.2 -68.18 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.07 -122.39 2.31 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.483 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 71.7 t -126.98 135.22 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.882 0.372 . . . . 0.0 111.16 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.48 130.93 36.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.158 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -55.09 104.51 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' MET . . . . . 0.499 ' SD ' ' N ' ' A' ' 396' ' ' PRO . 59.4 mmm -101.5 118.71 37.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -46.82 150.38 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -95.09 -23.6 17.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.64 -46.51 7.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.821 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 41.4 p -90.93 -14.1 32.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.16 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.45 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 55.32 30.41 55.12 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.529 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -118.67 153.18 52.14 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.556 0.693 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.499 ' N ' ' SD ' ' A' ' 389' ' ' MET . 54.1 Cg_endo -69.8 147.95 63.76 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.682 2.255 . . . . 0.0 112.345 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' MET . . . . . 0.443 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 19.7 mmt -81.84 40.58 0.61 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.829 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.458 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.2 mt -96.71 143.66 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.144 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -123.66 138.11 54.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . 0.465 ' CD1' HD13 ' A' ' 377' ' ' LEU . 60.3 mt -131.73 96.23 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.136 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -63.75 124.46 21.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.461 HD22 ' N ' ' A' ' 409' ' ' PRO . 24.7 mt -109.84 136.16 49.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.935 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.5 t70 -56.72 134.67 55.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.806 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -5.82 55.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -97.31 -26.37 14.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.43 ' OG1' ' CG ' ' A' ' 408' ' ' LYS . 65.2 p -123.1 -36.16 2.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.074 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 95.17 -6.61 68.99 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.461 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . 0.43 ' CG ' ' OG1' ' A' ' 406' ' ' THR . 3.7 ptpt -86.97 159.42 51.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.592 0.711 . . . . 0.0 110.858 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.473 ' O ' ' C ' ' A' ' 410' ' ' LYS . 54.0 Cg_endo -69.76 92.57 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.61 2.207 . . . . 0.0 112.404 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -32.39 -51.98 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 153.77 -13.96 0.59 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -90.43 157.08 17.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.903 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -170.17 169.63 7.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.056 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.6 p -140.05 139.15 35.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.138 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.595 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 60.5 t -125.66 120.85 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' SER . . . . . 0.443 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 4.8 m -95.46 116.42 28.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.827 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.441 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 60.4 m-85 -89.29 163.6 15.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.898 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -58.49 -66.35 0.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.831 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.505 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.5 m-20 -112.31 156.44 42.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.663 0.744 . . . . 0.0 110.793 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.37 -42.99 56.12 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.7 2.267 . . . . 0.0 112.349 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.3 Cg_exo -50.21 -32.63 33.17 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.638 2.225 . . . . 0.0 112.345 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 89.1 m -81.75 -38.57 25.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.441 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -62.33 -50.64 70.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.181 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -58.94 -35.61 73.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.64 -32.05 57.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.25 -33.38 71.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.069 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 97.2 t -55.91 -63.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.13 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -65.73 -9.74 30.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.534 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.2 t-105 -83.77 -55.09 4.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.555 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 93.2 m-85 -87.29 -18.52 30.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.856 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.8 t70 -55.81 98.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 103.92 12.22 30.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.518 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.431 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 16.2 mmtm -71.05 175.03 5.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.766 0.317 . . . . 0.0 110.894 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -121.72 127.94 51.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -123.92 100.74 6.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . 0.543 ' NE2' HD22 ' A' ' 369' ' ' ASN . 56.9 mt-30 62.17 36.85 14.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 93.3 -21.36 40.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.47 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 24.4 p -85.53 166.84 15.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.96 0.41 . . . . 0.0 110.842 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -112.43 137.02 51.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.4 mt -108.71 151.19 26.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -125.31 106.78 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.463 ' CG1' ' HB ' ' A' ' 363' ' ' ILE . 15.0 t -96.74 138.95 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 47.7 m -157.51 126.1 5.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 445' ' ' ALA . 19.7 mt -38.74 106.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 444' ' ' LEU . . . -37.33 100.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -69.9 -40.2 75.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -48.34 150.72 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.948 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . 0.465 ' CG ' ' HD2' ' A' ' 449' ' ' PRO . 21.2 tttp -128.51 139.43 35.51 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.532 0.682 . . . . 0.0 110.929 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 448' ' ' LYS . 53.9 Cg_endo -69.72 164.23 35.28 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.757 2.305 . . . . 0.0 112.311 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 452' ' ' ASN . 54.0 Cg_endo -69.75 2.59 3.38 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.674 2.249 . . . . 0.0 112.314 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 10.7 tpt -46.12 89.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.855 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 450' ' ' PRO . 1.2 p-10 -172.02 159.64 5.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 3.1 t -174.75 165.91 3.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.825 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -156.47 -174.28 26.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.429 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.66 120.92 7.65 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.718 2.279 . . . . 0.0 112.407 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 33.3 t -87.43 -55.04 3.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.856 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 22.7 t -59.65 123.83 18.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.485 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 13.0 t -151.02 110.93 4.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.903 0.382 . . . . 0.0 110.832 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 59.6 p -39.21 -35.41 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -99.47 -148.81 23.5 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.441 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.9 m 38.27 42.09 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.873 0.368 . . . . 0.0 110.839 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 77.5 p -149.76 146.36 27.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 79.01 96.17 0.27 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.533 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -129.86 144.17 51.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.52 0.676 . . . . 0.0 110.867 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -175.61 1.22 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.727 2.285 . . . . 0.0 112.345 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -80.62 116.83 20.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -99.14 175.18 5.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.836 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -122.04 -46.03 2.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.816 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 3.3 m -41.35 -46.8 3.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.31 35.77 23.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 445' ' ' ALA . 6.4 t30 -87.75 100.93 13.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.6 p -85.62 23.96 1.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -126.52 158.96 34.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.112 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . 0.443 ' CG2' HG23 ' A' ' 427' ' ' VAL . 38.2 pt -130.76 143.3 41.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.154 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -102.57 110.9 22.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.521 HG23 ' CZ ' ' A' ' 381' ' ' PHE . 12.0 t -95.13 142.23 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.149 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -146.66 121.09 9.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.88 14.49 2.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.519 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.47 154.85 39.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -77.11 178.79 6.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.99 6.25 40.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.9 t -121.91 13.57 10.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.858 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.7 p -74.31 138.02 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.156 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 35.4 p -122.45 158.7 29.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.447 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 17.6 tp -54.81 -60.4 3.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -50.9 -29.74 12.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -75.8 -34.24 60.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 53.0 mt -82.63 -27.96 31.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -74.26 -37.87 63.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.074 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.42 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 13.5 t70 -76.08 -21.58 56.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.848 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -92.53 -49.32 6.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.935 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.577 ' CD2' ' CG2' ' A' ' 415' ' ' VAL . 16.6 m-85 -63.82 -11.6 28.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . 0.42 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 13.5 ptmt -88.63 -5.13 58.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -54.54 -54.04 46.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.51 -67.36 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -130.71 -127.43 2.89 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.514 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 78.3 t -125.86 130.78 72.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 111.195 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 56.0 t -82.0 128.58 38.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -50.03 105.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 82.7 mmm -100.57 124.08 45.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.404 ' CB ' ' OG1' ' A' ' 393' ' ' THR . 8.0 t-20 -50.38 144.78 7.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -94.46 -18.83 21.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -99.93 -44.1 6.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.404 ' OG1' ' CB ' ' A' ' 390' ' ' ASN . 25.6 p -92.18 -22.14 19.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.185 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 65.89 29.95 76.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -120.03 153.11 55.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.86 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.83 145.72 57.6 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.721 2.281 . . . . 0.0 112.298 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' MET . . . . . 0.4 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 11.8 mmt -81.33 41.21 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.447 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 98.6 mt -98.76 140.86 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -121.05 140.25 52.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 61.3 mt -132.64 99.86 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -68.12 131.61 45.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 409' ' ' PRO . 26.0 mt -115.51 138.28 51.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.921 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 407' ' ' GLY . 6.0 t0 -59.53 124.52 20.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -71.34 -1.17 12.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -89.5 -39.66 13.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 82.8 p -121.72 -33.42 3.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 103.9 -4.49 45.84 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.523 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -82.54 152.86 67.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.6 0.714 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.468 ' N ' HD23 ' A' ' 402' ' ' LEU . 54.1 Cg_endo -69.76 95.64 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.689 2.26 . . . . 0.0 112.336 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 409' ' ' PRO . 8.7 ptmt -32.76 -54.62 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.51 -13.87 0.52 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.2 p-10 -87.73 157.21 19.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.743 0.306 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.38 169.4 9.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.052 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 2.3 p -137.84 139.69 40.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.192 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.577 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 48.6 t -127.15 114.78 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' SER . . . . . 0.4 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 2.8 m -91.11 112.17 23.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.841 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.515 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 68.8 m-85 -86.84 160.93 18.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.88 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -55.18 -67.44 0.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.83 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.506 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.4 m-20 -107.41 156.21 38.15 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.517 0.675 . . . . 0.0 110.942 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.34 -42.94 56.76 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.712 2.275 . . . . 0.0 112.324 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 53.0 Cg_exo -50.03 -46.82 26.35 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.733 2.289 . . . . 0.0 112.253 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 28.6 m -64.45 -43.77 93.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.17 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.515 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -58.85 -45.8 89.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.093 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -64.49 -35.33 80.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.03 -33.53 57.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.078 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -69.38 -33.87 73.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.075 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.474 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 77.1 t -54.71 -61.43 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.55 -15.03 63.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.535 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -78.14 -52.39 8.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.903 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.555 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 89.1 m-85 -88.92 -16.68 31.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.869 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.0 t70 -59.9 97.04 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 111.57 1.26 27.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.547 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 19.5 mmtm -67.36 168.34 10.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.803 0.335 . . . . 0.0 110.956 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 434' ' ' ASP . 1.4 p-10 -115.78 111.55 20.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -111.27 106.55 15.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 61.42 37.73 16.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 74.6 23.61 74.79 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.415 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 36.5 m -132.35 128.78 38.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.919 0.39 . . . . 0.0 110.832 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.17 133.75 48.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.925 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 17.1 mt -101.05 156.81 17.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.96 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -129.74 100.58 5.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.886 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 14.2 t -100.58 131.89 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.171 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 444' ' ' LEU . 13.3 m -157.37 124.27 5.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 443' ' ' SER . 34.9 mt -35.05 128.22 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.499 ' O ' ' ND2' ' A' ' 360' ' ' ASN . . . -68.76 138.16 54.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.156 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -93.55 146.97 23.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -93.65 171.38 8.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . 0.468 ' CD ' ' HD2' ' A' ' 449' ' ' PRO . 6.1 tppt? -118.83 138.65 26.24 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.542 0.687 . . . . 0.0 110.936 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . 0.468 ' HD2' ' CD ' ' A' ' 448' ' ' LYS . 53.3 Cg_endo -69.78 162.2 43.0 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.647 2.232 . . . . 0.0 112.379 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -36.96 9.86 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.685 2.257 . . . . 0.0 112.346 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 22.2 mmt -42.51 163.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.86 159.41 30.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 1.3 t -100.09 115.29 29.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -40.3 140.33 1.02 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.557 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 124.41 11.06 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.681 2.254 . . . . 0.0 112.371 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 95.6 p -116.27 162.91 16.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.838 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 8.7 t -67.84 83.63 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.438 179.969 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 17.2 m -107.45 -59.96 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.372 . . . . 0.0 110.853 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 3.0 t -76.64 -55.78 5.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.873 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -64.92 138.19 39.36 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.465 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 14.4 t -101.53 43.46 1.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.797 0.332 . . . . 0.0 110.815 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 96.3 p -109.43 148.45 31.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 74.35 -175.65 48.59 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.479 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.415 ' CG ' ' HD2' ' A' ' 354' ' ' PRO . 8.5 t70 -124.35 139.76 33.61 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.529 0.681 . . . . 0.0 110.866 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' A' ' 353' ' ' ASP . 53.8 Cg_endo -69.77 2.24 3.72 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.709 2.272 . . . . 0.0 112.321 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.69 -176.57 3.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.861 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -113.66 97.08 6.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -65.3 121.94 15.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.893 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 5.7 t -60.54 163.74 5.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.855 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.67 56.93 3.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.848 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -85.92 80.75 8.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.93 39.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -142.85 161.65 37.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.091 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . 0.413 ' CG2' HG23 ' A' ' 427' ' ' VAL . 38.9 pt -135.52 141.14 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.113 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -100.03 122.04 42.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 8.1 t -107.5 141.75 21.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.076 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -145.62 123.59 12.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 126.54 16.33 2.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.458 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 93.9 mt -73.84 152.89 40.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 372' ' ' VAL . 6.1 p30 -73.96 -176.53 2.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.96 3.6 54.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.8 m -120.79 17.7 11.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . 0.423 ' N ' ' OD1' ' A' ' 369' ' ' ASN . 11.5 p -79.31 143.23 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.181 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 82.2 p -126.82 155.51 42.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.183 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.466 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 16.5 tp -49.64 -62.05 1.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -48.74 -37.85 20.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.83 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -66.53 -27.43 67.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 89.6 mt -91.09 -30.06 16.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.66 -37.53 67.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.089 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.418 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 27.7 t70 -78.39 -19.63 52.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.895 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -92.61 -51.9 4.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 19.1 m-85 -60.34 -24.87 65.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . 0.418 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 8.8 ptmt -70.87 -10.48 59.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.934 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -51.71 -57.4 9.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.3 t -53.93 -66.82 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -136.59 -122.67 2.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 75.4 t -126.01 130.66 72.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.92 0.39 . . . . 0.0 111.115 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.61 131.15 34.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -54.54 107.76 0.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' MET . . . . . 0.467 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 64.0 mmm -104.35 122.76 46.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.449 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 14.4 t-20 -48.8 148.98 1.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -94.91 -22.38 18.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.85 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -93.98 -48.39 6.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.842 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.449 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 41.1 p -88.42 -24.07 23.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.098 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.467 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 68.0 25.88 74.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.433 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -114.94 153.22 47.05 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.571 0.7 . . . . 0.0 110.965 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.433 ' CA ' ' SD ' ' A' ' 389' ' ' MET . 53.4 Cg_endo -69.78 147.03 61.86 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.7 2.267 . . . . 0.0 112.339 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' MET . . . . . 0.45 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 15.0 mmt -81.27 41.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.466 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.2 mt -98.04 136.52 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.182 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -117.47 142.19 47.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 61.4 mt -134.81 94.08 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -61.17 121.84 13.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.465 HD21 ' N ' ' A' ' 409' ' ' PRO . 31.3 mt -108.88 135.37 50.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.931 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 407' ' ' GLY . 11.7 t0 -55.33 122.36 10.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -69.89 -0.9 8.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.772 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -91.35 -41.21 11.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.6 p -118.78 -34.39 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 101.7 5.06 51.71 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.46 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -91.09 153.15 44.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.552 0.692 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.484 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.4 Cg_endo -69.76 91.89 0.51 Allowed 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.652 2.235 . . . . 0.0 112.372 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 409' ' ' PRO . 9.2 ptmt -31.67 -52.41 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.33 -17.13 0.59 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -87.63 157.22 19.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.856 0.36 . . . . 0.0 110.872 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.4 174.17 6.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 2.2 p -143.61 141.32 30.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.113 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.534 HG21 ' CD2' ' A' ' 381' ' ' PHE . 95.8 t -129.41 115.23 34.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' SER . . . . . 0.45 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 1.9 m -90.67 114.76 27.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.494 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 51.8 m-85 -87.94 161.1 17.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -54.34 -66.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.835 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.507 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 7.1 m-20 -116.34 158.35 43.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.632 0.729 . . . . 0.0 110.878 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.8 Cg_exo -57.44 -43.23 53.44 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.71 2.273 . . . . 0.0 112.332 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 53.1 Cg_exo -49.99 -27.44 16.48 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.65 2.234 . . . . 0.0 112.374 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 40.4 m -89.61 -41.78 11.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.117 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.494 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -59.84 -48.89 79.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -59.7 -38.96 83.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.82 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -72.84 -32.99 65.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -69.09 -35.07 76.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 94.7 t -55.27 -62.52 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -66.9 -11.11 55.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.551 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -81.02 -55.39 4.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.925 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 91.0 m-85 -87.34 -19.65 27.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.859 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.1 t70 -51.65 96.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.854 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 103.93 20.8 10.19 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.485 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.441 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 16.1 mmtm -76.81 170.99 15.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.769 0.319 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . 0.426 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 1.7 p30 -115.04 109.29 17.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.841 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -112.79 108.07 16.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 62.08 33.72 16.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 89.2 -16.38 55.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.448 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 3.1 m -92.66 164.04 13.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.964 0.411 . . . . 0.0 110.836 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -101.62 138.38 38.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 12.4 mt -106.89 144.86 32.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -118.94 107.93 14.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.408 ' CG1' HD11 ' A' ' 363' ' ' ILE . 9.1 t -100.85 131.99 47.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.12 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 10.3 p -152.12 128.81 10.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.885 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 33.2 mt -40.41 111.81 0.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -48.65 170.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.04 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -110.52 100.03 8.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.51 116.4 31.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.851 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.87 132.22 86.63 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.605 0.717 . . . . 0.0 110.884 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 146.31 59.86 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.702 2.268 . . . . 0.0 112.337 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . 0.405 ' C ' ' SD ' ' A' ' 451' ' ' MET . 54.1 Cg_endo -69.66 -172.52 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.62 2.213 . . . . 0.0 112.37 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' MET . . . . . 0.405 ' SD ' ' C ' ' A' ' 450' ' ' PRO . 0.5 OUTLIER -125.92 89.61 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.937 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -82.3 39.89 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 10.6 t 64.67 35.88 8.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -87.53 -69.06 1.3 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 2.11 3.88 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.662 2.242 . . . . 0.0 112.312 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 6.2 t 73.35 50.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 2.7 t -80.4 -32.47 37.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.863 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 2.3 m -104.13 42.88 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.0 110.85 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 13.2 t -108.67 147.42 31.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 160.55 -171.75 36.78 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.551 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 93.6 p -144.64 127.76 16.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.346 . . . . 0.0 110.849 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 2.2 t -97.35 85.58 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.813 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -155.84 124.38 1.47 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.503 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -109.12 79.47 1.17 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.592 0.71 . . . . 0.0 110.869 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 2.64 3.35 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.65 2.234 . . . . 0.0 112.313 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 73.95 48.57 0.13 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.789 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -150.62 114.22 4.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.79 48.67 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 93.9 p -85.91 76.37 9.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.863 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -164.5 -179.77 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.7 82.37 2.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.8 p -96.8 6.75 48.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -108.86 158.71 17.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . 0.461 ' CG1' ' HB ' ' A' ' 415' ' ' VAL . 28.9 pt -125.84 142.33 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -103.09 116.32 32.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.418 ' CG2' ' CZ ' ' A' ' 381' ' ' PHE . 9.3 t -101.73 144.21 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.123 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -149.06 120.13 7.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.01 20.25 1.33 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.454 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 90.9 mt -79.94 154.53 28.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.808 0.337 . . . . 0.0 110.965 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -77.61 -178.53 5.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.69 3.5 52.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.0 t -118.83 15.72 13.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.859 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.13 136.15 25.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 34.0 p -121.48 157.16 31.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.14 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.47 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 21.8 tp -53.75 -65.99 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -45.47 -32.75 2.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.21 -32.34 64.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 374' ' ' LEU . 27.8 mt -82.59 -31.11 29.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.918 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -71.03 -44.93 64.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.107 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -72.57 -18.63 61.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -92.62 -41.6 10.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 16.3 m-85 -73.6 -25.01 60.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -67.06 -6.84 18.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.982 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -56.04 -60.19 3.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 35.2 t -49.46 -64.45 0.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.907 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -143.98 -122.55 1.64 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.451 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 69.0 t -121.79 122.04 65.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 0.0 111.131 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 81.8 t -77.53 127.75 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.226 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.462 ' CD ' ' HA ' ' A' ' 418' ' ' GLU . 33.2 tptt -46.09 103.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 73.0 mmm -103.32 126.33 50.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -51.43 145.7 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.92 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -94.59 -20.81 19.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -97.38 -45.47 6.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 25.0 p -90.72 -25.26 20.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 68.98 29.47 72.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -117.9 153.76 51.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.644 0.735 . . . . 0.0 110.927 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 144.11 53.17 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.68 2.253 . . . . 0.0 112.379 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' MET . . . . . 0.414 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 15.2 mmt -82.1 40.26 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.47 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.4 mt -96.06 141.42 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.158 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -122.03 139.48 53.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 61.2 mt -132.08 94.48 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.126 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -61.29 130.11 44.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 409' ' ' PRO . 35.8 mt -114.36 136.82 52.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.861 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 407' ' ' GLY . 6.4 t0 -56.83 126.52 27.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.812 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.57 -1.15 17.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -92.02 -36.74 13.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 31.2 p -123.57 -33.6 3.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 101.64 -1.52 52.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.524 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -84.27 152.93 62.15 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.612 0.72 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.48 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.2 Cg_endo -69.76 92.42 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.306 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.48 ' C ' ' O ' ' A' ' 409' ' ' PRO . 8.1 ptmt -31.82 -51.99 0.23 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.86 -15.6 0.8 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.531 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -88.23 151.64 22.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -164.29 172.04 14.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.1 p -140.21 141.3 35.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.12 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.461 ' HB ' ' CG1' ' A' ' 363' ' ' ILE . 58.0 t -128.29 113.63 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.076 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' SER . . . . . 0.414 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 2.1 m -87.48 119.25 27.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.559 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 37.2 m-85 -91.55 159.02 16.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.959 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . 0.462 ' HA ' ' CD ' ' A' ' 388' ' ' LYS . 15.9 mm-40 -58.2 -60.88 3.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.512 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.2 m-20 -113.69 156.9 42.96 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.568 0.699 . . . . 0.0 110.899 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.4 Cg_exo -57.01 -42.89 59.36 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.626 2.217 . . . . 0.0 112.323 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.5 Cg_exo -52.46 -41.99 64.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.727 2.285 . . . . 0.0 112.351 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 39.3 m -67.36 -40.82 85.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.167 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.559 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -62.18 -49.8 74.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.06 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -60.15 -36.14 76.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.55 -33.05 58.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.115 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 417' ' ' TYR . . . -72.43 -33.24 66.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.476 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 86.1 t -57.33 -62.06 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.179 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -68.12 -11.35 58.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.549 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.62 -54.81 5.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 91.7 m-85 -87.76 -19.6 27.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.4 t0 -54.15 89.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 116.46 13.99 7.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.533 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.459 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 2.4 mmmp? -79.44 176.2 9.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 0.0 110.903 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -121.36 126.9 50.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -126.24 105.53 8.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 62.58 31.01 17.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.889 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 83.94 18.38 63.38 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.527 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 19.4 m -128.6 126.67 40.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.969 0.414 . . . . 0.0 110.862 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.9 138.07 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 10.0 mt -108.89 147.49 32.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -119.37 108.5 14.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.433 ' CG1' ' HA ' ' A' ' 427' ' ' VAL . 13.0 t -100.85 132.2 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 9.5 p -151.7 127.54 10.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.806 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 16.4 mt -45.76 113.9 0.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.41 109.38 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.053 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 446' ' ' ARG . 21.7 ttm105 -110.79 -56.03 2.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 22.3 tttm 56.89 31.6 19.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 38.9 tttt -129.76 134.79 26.59 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.607 0.718 . . . . 0.0 110.886 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 148.41 65.05 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.697 2.265 . . . . 0.0 112.334 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 175.38 8.16 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.701 2.267 . . . . 0.0 112.343 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.59 -176.66 3.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.933 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -109.81 109.5 20.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.916 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 21.2 m -161.12 122.97 3.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -89.63 151.54 21.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.412 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.73 -10.34 28.34 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.642 2.228 . . . . 0.0 112.352 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 37.1 m -71.79 168.5 17.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.849 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 2.7 m -56.81 103.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.793 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.257 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.456 179.984 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 347' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 346' ' ' GLY . 3.8 m -36.4 123.06 0.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.906 0.384 . . . . 0.0 110.84 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 93.4 p -127.76 106.5 9.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.834 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 142.49 -146.5 17.46 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.464 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 29.0 t -109.79 109.28 19.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.006 0.431 . . . . 0.0 110.886 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 3.8 m -51.46 -56.04 15.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.848 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 162.17 -50.54 0.33 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.47 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -110.25 80.91 2.04 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.707 . . . . 0.0 110.868 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.66 1.16 4.62 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.737 2.291 . . . . 0.0 112.327 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.86 94.1 1.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.825 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -50.9 108.58 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -100.88 -43.54 6.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 30.2 p -107.27 90.06 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -104.26 104.75 14.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -145.0 114.81 7.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.857 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 417' ' ' TYR . 8.5 p -121.97 44.17 2.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -146.99 169.24 19.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.068 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . 0.429 ' CG2' HG23 ' A' ' 427' ' ' VAL . 37.0 pt -144.96 142.68 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -101.1 113.11 25.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.488 HG22 ' CZ ' ' A' ' 381' ' ' PHE . 19.3 t -96.19 144.22 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.123 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -150.23 119.55 6.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.4 23.38 1.01 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.574 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 71.6 mt -83.72 152.71 24.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 0.0 110.887 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . 0.505 ' ND2' ' CD ' ' A' ' 436' ' ' GLN . 5.0 p30 -74.61 179.34 4.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.41 1.08 52.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 14.3 m -117.29 13.65 14.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.845 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.37 133.59 31.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.129 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 81.6 p -117.56 163.98 15.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.149 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.458 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 16.3 tp -58.9 -62.77 1.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.08 -38.37 7.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.92 -31.8 73.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 84.5 mt -86.97 -30.32 21.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.959 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.17 -33.76 65.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.081 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.405 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 8.4 t70 -84.6 -19.4 33.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.493 ' CE1' ' NE2' ' A' ' 383' ' ' GLN . 47.0 t80 -91.92 -50.89 5.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.56 ' CD2' HG23 ' A' ' 415' ' ' VAL . 20.0 m-85 -61.72 -23.6 66.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.876 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . 0.405 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 30.3 pttt -72.65 -6.95 47.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.865 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . 0.493 ' NE2' ' CE1' ' A' ' 380' ' ' PHE . 12.5 mt-30 -55.11 -51.91 64.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 7.3 t -62.79 -64.75 0.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -134.82 -129.87 2.93 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.49 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 50.3 t -122.07 129.11 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.808 0.337 . . . . 0.0 111.178 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.85 128.43 38.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -52.42 105.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.845 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 73.9 mmm -101.22 123.75 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.409 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 11.5 t-20 -50.1 147.27 4.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.844 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -94.71 -18.28 21.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -99.71 -44.22 6.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.409 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 67.0 p -93.53 -17.12 23.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 60.69 26.67 65.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.514 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -115.37 153.04 47.53 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.581 0.705 . . . . 0.0 110.942 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 146.66 61.21 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.696 2.264 . . . . 0.0 112.362 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 6.8 mmt -81.37 41.15 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.926 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.458 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 90.6 mt -98.96 135.02 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.137 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -114.77 138.08 51.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 60.7 mt -130.79 94.2 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.163 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -61.78 123.82 19.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 409' ' ' PRO . 45.3 mt -110.19 135.93 50.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 407' ' ' GLY . 11.1 t70 -55.42 124.37 16.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.932 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -73.09 -1.05 15.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -95.08 -35.12 12.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 37.2 p -121.24 -36.13 3.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.079 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 103.21 -6.99 51.21 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.551 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -82.55 153.04 67.87 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.592 0.71 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.473 ' N ' HD23 ' A' ' 402' ' ' LEU . 53.8 Cg_endo -69.69 94.51 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.7 2.267 . . . . 0.0 112.372 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -32.58 -50.15 0.24 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.817 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 150.14 -15.3 1.01 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.468 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -88.15 154.99 20.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.777 0.322 . . . . 0.0 110.927 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.05 170.93 10.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.121 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 2.5 p -137.91 142.04 40.62 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.167 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.56 HG23 ' CD2' ' A' ' 381' ' ' PHE . 47.3 t -127.81 115.25 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 1.9 m -92.65 114.97 27.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.498 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 54.2 m-85 -89.05 163.39 15.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.974 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -56.24 -65.49 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.505 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 4.7 m-20 -115.78 156.56 46.24 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.731 . . . . 0.0 110.842 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.2 Cg_exo -57.37 -42.89 57.11 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.636 2.224 . . . . 0.0 112.366 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.0 Cg_exo -50.69 -26.98 18.49 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.625 2.217 . . . . 0.0 112.361 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 52.9 m -89.05 -43.17 11.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.498 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -58.87 -48.13 82.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -59.86 -38.47 82.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.888 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.0 -32.83 63.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.079 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.73 -31.95 68.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.464 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 90.5 t -56.32 -60.69 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.082 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -67.06 -12.45 59.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.554 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.53 -54.6 5.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.551 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 88.9 m-85 -88.26 -14.56 38.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.88 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.7 OUTLIER -58.49 93.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 108.1 14.72 16.06 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.466 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.402 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 15.7 mmtm -73.92 169.67 16.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.76 0.315 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -112.28 112.92 24.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -115.47 106.48 14.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . 0.505 ' CD ' ' ND2' ' A' ' 369' ' ' ASN . 69.1 mt-30 61.59 38.56 15.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.968 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 84.49 -14.53 45.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.5 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 6.1 m -94.25 168.92 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.815 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -106.62 135.95 47.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 9.4 mt -102.69 145.05 30.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -119.78 107.39 13.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.832 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.412 ' CG1' ' HB ' ' A' ' 363' ' ' ILE . 6.3 t -103.08 136.26 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.1 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 444' ' ' LEU . 22.0 m -157.3 126.38 5.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 443' ' ' SER . 19.4 mt -35.03 123.75 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -61.79 129.69 42.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.067 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 46.5 mmt-85 61.64 42.01 11.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -76.21 148.45 37.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . 0.469 ' CD ' ' HD2' ' A' ' 449' ' ' PRO . 1.9 tppp? -68.69 136.38 90.31 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 0.0 110.886 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . 0.469 ' HD2' ' CD ' ' A' ' 448' ' ' LYS . 53.8 Cg_endo -69.7 129.51 17.78 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.745 2.297 . . . . 0.0 112.326 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -170.44 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.709 2.273 . . . . 0.0 112.343 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 72.6 mmm -114.22 96.38 5.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -57.21 98.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 8.3 t -111.99 145.3 39.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -135.34 -94.76 0.46 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.549 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 108.73 2.14 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.623 2.215 . . . . 0.0 112.377 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 73.9 m -95.46 119.69 34.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.833 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.4 t -80.34 115.62 19.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.466 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.25 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 53.4 m -138.39 135.32 35.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.901 0.381 . . . . 0.0 110.935 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 90.1 p -159.42 162.66 35.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -79.5 104.2 2.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.535 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 32.0 t -149.05 105.87 3.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.865 0.364 . . . . 0.0 110.872 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 78.9 p -94.91 -46.23 6.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 145.71 98.58 0.24 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.483 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.57 150.36 97.88 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.631 0.729 . . . . 0.0 110.847 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 138.57 38.1 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.708 2.272 . . . . 0.0 112.397 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -70.39 98.19 1.38 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 357' ' ' ASP . 7.8 tp10 -48.35 158.51 0.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . 0.406 ' N ' ' HG3' ' A' ' 356' ' ' GLU . 6.9 t0 -54.49 -53.48 53.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 99.2 p -129.87 156.48 44.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.793 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.7 44.29 1.78 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.865 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -51.86 99.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.951 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.7 m -93.95 42.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.863 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -145.68 156.73 43.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.105 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . 0.453 ' HB ' ' CG1' ' A' ' 442' ' ' VAL . 44.8 pt -128.67 140.12 50.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -98.75 111.36 23.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.461 HG23 ' CZ ' ' A' ' 381' ' ' PHE . 13.0 t -95.19 140.09 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.148 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -147.39 122.4 10.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 131.81 6.07 3.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.517 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 19.8 mt -71.99 156.42 39.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.871 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . 0.519 ' H ' ' ND2' ' A' ' 369' ' ' ASN . 0.3 OUTLIER -83.88 175.37 9.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -83.61 7.45 17.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.5 t -116.92 3.51 12.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 5.0 p -75.05 134.61 29.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.083 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 41.1 p -113.59 170.69 8.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.155 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.467 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 12.0 tp -65.93 -65.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -45.59 -26.58 0.62 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -73.41 -36.39 65.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.828 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 374' ' ' LEU . 81.1 mt -87.32 -25.48 23.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.6 -35.3 72.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -89.15 -15.04 34.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -92.53 -42.58 9.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 20.3 m-85 -72.49 -22.19 61.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 2.7 ptmm? -68.87 -5.05 18.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -56.13 -59.99 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 4.1 t -52.8 -64.26 0.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -139.05 -123.43 2.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.445 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 92.8 t -125.53 131.41 72.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 111.099 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 64.7 t -82.52 122.36 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -47.06 110.39 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' MET . . . . . 0.478 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 27.9 mtp -107.94 128.75 54.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.879 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -54.83 147.6 14.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.63 -14.25 25.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -101.09 -46.5 5.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.836 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 67.3 p -91.76 -19.28 22.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.118 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.478 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 64.89 19.9 66.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.464 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -107.64 152.65 41.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 0.0 110.917 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 147.41 62.47 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.66 2.24 . . . . 0.0 112.38 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 11.0 mmt -81.36 41.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.467 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 91.8 mt -98.63 135.97 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -115.59 138.07 51.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.827 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 67.0 mt -134.41 94.0 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.095 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -59.63 122.34 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.931 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.439 HD21 ' N ' ' A' ' 409' ' ' PRO . 49.0 mt -106.76 136.35 46.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.939 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 407' ' ' GLY . 1.5 t70 -55.14 125.93 22.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -73.1 -1.24 16.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.441 ' CG ' ' OD1' ' A' ' 403' ' ' ASP . 3.4 mm-40 -96.48 -36.59 10.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 34.6 p -119.74 -35.22 3.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 100.25 -1.02 56.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.507 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -86.8 155.95 55.7 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.597 0.713 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.9 Cg_endo -69.75 91.3 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.72 2.28 . . . . 0.0 112.272 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.482 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -31.49 -48.45 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.864 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 148.95 -10.63 1.03 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -95.35 154.53 17.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 0.0 110.828 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.39 171.47 9.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.13 128.63 20.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.512 HG21 ' CE2' ' A' ' 381' ' ' PHE . 62.5 t -112.3 118.38 57.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 3.2 m -92.59 116.08 28.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.849 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 52.9 m-85 -89.74 160.3 16.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -57.5 -63.97 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.501 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.7 m-20 -115.59 156.66 45.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.625 0.726 . . . . 0.0 110.845 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.8 Cg_exo -57.4 -43.02 55.66 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.705 2.27 . . . . 0.0 112.3 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 61.7 Cg_exo -48.68 -29.43 14.44 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 90.7 m -88.58 -39.45 14.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.133 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -61.5 -50.23 73.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -60.08 -38.5 83.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.98 -31.29 61.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.104 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . 0.421 ' CB ' ' CE2' ' A' ' 417' ' ' TYR . . . -70.04 -33.81 72.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.156 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.486 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 76.3 t -55.85 -64.11 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.157 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -64.99 -12.58 51.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.534 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -80.16 -54.64 5.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 90.9 m-85 -89.47 -14.1 36.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.7 t0 -58.15 99.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.768 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 99.79 22.85 11.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.53 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.435 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 19.9 mmtt -78.72 167.92 20.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.794 0.33 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 4.3 p-10 -110.7 108.29 18.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.792 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -115.42 108.33 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.82 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 61.28 36.94 17.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 75.2 21.17 78.44 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.555 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 72.1 m -130.85 129.69 42.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.908 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -70.27 136.56 49.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 8.0 mt -104.66 157.41 17.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.894 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -130.39 106.01 8.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 363' ' ' ILE . 10.2 t -103.1 133.06 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.106 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 84.7 p -150.04 132.21 15.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 24.3 mt -44.42 116.46 1.04 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.902 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -50.36 115.65 1.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.193 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 22.5 ttt-85 -129.27 106.28 8.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.46 24.57 5.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -107.56 136.79 19.59 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.535 0.683 . . . . 0.0 110.91 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 110.35 2.56 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.643 2.229 . . . . 0.0 112.333 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -22.13 32.68 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.666 2.244 . . . . 0.0 112.358 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -134.62 134.02 40.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -82.36 -48.64 10.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 94.7 p -126.55 -43.16 1.76 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.776 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -165.89 179.83 39.89 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.504 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -7.84 22.07 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.666 2.244 . . . . 0.0 112.383 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 3.2 m -65.5 128.96 38.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 4.6 t -118.92 120.76 38.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.505 -179.973 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 8.4 t -82.38 101.41 10.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.372 . . . . 0.0 110.844 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 96.9 p -107.29 118.07 35.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.919 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -156.89 82.11 0.16 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.2 t -89.2 106.07 18.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.906 0.384 . . . . 0.0 110.836 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 95.0 p -105.85 -34.37 7.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.863 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 78.11 178.55 49.32 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -154.1 120.52 2.82 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.649 0.737 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -30.42 22.12 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.691 2.261 . . . . 0.0 112.358 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -94.24 122.83 37.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.833 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.99 -9.36 22.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.892 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.26 171.94 12.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 73.5 m 61.39 44.99 8.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.757 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -38.81 102.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.11 72.54 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.4 m -89.0 38.45 0.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.858 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -140.25 155.83 46.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.102 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . 0.425 HD12 ' CG1' ' A' ' 442' ' ' VAL . 31.4 pt -128.85 143.48 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.102 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.69 123.35 44.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.479 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 11.3 t -107.45 139.34 29.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.135 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -145.79 122.87 11.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 128.63 11.11 3.06 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.518 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 30.6 mt -70.98 155.84 40.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.798 0.332 . . . . 0.0 110.921 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . 0.478 ' OD1' ' NE2' ' A' ' 436' ' ' GLN . 6.6 p30 -78.2 174.46 11.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.68 14.53 5.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.4 t -131.71 19.57 4.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.831 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 8.2 p -82.69 130.15 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.133 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 58.8 p -110.44 156.69 20.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.141 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.463 ' CD1' ' HG2' ' A' ' 396' ' ' PRO . 9.1 tp -54.46 -54.16 44.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -54.57 -35.13 62.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -69.88 -28.49 65.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 60.2 mt -89.42 -29.06 19.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -71.67 -38.48 70.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.417 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 8.9 t70 -82.56 -17.37 45.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -92.67 -41.73 10.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.616 ' CD2' ' CG2' ' A' ' 415' ' ' VAL . 15.2 m-85 -71.95 -16.91 62.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . 0.417 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 9.5 ptpt -77.79 -6.59 54.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -55.74 -50.28 70.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.0 t -62.14 -60.84 3.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.91 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -142.65 -126.46 2.08 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.82 128.81 75.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 0.0 111.195 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 84.2 t -84.9 130.05 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.099 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -54.8 113.29 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' MET . . . . . 0.501 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 43.7 mmm -109.74 123.63 49.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -49.55 144.15 6.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -94.75 -8.39 37.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -101.9 -46.82 4.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 35.0 p -97.42 -16.63 20.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.101 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.501 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 65.6 26.66 72.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.568 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -112.43 152.95 44.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.557 0.694 . . . . 0.0 110.967 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.463 ' HG2' ' CD1' ' A' ' 374' ' ' LEU . 54.6 Cg_endo -69.69 149.12 66.91 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.74 2.293 . . . . 0.0 112.333 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 7.0 mmt -82.69 38.09 0.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.463 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 91.8 mt -95.98 140.97 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.158 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -121.5 138.01 54.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 61.6 mt -131.1 93.83 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.076 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -59.44 124.4 19.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.965 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.426 HD22 ' N ' ' A' ' 409' ' ' PRO . 35.1 mt -107.9 137.16 46.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.891 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 407' ' ' GLY . 8.1 t0 -55.46 123.92 15.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -71.2 -1.12 11.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -96.08 -39.1 9.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 33.0 p -117.31 -35.43 4.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 101.23 -1.65 54.35 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.446 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -85.94 155.55 58.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.646 0.736 . . . . 0.0 110.856 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.1 Cg_endo -69.76 90.95 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.702 2.268 . . . . 0.0 112.279 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.482 ' C ' ' O ' ' A' ' 409' ' ' PRO . 2.3 ptmt -31.73 -53.89 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 155.01 -15.96 0.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.507 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -88.9 156.99 18.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.769 0.319 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.93 175.23 5.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.14 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.56 132.71 23.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.147 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.616 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 38.8 t -118.87 113.3 41.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.168 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 2.6 m -89.54 116.78 27.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.49 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 57.7 m-85 -93.04 164.18 13.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -56.84 -66.46 0.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.939 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.509 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.4 m-20 -114.54 156.97 43.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.614 0.721 . . . . 0.0 110.83 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.34 -42.97 56.48 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.634 2.223 . . . . 0.0 112.355 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.1 Cg_exo -50.53 -27.19 18.35 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.652 2.235 . . . . 0.0 112.412 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 29.4 m -87.91 -42.36 12.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -60.44 -41.42 93.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.113 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -65.77 -38.36 88.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.887 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.38 -30.89 62.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.138 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -72.1 -30.78 65.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.438 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 64.0 t -58.74 -63.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.144 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -64.23 -13.21 47.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.523 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -80.08 -54.65 5.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.552 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 79.3 m-85 -87.56 -14.06 41.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.4 t70 -61.51 95.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 117.8 -19.05 11.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.496 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.409 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 2.5 mmmp? -47.88 176.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.764 0.316 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -124.53 130.4 52.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.811 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -129.75 107.27 9.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . 0.478 ' NE2' ' OD1' ' A' ' 369' ' ' ASN . 63.7 mt-30 61.8 32.53 18.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 81.12 19.53 66.89 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.465 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 12.2 m -128.11 129.31 46.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.911 0.386 . . . . 0.0 110.844 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -68.67 134.52 49.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 22.1 mt -100.81 143.07 31.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -119.37 101.81 8.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.425 ' CG1' HD12 ' A' ' 363' ' ' ILE . 14.0 t -99.27 129.8 49.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.143 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.5 m -154.21 128.46 9.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.866 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 28.6 mt -40.41 132.06 2.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.967 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -76.23 109.89 10.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.071 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -146.69 109.64 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -155.48 111.6 3.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -127.51 150.45 72.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.554 0.692 . . . . 0.0 110.856 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.88 167.2 25.28 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.637 2.225 . . . . 0.0 112.267 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 451' ' ' MET . 54.1 Cg_endo -69.79 2.94 3.09 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.683 2.255 . . . . 0.0 112.276 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' MET . . . . . 0.449 ' C ' ' O ' ' A' ' 450' ' ' PRO . 7.5 mmt -34.44 -47.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.933 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -104.78 137.77 42.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.818 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 7.6 t -137.72 129.63 28.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -148.72 -94.45 0.13 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.498 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 129.3 17.36 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.671 2.247 . . . . 0.0 112.34 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 38.4 m -120.36 148.21 44.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.785 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 91.8 p -125.88 -43.16 1.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.813 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.525 -179.942 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 1.6 t -148.24 115.92 6.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.907 0.384 . . . . 0.0 110.926 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 20.1 t -54.47 147.89 13.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.914 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -176.45 40.47 0.1 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.507 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 76.4 p -59.53 160.66 6.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.858 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 28.2 p -117.46 -56.31 2.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.858 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 83.07 148.54 7.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.491 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -111.5 85.21 5.64 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.634 0.731 . . . . 0.0 110.919 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.61 62.88 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.663 2.242 . . . . 0.0 112.373 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -144.48 162.94 35.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -43.49 141.08 1.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 49.75 41.81 22.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.813 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 20.3 t -44.33 110.35 0.21 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -91.84 111.84 23.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -133.15 102.35 5.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.3 m -90.2 37.68 0.9 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -137.39 164.78 27.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . 0.449 ' CG2' HG22 ' A' ' 427' ' ' VAL . 36.7 pt -138.32 142.22 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.11 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -102.52 115.25 30.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.977 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.419 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 12.1 t -101.35 142.59 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -150.55 122.29 8.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 133.16 6.82 2.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.455 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 28.2 mt -72.82 156.4 38.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.812 0.339 . . . . 0.0 110.954 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.62 179.86 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.81 6.1 33.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.78 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 10.9 t -114.23 4.21 15.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.839 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 6.2 p -76.1 139.06 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.107 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 68.9 p -122.21 173.88 7.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.448 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 14.9 tp -67.29 -63.3 1.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -47.64 -28.63 2.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.909 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.07 -32.6 56.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 381' ' ' PHE . 48.4 mt -84.78 -27.94 26.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.872 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.77 -37.29 65.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.413 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 21.7 t0 -78.75 -20.25 50.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -92.69 -51.31 5.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.555 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 15.9 m-85 -60.01 -24.64 64.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . 0.413 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -71.27 -15.08 62.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.894 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -45.35 -53.58 8.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 38.3 t -59.23 -69.0 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.14 -124.99 2.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.47 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 67.1 t -124.73 135.25 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.921 0.391 . . . . 0.0 111.113 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.16 131.57 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -55.8 111.74 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.955 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' MET . . . . . 0.434 ' SD ' ' CA ' ' A' ' 396' ' ' PRO . 64.7 mmm -106.8 121.72 44.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -48.3 148.15 2.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -94.77 -19.16 20.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -96.78 -46.67 6.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.816 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 37.1 p -91.09 -21.7 21.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 65.6 27.93 73.1 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.507 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -117.18 153.24 49.77 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.532 0.682 . . . . 0.0 110.932 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.434 ' CA ' ' SD ' ' A' ' 389' ' ' MET . 53.2 Cg_endo -69.79 146.99 61.64 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.694 2.262 . . . . 0.0 112.293 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' MET . . . . . 0.4 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.5 mmt -81.17 41.47 0.6 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.448 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.7 mt -99.27 135.93 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.18 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -115.5 141.03 48.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 67.6 mt -134.12 93.72 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -59.71 122.35 13.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.467 HD22 ' N ' ' A' ' 409' ' ' PRO . 45.0 mt -107.57 136.4 47.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.889 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 407' ' ' GLY . 2.0 t70 -55.19 133.63 49.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.09 -6.54 57.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -97.46 -22.88 16.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 69.5 p -128.17 -36.06 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 94.8 0.54 64.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.507 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -90.7 156.93 44.6 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.615 0.721 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.489 ' O ' ' C ' ' A' ' 410' ' ' LYS . 54.3 Cg_endo -69.73 89.38 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 0.0 112.392 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.489 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.1 OUTLIER -30.54 -54.74 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 156.77 -15.27 0.36 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.482 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -91.22 153.53 19.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.909 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -166.87 174.85 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.083 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 3.0 p -141.78 143.37 33.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.154 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.456 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 45.3 t -130.69 119.87 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' SER . . . . . 0.4 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 2.1 m -94.66 114.01 25.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.508 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 50.4 m-85 -86.8 162.32 17.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.41 -65.5 0.6 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.51 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 4.5 m-20 -115.5 157.72 43.44 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.669 0.747 . . . . 0.0 110.843 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.2 Cg_exo -57.16 -43.11 56.2 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.617 2.212 . . . . 0.0 112.371 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.4 Cg_exo -50.81 -29.37 26.13 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.648 2.232 . . . . 0.0 112.369 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 40.9 m -86.26 -39.27 16.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.185 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.508 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -62.3 -53.95 47.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.093 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -56.51 -33.94 66.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.81 -32.07 52.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.063 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -72.1 -33.81 68.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.084 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.486 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 77.8 t -55.17 -61.58 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -66.59 -12.79 59.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.548 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.76 -54.31 5.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.555 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 91.3 m-85 -88.75 -18.01 28.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.835 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.6 t70 -52.93 97.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 100.95 23.56 9.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.503 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.44 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 25.0 mmtt -76.5 175.87 8.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.32 . . . . 0.0 110.906 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.39 112.33 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -108.12 98.61 8.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.886 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 61.04 35.25 18.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 96.37 -21.55 44.87 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.45 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.2 p -82.55 152.77 25.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.976 0.417 . . . . 0.0 110.834 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -99.72 130.75 45.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.81 144.39 32.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.954 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -122.02 107.7 12.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 7.1 t -100.23 135.52 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 10.0 p -155.99 130.72 9.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.816 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 445' ' ' ALA . 19.2 mt -43.99 111.37 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.887 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 444' ' ' LEU . . . -35.34 -65.6 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -61.5 113.95 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -86.18 123.72 31.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.967 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -106.82 134.12 19.98 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.595 0.712 . . . . 0.0 110.921 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 164.87 32.94 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.68 2.253 . . . . 0.0 112.383 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -6.54 18.85 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.628 2.219 . . . . 0.0 112.357 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 2.0 ttt -47.51 99.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.801 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -150.51 143.28 24.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.942 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 28.7 t -161.59 153.23 18.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.856 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -162.31 -94.81 0.1 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.551 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 107.98 1.99 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.628 2.219 . . . . 0.0 112.396 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 91.3 p -88.88 -47.27 8.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.822 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 10.0 m -58.01 112.43 1.51 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.45 -179.945 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 1.2 t -126.2 -59.25 1.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 110.919 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 44.6 m -98.76 147.27 25.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -156.87 127.18 1.9 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.449 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 53.8 p -74.53 154.4 38.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.881 0.372 . . . . 0.0 110.887 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 37.0 p -132.74 158.8 41.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.927 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -123.61 -40.62 0.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.539 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.71 132.0 78.24 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.651 0.739 . . . . 0.0 110.917 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 170.46 16.49 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.713 2.275 . . . . 0.0 112.33 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -95.66 122.67 38.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.946 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -98.06 86.2 3.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.847 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 45.45 41.64 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.834 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 69.5 m -116.76 90.67 3.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -102.32 88.69 3.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -125.16 79.02 1.76 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 4.1 p -87.19 23.73 1.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -123.39 156.7 34.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.153 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . 0.421 ' CG1' ' HB ' ' A' ' 415' ' ' VAL . 29.4 pt -126.08 142.74 41.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.085 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -104.5 111.68 24.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.994 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.501 ' CG2' ' CZ ' ' A' ' 381' ' ' PHE . 8.5 t -95.7 141.09 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.148 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -145.67 120.3 9.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.1 19.95 1.51 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.68 151.74 32.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.768 0.318 . . . . 0.0 110.955 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -74.68 -176.36 2.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.23 4.62 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.5 t -120.32 17.67 12.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.3 p -80.64 136.72 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.178 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 77.5 p -121.3 162.47 20.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.134 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.463 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 17.8 tp -57.28 -66.1 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -45.98 -30.19 1.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.95 -34.04 66.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.83 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.423 ' HB3' ' CE2' ' A' ' 381' ' ' PHE . 54.1 mt -85.5 -28.99 24.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.853 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.64 -28.88 62.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.408 ' HA ' ' NZ ' ' A' ' 382' ' ' LYS . 10.4 t70 -84.99 -22.34 29.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.437 ' CE2' ' CD1' ' A' ' 430' ' ' PHE . 68.0 t80 -92.63 -48.14 6.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.554 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 17.7 m-85 -62.57 -21.02 65.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . 0.408 ' NZ ' ' HA ' ' A' ' 379' ' ' ASP . 2.0 ptpp? -78.19 -4.57 48.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -56.05 -57.92 10.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.947 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . 0.568 ' SG ' ' CE3' ' A' ' 429' ' ' TRP . 1.9 t -56.38 -64.63 0.8 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.68 -127.22 2.74 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.409 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 77.3 t -125.87 131.51 71.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.897 0.38 . . . . 0.0 111.183 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 57.3 t -84.55 128.44 38.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -51.04 105.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' A' ' 396' ' ' PRO . 64.1 mmm -101.55 122.13 43.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -46.52 145.65 1.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -94.39 -21.58 18.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -96.25 -46.93 6.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 30.2 p -88.94 -26.63 21.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 70.25 32.08 68.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.477 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -121.07 153.66 57.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.586 0.707 . . . . 0.0 110.95 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.43 ' N ' ' SD ' ' A' ' 389' ' ' MET . 53.3 Cg_endo -69.8 145.15 56.05 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.677 2.251 . . . . 0.0 112.276 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' MET . . . . . 0.433 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 7.0 mmt -81.52 41.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.827 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.463 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 94.4 mt -97.97 142.75 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.156 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -120.98 141.34 50.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 60.1 mt -134.91 94.73 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.189 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -62.44 127.41 31.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.409 HD23 ' N ' ' A' ' 409' ' ' PRO . 37.0 mt -112.11 134.56 53.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.878 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 407' ' ' GLY . 13.1 t0 -55.43 120.21 6.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.856 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -1.98 8.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -88.0 -39.67 14.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 33.4 p -121.88 -35.92 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 107.27 -0.87 35.07 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.47 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -86.53 152.56 54.87 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.53 0.681 . . . . 0.0 110.935 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.461 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.8 Cg_endo -69.71 94.82 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.748 2.299 . . . . 0.0 112.321 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 409' ' ' PRO . 8.4 ptmt -33.19 -52.02 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.883 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.65 -14.39 0.8 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -89.88 149.01 22.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.785 0.326 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -162.09 170.17 19.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.067 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.4 p -138.96 143.29 38.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.184 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.487 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 59.4 t -129.01 118.58 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.17 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' SER . . . . . 0.433 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 17.3 m -92.67 114.03 26.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.554 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 43.6 m-85 -86.82 165.68 15.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -61.4 -64.28 1.0 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.846 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.509 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.9 m-20 -112.63 156.68 42.04 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.672 0.749 . . . . 0.0 110.789 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.3 Cg_exo -57.11 -43.0 57.48 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.654 2.236 . . . . 0.0 112.339 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.5 Cg_exo -50.96 -43.15 49.2 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.708 2.272 . . . . 0.0 112.361 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 52.3 m -67.8 -43.22 80.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.111 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.554 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -57.2 -57.61 11.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.1 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -51.89 -36.96 50.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.85 64.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . 0.482 ' CB ' ' CE2' ' A' ' 417' ' ' TYR . . . -69.51 -30.8 68.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.052 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.491 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 85.0 t -58.66 -62.14 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.159 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -67.5 -9.71 44.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.568 ' CE3' ' SG ' ' A' ' 384' ' ' CYS . 1.2 t-105 -82.44 -54.16 5.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.972 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.554 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 91.2 m-85 -89.05 -20.96 23.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.491 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.0 OUTLIER -49.7 94.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.823 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.15 20.29 9.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.535 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.457 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 14.3 mmtm -78.11 161.47 27.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.842 0.353 . . . . 0.0 110.851 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -107.08 106.45 16.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . 0.44 ' HB2' ' CD1' ' A' ' 440' ' ' LEU . 4.3 t80 -107.17 110.11 22.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 58.22 35.26 24.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 89.76 -18.94 44.18 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.519 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.4 m -90.35 164.21 14.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.4 . . . . 0.0 110.886 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.86 140.53 33.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.44 ' CD1' ' HB2' ' A' ' 435' ' ' PHE . 11.4 mt -108.06 139.66 42.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -115.82 103.93 11.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 19.2 t -99.34 132.37 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.077 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 9.5 p -151.6 132.35 14.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.824 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 12.5 mt -48.84 105.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.868 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -40.74 132.44 2.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.104 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -113.77 81.12 1.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 4.0 ptmm? -77.65 172.91 12.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -165.37 149.69 7.63 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.597 0.713 . . . . 0.0 110.921 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 135.05 29.49 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.693 2.262 . . . . 0.0 112.33 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 165.57 30.49 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.714 2.276 . . . . 0.0 112.356 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 29.1 tpp -170.22 105.84 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -160.9 155.61 23.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 51.0 m -107.77 103.27 12.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.819 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -107.5 137.15 13.85 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.45 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -24.06 30.2 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.688 2.259 . . . . 0.0 112.398 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 20.7 m -45.57 140.66 3.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.881 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 35.8 p -88.86 172.05 9.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.803 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.487 -179.99 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.562 -0.215 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 3.8 m -121.02 -65.03 1.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 0.0 110.825 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 56.6 p -76.99 120.81 22.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -73.22 -93.3 0.11 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.511 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 20.5 m -146.62 109.69 4.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.92 0.39 . . . . 0.0 110.881 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 60.2 p -92.22 160.65 15.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -113.1 -168.61 17.14 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.483 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -142.56 141.65 21.14 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.588 0.709 . . . . 0.0 110.93 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 172.17 13.19 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.649 2.233 . . . . 0.0 112.308 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.11 149.77 21.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -119.23 40.83 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -114.45 41.47 2.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.864 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 38.2 p -166.89 133.24 2.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.22 98.38 9.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.864 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -144.62 111.79 5.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.3 m -87.2 25.05 1.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.842 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -130.92 166.68 20.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.077 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 39.8 pt -134.7 142.49 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -99.31 115.02 28.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.553 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 4.5 t -103.06 142.31 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.128 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -149.12 124.84 10.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.27 12.59 2.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.489 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 30.2 mt -77.84 156.38 30.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.72 -179.32 7.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.945 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.92 -2.02 58.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 39.4 t -106.14 3.14 27.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.782 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 12.2 p -69.46 144.77 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 80.7 p -127.85 170.6 12.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.16 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.461 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 12.1 tp -68.26 -49.69 58.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -59.74 -34.46 72.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.841 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.37 -31.41 68.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.443 ' HB3' ' CE2' ' A' ' 381' ' ' PHE . 60.0 mt -87.96 -28.09 21.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.932 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.41 -35.83 68.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.413 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 12.5 t70 -85.36 -17.92 35.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -92.31 -43.94 9.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.575 ' CD2' ' CG2' ' A' ' 415' ' ' VAL . 15.8 m-85 -69.9 -21.85 63.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.861 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . 0.413 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -72.9 -9.49 58.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.947 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -50.08 -54.65 19.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 3.5 t -58.88 -65.9 0.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -135.19 -126.34 2.6 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.462 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 93.2 t -124.44 131.29 72.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.837 0.351 . . . . 0.0 111.177 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 57.0 t -82.44 126.03 39.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -49.22 107.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' MET . . . . . 0.468 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 19.5 mtp -104.47 122.3 45.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -50.73 147.07 5.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -94.59 -18.41 21.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -95.22 -47.89 6.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 37.8 p -90.36 -26.85 19.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.202 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.468 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 73.39 20.32 79.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -108.97 152.81 42.63 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.546 0.688 . . . . 0.0 110.978 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 147.73 63.18 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.636 2.224 . . . . 0.0 112.345 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 9.5 mmt -81.52 40.96 0.6 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.461 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.1 mt -98.82 136.36 30.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -115.71 136.17 53.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 67.7 mt -132.33 93.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -59.17 124.54 20.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.465 HD21 ' N ' ' A' ' 409' ' ' PRO . 35.1 mt -109.34 135.14 50.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.9 t0 -55.37 128.1 32.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -75.11 -1.0 21.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -93.66 -31.24 14.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.9 p -128.32 -35.89 1.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.089 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 100.57 9.92 45.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.501 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -95.7 155.62 38.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.533 0.682 . . . . 0.0 110.944 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.6 Cg_endo -69.78 89.47 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.629 2.219 . . . . 0.0 112.381 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 409' ' ' PRO . 5.1 ptmt -31.58 -53.23 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 155.64 -14.68 0.44 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -90.64 155.07 19.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.5 169.47 10.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.3 p -141.79 124.16 15.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.173 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.575 ' CG2' ' CD2' ' A' ' 381' ' ' PHE . 59.3 t -109.33 121.35 62.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 2.2 m -95.96 114.08 25.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.914 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.532 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 67.2 m-85 -87.1 162.85 17.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -57.63 -67.12 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.51 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 5.7 m-20 -111.6 157.55 38.99 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.626 0.727 . . . . 0.0 110.858 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.16 -43.0 57.28 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.696 2.264 . . . . 0.0 112.319 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.3 Cg_exo -50.81 -31.24 32.5 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.672 2.248 . . . . 0.0 112.299 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 23.6 m -84.26 -37.72 21.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.105 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.532 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -64.55 -47.86 77.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.074 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -62.4 -36.56 82.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.01 -31.24 58.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . 0.407 ' CB ' ' CZ ' ' A' ' 417' ' ' TYR . . . -70.39 -31.88 69.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.465 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 94.2 t -57.18 -64.02 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.196 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.0 -11.55 29.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.526 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -81.3 -54.33 5.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 89.7 m-85 -89.79 -13.39 36.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.2 t0 -60.23 95.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 108.29 -0.03 33.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.465 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.441 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 18.7 mmtt -61.13 173.75 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.773 0.32 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -121.18 120.61 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.909 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . 0.415 ' HB2' ' CD1' ' A' ' 440' ' ' LEU . 5.4 t80 -117.85 105.12 11.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 62.36 26.09 15.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.903 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 97.27 -16.47 60.69 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.539 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 75.5 m -96.8 127.02 42.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.949 0.404 . . . . 0.0 110.817 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -71.12 140.22 50.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.415 ' CD1' ' HB2' ' A' ' 435' ' ' PHE . 10.6 mt -108.87 151.65 25.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.953 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -122.63 108.16 12.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.912 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 10.4 t -104.36 135.49 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.197 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.4 m -154.86 127.49 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.891 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 24.6 mt -40.86 122.57 1.74 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.0 126.99 29.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.12 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 29.9 mtm-85 -99.67 95.51 7.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.823 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 6.8 ptmm? -100.45 29.15 4.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.859 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -121.96 134.89 24.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.556 0.693 . . . . 0.0 110.842 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 152.37 69.19 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.717 2.278 . . . . 0.0 112.354 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 -9.07 25.22 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.653 2.235 . . . . 0.0 112.349 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 14.2 tpp -95.06 123.13 38.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -118.65 -57.56 2.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.934 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 17.4 t -90.36 110.51 21.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -122.4 -95.07 1.26 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.512 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 80.75 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.64 2.227 . . . . 0.0 112.361 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 6.8 m -128.87 114.61 16.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 2.6 m 51.94 48.21 23.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.827 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.467 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.223 0 N-CA-C 112.417 -0.273 . . . . 0.0 112.417 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 57.2 p -122.66 -57.9 1.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.358 . . . . 0.0 110.789 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 22.4 t -63.05 134.67 56.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.845 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 167.53 -111.97 0.47 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.474 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 45.2 m -109.31 171.2 7.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.857 0.36 . . . . 0.0 110.867 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 15.0 m -39.86 -61.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 90.68 -136.22 13.28 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.478 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.443 ' N ' ' CD ' ' A' ' 354' ' ' PRO . 0.9 OUTLIER 48.54 54.7 16.4 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.59 0.71 . . . . 0.0 110.831 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 353' ' ' ASP . 53.1 Cg_endo -69.88 -170.03 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.711 2.274 . . . . 0.0 112.236 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -97.48 41.66 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.802 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 357' ' ' ASP . 22.2 tt0 -64.48 146.44 54.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.894 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 356' ' ' GLU . 16.4 t70 35.51 40.7 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 8.2 t -118.2 141.34 48.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -133.87 152.34 51.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.79 81.27 1.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 6.3 p -100.81 19.51 17.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.833 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.99 159.13 22.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.074 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . 0.434 ' CG2' HG23 ' A' ' 427' ' ' VAL . 38.6 pt -131.8 142.28 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -98.72 117.38 33.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.422 HG22 ' CZ ' ' A' ' 381' ' ' PHE . 15.7 t -102.34 141.94 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.137 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -148.83 122.58 9.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.43 18.82 1.59 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.418 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 64.6 mt -80.87 154.4 27.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -81.44 171.01 15.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.84 6.59 10.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 31.7 m -119.67 14.43 12.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 6.5 p -79.58 137.33 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 74.8 p -119.93 156.82 30.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.174 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.465 ' CD1' ' HB ' ' A' ' 398' ' ' ILE . 11.6 tp -53.24 -60.69 2.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -51.76 -33.58 35.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.796 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.47 -29.74 68.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 49.1 mt -89.9 -29.5 18.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.78 72.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.086 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' ASP . . . . . 0.412 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 21.1 t70 -80.38 -18.91 47.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -92.47 -52.93 4.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.56 ' HA ' ' CZ ' ' A' ' 430' ' ' PHE . 28.3 m-85 -59.58 -21.66 60.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . 0.412 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 2.6 ptmm? -75.38 -6.1 48.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -58.62 -56.25 24.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 28.3 t -57.57 -63.09 1.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.839 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -136.02 -126.54 2.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.463 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 76.2 t -125.46 133.92 68.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 111.124 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 68.4 t -87.14 129.97 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.163 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -56.62 106.85 0.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' MET . . . . . 0.5 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 47.6 mmm -103.34 125.94 50.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.869 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.402 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 15.5 t-20 -51.14 148.88 4.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -94.88 -17.99 21.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.944 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -97.28 -48.32 5.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.402 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 38.2 p -90.63 -17.95 25.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.173 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.5 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 62.16 27.47 69.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.436 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -114.63 153.19 46.78 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.608 0.718 . . . . 0.0 110.922 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.461 ' N ' ' SD ' ' A' ' 389' ' ' MET . 53.7 Cg_endo -69.68 146.64 61.28 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.67 2.247 . . . . 0.0 112.366 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' MET . . . . . 0.434 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.8 mmt -81.25 41.26 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.846 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.465 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.1 mt -98.64 136.4 29.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.124 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -115.64 142.24 47.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 66.9 mt -134.86 94.03 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.084 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -59.7 125.28 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' LEU . . . . . 0.446 HD23 ' N ' ' A' ' 409' ' ' PRO . 50.0 mt -109.13 136.7 48.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.971 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.4 t0 -55.24 132.33 47.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -79.74 -5.58 55.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -97.3 -24.05 15.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 70.4 p -128.15 -36.09 1.97 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.135 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 97.4 -4.49 62.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.565 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -85.69 156.05 58.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.56 0.695 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.48 ' O ' ' C ' ' A' ' 410' ' ' LYS . 54.2 Cg_endo -69.78 91.37 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.738 2.292 . . . . 0.0 112.305 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.48 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.1 OUTLIER -31.67 -51.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.873 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.46 -12.0 0.76 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -93.68 152.79 18.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.83 0.348 . . . . 0.0 110.846 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -165.68 173.4 10.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 p -138.81 140.63 38.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.172 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . 0.431 HG22 ' CE2' ' A' ' 381' ' ' PHE . 46.0 t -124.77 116.93 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.144 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' SER . . . . . 0.434 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 13.4 m -92.85 112.16 24.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 59.0 m-85 -86.84 161.41 18.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.897 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.86 -66.51 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.953 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.504 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.4 m-20 -115.17 156.72 45.12 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.617 0.723 . . . . 0.0 110.848 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.591 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.31 -42.97 56.64 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.659 2.239 . . . . 0.0 112.373 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.8 Cg_exo -50.42 -26.85 17.05 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.743 2.295 . . . . 0.0 112.323 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 56.0 m -89.09 -41.07 12.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.513 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -60.23 -47.31 86.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.077 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -60.92 -38.11 84.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.24 -34.59 63.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.029 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.99 -32.62 72.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 431' ' ' ASP . 70.1 t -56.04 -60.02 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.061 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -67.62 -13.89 62.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' TRP . . . . . 0.551 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -78.75 -55.14 5.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . 0.56 ' CZ ' ' HA ' ' A' ' 381' ' ' PHE . 82.8 m-85 -87.41 -14.81 39.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.6 OUTLIER -55.74 93.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.875 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.8 21.54 8.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.505 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' LYS . . . . . 0.448 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 15.5 mmtm -77.3 176.78 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.7 124.82 44.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.803 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -128.16 100.44 5.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 62.52 34.52 15.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.902 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 82.4 19.96 63.25 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.468 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 19.7 p -126.36 130.09 50.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 110.868 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -75.95 131.37 39.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.861 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 5.8 mt -105.49 133.83 49.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.59 113.71 27.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 9.2 t -107.8 131.19 58.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.096 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 2.7 m -156.89 130.98 8.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.772 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 26.5 mt -39.15 133.86 1.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -73.37 143.9 46.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.085 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? 60.35 35.02 20.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -142.35 124.24 15.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 13.0 ttpp -165.25 135.43 2.93 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.632 0.73 . . . . 0.0 110.912 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.62 122.83 9.54 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.729 2.286 . . . . 0.0 112.383 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 -17.34 37.38 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.731 2.287 . . . . 0.0 112.331 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -128.7 149.35 50.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -172.14 157.16 4.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 48.9 m -49.29 -46.32 46.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -177.25 -156.66 16.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.469 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 456' ' ' SER . 53.9 Cg_endo -69.76 106.93 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.259 . . . . 0.0 112.348 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 455' ' ' PRO . 46.9 t -35.94 -63.96 0.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.821 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 33.4 p -86.72 152.84 22.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.517 -179.968 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.929 0.395 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -112.75 160.81 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.605 HD12 ' CG1' ' A' ' 442' ' ' VAL . 31.3 pt -131.89 144.48 37.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -103.44 111.47 23.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 1.039 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 8.2 t -96.42 140.12 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.098 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -145.91 122.44 11.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.26 17.97 1.72 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.489 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.557 HD13 HD11 ' A' ' 377' ' ' LEU . 87.0 mt -78.2 153.09 32.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.873 0.368 . . . . 0.0 110.861 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -76.17 -179.52 5.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.85 3.54 50.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 12.5 m -119.27 15.81 13.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' VAL . . . . . 0.481 HG21 HD22 ' A' ' 368' ' ' LEU . 8.7 p -80.61 134.02 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.152 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 70.2 p -117.87 160.22 21.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.158 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.848 HD11 ' HG2' ' A' ' 396' ' ' PRO . 12.3 tp -53.11 -64.17 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.95 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -46.1 -38.75 8.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.55 -32.69 74.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.631 HD12 HD11 ' A' ' 400' ' ' ILE . 75.7 mt -87.09 -28.08 22.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.8 -39.56 66.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.015 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.433 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 40.0 t0 -76.51 -20.82 56.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -91.6 -53.84 4.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 1.039 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.6 m-85 -57.56 -23.67 51.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.433 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 13.9 ptmt -74.44 -12.16 60.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.925 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -48.68 -53.4 18.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 2.3 t -59.74 -65.17 0.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -136.82 -124.3 2.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.459 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 95.1 t -125.51 128.82 72.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.841 0.353 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 58.2 t -82.53 124.79 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.101 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -45.85 107.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.975 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' MET . . . . . 0.471 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 20.4 mtp -102.91 127.28 50.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.894 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -53.7 146.01 14.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.75 -13.69 25.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' ARG . . . . . 0.463 ' HG3' HG23 ' A' ' 393' ' ' THR . 15.9 ptt180 -102.52 -42.09 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.463 HG23 ' HG3' ' A' ' 392' ' ' ARG . 66.8 p -96.93 -19.57 18.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.157 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' GLY . . . . . 0.471 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 66.04 18.44 66.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.442 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -107.14 152.75 41.2 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.554 0.692 . . . . 0.0 110.934 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.848 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.6 Cg_endo -69.77 147.62 63.2 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.684 2.256 . . . . 0.0 112.349 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.439 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 11.3 mmt -81.61 40.76 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.846 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.53 HG12 HG22 ' A' ' 415' ' ' VAL . 97.7 mt -99.33 137.68 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.171 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -118.5 143.56 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.808 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.631 HD11 HD12 ' A' ' 377' ' ' LEU . 58.6 mt -134.59 93.9 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -59.77 125.23 22.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.844 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 409' ' ' PRO . 36.5 mt -109.38 134.57 51.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.9 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 407' ' ' GLY . 11.1 t0 -55.67 121.25 8.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -69.23 -1.29 7.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -88.5 -38.5 14.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 70.1 p -124.74 -35.05 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.85 -1.47 35.96 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.475 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 12.0 pttp -84.37 152.62 61.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.483 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.8 Cg_endo -69.75 94.69 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.68 2.253 . . . . 0.0 112.341 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -33.55 -52.75 0.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 153.19 -15.85 0.67 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.487 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' ASP . . . . . 0.416 ' CG ' ' HE3' ' A' ' 410' ' ' LYS . 49.5 p-10 -87.74 157.24 19.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -170.15 171.67 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.096 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.4 142.91 37.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.183 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.879 HG21 ' CD2' ' A' ' 381' ' ' PHE . 57.0 t -130.13 111.94 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 416' ' ' SER . . . . . 0.439 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 9.1 m -87.35 114.39 23.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.429 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 47.3 m-85 -88.07 164.41 15.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.77 -63.29 1.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.508 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.4 m-20 -115.9 156.05 47.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.604 0.716 . . . . 0.0 110.84 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.602 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.39 -43.01 55.77 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.644 2.23 . . . . 0.0 112.356 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.7 Cg_exo -50.06 -29.57 22.3 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.686 2.257 . . . . 0.0 112.286 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 70.0 m -85.8 -40.07 16.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.159 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.682 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -61.93 -51.5 67.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.131 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.574 ' HG2' HD11 ' A' ' 444' ' ' LEU . 33.2 mtmt -58.93 -35.58 73.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.849 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.29 -31.69 54.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.041 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.23 68.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.147 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 423' ' ' ALA . 92.6 t -54.68 -60.83 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -66.7 -14.65 62.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.55 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.1 t-105 -77.85 -52.04 9.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.975 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.901 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.2 m-85 -90.37 -17.37 27.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 3.8 t70 -57.12 100.28 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 101.5 13.78 31.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.458 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 18.7 mmtp -71.7 -178.75 2.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.748 0.309 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.79 102.87 6.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.776 ' HB2' HD11 ' A' ' 440' ' ' LEU . 5.0 t80 -102.76 113.1 26.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 59.01 27.16 15.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 96.02 -16.66 60.72 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.431 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 24.3 m -90.62 150.46 21.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.965 0.412 . . . . 0.0 110.819 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' LYS . . . . . 0.431 ' C ' HD23 ' A' ' 440' ' ' LEU . 13.9 ttmt -87.61 133.74 33.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 435' ' ' PHE . 6.0 mt -102.66 143.09 32.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.932 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.03 101.42 7.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.983 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.901 HG21 ' HB2' ' A' ' 430' ' ' PHE . 20.5 t -96.98 132.6 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.079 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.5 m -154.24 128.73 9.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.574 HD11 ' HG2' ' A' ' 424' ' ' LYS . 22.4 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.804 0.335 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -141.82 156.15 45.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.474 HG22 HG22 ' A' ' 427' ' ' VAL . 18.8 pt -128.8 141.88 45.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.121 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -103.5 112.02 24.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 1.07 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 9.1 t -97.96 138.99 21.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -145.03 120.66 10.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.64 16.51 1.83 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.503 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.509 HD13 HD11 ' A' ' 377' ' ' LEU . 97.7 mt -74.51 155.39 38.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.821 0.343 . . . . 0.0 110.861 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -75.12 -178.88 4.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.55 3.69 53.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.2 t -121.05 16.58 11.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 8.5 p -76.89 133.99 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 81.8 p -118.28 154.8 31.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.919 HD11 ' HG2' ' A' ' 396' ' ' PRO . 11.1 tp -50.75 -62.82 1.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -46.72 -38.15 9.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.864 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.26 -29.59 68.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.825 HD12 HD11 ' A' ' 400' ' ' ILE . 45.5 mt -87.08 -28.52 22.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.16 62.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.146 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -75.11 -18.48 60.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -92.63 -47.17 7.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 1.07 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 15.7 m-85 -66.98 -26.44 66.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -9.13 57.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -51.58 -51.75 52.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 42.4 t -61.02 -65.45 0.69 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -134.55 -126.74 2.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.508 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.441 ' CG1' ' OE2' ' A' ' 418' ' ' GLU . 91.0 t -123.53 128.47 74.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.83 0.347 . . . . 0.0 111.127 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 84.5 t -83.64 123.1 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.076 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -47.55 108.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' MET . . . . . 0.427 ' HE2' ' O ' ' A' ' 394' ' ' GLY . 23.8 mtp -105.41 124.18 49.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.896 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -50.9 143.94 9.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -94.72 -8.41 37.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -102.47 -45.55 5.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.967 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 20.5 p -95.82 -22.16 17.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.157 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' GLY . . . . . 0.427 ' O ' ' HE2' ' A' ' 389' ' ' MET . . . 71.1 23.29 78.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.503 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -112.09 152.49 44.39 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.523 0.678 . . . . 0.0 110.929 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.919 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.9 Cg_endo -69.67 149.41 67.4 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.693 2.262 . . . . 0.0 112.352 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.412 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 11.1 mmt -82.19 40.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.794 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.46 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 93.6 mt -97.52 137.4 25.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.148 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -116.78 138.75 51.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.825 HD11 HD12 ' A' ' 377' ' ' LEU . 58.0 mt -132.41 94.99 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -62.47 127.6 32.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 409' ' ' PRO . 36.2 mt -112.06 135.48 52.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 407' ' ' GLY . 6.6 t70 -56.14 122.25 11.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -1.05 9.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -89.04 -38.46 14.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.809 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 59.0 p -123.65 -34.73 3.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.3 -3.28 37.51 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.481 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -83.61 152.69 63.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.505 0.669 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.543 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.4 Cg_endo -69.74 95.17 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.673 2.248 . . . . 0.0 112.356 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 409' ' ' PRO . 9.2 ptmt -33.33 -52.01 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.882 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 152.2 -15.61 0.77 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.519 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -87.68 154.51 20.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 110.825 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -167.68 170.51 10.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.23 142.4 37.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.107 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 381' ' ' PHE . 39.2 t -128.23 112.88 28.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.123 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 416' ' ' SER . . . . . 0.412 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 9.6 m -87.82 114.03 24.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.556 ' CE2' ' CB ' ' A' ' 426' ' ' ALA . 38.5 m-85 -87.06 167.21 14.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.965 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 418' ' ' GLU . . . . . 0.441 ' OE2' ' CG1' ' A' ' 386' ' ' VAL . 4.0 mt-10 -65.5 -61.96 1.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.513 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.8 m-20 -116.43 156.28 47.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.552 0.692 . . . . 0.0 110.884 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.3 -43.01 56.27 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.773 2.316 . . . . 0.0 112.335 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.8 Cg_exo -50.7 -27.36 19.62 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.7 2.267 . . . . 0.0 112.354 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 55.4 m -87.35 -40.72 14.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.154 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -60.17 -54.66 43.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.532 ' HG2' HD11 ' A' ' 444' ' ' LEU . 37.5 mtpt -55.63 -35.39 65.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.29 -33.09 55.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.159 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' ALA . . . . . 0.556 ' CB ' ' CE2' ' A' ' 417' ' ' TYR . . . -70.51 -31.83 69.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.101 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 423' ' ' ALA . 72.9 t -58.16 -64.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.151 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -65.11 -10.92 34.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.546 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.2 t-105 -80.3 -56.22 4.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.985 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.913 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.2 m-85 -88.09 -18.19 29.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.485 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.2 t70 -54.66 96.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.38 17.3 13.95 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.515 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.429 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 17.1 mmtm -76.87 170.7 16.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.721 0.296 . . . . 0.0 110.913 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' ASP . . . . . 0.441 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 2.8 p-10 -115.83 110.49 19.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.563 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.7 t80 -113.42 106.87 15.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 62.15 25.91 15.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.919 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 93.29 -5.92 75.09 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.51 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.4 m -104.87 129.39 53.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.877 0.37 . . . . 0.0 110.878 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -70.83 137.83 49.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 435' ' ' PHE . 12.4 mt -103.66 150.89 23.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -123.81 100.04 6.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.913 HG21 ' HB2' ' A' ' 430' ' ' PHE . 17.8 t -95.13 128.22 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.103 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 89.7 p -146.42 125.44 12.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.562 ' HG ' HG21 ' A' ' 427' ' ' VAL . 19.8 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.915 0.388 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -129.65 162.67 27.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.138 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.659 HD12 ' CG1' ' A' ' 442' ' ' VAL . 34.3 pt -133.34 144.55 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -102.15 115.09 29.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.888 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 13.5 t -100.31 136.34 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.142 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -143.64 120.74 11.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 128.96 20.18 1.5 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.441 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 88.0 mt -79.25 155.34 28.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 110.944 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' ASN . . . . . 0.487 ' OD1' ' NE2' ' A' ' 436' ' ' GLN . 4.2 p30 -75.07 178.07 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.844 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -91.31 13.4 17.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.857 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.1 m -130.13 13.22 5.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.69 141.93 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 72.2 p -121.59 160.42 24.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.126 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.877 HD11 ' HG2' ' A' ' 396' ' ' PRO . 10.6 tp -56.22 -58.1 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -50.61 -38.17 44.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.823 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -66.71 -27.77 67.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.847 HD12 HD11 ' A' ' 400' ' ' ILE . 51.6 mt -89.03 -32.02 17.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.12 -33.78 65.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.427 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 15.8 t0 -82.93 -20.24 35.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -92.69 -48.43 6.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.888 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 18.7 m-85 -63.75 -19.08 64.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.427 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -76.27 -6.69 52.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.916 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -54.31 -56.86 14.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.6 t -56.56 -65.54 0.59 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -135.67 -126.01 2.55 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.448 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 44.5 t -125.06 132.59 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 111.111 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 60.3 t -87.25 128.62 39.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.206 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 49.6 tttt -50.31 108.32 0.22 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 396' ' ' PRO . 73.6 mmm -104.05 122.79 45.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -47.66 143.18 4.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -93.38 -18.64 22.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 37.5 ttt85 -99.01 -46.6 5.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 30.1 p -89.72 -24.96 21.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.047 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 69.24 31.92 72.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.513 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -121.85 153.62 60.4 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.619 0.723 . . . . 0.0 110.899 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.877 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.6 Cg_endo -69.55 146.17 60.67 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.736 2.29 . . . . 0.0 112.432 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 9.1 mmt -82.12 40.32 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.825 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.531 HG12 HG22 ' A' ' 415' ' ' VAL . 94.3 mt -96.53 145.84 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' HIS . . . . . 0.409 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 6.3 t60 -126.04 136.11 52.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.847 HD11 HD12 ' A' ' 377' ' ' LEU . 59.5 mt -131.04 94.79 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -61.6 127.78 33.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.898 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 409' ' ' PRO . 33.5 mt -112.24 135.56 52.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.953 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 407' ' ' GLY . 8.1 t0 -55.44 122.78 11.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -1.18 12.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -90.03 -36.03 15.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 37.7 p -125.21 -35.63 2.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.73 -3.66 36.42 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.487 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -83.33 152.59 64.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.679 0.752 . . . . 0.0 110.814 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.524 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.2 Cg_endo -69.74 94.99 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.726 2.284 . . . . 0.0 112.281 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -33.37 -50.56 0.32 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.955 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 150.6 -16.4 0.96 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.489 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -87.79 156.09 19.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 110.856 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -169.48 173.14 6.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.081 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.06 142.13 32.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.168 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.848 HG21 ' CD2' ' A' ' 381' ' ' PHE . 57.4 t -128.74 117.68 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 24.0 m -92.73 112.86 24.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.493 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 51.9 m-85 -87.17 163.29 17.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.947 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -58.01 -65.3 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.511 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.5 m-20 -114.11 155.89 44.88 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.603 0.716 . . . . 0.0 110.903 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.42 -42.84 57.36 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.677 2.251 . . . . 0.0 112.334 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 54.3 Cg_exo -49.58 -28.81 17.47 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.719 2.279 . . . . 0.0 112.373 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 48.6 m -86.94 -42.98 12.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.77 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.7 -48.34 82.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.188 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.599 ' HG2' HD11 ' A' ' 444' ' ' LEU . 72.8 mttt -61.5 -39.62 91.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.45 -32.84 62.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.094 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.29 -32.91 70.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 423' ' ' ALA . 84.1 t -55.85 -60.85 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.164 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.12 -13.0 61.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.561 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.0 OUTLIER -79.49 -52.27 8.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.827 ' HB2' HG21 ' A' ' 442' ' ' VAL . 89.5 m-85 -88.5 -16.68 32.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.871 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.5 OUTLIER -60.4 93.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.22 16.79 7.55 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.401 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 2.6 mmmp? -82.37 163.91 21.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 110.862 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -110.24 108.54 18.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.931 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.647 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.2 t80 -109.12 108.65 19.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' GLN . . . . . 0.487 ' NE2' ' OD1' ' A' ' 369' ' ' ASN . 62.2 mt-30 61.32 26.56 16.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.972 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 94.38 -13.71 66.74 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.526 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.6 m -100.67 128.9 46.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 110.864 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -70.41 138.77 51.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.647 HD11 ' HB2' ' A' ' 435' ' ' PHE . 12.8 mt -104.05 152.95 21.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -126.26 106.08 9.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.827 HG21 ' HB2' ' A' ' 430' ' ' PHE . 14.2 t -99.41 138.56 23.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 3.6 p -161.12 130.17 4.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.825 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 424' ' ' LYS . 45.7 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.83 0.347 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -131.85 166.18 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.065 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.723 HD12 ' CG1' ' A' ' 442' ' ' VAL . 27.4 pt -140.38 144.47 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -100.05 124.53 45.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.98 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.928 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 21.8 t -108.68 143.33 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -149.73 121.11 7.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.48 19.86 1.46 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.506 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.503 ' HB3' HG11 ' A' ' 372' ' ' VAL . 97.4 mt -78.76 154.35 30.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.885 0.374 . . . . 0.0 110.926 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' ASN . . . . . 0.432 ' ND2' ' CD ' ' A' ' 436' ' ' GLN . 9.4 p30 -76.37 179.32 5.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.4 1.87 53.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.2 m -119.85 18.73 12.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 368' ' ' LEU . 8.1 p -82.38 133.05 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.131 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 69.4 p -115.99 163.46 15.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.06 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.962 HD11 ' HG2' ' A' ' 396' ' ' PRO . 12.2 tp -54.64 -59.92 4.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.17 -47.38 23.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -53.15 -38.48 62.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.715 HD12 HD11 ' A' ' 400' ' ' ILE . 81.5 mt -82.82 -30.04 29.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.957 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -71.99 -25.64 61.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.074 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.408 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 17.9 t70 -93.27 -19.96 20.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -91.9 -52.34 4.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.928 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 21.2 m-85 -59.83 -23.47 63.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.408 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 5.4 ptmt -72.35 -10.98 60.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -49.9 -58.03 6.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 37.7 t -56.45 -69.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -130.56 -124.24 2.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 71.0 t -126.87 131.41 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.104 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 85.7 t -83.81 123.42 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.146 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -46.72 105.05 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.917 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' MET . . . . . 0.445 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 26.7 mtp -102.85 128.17 49.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -53.97 147.09 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -94.61 -16.13 23.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 15.8 ttm105 -96.43 -49.65 5.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 46.9 p -90.45 -22.11 21.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' GLY . . . . . 0.445 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 69.49 23.66 76.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.438 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -110.93 153.02 43.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.571 0.7 . . . . 0.0 110.951 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.962 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.7 Cg_endo -69.82 148.13 64.0 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.652 2.235 . . . . 0.0 112.3 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.428 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 7.6 mmt -81.74 40.68 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.427 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.3 mt -98.53 138.86 21.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.204 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -116.97 141.78 47.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.715 HD11 HD12 ' A' ' 377' ' ' LEU . 75.0 mt -134.7 95.4 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.222 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -62.69 124.94 22.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' A' ' 409' ' ' PRO . 44.1 mt -110.67 135.37 51.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 407' ' ' GLY . 9.0 t70 -55.49 126.36 24.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -75.16 -1.07 21.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -93.47 -30.29 15.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 43.4 p -127.97 -36.09 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 104.3 -5.89 45.6 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.474 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 8.8 pttm -82.94 152.8 66.38 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.569 0.699 . . . . 0.0 110.845 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.554 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.1 Cg_endo -69.73 95.29 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.66 2.24 . . . . 0.0 112.343 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 409' ' ' PRO . 9.4 ptmt -32.88 -51.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.866 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.15 -12.34 0.8 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.491 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -90.93 157.95 17.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.777 0.322 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.53 172.65 6.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.079 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.88 136.59 30.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.174 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.757 HG21 ' CD2' ' A' ' 381' ' ' PHE . 40.6 t -120.89 127.69 75.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.133 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' SER . . . . . 0.428 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 3.3 m -102.46 111.17 23.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.509 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 62.9 m-85 -87.4 157.68 19.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.944 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -53.46 -65.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.9 m-20 -113.31 155.81 44.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.644 0.735 . . . . 0.0 110.838 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.589 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.1 -42.96 58.0 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.689 2.259 . . . . 0.0 112.32 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.0 Cg_exo -50.34 -27.37 17.98 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.377 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 44.9 m -88.89 -34.3 17.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.582 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -64.76 -50.61 66.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.116 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.95 ' HG2' HD11 ' A' ' 444' ' ' LEU . 23.1 mttp -61.05 -40.01 92.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -69.56 -35.27 75.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.087 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.41 -34.68 76.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.043 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 423' ' ' ALA . 72.6 t -54.75 -61.73 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.74 -12.89 60.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.551 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.82 -54.21 6.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.899 ' HB2' HG21 ' A' ' 442' ' ' VAL . 84.5 m-85 -87.63 -20.12 26.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.2 t70 -54.74 99.93 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 104.42 11.72 30.6 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.539 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -74.44 176.16 7.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.757 0.313 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -122.27 112.59 18.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.926 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.579 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -113.4 112.59 23.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' GLN . . . . . 0.432 ' CD ' ' ND2' ' A' ' 369' ' ' ASN . 53.6 mt-30 58.44 36.89 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 85.9 -15.76 46.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.1 t -92.69 165.8 12.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.845 0.355 . . . . 0.0 110.901 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -102.95 134.09 46.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.921 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.579 HD11 ' HB2' ' A' ' 435' ' ' PHE . 11.7 mt -102.05 143.97 31.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -119.75 104.57 10.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.899 HG21 ' HB2' ' A' ' 430' ' ' PHE . 6.2 t -99.95 140.91 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.146 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 20.0 m -162.47 125.73 2.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.808 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.95 HD11 ' HG2' ' A' ' 424' ' ' LYS . 17.4 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.864 0.364 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -135.02 165.07 26.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.089 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.699 HD12 ' CG1' ' A' ' 442' ' ' VAL . 41.6 pt -135.26 145.79 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -103.89 112.94 26.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 1.05 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 20.5 t -97.04 142.34 14.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.133 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -148.16 122.78 9.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.59 17.05 1.77 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.47 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.521 HD13 HD11 ' A' ' 377' ' ' LEU . 87.5 mt -76.23 155.97 33.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.842 0.353 . . . . 0.0 110.907 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -79.37 -174.99 4.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.82 1.57 56.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.7 m -118.74 20.56 12.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' VAL . . . . . 0.51 HG23 ' CE2' ' A' ' 435' ' ' PHE . 6.2 p -87.15 137.29 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.083 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 59.2 p -120.22 163.46 17.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.197 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.792 HD11 ' HG2' ' A' ' 396' ' ' PRO . 10.0 tp -57.35 -63.35 1.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -44.87 -30.78 1.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.838 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -74.21 -34.19 63.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.828 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.521 HD11 HD13 ' A' ' 368' ' ' LEU . 61.0 mt -86.26 -23.53 26.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -75.86 -32.53 59.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.111 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.426 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 19.6 t0 -87.47 -18.01 30.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.825 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -92.07 -50.72 5.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 1.05 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.3 m-85 -62.03 -22.13 65.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.826 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.426 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 12.7 ptmt -75.55 -10.62 59.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -51.14 -53.96 29.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 34.4 t -58.93 -66.0 0.57 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.24 -124.76 2.55 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.454 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.32 130.71 71.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.878 0.371 . . . . 0.0 111.103 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.56 129.27 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.188 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -54.41 108.14 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' MET . . . . . 0.443 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 67.4 mmm -103.75 122.04 44.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.436 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 17.6 t-20 -48.51 149.06 1.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.839 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -94.87 -18.86 20.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.875 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -97.77 -47.32 5.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.436 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 49.0 p -90.68 -18.95 24.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.181 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' GLY . . . . . 0.443 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 62.13 27.53 69.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.448 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -114.77 153.5 46.88 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.611 0.719 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.792 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.5 Cg_endo -69.75 146.07 59.15 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.69 2.26 . . . . 0.0 112.282 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.45 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 16.6 mmt -81.17 41.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.462 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 95.7 mt -99.44 135.87 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.094 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -116.39 141.55 48.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 71.4 mt -133.65 93.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -60.69 124.41 20.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 409' ' ' PRO . 33.7 mt -108.98 136.71 48.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.94 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 407' ' ' GLY . 3.1 t70 -55.42 127.23 28.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.837 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.0 pttm -74.29 -1.03 18.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -97.18 -34.89 10.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 37.5 p -121.09 -34.97 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.154 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 99.59 -1.06 56.87 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.533 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -86.94 155.95 55.3 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.512 0.673 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.7 Cg_endo -69.82 91.36 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.697 2.265 . . . . 0.0 112.307 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.482 ' C ' ' O ' ' A' ' 409' ' ' PRO . 10.2 ptmt -31.75 -53.14 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.892 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.9 -14.78 0.51 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.501 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -88.45 156.81 18.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.868 0.366 . . . . 0.0 110.803 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.99 167.75 10.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.106 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.9 p -136.76 140.17 42.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.905 HG21 ' CD2' ' A' ' 381' ' ' PHE . 37.0 t -127.1 112.26 28.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.121 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' SER . . . . . 0.45 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 6.0 m -89.39 113.75 25.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.475 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 69.1 m-85 -88.8 164.97 14.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -57.27 -68.86 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.518 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 4.0 m-20 -112.68 156.97 41.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.605 0.717 . . . . 0.0 110.886 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.32 -43.06 55.79 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.704 2.269 . . . . 0.0 112.329 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.2 Cg_exo -50.25 -26.64 15.87 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.651 2.234 . . . . 0.0 112.326 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 35.2 m -90.0 -39.87 12.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.538 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -60.37 -51.31 70.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.065 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.463 ' HG2' HD11 ' A' ' 444' ' ' LEU . 4.3 mtpm? -57.52 -39.31 76.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.09 70.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.046 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.68 71.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.08 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 423' ' ' ALA . 85.6 t -56.89 -64.15 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.58 -11.44 24.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.537 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.3 t-105 -82.09 -55.29 4.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.889 ' HB2' HG21 ' A' ' 442' ' ' VAL . 89.1 m-85 -88.3 -13.88 39.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.831 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.8 t0 -58.64 96.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 112.26 -16.07 24.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.529 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -49.7 165.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.737 0.303 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -122.33 110.37 15.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.793 ' HB2' HD11 ' A' ' 440' ' ' LEU . 5.6 t80 -97.78 105.43 17.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 62.98 34.37 14.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 83.58 19.66 61.51 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.503 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 22.2 p -125.19 128.66 48.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.952 0.406 . . . . 0.0 110.828 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' LYS . . . . . 0.407 ' C ' HD23 ' A' ' 440' ' ' LEU . 0.5 OUTLIER -71.65 133.1 45.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 435' ' ' PHE . 8.6 mt -107.2 160.59 15.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -133.41 101.04 5.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.889 HG21 ' HB2' ' A' ' 430' ' ' PHE . 13.8 t -98.26 131.99 44.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.17 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.3 m -153.2 128.98 10.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.463 HD11 ' HG2' ' A' ' 424' ' ' LYS . 39.5 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.909 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 417' ' ' TYR . 3.3 p . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.896 0.379 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -144.25 166.98 23.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.084 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.731 HD12 ' CG1' ' A' ' 442' ' ' VAL . 37.7 pt -142.49 142.73 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -100.79 114.36 28.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.981 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.971 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 9.4 t -97.52 142.19 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.176 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -147.79 120.06 8.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.43 20.55 1.39 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.424 HD13 HD11 ' A' ' 377' ' ' LEU . 96.6 mt -79.48 154.43 28.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.865 0.364 . . . . 0.0 110.85 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -74.04 -177.95 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.24 0.42 57.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 20.1 m -118.68 16.9 13.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.837 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' VAL . . . . . 0.441 HG23 ' CE2' ' A' ' 435' ' ' PHE . 7.6 p -76.48 135.18 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.131 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 75.5 p -117.26 158.82 23.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.195 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.755 HD11 ' HG2' ' A' ' 396' ' ' PRO . 10.7 tp -56.99 -60.03 4.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.871 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -48.13 -40.12 22.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -28.8 68.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.769 HD12 HD11 ' A' ' 400' ' ' ILE . 47.6 mt -86.44 -31.44 21.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.38 -33.73 67.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.101 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.437 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 9.3 t70 -81.79 -20.16 39.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -92.45 -46.55 7.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.971 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 17.4 m-85 -65.76 -19.11 65.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.437 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -78.65 -4.28 48.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.914 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -56.74 -54.0 51.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.5 t -59.44 -65.92 0.59 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -134.41 -125.6 2.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.48 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 50.9 t -124.21 136.61 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.946 0.403 . . . . 0.0 111.105 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.22 132.26 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.089 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -57.18 106.87 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' MET . . . . . 0.49 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 73.4 mmm -102.44 121.08 41.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.78 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -46.79 150.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.72 -23.06 17.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.931 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' ARG . . . . . 0.598 ' HG3' HG23 ' A' ' 393' ' ' THR . 35.0 ptt180 -96.37 -47.11 6.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.598 HG23 ' HG3' ' A' ' 392' ' ' ARG . 61.9 p -89.46 -16.34 31.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 394' ' ' GLY . . . . . 0.49 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 58.59 24.09 56.07 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.478 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -111.45 153.34 44.2 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.638 0.733 . . . . 0.0 110.883 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.755 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.7 Cg_endo -69.8 146.67 60.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.667 2.245 . . . . 0.0 112.362 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.426 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.6 mmt -81.79 40.83 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.569 HG12 HG22 ' A' ' 415' ' ' VAL . 95.6 mt -98.8 136.22 30.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.122 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' HIS . . . . . 0.41 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 8.6 t60 -116.3 141.09 48.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.769 HD11 HD12 ' A' ' 377' ' ' LEU . 76.9 mt -134.67 94.13 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -60.65 124.41 20.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 409' ' ' PRO . 36.3 mt -109.82 135.17 51.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 407' ' ' GLY . 7.7 t0 -55.57 123.42 13.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.819 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -70.75 -2.03 13.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -89.28 -38.93 13.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 27.4 p -122.7 -34.74 3.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.177 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 104.79 -1.45 41.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.537 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -84.55 152.69 60.8 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.523 0.678 . . . . 0.0 110.915 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.486 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.2 Cg_endo -69.8 94.0 0.53 Allowed 'Trans proline' 0 N--CA 1.466 -0.132 0 C-N-CA 122.689 2.259 . . . . 0.0 112.354 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 409' ' ' PRO . 7.9 ptmt -32.94 -49.57 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 149.72 -13.58 1.02 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -90.53 155.83 18.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.84 0.353 . . . . 0.0 110.876 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -168.46 170.51 9.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.1 p -139.73 132.83 29.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.882 HG21 ' CD2' ' A' ' 381' ' ' PHE . 99.7 t -118.25 122.8 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' SER . . . . . 0.426 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 1.8 m -98.42 113.12 24.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.487 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 58.4 m-85 -86.74 169.85 12.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -63.44 -66.28 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.9 m-20 -114.53 156.25 44.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.708 . . . . 0.0 110.895 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.15 -43.01 57.2 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.706 2.271 . . . . 0.0 112.381 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.0 Cg_exo -50.42 -27.03 17.42 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.769 2.312 . . . . 0.0 112.348 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 90.2 m -90.4 -41.17 11.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.196 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.604 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.34 -49.6 77.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.077 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.522 ' HG2' HD11 ' A' ' 444' ' ' LEU . 47.4 mtpt -59.34 -40.24 85.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.94 -33.98 71.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.037 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.5 -33.94 75.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 423' ' ' ALA . 97.6 t -55.38 -60.88 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.97 -12.7 60.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.942 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.549 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.1 t-105 -80.16 -55.19 5.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.918 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.853 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.2 m-85 -86.73 -17.68 33.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.6 OUTLIER -54.16 94.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.861 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.2 20.26 9.89 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.464 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.453 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 15.2 mmtm -78.16 170.4 16.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.877 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -114.36 112.93 23.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.605 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.7 t80 -120.96 105.21 10.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 62.25 38.08 13.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.937 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 73.97 23.38 76.41 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 71.3 m -132.38 131.05 41.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 0.0 110.868 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -72.51 136.06 45.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' A' ' 435' ' ' PHE . 8.5 mt -104.15 143.27 33.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -117.45 104.23 10.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.853 HG21 ' HB2' ' A' ' 430' ' ' PHE . 7.5 t -101.11 133.86 43.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.128 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 3.8 m -156.07 132.09 9.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.522 HD11 ' HG2' ' A' ' 424' ' ' LYS . 18.5 mt . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 7.6 m . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.888 0.375 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -136.95 166.04 24.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.071 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.428 HD12 HG13 ' A' ' 442' ' ' VAL . 12.5 pt -137.69 142.14 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.139 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -100.44 117.91 35.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.986 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 40.4 t -101.78 144.41 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.033 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -150.31 118.06 6.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.38 23.11 1.03 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.447 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.497 HD13 HD11 ' A' ' 377' ' ' LEU . 93.9 mt -81.36 156.37 25.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.817 0.341 . . . . 0.0 110.895 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' A' ' 436' ' ' GLN . 8.5 p30 -79.9 179.94 7.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.87 1.5 53.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.844 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.9 m -117.31 16.0 14.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.83 136.59 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.098 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 73.4 p -123.05 156.21 35.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.136 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.955 HD11 ' HG2' ' A' ' 396' ' ' PRO . 10.6 tp -52.56 -65.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -46.61 -36.94 7.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -69.15 -31.56 70.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 400' ' ' ILE . 43.4 mt -84.93 -28.45 25.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.93 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.8 -40.38 63.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.438 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 23.2 t0 -73.14 -21.39 60.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -92.58 -49.42 6.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.986 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 14.8 m-85 -62.51 -22.65 66.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.438 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -74.67 -12.77 60.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.881 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -48.47 -56.11 9.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 32.6 t -55.74 -69.58 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -132.46 -123.4 2.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.439 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 55.8 t -125.5 133.52 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 111.165 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.38 131.21 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.167 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -54.95 109.28 0.5 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' MET . . . . . 0.402 ' SD ' ' CA ' ' A' ' 396' ' ' PRO . 65.0 mmm -104.29 123.16 46.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -50.51 145.51 6.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.867 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -94.85 -8.81 36.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' ARG . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 392' ' ' ARG . 3.8 ptp180 -102.98 -49.46 3.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.887 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.407 HG23 ' HG3' ' A' ' 392' ' ' ARG . 41.1 p -94.11 -14.92 25.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.179 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 62.53 30.19 75.8 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.469 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -116.52 153.28 48.91 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.6 0.714 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.955 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.6 Cg_endo -69.82 147.61 62.87 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.415 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 12.5 mmt -81.36 41.23 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.47 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.0 mt -97.79 135.67 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.074 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -116.09 139.99 49.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.765 HD11 HD12 ' A' ' 377' ' ' LEU . 60.7 mt -133.34 94.29 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.187 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -59.83 129.83 43.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.557 HD23 ' HA ' ' A' ' 409' ' ' PRO . 27.0 mt -114.09 137.12 52.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 407' ' ' GLY . 5.0 t70 -55.43 128.95 36.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -76.15 -1.62 27.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -97.46 -30.18 13.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.883 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 52.5 p -124.38 -36.17 2.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 97.62 7.84 56.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.452 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.8 156.66 37.06 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.584 0.707 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.557 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.0 Cg_endo -69.68 89.08 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.644 2.229 . . . . 0.0 112.382 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 409' ' ' PRO . 6.7 ptmt -31.22 -55.45 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 157.67 -15.93 0.31 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.484 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -88.76 158.0 18.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.349 . . . . 0.0 110.842 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -170.55 173.57 5.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.139 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.4 p -141.91 137.63 31.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.157 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.873 HG21 ' CD2' ' A' ' 381' ' ' PHE . 45.9 t -123.55 111.63 30.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.127 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 416' ' ' SER . . . . . 0.415 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 3.6 m -87.67 113.9 23.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.518 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 55.5 m-85 -87.72 166.91 14.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.859 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -61.33 -66.24 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.524 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.3 m-20 -110.73 156.63 40.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.636 0.731 . . . . 0.0 110.831 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.04 -42.91 58.88 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.674 2.249 . . . . 0.0 112.38 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.0 Cg_exo -50.86 -46.0 32.87 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.713 2.276 . . . . 0.0 112.394 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 86.2 m -68.36 -39.22 81.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.166 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -61.82 -48.13 81.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.116 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -61.33 -39.38 90.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.59 -34.93 72.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.152 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -67.7 -34.16 76.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.053 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 423' ' ' ALA . 94.3 t -54.93 -62.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -66.48 -10.83 48.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.548 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.2 t-105 -82.01 -55.63 4.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.918 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.819 ' HB2' HG21 ' A' ' 442' ' ' VAL . 90.7 m-85 -86.14 -21.43 27.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.5 t70 -52.62 97.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 103.42 21.37 9.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.494 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.426 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 19.5 mmtt -81.46 176.02 10.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.853 0.358 . . . . 0.0 110.845 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 1.6 p-10 -119.9 114.91 22.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.728 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -121.69 104.08 9.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' GLN . . . . . 0.419 ' HB2' ' ND2' ' A' ' 369' ' ' ASN . 41.9 mt-30 62.69 40.61 9.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.829 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 71.79 25.56 74.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.5 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 67.8 m -134.79 127.69 31.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.902 0.382 . . . . 0.0 110.891 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -68.95 136.77 53.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.9 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.728 HD11 ' HB2' ' A' ' 435' ' ' PHE . 12.4 mt -106.37 140.05 39.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -116.06 106.26 13.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.819 HG21 ' HB2' ' A' ' 430' ' ' PHE . 11.5 t -100.6 135.77 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.093 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 12.6 p -156.13 127.41 7.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 25.0 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.978 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.83 0.348 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -115.29 163.1 16.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.066 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.664 HD12 ' CG1' ' A' ' 442' ' ' VAL . 37.7 pt -137.06 141.99 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -100.93 114.67 28.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.935 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.891 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 5.1 t -101.2 141.9 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.105 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -147.4 123.67 10.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 128.66 14.26 2.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.521 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.09 152.61 41.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 372' ' ' VAL . 6.1 p30 -72.94 -176.41 2.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.95 -0.15 57.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.827 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.0 t -117.02 17.8 14.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' VAL . . . . . 0.4 ' N ' ' OD1' ' A' ' 369' ' ' ASN . 9.0 p -79.04 139.71 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.089 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 72.7 p -122.81 160.21 26.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.884 HD11 ' HG2' ' A' ' 396' ' ' PRO . 9.1 tp -56.55 -60.33 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -48.0 -37.1 13.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -30.12 68.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.745 HD12 HD11 ' A' ' 400' ' ' ILE . 63.2 mt -85.39 -31.34 22.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.95 -35.14 66.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.44 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 23.3 t0 -80.63 -20.56 42.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.828 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -92.65 -51.61 5.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.891 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.3 m-85 -61.11 -21.48 63.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.44 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 8.4 ptpt -75.79 -13.34 60.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -47.21 -54.53 10.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 21.6 t -57.34 -70.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -131.84 -124.22 2.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.508 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 96.3 t -124.55 136.67 59.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.392 . . . . 0.0 111.08 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 96.3 t -92.17 129.26 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.143 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -51.05 107.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 62.7 mmm -103.89 124.64 49.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.791 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.405 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 11.4 t-20 -47.44 145.48 2.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -94.69 -18.32 21.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 19.2 tpp85 -99.74 -45.26 5.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.863 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.405 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 23.6 p -91.85 -24.28 19.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.216 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 68.55 29.0 72.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.537 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.76 153.07 47.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.536 0.684 . . . . 0.0 110.961 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.884 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.2 Cg_endo -69.83 144.95 55.28 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.625 2.216 . . . . 0.0 112.326 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.449 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 12.5 mmt -81.37 41.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.471 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.5 mt -97.81 142.79 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.151 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -122.22 139.62 53.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.745 HD11 HD12 ' A' ' 377' ' ' LEU . 64.3 mt -133.31 94.6 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.191 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -61.23 122.32 14.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 409' ' ' PRO . 33.3 mt -107.12 135.06 49.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 407' ' ' GLY . 9.9 t0 -55.51 121.54 9.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -1.16 8.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -89.08 -37.64 14.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 43.1 p -125.19 -35.67 2.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.109 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.36 1.7 38.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.467 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -87.12 152.58 53.27 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.561 0.696 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.517 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.6 Cg_endo -69.72 93.06 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.701 2.267 . . . . 0.0 112.317 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 409' ' ' PRO . 6.5 ptmt -32.76 -52.93 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.884 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 153.95 -16.08 0.61 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.494 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -87.68 155.49 19.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.848 0.356 . . . . 0.0 110.84 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.46 168.59 11.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.9 p -136.7 139.85 42.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.765 HG21 ' CD2' ' A' ' 381' ' ' PHE . 31.9 t -124.81 116.62 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' SER . . . . . 0.449 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 22.9 m -92.06 110.76 22.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.869 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.505 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 51.9 m-85 -86.79 161.89 18.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -57.94 -63.54 1.22 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.511 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 1.2 m-20 -118.59 157.13 50.51 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.576 0.703 . . . . 0.0 110.84 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.51 -43.0 55.12 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.648 2.232 . . . . 0.0 112.383 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 56.9 Cg_exo -49.48 -26.43 12.23 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.641 2.227 . . . . 0.0 112.397 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 98.8 m -91.33 -41.13 11.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.04 -51.0 71.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.448 ' HG2' HD11 ' A' ' 444' ' ' LEU . 27.2 mtpp -58.63 -39.05 79.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -72.62 -32.18 65.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.104 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.87 72.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.073 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 423' ' ' ALA . 94.6 t -54.39 -61.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.187 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -66.25 -13.03 59.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.533 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.3 t-105 -80.46 -50.84 9.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.878 ' HB2' HG21 ' A' ' 442' ' ' VAL . 82.3 m-85 -92.88 -13.09 29.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.0 OUTLIER -59.51 92.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.97 -13.64 19.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.433 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 9.8 mmtm -45.68 166.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.749 0.309 . . . . 0.0 110.916 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 434' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 4.4 p-10 -115.1 112.24 22.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.501 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.2 t80 -111.76 108.6 18.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 61.64 31.06 18.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 91.49 -15.96 60.16 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.563 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.2 t -91.11 159.05 16.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.382 . . . . 0.0 110.898 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -96.23 134.52 39.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 435' ' ' PHE . 8.6 mt -100.01 140.05 34.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -117.36 100.13 7.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.878 HG21 ' HB2' ' A' ' 430' ' ' PHE . 12.5 t -97.67 133.08 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 6.1 p -156.49 128.43 7.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.825 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.448 HD11 ' HG2' ' A' ' 424' ' ' LYS . 18.8 mt . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.829 0.347 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -139.05 166.98 23.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.069 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.632 HD12 ' CG1' ' A' ' 442' ' ' VAL . 33.7 pt -137.71 143.78 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -102.32 114.31 28.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 1.029 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 15.6 t -97.72 141.31 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.177 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -147.89 121.05 8.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.49 20.72 1.36 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.438 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.486 HD13 HD11 ' A' ' 377' ' ' LEU . 65.8 mt -81.28 153.4 27.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.766 0.317 . . . . 0.0 110.979 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' ASN . . . . . 0.406 ' H ' ' ND2' ' A' ' 369' ' ' ASN . 3.8 p30 -75.71 -177.21 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.25 7.59 40.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.8 t -123.2 14.11 9.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 10.8 p -75.57 132.9 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 58.6 p -114.53 159.68 20.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.203 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.756 HD11 ' HG2' ' A' ' 396' ' ' PRO . 13.1 tp -58.95 -61.29 2.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -48.74 -32.74 9.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.97 -31.09 65.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.579 HD12 HD11 ' A' ' 400' ' ' ILE . 38.6 mt -86.21 -30.03 22.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.87 -33.26 65.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.67 -20.97 35.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.428 ' CE2' ' CD1' ' A' ' 430' ' ' PHE . 63.6 t80 -92.32 -49.5 6.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 1.029 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.1 m-85 -59.9 -26.38 65.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -75.89 -4.39 40.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -55.43 -48.88 73.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 39.3 t -63.71 -57.87 8.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -142.22 -123.19 1.83 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.488 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 71.9 t -124.84 135.98 62.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 85.9 t -92.04 128.35 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -53.18 108.96 0.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 389' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 40.1 mmm -105.87 127.53 53.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.431 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 14.4 t-20 -50.23 146.17 5.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -94.86 -13.39 25.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -100.47 -48.27 4.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.431 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 30.4 p -92.49 -19.62 21.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' GLY . . . . . 0.473 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 66.12 26.65 72.49 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.472 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -112.59 153.28 45.03 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.654 0.74 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.756 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.9 Cg_endo -69.67 146.61 61.32 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.722 2.281 . . . . 0.0 112.379 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.44 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.2 mmt -81.49 40.69 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.52 HG12 HG22 ' A' ' 415' ' ' VAL . 97.1 mt -98.05 138.76 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -118.3 137.16 53.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.579 HD11 HD12 ' A' ' 377' ' ' LEU . 73.6 mt -130.8 95.54 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.157 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -63.16 126.15 26.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 409' ' ' PRO . 35.8 mt -110.96 135.49 51.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.913 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.7 t0 -56.58 121.46 9.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.416 ' HD3' ' C ' ' A' ' 404' ' ' LYS . 0.0 OUTLIER -70.12 -1.05 8.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -89.04 -37.27 15.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.0 p -124.18 -36.01 2.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.098 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 107.56 -2.87 34.39 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.45 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -85.15 152.82 59.09 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.515 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.6 Cg_endo -69.76 95.79 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.707 2.271 . . . . 0.0 112.292 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 409' ' ' PRO . 6.4 ptmt -33.39 -52.37 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.99 -12.8 0.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.51 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -91.39 152.03 20.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -165.26 170.6 14.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.4 p -139.1 142.12 38.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.924 HG21 ' CD2' ' A' ' 381' ' ' PHE . 48.1 t -128.99 116.28 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' SER . . . . . 0.44 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 14.5 m -90.76 115.54 27.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.537 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 56.6 m-85 -88.36 163.98 15.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -62.17 -63.61 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.509 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 1.6 m-20 -116.01 156.29 46.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.634 0.731 . . . . 0.0 110.87 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.26 -43.02 56.44 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.745 2.297 . . . . 0.0 112.36 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 56.7 Cg_exo -49.31 -26.71 11.99 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.658 2.238 . . . . 0.0 112.373 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 93.4 m -91.89 -41.46 10.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.719 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.28 -47.36 85.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.126 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -63.26 -37.41 87.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.86 -32.33 61.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.041 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' ALA . . . . . 0.453 ' HB1' ' OH ' ' A' ' 417' ' ' TYR . . . -69.36 -33.85 73.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.027 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 423' ' ' ALA . 85.2 t -56.15 -64.42 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.127 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.59 -13.67 44.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.53 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.3 t-105 -79.21 -54.39 6.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.888 ' HB2' HG21 ' A' ' 442' ' ' VAL . 79.8 m-85 -90.61 -11.67 39.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 3.0 t70 -61.4 98.38 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 106.38 -7.93 40.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.511 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.444 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 30.8 mmtt -53.82 165.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 110.876 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -112.67 116.18 29.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.622 ' HB2' HD11 ' A' ' 440' ' ' LEU . 6.4 t80 -113.82 109.71 18.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 61.13 28.77 18.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 94.1 -14.83 64.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.512 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 19.7 m -91.81 160.59 15.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 0.0 110.834 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -97.39 134.46 40.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.937 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' A' ' 435' ' ' PHE . 9.6 mt -102.84 144.9 30.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -122.77 99.51 6.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.888 HG21 ' HB2' ' A' ' 430' ' ' PHE . 16.9 t -96.2 131.37 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 5.4 m -151.8 129.43 11.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.491 ' HG ' HG21 ' A' ' 427' ' ' VAL . 21.5 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.938 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 6.8 m . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.871 0.367 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -141.52 165.65 26.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.146 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.477 ' HB ' ' CG1' ' A' ' 442' ' ' VAL . 17.1 pt -137.66 139.29 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.081 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -99.45 113.49 25.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 1.052 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 23.2 t -96.93 143.31 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.132 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -149.95 120.57 7.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.82 20.76 1.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.498 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.512 HD23 HD22 ' A' ' 440' ' ' LEU . 44.2 mt -83.58 156.01 22.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -78.62 -176.3 4.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.58 10.06 29.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.5 t -122.91 10.04 9.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' VAL . . . . . 0.5 HG21 HD21 ' A' ' 377' ' ' LEU . 7.4 p -73.79 128.95 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 74.8 p -111.35 162.86 14.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.122 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.752 HD11 ' HG2' ' A' ' 396' ' ' PRO . 13.8 tp -58.74 -63.77 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -46.69 -38.24 9.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.869 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -67.09 -29.99 69.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.577 HD12 HD11 ' A' ' 400' ' ' ILE . 47.6 mt -87.33 -29.81 21.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.934 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.92 -41.04 64.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.431 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 30.7 t0 -76.17 -19.39 58.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -92.61 -45.58 8.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.943 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 1.052 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 15.0 m-85 -67.46 -19.36 65.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.838 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.431 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 5.7 ptmm? -77.14 -6.04 51.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -53.24 -53.08 55.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 13.2 t -59.2 -68.18 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.07 -122.39 2.31 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.483 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 71.7 t -126.98 135.22 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.882 0.372 . . . . 0.0 111.16 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.48 130.93 36.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.158 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -55.09 104.51 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' MET . . . . . 0.499 ' SD ' ' N ' ' A' ' 396' ' ' PRO . 59.4 mmm -101.5 118.71 37.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -46.82 150.38 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -95.09 -23.6 17.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' ARG . . . . . 0.415 ' CD ' HG23 ' A' ' 393' ' ' THR . 0.0 OUTLIER -93.64 -46.51 7.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.821 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.415 HG23 ' CD ' ' A' ' 392' ' ' ARG . 41.4 p -90.93 -14.1 32.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.16 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 394' ' ' GLY . . . . . 0.45 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 55.32 30.41 55.12 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.529 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -118.67 153.18 52.14 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.556 0.693 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.752 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.1 Cg_endo -69.8 147.95 63.76 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.682 2.255 . . . . 0.0 112.345 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.46 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 19.7 mmt -81.84 40.58 0.61 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.829 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.525 HG12 HG22 ' A' ' 415' ' ' VAL . 96.2 mt -96.71 143.66 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.144 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -123.66 138.11 54.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.577 HD11 HD12 ' A' ' 377' ' ' LEU . 60.3 mt -131.73 96.23 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.136 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -63.75 124.46 21.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 409' ' ' PRO . 24.7 mt -109.84 136.16 49.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.935 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.5 t70 -56.72 134.67 55.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.806 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -5.82 55.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -97.31 -26.37 14.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.43 ' OG1' ' CG ' ' A' ' 408' ' ' LYS . 65.2 p -123.1 -36.16 2.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.074 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 95.17 -6.61 68.99 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.461 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 408' ' ' LYS . . . . . 0.43 ' CG ' ' OG1' ' A' ' 406' ' ' THR . 3.7 ptpt -86.97 159.42 51.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.592 0.711 . . . . 0.0 110.858 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.524 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.0 Cg_endo -69.76 92.57 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.61 2.207 . . . . 0.0 112.404 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -32.39 -51.98 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 153.77 -13.96 0.59 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -90.43 157.08 17.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.903 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -170.17 169.63 7.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.056 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.6 p -140.05 139.15 35.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.138 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.975 HG21 ' CD2' ' A' ' 381' ' ' PHE . 60.5 t -125.66 120.85 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 416' ' ' SER . . . . . 0.46 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 4.8 m -95.46 116.42 28.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.827 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.434 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 60.4 m-85 -89.29 163.6 15.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.898 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -58.49 -66.35 0.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.831 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.5 m-20 -112.31 156.44 42.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.663 0.744 . . . . 0.0 110.793 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.37 -42.99 56.12 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.7 2.267 . . . . 0.0 112.349 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.3 Cg_exo -50.21 -32.63 33.17 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.638 2.225 . . . . 0.0 112.345 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 89.1 m -81.75 -38.57 25.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -62.33 -50.64 70.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.181 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.664 ' HG2' HD11 ' A' ' 444' ' ' LEU . 39.3 mtmt -58.94 -35.61 73.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.64 -32.05 57.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.25 -33.38 71.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.069 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.614 HG21 ' HG ' ' A' ' 444' ' ' LEU . 97.2 t -55.91 -63.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.13 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -65.73 -9.74 30.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.534 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.2 t-105 -83.77 -55.09 4.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.938 ' HB2' HG21 ' A' ' 442' ' ' VAL . 93.2 m-85 -87.29 -18.52 30.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.856 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.8 t70 -55.81 98.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 103.92 12.22 30.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.518 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.444 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 16.2 mmtm -71.05 175.03 5.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.766 0.317 . . . . 0.0 110.894 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 434' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 438' ' ' SER . 1.2 m-20 -121.72 127.94 51.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.576 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.1 t80 -123.92 100.74 6.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 62.17 36.85 14.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 93.3 -21.36 40.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.47 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 434' ' ' ASP . 24.4 p -85.53 166.84 15.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.96 0.41 . . . . 0.0 110.842 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' LYS . . . . . 0.426 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.7 tmmm? -112.43 137.02 51.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.576 HD11 ' HB2' ' A' ' 435' ' ' PHE . 1.4 mt -108.71 151.19 26.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -125.31 106.78 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.938 HG21 ' HB2' ' A' ' 430' ' ' PHE . 15.0 t -96.74 138.95 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 47.7 m -157.51 126.1 5.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.664 HD11 ' HG2' ' A' ' 424' ' ' LYS . 19.7 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.909 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.913 0.387 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -126.52 158.96 34.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.112 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.688 HD12 ' CG1' ' A' ' 442' ' ' VAL . 38.2 pt -130.76 143.3 41.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.154 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -102.57 110.9 22.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.99 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 12.0 t -95.13 142.23 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.149 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -146.66 121.09 9.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.88 14.49 2.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.519 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.498 HD13 HD11 ' A' ' 377' ' ' LEU . 96.7 mt -73.47 154.85 39.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -77.11 178.79 6.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.99 6.25 40.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.9 t -121.91 13.57 10.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.858 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' VAL . . . . . 0.471 HG21 HD21 ' A' ' 377' ' ' LEU . 11.7 p -74.31 138.02 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.156 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 35.4 p -122.45 158.7 29.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.825 HD11 ' HG2' ' A' ' 396' ' ' PRO . 17.6 tp -54.81 -60.4 3.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -50.9 -29.74 12.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -75.8 -34.24 60.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.641 HD12 HD11 ' A' ' 400' ' ' ILE . 53.0 mt -82.63 -27.96 31.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -74.26 -37.87 63.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.074 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.438 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 13.5 t70 -76.08 -21.58 56.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.848 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -92.53 -49.32 6.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.935 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.99 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.6 m-85 -63.82 -11.6 28.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.438 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 13.5 ptmt -88.63 -5.13 58.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -54.54 -54.04 46.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.51 -67.36 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -130.71 -127.43 2.89 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.514 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 78.3 t -125.86 130.78 72.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 111.195 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 56.0 t -82.0 128.58 38.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -50.03 105.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 82.7 mmm -100.57 124.08 45.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.404 ' CB ' ' OG1' ' A' ' 393' ' ' THR . 8.0 t-20 -50.38 144.78 7.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -94.46 -18.83 21.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -99.93 -44.1 6.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.404 ' OG1' ' CB ' ' A' ' 390' ' ' ASN . 25.6 p -92.18 -22.14 19.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.185 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 65.89 29.95 76.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -120.03 153.11 55.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.86 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.825 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.0 Cg_endo -69.83 145.72 57.6 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.721 2.281 . . . . 0.0 112.298 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.42 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 11.8 mmt -81.33 41.21 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.458 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 98.6 mt -98.76 140.86 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -121.05 140.25 52.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.641 HD11 HD12 ' A' ' 377' ' ' LEU . 61.3 mt -132.64 99.86 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -68.12 131.61 45.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 409' ' ' PRO . 26.0 mt -115.51 138.28 51.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.921 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 407' ' ' GLY . 6.0 t0 -59.53 124.52 20.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -71.34 -1.17 12.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -89.5 -39.66 13.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 82.8 p -121.72 -33.42 3.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 103.9 -4.49 45.84 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.523 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -82.54 152.86 67.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.6 0.714 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.561 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.1 Cg_endo -69.76 95.64 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.689 2.26 . . . . 0.0 112.336 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 409' ' ' PRO . 8.7 ptmt -32.76 -54.62 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.51 -13.87 0.52 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.2 p-10 -87.73 157.21 19.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.743 0.306 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.38 169.4 9.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.052 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 2.3 p -137.84 139.69 40.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.192 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.881 HG21 ' CD2' ' A' ' 381' ' ' PHE . 48.6 t -127.15 114.78 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 416' ' ' SER . . . . . 0.42 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 2.8 m -91.11 112.17 23.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.841 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 68.8 m-85 -86.84 160.93 18.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.88 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -55.18 -67.44 0.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.83 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.517 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.4 m-20 -107.41 156.21 38.15 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.517 0.675 . . . . 0.0 110.942 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.34 -42.94 56.76 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.712 2.275 . . . . 0.0 112.324 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 53.0 Cg_exo -50.03 -46.82 26.35 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.733 2.289 . . . . 0.0 112.253 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 28.6 m -64.45 -43.77 93.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.17 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.727 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -58.85 -45.8 89.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.093 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.605 ' HG2' HD11 ' A' ' 444' ' ' LEU . 68.1 mttt -64.49 -35.33 80.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.03 -33.53 57.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.078 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -69.38 -33.87 73.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.075 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 423' ' ' ALA . 77.1 t -54.71 -61.43 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.55 -15.03 63.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.535 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.3 t-105 -78.14 -52.39 8.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.903 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.748 ' HB2' HG21 ' A' ' 442' ' ' VAL . 89.1 m-85 -88.92 -16.68 31.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.869 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.0 t70 -59.9 97.04 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 111.57 1.26 27.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.547 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 19.5 mmtm -67.36 168.34 10.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.803 0.335 . . . . 0.0 110.956 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 434' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 1.4 p-10 -115.78 111.55 20.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.657 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -111.27 106.55 15.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 61.42 37.73 16.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 74.6 23.61 74.79 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.415 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 36.5 m -132.35 128.78 38.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.919 0.39 . . . . 0.0 110.832 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.17 133.75 48.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.925 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.657 HD11 ' HB2' ' A' ' 435' ' ' PHE . 17.1 mt -101.05 156.81 17.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.96 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -129.74 100.58 5.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.886 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.748 HG21 ' HB2' ' A' ' 430' ' ' PHE . 14.2 t -100.58 131.89 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.171 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 443' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 444' ' ' LEU . 13.3 m -157.37 124.27 5.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.605 HD11 ' HG2' ' A' ' 424' ' ' LYS . 34.9 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.858 0.361 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -142.85 161.65 37.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.091 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.554 HD12 ' CG1' ' A' ' 442' ' ' VAL . 38.9 pt -135.52 141.14 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.113 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -100.03 122.04 42.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.897 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 8.1 t -107.5 141.75 21.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.076 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -145.62 123.59 12.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 126.54 16.33 2.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.458 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 93.9 mt -73.84 152.89 40.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 372' ' ' VAL . 6.1 p30 -73.96 -176.53 2.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.96 3.6 54.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.8 m -120.79 17.7 11.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 372' ' ' VAL . . . . . 0.423 ' N ' ' OD1' ' A' ' 369' ' ' ASN . 11.5 p -79.31 143.23 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.181 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 82.2 p -126.82 155.51 42.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.183 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.708 HD11 ' HG2' ' A' ' 396' ' ' PRO . 16.5 tp -49.64 -62.05 1.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -48.74 -37.85 20.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.83 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -66.53 -27.43 67.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 400' ' ' ILE . 89.6 mt -91.09 -30.06 16.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.66 -37.53 67.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.089 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.436 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 27.7 t70 -78.39 -19.63 52.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.895 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -92.61 -51.9 4.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.897 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 19.1 m-85 -60.34 -24.87 65.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.436 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 8.8 ptmt -70.87 -10.48 59.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.934 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -51.71 -57.4 9.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.3 t -53.93 -66.82 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -136.59 -122.67 2.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 75.4 t -126.01 130.66 72.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.92 0.39 . . . . 0.0 111.115 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.61 131.15 34.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -54.54 107.76 0.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' MET . . . . . 0.467 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 64.0 mmm -104.35 122.76 46.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.449 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 14.4 t-20 -48.8 148.98 1.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -94.91 -22.38 18.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.85 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -93.98 -48.39 6.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.842 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.449 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 41.1 p -88.42 -24.07 23.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.098 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 394' ' ' GLY . . . . . 0.467 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 68.0 25.88 74.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.433 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -114.94 153.22 47.05 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.571 0.7 . . . . 0.0 110.965 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.708 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.4 Cg_endo -69.78 147.03 61.86 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.7 2.267 . . . . 0.0 112.339 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.471 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 15.0 mmt -81.27 41.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.638 HG12 HG22 ' A' ' 415' ' ' VAL . 96.2 mt -98.04 136.52 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.182 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -117.47 142.19 47.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.765 HD11 HD12 ' A' ' 377' ' ' LEU . 61.4 mt -134.81 94.08 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -61.17 121.84 13.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' A' ' 409' ' ' PRO . 31.3 mt -108.88 135.37 50.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.931 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 407' ' ' GLY . 11.7 t0 -55.33 122.36 10.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -69.89 -0.9 8.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.772 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -91.35 -41.21 11.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.6 p -118.78 -34.39 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 101.7 5.06 51.71 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.46 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -91.09 153.15 44.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.552 0.692 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.554 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.4 Cg_endo -69.76 91.89 0.51 Allowed 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.652 2.235 . . . . 0.0 112.372 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 409' ' ' PRO . 9.2 ptmt -31.67 -52.41 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.33 -17.13 0.59 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -87.63 157.22 19.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.856 0.36 . . . . 0.0 110.872 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.4 174.17 6.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 2.2 p -143.61 141.32 30.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.113 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.879 HG21 ' CD2' ' A' ' 381' ' ' PHE . 95.8 t -129.41 115.23 34.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 416' ' ' SER . . . . . 0.471 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 1.9 m -90.67 114.76 27.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 51.8 m-85 -87.94 161.1 17.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -54.34 -66.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.835 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.517 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 7.1 m-20 -116.34 158.35 43.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.632 0.729 . . . . 0.0 110.878 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.8 Cg_exo -57.44 -43.23 53.44 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.71 2.273 . . . . 0.0 112.332 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 53.1 Cg_exo -49.99 -27.44 16.48 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.65 2.234 . . . . 0.0 112.374 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 40.4 m -89.61 -41.78 11.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.117 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.64 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.84 -48.89 79.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -59.7 -38.96 83.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.82 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -72.84 -32.99 65.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -69.09 -35.07 76.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 423' ' ' ALA . 94.7 t -55.27 -62.52 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -66.9 -11.11 55.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.551 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.1 t-105 -81.02 -55.39 4.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.925 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.847 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.0 m-85 -87.34 -19.65 27.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.859 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.1 t70 -51.65 96.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.854 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 103.93 20.8 10.19 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.485 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.453 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 16.1 mmtm -76.81 170.99 15.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.769 0.319 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' ASP . . . . . 0.426 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 1.7 p30 -115.04 109.29 17.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.841 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.623 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.0 t80 -112.79 108.07 16.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 62.08 33.72 16.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 89.2 -16.38 55.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.448 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 3.1 m -92.66 164.04 13.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.964 0.411 . . . . 0.0 110.836 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -101.62 138.38 38.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 435' ' ' PHE . 12.4 mt -106.89 144.86 32.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -118.94 107.93 14.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.847 HG21 ' HB2' ' A' ' 430' ' ' PHE . 9.1 t -100.85 131.99 47.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.12 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 10.3 p -152.12 128.81 10.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.885 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.972 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 361' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 423' ' ' ALA . 3.8 p . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.896 0.379 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -108.86 158.71 17.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.468 ' CG1' ' HB ' ' A' ' 415' ' ' VAL . 28.9 pt -125.84 142.33 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -103.09 116.32 32.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.957 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 9.3 t -101.73 144.21 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.123 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -149.06 120.13 7.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.01 20.25 1.33 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.454 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.454 HD13 HD11 ' A' ' 377' ' ' LEU . 90.9 mt -79.94 154.53 28.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.808 0.337 . . . . 0.0 110.965 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -77.61 -178.53 5.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.69 3.5 52.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.405 ' HB3' HE22 ' A' ' 436' ' ' GLN . 3.0 t -118.83 15.72 13.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.859 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 372' ' ' VAL . . . . . 0.524 HG23 ' CE2' ' A' ' 435' ' ' PHE . 9.3 p -77.13 136.15 25.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 34.0 p -121.48 157.16 31.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.14 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.704 HD11 ' HG2' ' A' ' 396' ' ' PRO . 21.8 tp -53.75 -65.99 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -45.47 -32.75 2.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.21 -32.34 64.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.749 HD12 HD11 ' A' ' 400' ' ' ILE . 27.8 mt -82.59 -31.11 29.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.918 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -71.03 -44.93 64.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.107 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -72.57 -18.63 61.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -92.62 -41.6 10.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.957 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.3 m-85 -73.6 -25.01 60.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -67.06 -6.84 18.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.982 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -56.04 -60.19 3.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 35.2 t -49.46 -64.45 0.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.907 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -143.98 -122.55 1.64 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.451 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 69.0 t -121.79 122.04 65.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 0.0 111.131 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 81.8 t -77.53 127.75 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.226 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.472 ' CD ' ' HA ' ' A' ' 418' ' ' GLU . 33.2 tptt -46.09 103.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 73.0 mmm -103.32 126.33 50.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -51.43 145.7 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.92 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -94.59 -20.81 19.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -97.38 -45.47 6.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 25.0 p -90.72 -25.26 20.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 68.98 29.47 72.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -117.9 153.76 51.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.644 0.735 . . . . 0.0 110.927 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.704 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.0 Cg_endo -69.72 144.11 53.17 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.68 2.253 . . . . 0.0 112.379 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.435 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 15.2 mmt -82.1 40.26 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.625 HG12 HG22 ' A' ' 415' ' ' VAL . 96.4 mt -96.06 141.42 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.158 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -122.03 139.48 53.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.749 HD11 HD12 ' A' ' 377' ' ' LEU . 61.2 mt -132.08 94.48 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.126 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -61.29 130.11 44.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 409' ' ' PRO . 35.8 mt -114.36 136.82 52.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.861 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 407' ' ' GLY . 6.4 t0 -56.83 126.52 27.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.812 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.57 -1.15 17.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -92.02 -36.74 13.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 31.2 p -123.57 -33.6 3.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 101.64 -1.52 52.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.524 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -84.27 152.93 62.15 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.612 0.72 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.583 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.2 Cg_endo -69.76 92.42 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.306 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.48 ' C ' ' O ' ' A' ' 409' ' ' PRO . 8.1 ptmt -31.82 -51.99 0.23 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.86 -15.6 0.8 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.531 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -88.23 151.64 22.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -164.29 172.04 14.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.1 p -140.21 141.3 35.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.12 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.824 HG21 ' CD2' ' A' ' 381' ' ' PHE . 58.0 t -128.29 113.63 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.076 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 416' ' ' SER . . . . . 0.435 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 2.1 m -87.48 119.25 27.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.558 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 37.2 m-85 -91.55 159.02 16.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.959 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 418' ' ' GLU . . . . . 0.472 ' HA ' ' CD ' ' A' ' 388' ' ' LYS . 15.9 mm-40 -58.2 -60.88 3.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.524 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.2 m-20 -113.69 156.9 42.96 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.568 0.699 . . . . 0.0 110.899 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.4 Cg_exo -57.01 -42.89 59.36 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.626 2.217 . . . . 0.0 112.323 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.5 Cg_exo -52.46 -41.99 64.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.727 2.285 . . . . 0.0 112.351 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 39.3 m -67.36 -40.82 85.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.167 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -62.18 -49.8 74.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.06 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.578 ' HG2' HD11 ' A' ' 444' ' ' LEU . 43.3 mtpt -60.15 -36.14 76.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.55 -33.05 58.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.115 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' ALA . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 417' ' ' TYR . . . -72.43 -33.24 66.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 423' ' ' ALA . 86.1 t -57.33 -62.06 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.179 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -68.12 -11.35 58.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.549 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.62 -54.81 5.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.846 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.7 m-85 -87.76 -19.6 27.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.4 t0 -54.15 89.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 116.46 13.99 7.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.533 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.472 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 2.4 mmmp? -79.44 176.2 9.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 0.0 110.903 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -121.36 126.9 50.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.781 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.2 t80 -126.24 105.53 8.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 436' ' ' GLN . . . . . 0.405 HE22 ' HB3' ' A' ' 371' ' ' SER . 28.4 mt-30 62.58 31.01 17.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 83.94 18.38 63.38 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.527 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 19.4 m -128.6 126.67 40.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.969 0.414 . . . . 0.0 110.862 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.9 138.07 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.781 HD11 ' HB2' ' A' ' 435' ' ' PHE . 10.0 mt -108.89 147.49 32.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -119.37 108.5 14.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.846 HG21 ' HB2' ' A' ' 430' ' ' PHE . 13.0 t -100.85 132.2 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 9.5 p -151.7 127.54 10.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.806 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.719 ' HG ' HG21 ' A' ' 427' ' ' VAL . 16.4 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 417' ' ' TYR . 8.5 p . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.866 0.365 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -146.99 169.24 19.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.068 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.693 HD12 ' CG1' ' A' ' 442' ' ' VAL . 37.0 pt -144.96 142.68 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -101.1 113.11 25.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.979 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 19.3 t -96.19 144.22 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.123 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -150.23 119.55 6.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.4 23.38 1.01 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.574 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 71.6 mt -83.72 152.71 24.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 0.0 110.887 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' ASN . . . . . 0.505 ' ND2' ' CD ' ' A' ' 436' ' ' GLN . 5.0 p30 -74.61 179.34 4.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.41 1.08 52.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 14.3 m -117.29 13.65 14.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.845 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.37 133.59 31.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.129 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 81.6 p -117.56 163.98 15.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.149 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.766 HD11 ' HG2' ' A' ' 396' ' ' PRO . 16.3 tp -58.9 -62.77 1.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.08 -38.37 7.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.92 -31.8 73.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.55 HD12 HD11 ' A' ' 400' ' ' ILE . 84.5 mt -86.97 -30.32 21.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.959 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.17 -33.76 65.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.081 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.425 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 8.4 t70 -84.6 -19.4 33.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -91.92 -50.89 5.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.979 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 20.0 m-85 -61.72 -23.6 66.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.876 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.425 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 30.3 pttt -72.65 -6.95 47.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.865 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -55.11 -51.91 64.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 7.3 t -62.79 -64.75 0.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -134.82 -129.87 2.93 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.49 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 50.3 t -122.07 129.11 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.808 0.337 . . . . 0.0 111.178 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.85 128.43 38.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -52.42 105.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.845 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 73.9 mmm -101.22 123.75 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.409 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 11.5 t-20 -50.1 147.27 4.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.844 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -94.71 -18.28 21.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' ARG . . . . . 0.456 ' HG3' HG23 ' A' ' 393' ' ' THR . 19.6 ptt180 -99.71 -44.22 6.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.456 HG23 ' HG3' ' A' ' 392' ' ' ARG . 67.0 p -93.53 -17.12 23.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 60.69 26.67 65.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.514 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -115.37 153.04 47.53 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.581 0.705 . . . . 0.0 110.942 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.766 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.5 Cg_endo -69.7 146.66 61.21 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.696 2.264 . . . . 0.0 112.362 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.407 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 6.8 mmt -81.37 41.15 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.926 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.466 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 90.6 mt -98.96 135.02 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.137 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -114.77 138.08 51.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.55 HD11 HD12 ' A' ' 377' ' ' LEU . 60.7 mt -130.79 94.2 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.163 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -61.78 123.82 19.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.545 HD23 ' HA ' ' A' ' 409' ' ' PRO . 45.3 mt -110.19 135.93 50.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 407' ' ' GLY . 11.1 t70 -55.42 124.37 16.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.932 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -73.09 -1.05 15.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -95.08 -35.12 12.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 37.2 p -121.24 -36.13 3.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.079 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 103.21 -6.99 51.21 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.551 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -82.55 153.04 67.87 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.592 0.71 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.545 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.8 Cg_endo -69.69 94.51 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.7 2.267 . . . . 0.0 112.372 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -32.58 -50.15 0.24 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.817 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 150.14 -15.3 1.01 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.468 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -88.15 154.99 20.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.777 0.322 . . . . 0.0 110.927 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.05 170.93 10.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.121 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 2.5 p -137.91 142.04 40.62 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.167 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.852 HG21 ' CD2' ' A' ' 381' ' ' PHE . 47.3 t -127.81 115.25 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 416' ' ' SER . . . . . 0.407 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 1.9 m -92.65 114.97 27.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.493 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 54.2 m-85 -89.05 163.39 15.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.974 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -56.24 -65.49 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.517 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 4.7 m-20 -115.78 156.56 46.24 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.731 . . . . 0.0 110.842 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.2 Cg_exo -57.37 -42.89 57.11 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.636 2.224 . . . . 0.0 112.366 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.0 Cg_exo -50.69 -26.98 18.49 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.625 2.217 . . . . 0.0 112.361 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 52.9 m -89.05 -43.17 11.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.71 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -58.87 -48.13 82.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.522 ' HG2' HD11 ' A' ' 444' ' ' LEU . 7.9 mtmp? -59.86 -38.47 82.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.888 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.0 -32.83 63.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.079 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.73 -31.95 68.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 423' ' ' ALA . 90.5 t -56.32 -60.69 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.082 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -67.06 -12.45 59.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.554 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.53 -54.6 5.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.826 ' HB2' HG21 ' A' ' 442' ' ' VAL . 88.9 m-85 -88.26 -14.56 38.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.88 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.7 OUTLIER -58.49 93.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 108.1 14.72 16.06 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.466 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.413 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 15.7 mmtm -73.92 169.67 16.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.76 0.315 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -112.28 112.92 24.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.566 ' HB3' HD21 ' A' ' 440' ' ' LEU . 4.4 t80 -115.47 106.48 14.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 436' ' ' GLN . . . . . 0.505 ' CD ' ' ND2' ' A' ' 369' ' ' ASN . 20.4 mt-30 61.59 38.56 15.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.968 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 84.49 -14.53 45.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.5 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 6.1 m -94.25 168.92 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.815 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -106.62 135.95 47.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 435' ' ' PHE . 9.4 mt -102.69 145.05 30.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -119.78 107.39 13.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.832 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.826 HG21 ' HB2' ' A' ' 430' ' ' PHE . 6.3 t -103.08 136.26 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.1 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 443' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 444' ' ' LEU . 22.0 m -157.3 126.38 5.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.522 HD11 ' HG2' ' A' ' 424' ' ' LYS . 19.4 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.866 0.365 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -145.68 156.73 43.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.105 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.468 ' HB ' ' CG1' ' A' ' 442' ' ' VAL . 44.8 pt -128.67 140.12 50.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -98.75 111.36 23.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.918 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 13.0 t -95.19 140.09 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.148 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -147.39 122.4 10.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 131.81 6.07 3.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.517 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.487 HD13 HD11 ' A' ' 377' ' ' LEU . 19.8 mt -71.99 156.42 39.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.871 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 369' ' ' ASN . . . . . 0.603 ' H ' ' ND2' ' A' ' 369' ' ' ASN . 0.3 OUTLIER -83.88 175.37 9.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -83.61 7.45 17.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.5 t -116.92 3.51 12.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' VAL . . . . . 0.405 HG21 HD22 ' A' ' 368' ' ' LEU . 5.0 p -75.05 134.61 29.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.083 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 41.1 p -113.59 170.69 8.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.155 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.709 HD11 ' HG2' ' A' ' 396' ' ' PRO . 12.0 tp -65.93 -65.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -45.59 -26.58 0.62 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -73.41 -36.39 65.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.828 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.487 HD11 HD13 ' A' ' 368' ' ' LEU . 81.1 mt -87.32 -25.48 23.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.6 -35.3 72.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -89.15 -15.04 34.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -92.53 -42.58 9.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.918 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 20.3 m-85 -72.49 -22.19 61.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 2.7 ptmm? -68.87 -5.05 18.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -56.13 -59.99 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 4.1 t -52.8 -64.26 0.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -139.05 -123.43 2.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.445 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 92.8 t -125.53 131.41 72.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 111.099 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 64.7 t -82.52 122.36 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -47.06 110.39 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' MET . . . . . 0.478 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 27.9 mtp -107.94 128.75 54.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.879 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -54.83 147.6 14.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 391' ' ' LYS . 0.0 OUTLIER -94.63 -14.25 25.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 392' ' ' ARG . . . . . 0.445 ' HG3' HG23 ' A' ' 393' ' ' THR . 14.9 ptm180 -101.09 -46.5 5.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.836 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.445 HG23 ' HG3' ' A' ' 392' ' ' ARG . 67.3 p -91.76 -19.28 22.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.118 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' GLY . . . . . 0.478 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 64.89 19.9 66.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.464 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -107.64 152.65 41.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 0.0 110.917 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.709 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.7 Cg_endo -69.81 147.41 62.47 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.66 2.24 . . . . 0.0 112.38 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 11.0 mmt -81.36 41.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.477 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 91.8 mt -98.63 135.97 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 399' ' ' HIS . . . . . 0.42 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 7.3 t60 -115.59 138.07 51.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.827 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 67.0 mt -134.41 94.0 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.095 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -59.63 122.34 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.931 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' A' ' 409' ' ' PRO . 49.0 mt -106.76 136.35 46.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.939 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 407' ' ' GLY . 1.5 t70 -55.14 125.93 22.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -73.1 -1.24 16.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.441 ' CG ' ' OD1' ' A' ' 403' ' ' ASP . 3.4 mm-40 -96.48 -36.59 10.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 34.6 p -119.74 -35.22 3.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 100.25 -1.02 56.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.507 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -86.8 155.95 55.7 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.597 0.713 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.53 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.9 Cg_endo -69.75 91.3 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.72 2.28 . . . . 0.0 112.272 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.482 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -31.49 -48.45 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.864 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 148.95 -10.63 1.03 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -95.35 154.53 17.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 0.0 110.828 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 413' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -168.39 171.47 9.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.13 128.63 20.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.896 HG21 ' CD2' ' A' ' 381' ' ' PHE . 62.5 t -112.3 118.38 57.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 3.2 m -92.59 116.08 28.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.849 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.541 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 52.9 m-85 -89.74 160.3 16.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -57.5 -63.97 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.509 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.7 m-20 -115.59 156.66 45.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.625 0.726 . . . . 0.0 110.845 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.8 Cg_exo -57.4 -43.02 55.66 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.705 2.27 . . . . 0.0 112.3 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 61.7 Cg_exo -48.68 -29.43 14.44 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 90.7 m -88.58 -39.45 14.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.133 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.58 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -61.5 -50.23 73.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -60.08 -38.5 83.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.98 -31.29 61.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.104 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' ALA . . . . . 0.421 ' CB ' ' CE2' ' A' ' 417' ' ' TYR . . . -70.04 -33.81 72.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.156 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 423' ' ' ALA . 76.3 t -55.85 -64.11 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.157 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -64.99 -12.58 51.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.534 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.3 t-105 -80.16 -54.64 5.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.77 ' HB2' HG21 ' A' ' 442' ' ' VAL . 90.9 m-85 -89.47 -14.1 36.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.7 t0 -58.15 99.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.768 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 99.79 22.85 11.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.53 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.447 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 19.9 mmtt -78.72 167.92 20.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.794 0.33 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 434' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 4.3 p-10 -110.7 108.29 18.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.792 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.738 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.6 t80 -115.42 108.33 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.82 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 61.28 36.94 17.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 75.2 21.17 78.44 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.555 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 72.1 m -130.85 129.69 42.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.908 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -70.27 136.56 49.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.738 HD11 ' HB2' ' A' ' 435' ' ' PHE . 8.0 mt -104.66 157.41 17.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.894 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -130.39 106.01 8.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.77 HG21 ' HB2' ' A' ' 430' ' ' PHE . 10.2 t -103.1 133.06 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.106 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 84.7 p -150.04 132.21 15.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.441 ' HG ' HG21 ' A' ' 427' ' ' VAL . 24.3 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.902 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.913 0.387 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -140.25 155.83 46.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.102 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.768 HD12 ' CG1' ' A' ' 442' ' ' VAL . 31.4 pt -128.85 143.48 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.102 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.69 123.35 44.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.943 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 11.3 t -107.45 139.34 29.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.135 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -145.79 122.87 11.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 128.63 11.11 3.06 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.518 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.423 HD22 HG21 ' A' ' 372' ' ' VAL . 30.6 mt -70.98 155.84 40.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.798 0.332 . . . . 0.0 110.921 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 369' ' ' ASN . . . . . 0.402 ' CG ' ' CD ' ' A' ' 436' ' ' GLN . 6.6 p30 -78.2 174.46 11.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.68 14.53 5.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.4 t -131.71 19.57 4.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.831 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' VAL . . . . . 0.423 HG21 HD22 ' A' ' 368' ' ' LEU . 8.2 p -82.69 130.15 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.133 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 58.8 p -110.44 156.69 20.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.141 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.978 HD11 ' HG2' ' A' ' 396' ' ' PRO . 9.1 tp -54.46 -54.16 44.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -54.57 -35.13 62.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -69.88 -28.49 65.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.754 HD12 HD11 ' A' ' 400' ' ' ILE . 60.2 mt -89.42 -29.06 19.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -71.67 -38.48 70.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.436 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 8.9 t70 -82.56 -17.37 45.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -92.67 -41.73 10.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.943 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 15.2 m-85 -71.95 -16.91 62.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.436 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 9.5 ptpt -77.79 -6.59 54.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -55.74 -50.28 70.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.0 t -62.14 -60.84 3.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.91 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -142.65 -126.46 2.08 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.82 128.81 75.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 0.0 111.195 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 84.2 t -84.9 130.05 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.099 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -54.8 113.29 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 389' ' ' MET . . . . . 0.501 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 43.7 mmm -109.74 123.63 49.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -49.55 144.15 6.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -94.75 -8.39 37.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -101.9 -46.82 4.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 35.0 p -97.42 -16.63 20.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.101 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' GLY . . . . . 0.501 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 65.6 26.66 72.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.568 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -112.43 152.95 44.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.557 0.694 . . . . 0.0 110.967 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.978 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.6 Cg_endo -69.69 149.12 66.91 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.74 2.293 . . . . 0.0 112.333 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 7.0 mmt -82.69 38.09 0.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.469 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 91.8 mt -95.98 140.97 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.158 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 399' ' ' HIS . . . . . 0.408 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 5.5 t60 -121.5 138.01 54.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.754 HD11 HD12 ' A' ' 377' ' ' LEU . 61.6 mt -131.1 93.83 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.076 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -59.44 124.4 19.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.965 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 409' ' ' PRO . 35.1 mt -107.9 137.16 46.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.891 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 407' ' ' GLY . 8.1 t0 -55.46 123.92 15.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -71.2 -1.12 11.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -96.08 -39.1 9.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 33.0 p -117.31 -35.43 4.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 101.23 -1.65 54.35 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.446 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -85.94 155.55 58.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.646 0.736 . . . . 0.0 110.856 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.533 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.1 Cg_endo -69.76 90.95 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.702 2.268 . . . . 0.0 112.279 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.482 ' C ' ' O ' ' A' ' 409' ' ' PRO . 2.3 ptmt -31.73 -53.89 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 155.01 -15.96 0.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.507 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -88.9 156.99 18.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.769 0.319 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 413' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -168.93 175.23 5.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.14 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.56 132.71 23.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.147 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.92 HG21 ' CD2' ' A' ' 381' ' ' PHE . 38.8 t -118.87 113.3 41.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.168 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 2.6 m -89.54 116.78 27.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.487 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 57.7 m-85 -93.04 164.18 13.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -56.84 -66.46 0.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.939 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.52 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.4 m-20 -114.54 156.97 43.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.614 0.721 . . . . 0.0 110.83 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.34 -42.97 56.48 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.634 2.223 . . . . 0.0 112.355 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.1 Cg_exo -50.53 -27.19 18.35 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.652 2.235 . . . . 0.0 112.412 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 29.4 m -87.91 -42.36 12.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.843 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -60.44 -41.42 93.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.113 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.469 ' HG2' HD11 ' A' ' 444' ' ' LEU . 35.9 mtpt -65.77 -38.36 88.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.38 -30.89 62.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.138 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -72.1 -30.78 65.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 423' ' ' ALA . 64.0 t -58.74 -63.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.144 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -64.23 -13.21 47.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.523 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.3 t-105 -80.08 -54.65 5.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.919 ' HB2' HG21 ' A' ' 442' ' ' VAL . 79.3 m-85 -87.56 -14.06 41.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.4 t70 -61.51 95.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 117.8 -19.05 11.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.496 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.422 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 2.5 mmmp? -47.88 176.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.764 0.316 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -124.53 130.4 52.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.811 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.631 ' HB2' HD11 ' A' ' 440' ' ' LEU . 1.1 t80 -129.75 107.27 9.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' GLN . . . . . 0.402 ' CD ' ' CG ' ' A' ' 369' ' ' ASN . 26.8 mt-30 61.8 32.53 18.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 81.12 19.53 66.89 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.465 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 12.2 m -128.11 129.31 46.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.911 0.386 . . . . 0.0 110.844 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -68.67 134.52 49.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 435' ' ' PHE . 22.1 mt -100.81 143.07 31.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -119.37 101.81 8.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.919 HG21 ' HB2' ' A' ' 430' ' ' PHE . 14.0 t -99.27 129.8 49.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.143 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.5 m -154.21 128.46 9.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.866 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.469 HD11 ' HG2' ' A' ' 424' ' ' LYS . 28.6 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.967 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.867 0.365 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -137.39 164.78 27.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.485 HD12 ' CG1' ' A' ' 442' ' ' VAL . 36.7 pt -138.32 142.22 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.11 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -102.52 115.25 30.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.977 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.938 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 12.1 t -101.35 142.59 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -150.55 122.29 8.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 133.16 6.82 2.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.455 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.46 HD23 HD22 ' A' ' 440' ' ' LEU . 28.2 mt -72.82 156.4 38.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.812 0.339 . . . . 0.0 110.954 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.62 179.86 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.81 6.1 33.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.78 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 10.9 t -114.23 4.21 15.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.839 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 372' ' ' VAL . . . . . 0.486 HG21 HD21 ' A' ' 377' ' ' LEU . 6.2 p -76.1 139.06 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.107 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 68.9 p -122.21 173.88 7.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.755 HD11 ' HG2' ' A' ' 396' ' ' PRO . 14.9 tp -67.29 -63.3 1.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -47.64 -28.63 2.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.909 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.07 -32.6 56.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.523 HD12 HD11 ' A' ' 400' ' ' ILE . 48.4 mt -84.78 -27.94 26.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.872 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.77 -37.29 65.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.431 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 21.7 t0 -78.75 -20.25 50.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -92.69 -51.31 5.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.938 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 15.9 m-85 -60.01 -24.64 64.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.431 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -71.27 -15.08 62.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.894 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -45.35 -53.58 8.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 38.3 t -59.23 -69.0 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.14 -124.99 2.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.47 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 67.1 t -124.73 135.25 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.921 0.391 . . . . 0.0 111.113 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.16 131.57 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -55.8 111.74 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.955 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' MET . . . . . 0.434 ' SD ' ' CA ' ' A' ' 396' ' ' PRO . 64.7 mmm -106.8 121.72 44.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -48.3 148.15 2.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -94.77 -19.16 20.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -96.78 -46.67 6.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.816 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 37.1 p -91.09 -21.7 21.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 65.6 27.93 73.1 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.507 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -117.18 153.24 49.77 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.532 0.682 . . . . 0.0 110.932 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.755 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.2 Cg_endo -69.79 146.99 61.64 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.694 2.262 . . . . 0.0 112.293 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.419 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.5 mmt -81.17 41.47 0.6 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.466 HG12 HG22 ' A' ' 415' ' ' VAL . 96.7 mt -99.27 135.93 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.18 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 399' ' ' HIS . . . . . 0.434 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 6.0 t60 -115.5 141.03 48.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.523 HD11 HD12 ' A' ' 377' ' ' LEU . 67.6 mt -134.12 93.72 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -59.71 122.35 13.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.539 HD23 ' HA ' ' A' ' 409' ' ' PRO . 45.0 mt -107.57 136.4 47.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.889 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 407' ' ' GLY . 2.0 t70 -55.19 133.63 49.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.09 -6.54 57.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -97.46 -22.88 16.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 69.5 p -128.17 -36.06 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 94.8 0.54 64.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.507 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -90.7 156.93 44.6 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.615 0.721 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.539 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.3 Cg_endo -69.73 89.38 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 0.0 112.392 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.489 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.1 OUTLIER -30.54 -54.74 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 156.77 -15.27 0.36 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.482 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -91.22 153.53 19.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.909 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 413' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -166.87 174.85 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.083 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 3.0 p -141.78 143.37 33.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.154 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.827 HG21 ' CD2' ' A' ' 381' ' ' PHE . 45.3 t -130.69 119.87 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 416' ' ' SER . . . . . 0.419 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 2.1 m -94.66 114.01 25.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 50.4 m-85 -86.8 162.32 17.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.41 -65.5 0.6 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.522 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 4.5 m-20 -115.5 157.72 43.44 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.669 0.747 . . . . 0.0 110.843 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.2 Cg_exo -57.16 -43.11 56.2 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.617 2.212 . . . . 0.0 112.371 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.4 Cg_exo -50.81 -29.37 26.13 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.648 2.232 . . . . 0.0 112.369 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 40.9 m -86.26 -39.27 16.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.185 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.504 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -62.3 -53.95 47.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.093 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.641 ' HG2' HD11 ' A' ' 444' ' ' LEU . 32.6 mtmt -56.51 -33.94 66.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.81 -32.07 52.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.063 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -72.1 -33.81 68.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.084 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.515 HG21 ' HG ' ' A' ' 444' ' ' LEU . 77.8 t -55.17 -61.58 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -66.59 -12.79 59.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.548 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.76 -54.31 5.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.851 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.3 m-85 -88.75 -18.01 28.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.835 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.6 t70 -52.93 97.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 100.95 23.56 9.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.503 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.451 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 25.0 mmtt -76.5 175.87 8.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.32 . . . . 0.0 110.906 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.39 112.33 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.684 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -108.12 98.61 8.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.886 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 61.04 35.25 18.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 96.37 -21.55 44.87 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.45 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.2 p -82.55 152.77 25.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.976 0.417 . . . . 0.0 110.834 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' LYS . . . . . 0.495 ' C ' HD23 ' A' ' 440' ' ' LEU . 25.8 ttpt -99.72 130.75 45.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.684 HD11 ' HB2' ' A' ' 435' ' ' PHE . 1.1 mt -105.81 144.39 32.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.954 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -122.02 107.7 12.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.851 HG21 ' HB2' ' A' ' 430' ' ' PHE . 7.1 t -100.23 135.52 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 10.0 p -155.99 130.72 9.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.816 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.641 HD11 ' HG2' ' A' ' 424' ' ' LYS . 19.2 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.78 0.324 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -123.39 156.7 34.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.153 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.43 ' CG1' ' HB ' ' A' ' 415' ' ' VAL . 29.4 pt -126.08 142.74 41.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.085 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -104.5 111.68 24.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.994 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 1.033 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 8.5 t -95.7 141.09 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.148 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -145.67 120.3 9.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.1 19.95 1.51 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.479 HD13 HD11 ' A' ' 377' ' ' LEU . 90.3 mt -78.68 151.74 32.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.768 0.318 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -74.68 -176.36 2.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.23 4.62 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.5 t -120.32 17.67 12.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.3 p -80.64 136.72 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.178 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 77.5 p -121.3 162.47 20.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.134 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.876 HD11 ' HG2' ' A' ' 396' ' ' PRO . 17.8 tp -57.28 -66.1 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -45.98 -30.19 1.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.95 -34.04 66.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.83 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.551 HD12 HD11 ' A' ' 400' ' ' ILE . 54.1 mt -85.5 -28.99 24.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.853 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.64 -28.88 62.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.414 ' HA ' ' NZ ' ' A' ' 382' ' ' LYS . 10.4 t70 -84.99 -22.34 29.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.437 ' CE2' ' CD1' ' A' ' 430' ' ' PHE . 68.0 t80 -92.63 -48.14 6.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 1.033 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 17.7 m-85 -62.57 -21.02 65.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.414 ' NZ ' ' HA ' ' A' ' 379' ' ' ASP . 2.0 ptpp? -78.19 -4.57 48.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -56.05 -57.92 10.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.947 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' CYS . . . . . 0.567 ' SG ' ' CE3' ' A' ' 429' ' ' TRP . 1.9 t -56.38 -64.63 0.8 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.68 -127.22 2.74 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.409 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 77.3 t -125.87 131.51 71.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.897 0.38 . . . . 0.0 111.183 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 57.3 t -84.55 128.44 38.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -51.04 105.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' A' ' 396' ' ' PRO . 64.1 mmm -101.55 122.13 43.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -46.52 145.65 1.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -94.39 -21.58 18.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -96.25 -46.93 6.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 30.2 p -88.94 -26.63 21.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 70.25 32.08 68.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.477 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -121.07 153.66 57.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.586 0.707 . . . . 0.0 110.95 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.876 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.3 Cg_endo -69.8 145.15 56.05 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.677 2.251 . . . . 0.0 112.276 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.448 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 7.0 mmt -81.52 41.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.827 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.548 HG12 HG22 ' A' ' 415' ' ' VAL . 94.4 mt -97.97 142.75 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.156 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -120.98 141.34 50.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.551 HD11 HD12 ' A' ' 377' ' ' LEU . 60.1 mt -134.91 94.73 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.189 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -62.44 127.41 31.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 409' ' ' PRO . 37.0 mt -112.11 134.56 53.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.878 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 407' ' ' GLY . 13.1 t0 -55.43 120.21 6.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.856 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -1.98 8.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -88.0 -39.67 14.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 33.4 p -121.88 -35.92 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 107.27 -0.87 35.07 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.47 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -86.53 152.56 54.87 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.53 0.681 . . . . 0.0 110.935 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.49 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.8 Cg_endo -69.71 94.82 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.748 2.299 . . . . 0.0 112.321 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 409' ' ' PRO . 8.4 ptmt -33.19 -52.02 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.883 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.65 -14.39 0.8 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -89.88 149.01 22.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.785 0.326 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -162.09 170.17 19.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.067 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.4 p -138.96 143.29 38.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.184 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.853 HG21 ' CD2' ' A' ' 381' ' ' PHE . 59.4 t -129.01 118.58 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.17 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 416' ' ' SER . . . . . 0.448 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 17.3 m -92.67 114.03 26.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.552 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 43.6 m-85 -86.82 165.68 15.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -61.4 -64.28 1.0 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.846 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.518 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.9 m-20 -112.63 156.68 42.04 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.672 0.749 . . . . 0.0 110.789 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.3 Cg_exo -57.11 -43.0 57.48 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.654 2.236 . . . . 0.0 112.339 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.5 Cg_exo -50.96 -43.15 49.2 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.708 2.272 . . . . 0.0 112.361 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 52.3 m -67.8 -43.22 80.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.111 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.552 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -57.2 -57.61 11.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.1 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.786 ' HG2' HD11 ' A' ' 444' ' ' LEU . 23.2 mtmm -51.89 -36.96 50.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.85 64.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' ALA . . . . . 0.482 ' CB ' ' CE2' ' A' ' 417' ' ' TYR . . . -69.51 -30.8 68.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.052 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.568 HG21 ' HG ' ' A' ' 444' ' ' LEU . 85.0 t -58.66 -62.14 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.159 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -67.5 -9.71 44.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.567 ' CE3' ' SG ' ' A' ' 384' ' ' CYS . 1.2 t-105 -82.44 -54.16 5.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.972 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.854 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.2 m-85 -89.05 -20.96 23.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.491 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.0 OUTLIER -49.7 94.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.823 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.15 20.29 9.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.535 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.469 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 14.3 mmtm -78.11 161.47 27.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.842 0.353 . . . . 0.0 110.851 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -107.08 106.45 16.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.667 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -107.17 110.11 22.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 58.22 35.26 24.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 89.76 -18.94 44.18 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.519 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.4 m -90.35 164.21 14.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.4 . . . . 0.0 110.886 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.86 140.53 33.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 435' ' ' PHE . 11.4 mt -108.06 139.66 42.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -115.82 103.93 11.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.854 HG21 ' HB2' ' A' ' 430' ' ' PHE . 19.2 t -99.34 132.37 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.077 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 9.5 p -151.6 132.35 14.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.824 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.786 HD11 ' HG2' ' A' ' 424' ' ' LYS . 12.5 mt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.868 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.458 -0.047 0 CA-C-O 120.905 0.383 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -130.92 166.68 20.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.077 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.756 HD12 HG11 ' A' ' 442' ' ' VAL . 39.8 pt -134.7 142.49 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -99.31 115.02 28.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 4.5 t -103.06 142.31 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.128 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -149.12 124.84 10.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.27 12.59 2.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.489 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.521 HD13 HD11 ' A' ' 377' ' ' LEU . 30.2 mt -77.84 156.38 30.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.9 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 369' ' ' ASN . . . . . 0.496 ' H ' ' ND2' ' A' ' 369' ' ' ASN . 0.2 OUTLIER -81.72 -179.32 7.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.945 179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.92 -2.02 58.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 39.4 t -106.14 3.14 27.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.782 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 372' ' ' VAL . . . . . 0.46 ' HB ' ' ND2' ' A' ' 369' ' ' ASN . 12.2 p -69.46 144.77 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 80.7 p -127.85 170.6 12.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.16 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.853 HD11 ' HG2' ' A' ' 396' ' ' PRO . 12.1 tp -68.26 -49.69 58.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -59.74 -34.46 72.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.841 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.37 -31.41 68.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.659 HD12 HD11 ' A' ' 400' ' ' ILE . 60.0 mt -87.96 -28.09 21.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.932 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.41 -35.83 68.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.431 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 12.5 t70 -85.36 -17.92 35.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -92.31 -43.94 9.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.944 ' CD2' HG21 ' A' ' 415' ' ' VAL . 15.8 m-85 -69.9 -21.85 63.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.861 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.431 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -72.9 -9.49 58.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.947 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -50.08 -54.65 19.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 3.5 t -58.88 -65.9 0.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -135.19 -126.34 2.6 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.462 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 93.2 t -124.44 131.29 72.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.837 0.351 . . . . 0.0 111.177 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 57.0 t -82.44 126.03 39.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -49.22 107.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' MET . . . . . 0.468 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 19.5 mtp -104.47 122.3 45.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -50.73 147.07 5.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -94.59 -18.41 21.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -95.22 -47.89 6.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 37.8 p -90.36 -26.85 19.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.202 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' GLY . . . . . 0.468 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 73.39 20.32 79.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -108.97 152.81 42.63 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.546 0.688 . . . . 0.0 110.978 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.853 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.0 Cg_endo -69.81 147.73 63.18 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.636 2.224 . . . . 0.0 112.345 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 9.5 mmt -81.52 40.96 0.6 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.469 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.1 mt -98.82 136.36 30.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -115.71 136.17 53.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.659 HD11 HD12 ' A' ' 377' ' ' LEU . 67.7 mt -132.33 93.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -59.17 124.54 20.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.522 HD23 ' HA ' ' A' ' 409' ' ' PRO . 35.1 mt -109.34 135.14 50.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.9 t0 -55.37 128.1 32.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -75.11 -1.0 21.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -93.66 -31.24 14.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.9 p -128.32 -35.89 1.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.089 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 100.57 9.92 45.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.501 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -95.7 155.62 38.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.533 0.682 . . . . 0.0 110.944 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.522 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.6 Cg_endo -69.78 89.47 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.629 2.219 . . . . 0.0 112.381 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 409' ' ' PRO . 5.1 ptmt -31.58 -53.23 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 155.64 -14.68 0.44 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -90.64 155.07 19.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.5 169.47 10.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.3 p -141.79 124.16 15.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.173 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.944 HG21 ' CD2' ' A' ' 381' ' ' PHE . 59.3 t -109.33 121.35 62.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 2.2 m -95.96 114.08 25.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.914 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.529 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 67.2 m-85 -87.1 162.85 17.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -57.63 -67.12 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.52 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 5.7 m-20 -111.6 157.55 38.99 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.626 0.727 . . . . 0.0 110.858 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.16 -43.0 57.28 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.696 2.264 . . . . 0.0 112.319 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.3 Cg_exo -50.81 -31.24 32.5 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.672 2.248 . . . . 0.0 112.299 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 23.6 m -84.26 -37.72 21.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.105 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.622 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -64.55 -47.86 77.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.074 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.606 ' HG2' HD11 ' A' ' 444' ' ' LEU . 65.4 mttt -62.4 -36.56 82.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.01 -31.24 58.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' ALA . . . . . 0.407 ' CB ' ' CZ ' ' A' ' 417' ' ' TYR . . . -70.39 -31.88 69.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.649 HG21 ' HG ' ' A' ' 444' ' ' LEU . 94.2 t -57.18 -64.02 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.196 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.0 -11.55 29.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.526 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.3 t-105 -81.3 -54.33 5.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.753 ' HB2' HG21 ' A' ' 442' ' ' VAL . 89.7 m-85 -89.79 -13.39 36.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.2 t0 -60.23 95.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 108.29 -0.03 33.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.465 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.454 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 18.7 mmtt -61.13 173.75 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.773 0.32 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -121.18 120.61 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.909 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.782 ' HB2' HD11 ' A' ' 440' ' ' LEU . 5.4 t80 -117.85 105.12 11.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 62.36 26.09 15.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.903 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 97.27 -16.47 60.69 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.539 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 75.5 m -96.8 127.02 42.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.949 0.404 . . . . 0.0 110.817 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -71.12 140.22 50.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.782 HD11 ' HB2' ' A' ' 435' ' ' PHE . 10.6 mt -108.87 151.65 25.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.953 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -122.63 108.16 12.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.912 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.756 HG11 HD12 ' A' ' 363' ' ' ILE . 10.4 t -104.36 135.49 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.197 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.4 m -154.86 127.49 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.891 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.649 ' HG ' HG21 ' A' ' 427' ' ' VAL . 24.6 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.827 0.346 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.99 159.13 22.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.074 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.698 HD12 ' CG1' ' A' ' 442' ' ' VAL . 38.6 pt -131.8 142.28 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -98.72 117.38 33.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.879 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 15.7 t -102.34 141.94 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.137 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -148.83 122.58 9.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.43 18.82 1.59 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.418 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.536 HD13 HD11 ' A' ' 377' ' ' LEU . 64.6 mt -80.87 154.4 27.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 369' ' ' ASN . . . . . 0.423 ' H ' ' ND2' ' A' ' 369' ' ' ASN . 2.6 p30 -81.44 171.01 15.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.84 6.59 10.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 31.7 m -119.67 14.43 12.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' VAL . . . . . 0.404 HG21 HD22 ' A' ' 368' ' ' LEU . 6.5 p -79.58 137.33 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.148 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 74.8 p -119.93 156.82 30.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.174 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.942 HD11 ' HG2' ' A' ' 396' ' ' PRO . 11.6 tp -53.24 -60.69 2.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -51.76 -33.58 35.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.796 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.47 -29.74 68.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.536 HD11 HD13 ' A' ' 368' ' ' LEU . 49.1 mt -89.9 -29.5 18.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.78 72.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.086 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' ASP . . . . . 0.43 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 21.1 t70 -80.38 -18.91 47.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -92.47 -52.93 4.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.879 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 28.3 m-85 -59.58 -21.66 60.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.43 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 2.6 ptmm? -75.38 -6.1 48.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -58.62 -56.25 24.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 28.3 t -57.57 -63.09 1.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.839 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -136.02 -126.54 2.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.463 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 76.2 t -125.46 133.92 68.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 111.124 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 68.4 t -87.14 129.97 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.163 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -56.62 106.85 0.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' MET . . . . . 0.5 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 47.6 mmm -103.34 125.94 50.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.869 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' ASN . . . . . 0.402 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 15.5 t-20 -51.14 148.88 4.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -94.88 -17.99 21.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.944 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -97.28 -48.32 5.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.402 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 38.2 p -90.63 -17.95 25.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.173 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 394' ' ' GLY . . . . . 0.5 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 62.16 27.47 69.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.436 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -114.63 153.19 46.78 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.608 0.718 . . . . 0.0 110.922 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.942 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.7 Cg_endo -69.68 146.64 61.28 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.67 2.247 . . . . 0.0 112.366 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.45 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.8 mmt -81.25 41.26 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.846 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.473 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.1 mt -98.64 136.4 29.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.124 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 399' ' ' HIS . . . . . 0.528 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 9.2 t60 -115.64 142.24 47.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.402 HD11 HD12 ' A' ' 377' ' ' LEU . 66.9 mt -134.86 94.03 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.084 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -59.7 125.28 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 409' ' ' PRO . 50.0 mt -109.13 136.7 48.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.971 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.4 t0 -55.24 132.33 47.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -79.74 -5.58 55.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -97.3 -24.05 15.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 70.4 p -128.15 -36.09 1.97 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.135 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 97.4 -4.49 62.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.565 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -85.69 156.05 58.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.56 0.695 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.484 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.2 Cg_endo -69.78 91.37 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.738 2.292 . . . . 0.0 112.305 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.48 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.1 OUTLIER -31.67 -51.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.873 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.46 -12.0 0.76 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -93.68 152.79 18.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.83 0.348 . . . . 0.0 110.846 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 413' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -165.68 173.4 10.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 p -138.81 140.63 38.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.172 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.758 HG21 ' CD2' ' A' ' 381' ' ' PHE . 46.0 t -124.77 116.93 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.144 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 416' ' ' SER . . . . . 0.45 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 13.4 m -92.85 112.16 24.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 417' ' ' TYR . . . . . 0.51 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 59.0 m-85 -86.84 161.41 18.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.897 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.86 -66.51 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.953 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.4 m-20 -115.17 156.72 45.12 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.617 0.723 . . . . 0.0 110.848 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.591 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.31 -42.97 56.64 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.659 2.239 . . . . 0.0 112.373 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 421' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.8 Cg_exo -50.42 -26.85 17.05 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.743 2.295 . . . . 0.0 112.323 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 56.0 m -89.09 -41.07 12.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -60.23 -47.31 86.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.077 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.431 ' HG2' HD11 ' A' ' 444' ' ' LEU . 80.7 mttt -60.92 -38.11 84.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.24 -34.59 63.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.029 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.99 -32.62 72.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 423' ' ' ALA . 70.1 t -56.04 -60.02 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.061 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -67.62 -13.89 62.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' TRP . . . . . 0.551 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.1 t-105 -78.75 -55.14 5.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.861 ' HB2' HG21 ' A' ' 442' ' ' VAL . 82.8 m-85 -87.41 -14.81 39.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 431' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.6 OUTLIER -55.74 93.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.875 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.8 21.54 8.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.505 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 433' ' ' LYS . . . . . 0.459 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 15.5 mmtm -77.3 176.78 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.7 124.82 44.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.803 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.763 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.0 t80 -128.16 100.44 5.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 62.52 34.52 15.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.902 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 82.4 19.96 63.25 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.468 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 19.7 p -126.36 130.09 50.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 110.868 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' LYS . . . . . 0.413 ' C ' HD23 ' A' ' 440' ' ' LEU . 19.8 ttpt -75.95 131.37 39.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.861 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.763 HD11 ' HB2' ' A' ' 435' ' ' PHE . 5.8 mt -105.49 133.83 49.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.59 113.71 27.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.861 HG21 ' HB2' ' A' ' 430' ' ' PHE . 9.2 t -107.8 131.19 58.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.096 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 2.7 m -156.89 130.98 8.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.772 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.431 HD11 ' HG2' ' A' ' 424' ' ' LYS . 26.5 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 8.3 t -105.55 153.25 22.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.876 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 34.9 t -86.6 132.76 33.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.934 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 87.43 127.61 2.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 23.3 m -88.03 94.78 9.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.937 0.398 . . . . 0.0 110.834 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 47.7 t -98.29 82.77 2.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.819 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 68.21 132.17 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.51 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -107.18 147.2 34.72 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.618 0.723 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 154.29 68.05 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.705 2.27 . . . . 0.0 112.33 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -170.69 167.72 7.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -65.98 112.81 4.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -99.82 44.7 1.01 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.947 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 359' ' ' ASP . 20.1 m -79.4 70.41 5.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.854 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 358' ' ' SER . 3.9 m-20 -37.3 -37.75 0.2 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -45.36 112.13 0.41 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 6.3 p -107.35 15.8 24.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -112.75 160.81 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.605 HD12 ' CG1' ' A' ' 442' ' ' VAL . 31.3 pt -131.89 144.48 37.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -103.44 111.47 23.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 1.039 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 8.2 t -96.42 140.12 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.098 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -145.91 122.44 11.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.26 17.97 1.72 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.489 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.557 HD13 HD11 ' A' ' 377' ' ' LEU . 87.0 mt -78.2 153.09 32.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.873 0.368 . . . . 0.0 110.861 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -76.17 -179.52 5.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.85 3.54 50.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 12.5 m -119.27 15.81 13.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.481 HG21 HD22 ' A' ' 368' ' ' LEU . 8.7 p -80.61 134.02 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.152 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 70.2 p -117.87 160.22 21.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.158 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.848 HD11 ' HG2' ' A' ' 396' ' ' PRO . 12.3 tp -53.11 -64.17 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.95 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -46.1 -38.75 8.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.55 -32.69 74.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.631 HD12 HD11 ' A' ' 400' ' ' ILE . 75.7 mt -87.09 -28.08 22.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.8 -39.56 66.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.015 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.433 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 40.0 t0 -76.51 -20.82 56.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -91.6 -53.84 4.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 1.039 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.6 m-85 -57.56 -23.67 51.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.433 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 13.9 ptmt -74.44 -12.16 60.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.925 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -48.68 -53.4 18.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 2.3 t -59.74 -65.17 0.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -136.82 -124.3 2.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.459 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 95.1 t -125.51 128.82 72.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.841 0.353 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 58.2 t -82.53 124.79 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.101 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -45.85 107.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.975 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' MET . . . . . 0.471 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 20.4 mtp -102.91 127.28 50.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.894 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -53.7 146.01 14.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.75 -13.69 25.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' ARG . . . . . 0.463 ' HG3' HG23 ' A' ' 393' ' ' THR . 15.9 ptt180 -102.52 -42.09 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.463 HG23 ' HG3' ' A' ' 392' ' ' ARG . 66.8 p -96.93 -19.57 18.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.157 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.471 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 66.04 18.44 66.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.442 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -107.14 152.75 41.2 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.554 0.692 . . . . 0.0 110.934 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.848 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.6 Cg_endo -69.77 147.62 63.2 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.684 2.256 . . . . 0.0 112.349 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.439 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 11.3 mmt -81.61 40.76 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.846 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.53 HG12 HG22 ' A' ' 415' ' ' VAL . 97.7 mt -99.33 137.68 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.171 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -118.5 143.56 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.808 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.631 HD11 HD12 ' A' ' 377' ' ' LEU . 58.6 mt -134.59 93.9 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -59.77 125.23 22.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.844 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 409' ' ' PRO . 36.5 mt -109.38 134.57 51.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.9 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 407' ' ' GLY . 11.1 t0 -55.67 121.25 8.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -69.23 -1.29 7.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -88.5 -38.5 14.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 70.1 p -124.74 -35.05 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.85 -1.47 35.96 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.475 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 12.0 pttp -84.37 152.62 61.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.483 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.8 Cg_endo -69.75 94.69 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.68 2.253 . . . . 0.0 112.341 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -33.55 -52.75 0.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 153.19 -15.85 0.67 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.487 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' ASP . . . . . 0.416 ' CG ' ' HE3' ' A' ' 410' ' ' LYS . 49.5 p-10 -87.74 157.24 19.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -170.15 171.67 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.096 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.4 142.91 37.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.183 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.879 HG21 ' CD2' ' A' ' 381' ' ' PHE . 57.0 t -130.13 111.94 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' SER . . . . . 0.439 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 9.1 m -87.35 114.39 23.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.429 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 47.3 m-85 -88.07 164.41 15.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.77 -63.29 1.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.508 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.4 m-20 -115.9 156.05 47.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.604 0.716 . . . . 0.0 110.84 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.602 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.39 -43.01 55.77 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.644 2.23 . . . . 0.0 112.356 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.7 Cg_exo -50.06 -29.57 22.3 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.686 2.257 . . . . 0.0 112.286 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 70.0 m -85.8 -40.07 16.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.159 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.682 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -61.93 -51.5 67.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.131 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.574 ' HG2' HD11 ' A' ' 444' ' ' LEU . 33.2 mtmt -58.93 -35.58 73.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.849 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.29 -31.69 54.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.041 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.23 68.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.147 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 423' ' ' ALA . 92.6 t -54.68 -60.83 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -66.7 -14.65 62.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.55 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.1 t-105 -77.85 -52.04 9.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.975 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.901 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.2 m-85 -90.37 -17.37 27.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 3.8 t70 -57.12 100.28 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 101.5 13.78 31.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.458 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 18.7 mmtp -71.7 -178.75 2.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.748 0.309 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.79 102.87 6.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.776 ' HB2' HD11 ' A' ' 440' ' ' LEU . 5.0 t80 -102.76 113.1 26.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 59.01 27.16 15.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 96.02 -16.66 60.72 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.431 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 24.3 m -90.62 150.46 21.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.965 0.412 . . . . 0.0 110.819 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' LYS . . . . . 0.431 ' C ' HD23 ' A' ' 440' ' ' LEU . 13.9 ttmt -87.61 133.74 33.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 435' ' ' PHE . 6.0 mt -102.66 143.09 32.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.932 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.03 101.42 7.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.983 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.901 HG21 ' HB2' ' A' ' 430' ' ' PHE . 20.5 t -96.98 132.6 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.079 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.5 m -154.24 128.73 9.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.574 HD11 ' HG2' ' A' ' 424' ' ' LYS . 22.4 mt -43.76 109.8 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.849 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 444' ' ' LEU . . . -35.71 -55.96 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 -92.43 92.98 8.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -131.22 128.68 40.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' LYS . . . . . 0.459 ' CD ' ' HD2' ' A' ' 449' ' ' PRO . 35.7 tptt -162.68 137.06 4.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.535 0.683 . . . . 0.0 110.93 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.459 ' HD2' ' CD ' ' A' ' 448' ' ' LYS . 53.5 Cg_endo -69.8 149.54 66.78 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.638 2.226 . . . . 0.0 112.359 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -173.93 0.81 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.765 2.31 . . . . 0.0 112.307 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -94.07 -47.85 6.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.857 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -57.72 115.42 2.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 15.4 m 61.82 27.8 16.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -71.69 -79.8 0.39 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.515 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 145.08 56.28 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.705 2.27 . . . . 0.0 112.388 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 39.0 m -113.93 -50.32 2.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 57.9 p -158.78 178.38 10.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.844 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.46 -179.945 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 68.2 m -85.6 87.09 7.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.875 0.369 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 10.8 t -117.26 135.32 53.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 149.13 -51.83 0.54 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 3.7 t -101.24 -61.19 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 0.0 110.893 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 23.1 t -126.69 111.1 13.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.919 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -162.37 169.1 37.59 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.469 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.75 143.1 39.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.661 0.744 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 162.59 41.51 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.771 2.314 . . . . 0.0 112.327 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -141.36 162.38 35.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -132.22 141.93 49.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.86 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.433 ' C ' ' OD1' ' A' ' 357' ' ' ASP . 0.0 OUTLIER -104.08 -45.17 4.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 5.3 t -165.21 148.91 8.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -74.83 89.7 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.815 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -139.53 116.19 10.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.4 m -106.28 40.03 1.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.858 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -141.82 156.15 45.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.474 HG22 HG22 ' A' ' 427' ' ' VAL . 18.8 pt -128.8 141.88 45.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.121 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -103.5 112.02 24.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 1.07 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 9.1 t -97.96 138.99 21.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -145.03 120.66 10.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.64 16.51 1.83 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.503 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.509 HD13 HD11 ' A' ' 377' ' ' LEU . 97.7 mt -74.51 155.39 38.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.821 0.343 . . . . 0.0 110.861 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -75.12 -178.88 4.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.55 3.69 53.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.2 t -121.05 16.58 11.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 8.5 p -76.89 133.99 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 81.8 p -118.28 154.8 31.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.919 HD11 ' HG2' ' A' ' 396' ' ' PRO . 11.1 tp -50.75 -62.82 1.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -46.72 -38.15 9.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.864 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.26 -29.59 68.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.825 HD12 HD11 ' A' ' 400' ' ' ILE . 45.5 mt -87.08 -28.52 22.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.16 62.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.146 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -75.11 -18.48 60.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -92.63 -47.17 7.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 1.07 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 15.7 m-85 -66.98 -26.44 66.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -9.13 57.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -51.58 -51.75 52.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 42.4 t -61.02 -65.45 0.69 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -134.55 -126.74 2.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.508 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.441 ' CG1' ' OE2' ' A' ' 418' ' ' GLU . 91.0 t -123.53 128.47 74.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.83 0.347 . . . . 0.0 111.127 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 84.5 t -83.64 123.1 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.076 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -47.55 108.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' MET . . . . . 0.427 ' HE2' ' O ' ' A' ' 394' ' ' GLY . 23.8 mtp -105.41 124.18 49.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.896 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -50.9 143.94 9.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -94.72 -8.41 37.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -102.47 -45.55 5.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.967 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 20.5 p -95.82 -22.16 17.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.157 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.427 ' O ' ' HE2' ' A' ' 389' ' ' MET . . . 71.1 23.29 78.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.503 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -112.09 152.49 44.39 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.523 0.678 . . . . 0.0 110.929 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.919 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.9 Cg_endo -69.67 149.41 67.4 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.693 2.262 . . . . 0.0 112.352 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.412 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 11.1 mmt -82.19 40.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.794 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.46 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 93.6 mt -97.52 137.4 25.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.148 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -116.78 138.75 51.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.825 HD11 HD12 ' A' ' 377' ' ' LEU . 58.0 mt -132.41 94.99 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -62.47 127.6 32.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 409' ' ' PRO . 36.2 mt -112.06 135.48 52.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 407' ' ' GLY . 6.6 t70 -56.14 122.25 11.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -1.05 9.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -89.04 -38.46 14.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.809 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 59.0 p -123.65 -34.73 3.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.3 -3.28 37.51 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.481 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -83.61 152.69 63.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.505 0.669 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.543 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.4 Cg_endo -69.74 95.17 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.673 2.248 . . . . 0.0 112.356 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 409' ' ' PRO . 9.2 ptmt -33.33 -52.01 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.882 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 152.2 -15.61 0.77 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.519 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -87.68 154.51 20.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 110.825 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -167.68 170.51 10.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.23 142.4 37.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.107 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 381' ' ' PHE . 39.2 t -128.23 112.88 28.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.123 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' SER . . . . . 0.412 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 9.6 m -87.82 114.03 24.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.556 ' CE2' ' CB ' ' A' ' 426' ' ' ALA . 38.5 m-85 -87.06 167.21 14.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.965 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 418' ' ' GLU . . . . . 0.441 ' OE2' ' CG1' ' A' ' 386' ' ' VAL . 4.0 mt-10 -65.5 -61.96 1.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.513 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.8 m-20 -116.43 156.28 47.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.552 0.692 . . . . 0.0 110.884 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.3 -43.01 56.27 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.773 2.316 . . . . 0.0 112.335 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.8 Cg_exo -50.7 -27.36 19.62 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.7 2.267 . . . . 0.0 112.354 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 55.4 m -87.35 -40.72 14.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.154 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -60.17 -54.66 43.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.532 ' HG2' HD11 ' A' ' 444' ' ' LEU . 37.5 mtpt -55.63 -35.39 65.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.29 -33.09 55.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.159 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.556 ' CB ' ' CE2' ' A' ' 417' ' ' TYR . . . -70.51 -31.83 69.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.101 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 423' ' ' ALA . 72.9 t -58.16 -64.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.151 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -65.11 -10.92 34.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.546 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.2 t-105 -80.3 -56.22 4.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.985 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.913 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.2 m-85 -88.09 -18.19 29.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.485 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.2 t70 -54.66 96.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.38 17.3 13.95 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.515 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.429 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 17.1 mmtm -76.87 170.7 16.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.721 0.296 . . . . 0.0 110.913 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' ASP . . . . . 0.441 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 2.8 p-10 -115.83 110.49 19.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.563 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.7 t80 -113.42 106.87 15.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 62.15 25.91 15.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.919 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 93.29 -5.92 75.09 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.51 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.4 m -104.87 129.39 53.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.877 0.37 . . . . 0.0 110.878 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -70.83 137.83 49.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 435' ' ' PHE . 12.4 mt -103.66 150.89 23.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -123.81 100.04 6.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.913 HG21 ' HB2' ' A' ' 430' ' ' PHE . 17.8 t -95.13 128.22 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.103 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 89.7 p -146.42 125.44 12.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.562 ' HG ' HG21 ' A' ' 427' ' ' VAL . 19.8 mt -38.58 102.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -45.3 127.84 7.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.143 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -118.32 121.58 40.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.864 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.0 -175.77 3.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.7 152.21 79.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.587 0.708 . . . . 0.0 110.871 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 149.22 66.39 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.676 2.25 . . . . 0.0 112.292 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -3.01 11.15 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.694 2.262 . . . . 0.0 112.339 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 62.9 mmm -133.19 147.26 52.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -65.4 136.66 56.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.934 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 29.2 t -112.03 85.29 2.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 143.13 82.68 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.505 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 136.6 33.33 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.605 2.203 . . . . 0.0 112.334 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 2.0 t -37.38 133.89 0.67 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 51.8 m -114.57 167.26 10.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.478 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 4.2 m -152.79 139.78 19.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.894 0.378 . . . . 0.0 110.804 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 96.4 p -57.92 -15.94 10.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.856 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 178.27 83.29 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.58 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 71.4 p -99.06 114.92 27.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 0.0 110.905 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 31.8 p -70.56 -43.71 68.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 130.93 -55.04 0.78 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.461 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' A' ' 354' ' ' PRO . 8.4 t70 -143.27 140.77 18.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.591 0.71 . . . . 0.0 110.818 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 353' ' ' ASP . 53.5 Cg_endo -69.76 79.68 0.93 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.684 2.256 . . . . 0.0 112.297 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -85.33 92.77 8.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.19 172.4 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.882 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.87 121.29 42.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 82.5 p -42.49 -41.42 2.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -95.95 155.84 16.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.863 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.76 82.68 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.3 m -99.44 28.26 4.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.875 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -129.65 162.67 27.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.138 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.659 HD12 ' CG1' ' A' ' 442' ' ' VAL . 34.3 pt -133.34 144.55 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -102.15 115.09 29.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.888 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 13.5 t -100.31 136.34 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.142 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -143.64 120.74 11.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 128.96 20.18 1.5 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.441 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 88.0 mt -79.25 155.34 28.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 110.944 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' ASN . . . . . 0.487 ' OD1' ' NE2' ' A' ' 436' ' ' GLN . 4.2 p30 -75.07 178.07 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.844 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -91.31 13.4 17.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.857 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.1 m -130.13 13.22 5.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.69 141.93 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 72.2 p -121.59 160.42 24.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.126 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.877 HD11 ' HG2' ' A' ' 396' ' ' PRO . 10.6 tp -56.22 -58.1 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -50.61 -38.17 44.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.823 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -66.71 -27.77 67.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.847 HD12 HD11 ' A' ' 400' ' ' ILE . 51.6 mt -89.03 -32.02 17.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.12 -33.78 65.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.427 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 15.8 t0 -82.93 -20.24 35.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -92.69 -48.43 6.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.888 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 18.7 m-85 -63.75 -19.08 64.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.427 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -76.27 -6.69 52.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.916 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -54.31 -56.86 14.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.6 t -56.56 -65.54 0.59 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -135.67 -126.01 2.55 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.448 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 44.5 t -125.06 132.59 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 111.111 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 60.3 t -87.25 128.62 39.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.206 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 49.6 tttt -50.31 108.32 0.22 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 396' ' ' PRO . 73.6 mmm -104.05 122.79 45.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -47.66 143.18 4.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -93.38 -18.64 22.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 37.5 ttt85 -99.01 -46.6 5.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 30.1 p -89.72 -24.96 21.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.047 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 69.24 31.92 72.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.513 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -121.85 153.62 60.4 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.619 0.723 . . . . 0.0 110.899 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.877 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.6 Cg_endo -69.55 146.17 60.67 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.736 2.29 . . . . 0.0 112.432 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 9.1 mmt -82.12 40.32 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.825 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.531 HG12 HG22 ' A' ' 415' ' ' VAL . 94.3 mt -96.53 145.84 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' HIS . . . . . 0.409 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 6.3 t60 -126.04 136.11 52.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.847 HD11 HD12 ' A' ' 377' ' ' LEU . 59.5 mt -131.04 94.79 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -61.6 127.78 33.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.898 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 409' ' ' PRO . 33.5 mt -112.24 135.56 52.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.953 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 407' ' ' GLY . 8.1 t0 -55.44 122.78 11.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -1.18 12.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -90.03 -36.03 15.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 37.7 p -125.21 -35.63 2.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.73 -3.66 36.42 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.487 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -83.33 152.59 64.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.679 0.752 . . . . 0.0 110.814 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.524 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.2 Cg_endo -69.74 94.99 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.726 2.284 . . . . 0.0 112.281 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -33.37 -50.56 0.32 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.955 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 150.6 -16.4 0.96 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.489 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -87.79 156.09 19.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 110.856 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -169.48 173.14 6.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.081 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.06 142.13 32.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.168 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.848 HG21 ' CD2' ' A' ' 381' ' ' PHE . 57.4 t -128.74 117.68 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 24.0 m -92.73 112.86 24.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.493 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 51.9 m-85 -87.17 163.29 17.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.947 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -58.01 -65.3 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.511 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.5 m-20 -114.11 155.89 44.88 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.603 0.716 . . . . 0.0 110.903 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.42 -42.84 57.36 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.677 2.251 . . . . 0.0 112.334 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 54.3 Cg_exo -49.58 -28.81 17.47 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.719 2.279 . . . . 0.0 112.373 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 48.6 m -86.94 -42.98 12.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.77 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.7 -48.34 82.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.188 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.599 ' HG2' HD11 ' A' ' 444' ' ' LEU . 72.8 mttt -61.5 -39.62 91.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.45 -32.84 62.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.094 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.29 -32.91 70.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 423' ' ' ALA . 84.1 t -55.85 -60.85 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.164 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.12 -13.0 61.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.561 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.0 OUTLIER -79.49 -52.27 8.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.827 ' HB2' HG21 ' A' ' 442' ' ' VAL . 89.5 m-85 -88.5 -16.68 32.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.871 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.5 OUTLIER -60.4 93.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.22 16.79 7.55 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.401 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 2.6 mmmp? -82.37 163.91 21.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 110.862 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -110.24 108.54 18.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.931 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.647 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.2 t80 -109.12 108.65 19.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' GLN . . . . . 0.487 ' NE2' ' OD1' ' A' ' 369' ' ' ASN . 62.2 mt-30 61.32 26.56 16.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.972 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 94.38 -13.71 66.74 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.526 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.6 m -100.67 128.9 46.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 110.864 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -70.41 138.77 51.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.647 HD11 ' HB2' ' A' ' 435' ' ' PHE . 12.8 mt -104.05 152.95 21.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -126.26 106.08 9.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.827 HG21 ' HB2' ' A' ' 430' ' ' PHE . 14.2 t -99.41 138.56 23.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 3.6 p -161.12 130.17 4.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.825 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 424' ' ' LYS . 45.7 mt -43.38 121.78 2.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.79 156.77 13.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.116 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? 66.03 29.68 9.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm -149.63 155.29 40.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.09 152.63 1.4 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.605 0.717 . . . . 0.0 110.889 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 162.03 43.68 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.713 2.275 . . . . 0.0 112.376 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 147.53 63.79 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.76 2.306 . . . . 0.0 112.333 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 9.7 ttt -123.3 160.09 27.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -83.99 104.59 14.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 14.1 m -144.06 122.84 12.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 147.17 -158.26 27.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.503 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 2.8 3.22 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.6 2.2 . . . . 0.0 112.359 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 88.4 p -136.57 130.23 32.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 43.5 t -104.56 95.48 5.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.515 179.986 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 30.6 t -106.87 122.05 45.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 0.0 110.859 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 35.3 m -111.31 42.04 1.74 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 132.15 -61.15 0.66 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.459 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 9.1 t -62.42 119.83 9.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.892 0.377 . . . . 0.0 110.807 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 17.5 t -81.39 -57.56 3.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.869 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 178.55 80.12 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.467 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.79 159.69 29.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.565 0.698 . . . . 0.0 110.813 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 175.71 7.69 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.691 2.261 . . . . 0.0 112.36 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -153.49 148.62 26.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -83.08 168.42 16.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -78.0 135.48 37.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.848 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 58.7 p -132.07 171.11 14.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.8 t0 66.34 38.01 4.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.824 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -96.05 76.19 3.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.944 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.2 m -88.73 29.59 1.0 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -131.85 166.18 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.065 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.723 HD12 ' CG1' ' A' ' 442' ' ' VAL . 27.4 pt -140.38 144.47 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -100.05 124.53 45.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.98 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.928 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 21.8 t -108.68 143.33 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -149.73 121.11 7.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.48 19.86 1.46 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.506 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.503 ' HB3' HG11 ' A' ' 372' ' ' VAL . 97.4 mt -78.76 154.35 30.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.885 0.374 . . . . 0.0 110.926 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' ASN . . . . . 0.432 ' ND2' ' CD ' ' A' ' 436' ' ' GLN . 9.4 p30 -76.37 179.32 5.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.4 1.87 53.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.2 m -119.85 18.73 12.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 368' ' ' LEU . 8.1 p -82.38 133.05 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.131 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 69.4 p -115.99 163.46 15.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.06 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.962 HD11 ' HG2' ' A' ' 396' ' ' PRO . 12.2 tp -54.64 -59.92 4.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.17 -47.38 23.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -53.15 -38.48 62.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.715 HD12 HD11 ' A' ' 400' ' ' ILE . 81.5 mt -82.82 -30.04 29.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.957 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -71.99 -25.64 61.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.074 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.408 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 17.9 t70 -93.27 -19.96 20.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -91.9 -52.34 4.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.928 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 21.2 m-85 -59.83 -23.47 63.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.408 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 5.4 ptmt -72.35 -10.98 60.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -49.9 -58.03 6.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 37.7 t -56.45 -69.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -130.56 -124.24 2.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 71.0 t -126.87 131.41 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.104 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 85.7 t -83.81 123.42 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.146 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -46.72 105.05 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.917 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' MET . . . . . 0.445 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 26.7 mtp -102.85 128.17 49.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -53.97 147.09 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -94.61 -16.13 23.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 15.8 ttm105 -96.43 -49.65 5.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 46.9 p -90.45 -22.11 21.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.445 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 69.49 23.66 76.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.438 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -110.93 153.02 43.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.571 0.7 . . . . 0.0 110.951 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.962 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.7 Cg_endo -69.82 148.13 64.0 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.652 2.235 . . . . 0.0 112.3 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.428 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 7.6 mmt -81.74 40.68 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.427 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.3 mt -98.53 138.86 21.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.204 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -116.97 141.78 47.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.715 HD11 HD12 ' A' ' 377' ' ' LEU . 75.0 mt -134.7 95.4 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.222 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -62.69 124.94 22.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' A' ' 409' ' ' PRO . 44.1 mt -110.67 135.37 51.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 407' ' ' GLY . 9.0 t70 -55.49 126.36 24.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -75.16 -1.07 21.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -93.47 -30.29 15.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 43.4 p -127.97 -36.09 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 104.3 -5.89 45.6 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.474 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 8.8 pttm -82.94 152.8 66.38 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.569 0.699 . . . . 0.0 110.845 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.554 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.1 Cg_endo -69.73 95.29 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.66 2.24 . . . . 0.0 112.343 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 409' ' ' PRO . 9.4 ptmt -32.88 -51.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.866 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.15 -12.34 0.8 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.491 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -90.93 157.95 17.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.777 0.322 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.53 172.65 6.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.079 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.88 136.59 30.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.174 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.757 HG21 ' CD2' ' A' ' 381' ' ' PHE . 40.6 t -120.89 127.69 75.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.133 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' SER . . . . . 0.428 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 3.3 m -102.46 111.17 23.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.509 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 62.9 m-85 -87.4 157.68 19.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.944 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -53.46 -65.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.9 m-20 -113.31 155.81 44.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.644 0.735 . . . . 0.0 110.838 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.589 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.1 -42.96 58.0 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.689 2.259 . . . . 0.0 112.32 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.0 Cg_exo -50.34 -27.37 17.98 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.377 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 44.9 m -88.89 -34.3 17.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.582 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -64.76 -50.61 66.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.116 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.95 ' HG2' HD11 ' A' ' 444' ' ' LEU . 23.1 mttp -61.05 -40.01 92.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -69.56 -35.27 75.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.087 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.41 -34.68 76.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.043 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 423' ' ' ALA . 72.6 t -54.75 -61.73 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.74 -12.89 60.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.551 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.82 -54.21 6.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.899 ' HB2' HG21 ' A' ' 442' ' ' VAL . 84.5 m-85 -87.63 -20.12 26.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.2 t70 -54.74 99.93 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 104.42 11.72 30.6 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.539 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -74.44 176.16 7.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.757 0.313 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -122.27 112.59 18.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.926 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.579 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -113.4 112.59 23.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' GLN . . . . . 0.432 ' CD ' ' ND2' ' A' ' 369' ' ' ASN . 53.6 mt-30 58.44 36.89 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 85.9 -15.76 46.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.1 t -92.69 165.8 12.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.845 0.355 . . . . 0.0 110.901 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -102.95 134.09 46.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.921 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.579 HD11 ' HB2' ' A' ' 435' ' ' PHE . 11.7 mt -102.05 143.97 31.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -119.75 104.57 10.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.899 HG21 ' HB2' ' A' ' 430' ' ' PHE . 6.2 t -99.95 140.91 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.146 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 20.0 m -162.47 125.73 2.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.808 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.95 HD11 ' HG2' ' A' ' 424' ' ' LYS . 17.4 mt -36.99 118.72 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.29 96.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.079 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -106.15 91.41 3.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.872 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.82 146.6 26.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' LYS . . . . . 0.427 ' CG ' ' HD2' ' A' ' 449' ' ' PRO . 38.5 tttp -141.76 140.16 19.59 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.544 0.688 . . . . 0.0 110.942 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.427 ' HD2' ' CG ' ' A' ' 448' ' ' LYS . 53.5 Cg_endo -69.83 157.79 59.06 Favored 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.728 2.285 . . . . 0.0 112.281 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 114.86 3.84 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.66 2.24 . . . . 0.0 112.359 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 12.2 mmt -118.14 -45.56 2.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.88 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 56.06 39.96 30.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 35.7 p -83.35 99.45 10.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -159.17 84.04 0.13 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.491 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 2.78 3.28 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.706 2.271 . . . . 0.0 112.305 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 77.3 p -104.55 -43.76 5.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 80.1 p -73.03 140.77 47.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.46 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 24.3 m -46.4 121.99 3.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.35 . . . . 0.0 110.913 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 78.4 p -65.75 -45.72 81.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 98.56 115.14 3.51 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.544 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 9.5 m -60.57 128.69 37.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.764 0.316 . . . . 0.0 110.87 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 83.8 p -154.61 158.53 39.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -100.16 117.72 5.96 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.505 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.7 147.38 34.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.599 0.714 . . . . 0.0 110.872 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 0.22 5.99 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.679 2.252 . . . . 0.0 112.337 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -151.98 150.5 30.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.851 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -53.09 -30.9 38.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -145.35 135.18 23.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' SER . . . . . 0.457 ' O ' ' ND2' ' A' ' 360' ' ' ASN . 3.6 m -100.75 42.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -45.28 97.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.87 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 358' ' ' SER . 48.3 m-80 -156.83 107.09 2.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.939 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.4 m -89.56 30.45 1.02 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -135.02 165.07 26.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.089 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.699 HD12 ' CG1' ' A' ' 442' ' ' VAL . 41.6 pt -135.26 145.79 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -103.89 112.94 26.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 1.05 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 20.5 t -97.04 142.34 14.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.133 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -148.16 122.78 9.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.59 17.05 1.77 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.47 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.521 HD13 HD11 ' A' ' 377' ' ' LEU . 87.5 mt -76.23 155.97 33.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.842 0.353 . . . . 0.0 110.907 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -79.37 -174.99 4.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.82 1.57 56.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.7 m -118.74 20.56 12.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.51 HG23 ' CE2' ' A' ' 435' ' ' PHE . 6.2 p -87.15 137.29 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.083 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 59.2 p -120.22 163.46 17.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.197 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.792 HD11 ' HG2' ' A' ' 396' ' ' PRO . 10.0 tp -57.35 -63.35 1.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -44.87 -30.78 1.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.838 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -74.21 -34.19 63.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.828 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.521 HD11 HD13 ' A' ' 368' ' ' LEU . 61.0 mt -86.26 -23.53 26.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -75.86 -32.53 59.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.111 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.426 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 19.6 t0 -87.47 -18.01 30.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.825 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -92.07 -50.72 5.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 1.05 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.3 m-85 -62.03 -22.13 65.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.826 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.426 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 12.7 ptmt -75.55 -10.62 59.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -51.14 -53.96 29.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 34.4 t -58.93 -66.0 0.57 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.24 -124.76 2.55 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.454 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.32 130.71 71.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.878 0.371 . . . . 0.0 111.103 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.56 129.27 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.188 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -54.41 108.14 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' MET . . . . . 0.443 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 67.4 mmm -103.75 122.04 44.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.436 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 17.6 t-20 -48.51 149.06 1.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.839 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -94.87 -18.86 20.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.875 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -97.77 -47.32 5.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.436 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 49.0 p -90.68 -18.95 24.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.181 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.443 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 62.13 27.53 69.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.448 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -114.77 153.5 46.88 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.611 0.719 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.792 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.5 Cg_endo -69.75 146.07 59.15 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.69 2.26 . . . . 0.0 112.282 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.45 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 16.6 mmt -81.17 41.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.462 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 95.7 mt -99.44 135.87 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.094 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -116.39 141.55 48.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 71.4 mt -133.65 93.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -60.69 124.41 20.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 409' ' ' PRO . 33.7 mt -108.98 136.71 48.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.94 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 407' ' ' GLY . 3.1 t70 -55.42 127.23 28.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.837 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.0 pttm -74.29 -1.03 18.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -97.18 -34.89 10.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 37.5 p -121.09 -34.97 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.154 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 99.59 -1.06 56.87 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.533 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -86.94 155.95 55.3 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.512 0.673 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.7 Cg_endo -69.82 91.36 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.697 2.265 . . . . 0.0 112.307 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.482 ' C ' ' O ' ' A' ' 409' ' ' PRO . 10.2 ptmt -31.75 -53.14 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.892 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.9 -14.78 0.51 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.501 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -88.45 156.81 18.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.868 0.366 . . . . 0.0 110.803 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.99 167.75 10.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.106 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.9 p -136.76 140.17 42.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.905 HG21 ' CD2' ' A' ' 381' ' ' PHE . 37.0 t -127.1 112.26 28.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.121 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' SER . . . . . 0.45 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 6.0 m -89.39 113.75 25.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.475 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 69.1 m-85 -88.8 164.97 14.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -57.27 -68.86 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.518 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 4.0 m-20 -112.68 156.97 41.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.605 0.717 . . . . 0.0 110.886 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.32 -43.06 55.79 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.704 2.269 . . . . 0.0 112.329 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.2 Cg_exo -50.25 -26.64 15.87 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.651 2.234 . . . . 0.0 112.326 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 35.2 m -90.0 -39.87 12.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.538 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -60.37 -51.31 70.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.065 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.463 ' HG2' HD11 ' A' ' 444' ' ' LEU . 4.3 mtpm? -57.52 -39.31 76.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.09 70.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.046 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.68 71.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.08 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 423' ' ' ALA . 85.6 t -56.89 -64.15 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.58 -11.44 24.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.537 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.3 t-105 -82.09 -55.29 4.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.889 ' HB2' HG21 ' A' ' 442' ' ' VAL . 89.1 m-85 -88.3 -13.88 39.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.831 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.8 t0 -58.64 96.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 112.26 -16.07 24.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.529 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -49.7 165.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.737 0.303 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -122.33 110.37 15.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.793 ' HB2' HD11 ' A' ' 440' ' ' LEU . 5.6 t80 -97.78 105.43 17.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 62.98 34.37 14.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 83.58 19.66 61.51 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.503 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 22.2 p -125.19 128.66 48.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.952 0.406 . . . . 0.0 110.828 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' LYS . . . . . 0.407 ' C ' HD23 ' A' ' 440' ' ' LEU . 0.5 OUTLIER -71.65 133.1 45.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 435' ' ' PHE . 8.6 mt -107.2 160.59 15.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -133.41 101.04 5.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.889 HG21 ' HB2' ' A' ' 430' ' ' PHE . 13.8 t -98.26 131.99 44.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.17 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.3 m -153.2 128.98 10.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.463 HD11 ' HG2' ' A' ' 424' ' ' LYS . 39.5 mt -37.96 136.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.909 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -81.83 162.13 22.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.84 159.07 6.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -139.03 115.49 10.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.42 148.01 62.31 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.574 0.702 . . . . 0.0 110.868 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 159.34 53.77 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.88 158.43 56.83 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.635 2.224 . . . . 0.0 112.304 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -87.53 160.75 18.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.9 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -174.46 137.04 0.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 37.2 p -97.85 175.39 6.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 79.73 84.46 0.64 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.477 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 115.49 4.13 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.64 2.226 . . . . 0.0 112.342 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 54.2 p -153.49 145.48 23.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 3.1 t -77.66 92.46 4.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.477 179.996 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 15.6 t -79.36 154.38 29.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.892 0.377 . . . . 0.0 110.843 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 15.6 t -86.04 125.0 33.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.893 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 40.92 88.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.574 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 15.2 t -142.88 112.9 7.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.84 0.352 . . . . 0.0 110.871 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 7.6 m -72.2 136.0 46.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.811 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 147.32 42.63 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.471 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -120.3 140.43 30.12 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.584 0.707 . . . . 0.0 110.899 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -175.02 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.701 2.267 . . . . 0.0 112.349 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -133.24 171.44 14.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -52.19 115.47 1.74 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -144.96 154.06 42.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.842 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 52.9 p -79.39 165.2 23.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -42.92 118.67 1.31 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -161.19 123.16 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.938 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 417' ' ' TYR . 3.3 p -120.71 37.69 4.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -144.25 166.98 23.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.084 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.731 HD12 ' CG1' ' A' ' 442' ' ' VAL . 37.7 pt -142.49 142.73 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -100.79 114.36 28.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.981 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.971 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 9.4 t -97.52 142.19 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.176 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -147.79 120.06 8.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.43 20.55 1.39 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.424 HD13 HD11 ' A' ' 377' ' ' LEU . 96.6 mt -79.48 154.43 28.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.865 0.364 . . . . 0.0 110.85 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -74.04 -177.95 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.24 0.42 57.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 20.1 m -118.68 16.9 13.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.837 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.441 HG23 ' CE2' ' A' ' 435' ' ' PHE . 7.6 p -76.48 135.18 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.131 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 75.5 p -117.26 158.82 23.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.195 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.755 HD11 ' HG2' ' A' ' 396' ' ' PRO . 10.7 tp -56.99 -60.03 4.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.871 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -48.13 -40.12 22.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -28.8 68.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.769 HD12 HD11 ' A' ' 400' ' ' ILE . 47.6 mt -86.44 -31.44 21.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.38 -33.73 67.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.101 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.437 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 9.3 t70 -81.79 -20.16 39.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -92.45 -46.55 7.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.971 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 17.4 m-85 -65.76 -19.11 65.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.437 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -78.65 -4.28 48.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.914 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -56.74 -54.0 51.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.5 t -59.44 -65.92 0.59 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -134.41 -125.6 2.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.48 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 50.9 t -124.21 136.61 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.946 0.403 . . . . 0.0 111.105 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.22 132.26 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.089 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -57.18 106.87 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' MET . . . . . 0.49 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 73.4 mmm -102.44 121.08 41.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.78 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -46.79 150.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.72 -23.06 17.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.931 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' ARG . . . . . 0.598 ' HG3' HG23 ' A' ' 393' ' ' THR . 35.0 ptt180 -96.37 -47.11 6.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.598 HG23 ' HG3' ' A' ' 392' ' ' ARG . 61.9 p -89.46 -16.34 31.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.49 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 58.59 24.09 56.07 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.478 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -111.45 153.34 44.2 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.638 0.733 . . . . 0.0 110.883 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.755 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.7 Cg_endo -69.8 146.67 60.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.667 2.245 . . . . 0.0 112.362 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.426 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.6 mmt -81.79 40.83 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.569 HG12 HG22 ' A' ' 415' ' ' VAL . 95.6 mt -98.8 136.22 30.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.122 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' HIS . . . . . 0.41 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 8.6 t60 -116.3 141.09 48.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.769 HD11 HD12 ' A' ' 377' ' ' LEU . 76.9 mt -134.67 94.13 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -60.65 124.41 20.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 409' ' ' PRO . 36.3 mt -109.82 135.17 51.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 407' ' ' GLY . 7.7 t0 -55.57 123.42 13.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.819 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -70.75 -2.03 13.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -89.28 -38.93 13.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 27.4 p -122.7 -34.74 3.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.177 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 104.79 -1.45 41.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.537 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -84.55 152.69 60.8 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.523 0.678 . . . . 0.0 110.915 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.486 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.2 Cg_endo -69.8 94.0 0.53 Allowed 'Trans proline' 0 N--CA 1.466 -0.132 0 C-N-CA 122.689 2.259 . . . . 0.0 112.354 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 409' ' ' PRO . 7.9 ptmt -32.94 -49.57 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 149.72 -13.58 1.02 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -90.53 155.83 18.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.84 0.353 . . . . 0.0 110.876 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -168.46 170.51 9.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.1 p -139.73 132.83 29.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.882 HG21 ' CD2' ' A' ' 381' ' ' PHE . 99.7 t -118.25 122.8 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' SER . . . . . 0.426 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 1.8 m -98.42 113.12 24.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.487 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 58.4 m-85 -86.74 169.85 12.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -63.44 -66.28 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.9 m-20 -114.53 156.25 44.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.708 . . . . 0.0 110.895 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.15 -43.01 57.2 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.706 2.271 . . . . 0.0 112.381 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.0 Cg_exo -50.42 -27.03 17.42 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.769 2.312 . . . . 0.0 112.348 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 90.2 m -90.4 -41.17 11.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.196 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.604 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.34 -49.6 77.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.077 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.522 ' HG2' HD11 ' A' ' 444' ' ' LEU . 47.4 mtpt -59.34 -40.24 85.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.94 -33.98 71.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.037 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.5 -33.94 75.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 423' ' ' ALA . 97.6 t -55.38 -60.88 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.97 -12.7 60.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.942 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.549 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.1 t-105 -80.16 -55.19 5.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.918 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.853 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.2 m-85 -86.73 -17.68 33.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.6 OUTLIER -54.16 94.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.861 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.2 20.26 9.89 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.464 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.453 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 15.2 mmtm -78.16 170.4 16.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.877 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -114.36 112.93 23.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.605 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.7 t80 -120.96 105.21 10.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 62.25 38.08 13.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.937 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 73.97 23.38 76.41 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 71.3 m -132.38 131.05 41.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 0.0 110.868 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -72.51 136.06 45.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' A' ' 435' ' ' PHE . 8.5 mt -104.15 143.27 33.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -117.45 104.23 10.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.853 HG21 ' HB2' ' A' ' 430' ' ' PHE . 7.5 t -101.11 133.86 43.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.128 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 3.8 m -156.07 132.09 9.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.522 HD11 ' HG2' ' A' ' 424' ' ' LYS . 18.5 mt -40.35 119.82 1.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.57 98.5 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -133.9 126.52 30.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.22 143.24 28.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -110.77 135.09 20.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.563 0.697 . . . . 0.0 110.907 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 162.43 42.09 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.619 2.213 . . . . 0.0 112.387 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -34.47 14.5 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.683 2.255 . . . . 0.0 112.369 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -75.11 148.47 39.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' ASN . . . . . 0.4 ' O ' ' ND2' ' A' ' 452' ' ' ASN . 0.7 OUTLIER -142.77 111.99 6.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.915 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 54.5 p 38.39 35.15 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.798 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -56.0 169.78 2.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.475 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 89.8 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.665 2.243 . . . . 0.0 112.328 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 57.1 m -101.85 106.11 17.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.89 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.1 t -60.45 96.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.489 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 89.2 p -78.69 140.42 38.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.877 0.37 . . . . 0.0 110.858 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 54.4 p -125.58 174.65 8.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -149.35 -82.77 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.47 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 46.5 p -75.05 91.65 2.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.349 . . . . 0.0 110.829 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 8.0 m -109.56 128.43 55.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.897 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 170.52 -135.03 3.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.477 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -140.9 141.28 23.71 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.62 0.724 . . . . 0.0 110.855 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 164.95 32.61 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.768 2.312 . . . . 0.0 112.353 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -69.05 79.05 0.33 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.29 141.3 58.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.13 136.29 57.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.829 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 73.2 m -101.08 44.15 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -110.38 177.52 4.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -97.01 94.02 6.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 7.6 m -90.88 37.06 0.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.806 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -136.95 166.04 24.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.071 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.428 HD12 HG13 ' A' ' 442' ' ' VAL . 12.5 pt -137.69 142.14 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.139 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -100.44 117.91 35.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.986 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 40.4 t -101.78 144.41 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.033 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -150.31 118.06 6.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.38 23.11 1.03 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.447 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.497 HD13 HD11 ' A' ' 377' ' ' LEU . 93.9 mt -81.36 156.37 25.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.817 0.341 . . . . 0.0 110.895 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' A' ' 436' ' ' GLN . 8.5 p30 -79.9 179.94 7.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.87 1.5 53.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.844 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.9 m -117.31 16.0 14.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.83 136.59 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.098 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 73.4 p -123.05 156.21 35.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.136 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.955 HD11 ' HG2' ' A' ' 396' ' ' PRO . 10.6 tp -52.56 -65.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -46.61 -36.94 7.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -69.15 -31.56 70.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 400' ' ' ILE . 43.4 mt -84.93 -28.45 25.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.93 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.8 -40.38 63.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.438 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 23.2 t0 -73.14 -21.39 60.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -92.58 -49.42 6.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.986 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 14.8 m-85 -62.51 -22.65 66.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.438 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -74.67 -12.77 60.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.881 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -48.47 -56.11 9.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 32.6 t -55.74 -69.58 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -132.46 -123.4 2.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.439 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 55.8 t -125.5 133.52 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 111.165 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.38 131.21 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.167 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -54.95 109.28 0.5 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' MET . . . . . 0.402 ' SD ' ' CA ' ' A' ' 396' ' ' PRO . 65.0 mmm -104.29 123.16 46.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -50.51 145.51 6.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.867 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -94.85 -8.81 36.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' ARG . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 392' ' ' ARG . 3.8 ptp180 -102.98 -49.46 3.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.887 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.407 HG23 ' HG3' ' A' ' 392' ' ' ARG . 41.1 p -94.11 -14.92 25.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.179 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 62.53 30.19 75.8 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.469 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -116.52 153.28 48.91 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.6 0.714 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.955 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.6 Cg_endo -69.82 147.61 62.87 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.415 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 12.5 mmt -81.36 41.23 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.47 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.0 mt -97.79 135.67 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.074 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -116.09 139.99 49.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.765 HD11 HD12 ' A' ' 377' ' ' LEU . 60.7 mt -133.34 94.29 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.187 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -59.83 129.83 43.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.557 HD23 ' HA ' ' A' ' 409' ' ' PRO . 27.0 mt -114.09 137.12 52.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 407' ' ' GLY . 5.0 t70 -55.43 128.95 36.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -76.15 -1.62 27.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -97.46 -30.18 13.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.883 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 52.5 p -124.38 -36.17 2.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 97.62 7.84 56.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.452 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.8 156.66 37.06 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.584 0.707 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.557 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.0 Cg_endo -69.68 89.08 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.644 2.229 . . . . 0.0 112.382 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 409' ' ' PRO . 6.7 ptmt -31.22 -55.45 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 157.67 -15.93 0.31 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.484 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -88.76 158.0 18.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.349 . . . . 0.0 110.842 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -170.55 173.57 5.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.139 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.4 p -141.91 137.63 31.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.157 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.873 HG21 ' CD2' ' A' ' 381' ' ' PHE . 45.9 t -123.55 111.63 30.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.127 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' SER . . . . . 0.415 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 3.6 m -87.67 113.9 23.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.518 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 55.5 m-85 -87.72 166.91 14.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.859 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -61.33 -66.24 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.524 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.3 m-20 -110.73 156.63 40.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.636 0.731 . . . . 0.0 110.831 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.04 -42.91 58.88 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.674 2.249 . . . . 0.0 112.38 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.0 Cg_exo -50.86 -46.0 32.87 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.713 2.276 . . . . 0.0 112.394 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 86.2 m -68.36 -39.22 81.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.166 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -61.82 -48.13 81.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.116 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -61.33 -39.38 90.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.59 -34.93 72.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.152 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -67.7 -34.16 76.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.053 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 423' ' ' ALA . 94.3 t -54.93 -62.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -66.48 -10.83 48.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.548 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.2 t-105 -82.01 -55.63 4.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.918 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.819 ' HB2' HG21 ' A' ' 442' ' ' VAL . 90.7 m-85 -86.14 -21.43 27.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.5 t70 -52.62 97.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 103.42 21.37 9.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.494 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.426 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 19.5 mmtt -81.46 176.02 10.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.853 0.358 . . . . 0.0 110.845 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 1.6 p-10 -119.9 114.91 22.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.728 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -121.69 104.08 9.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' GLN . . . . . 0.419 ' HB2' ' ND2' ' A' ' 369' ' ' ASN . 41.9 mt-30 62.69 40.61 9.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.829 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 71.79 25.56 74.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.5 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 67.8 m -134.79 127.69 31.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.902 0.382 . . . . 0.0 110.891 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -68.95 136.77 53.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.9 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.728 HD11 ' HB2' ' A' ' 435' ' ' PHE . 12.4 mt -106.37 140.05 39.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -116.06 106.26 13.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.819 HG21 ' HB2' ' A' ' 430' ' ' PHE . 11.5 t -100.6 135.77 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.093 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 12.6 p -156.13 127.41 7.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 25.0 mt -38.87 112.63 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.978 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -50.18 132.3 23.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -75.15 142.52 43.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -173.3 135.17 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.79 150.42 39.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.619 0.723 . . . . 0.0 110.929 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 155.64 65.5 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.362 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.73 159.18 54.4 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.704 2.27 . . . . 0.0 112.339 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 34.8 ttm -101.07 118.69 37.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.829 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -125.56 131.15 52.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 38.9 t -163.9 116.15 1.4 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.808 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -115.51 171.02 13.51 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.419 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 -178.43 2.36 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.649 2.233 . . . . 0.0 112.397 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 43.6 t -54.7 147.8 13.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.812 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 78.0 p -116.93 -48.75 2.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.464 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 14.2 m -97.42 135.47 39.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.846 0.355 . . . . 0.0 110.89 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 8.2 t -101.34 170.02 8.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 62.94 107.76 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.464 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 6.3 t -113.06 40.9 2.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.871 0.367 . . . . 0.0 110.867 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 4.0 t -129.86 166.78 19.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 93.68 141.5 11.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.443 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 353' ' ' ASP . 0.3 OUTLIER -96.6 158.42 33.71 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 0.0 110.866 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 355' ' ' ASP . 53.5 Cg_endo -69.77 -7.94 22.34 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.61 2.207 . . . . 0.0 112.347 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 354' ' ' PRO . 24.5 t0 -36.24 118.74 0.55 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -102.01 143.92 31.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -103.24 -52.7 2.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 35.5 t -105.04 92.17 4.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.95 130.52 41.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.846 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -113.84 88.85 2.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 32.6 t -86.06 21.63 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -115.29 163.1 16.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.066 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.664 HD12 ' CG1' ' A' ' 442' ' ' VAL . 37.7 pt -137.06 141.99 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -100.93 114.67 28.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.935 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.891 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 5.1 t -101.2 141.9 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.105 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -147.4 123.67 10.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 128.66 14.26 2.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.521 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.09 152.61 41.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 372' ' ' VAL . 6.1 p30 -72.94 -176.41 2.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.95 -0.15 57.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.827 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.0 t -117.02 17.8 14.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.4 ' N ' ' OD1' ' A' ' 369' ' ' ASN . 9.0 p -79.04 139.71 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.089 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 72.7 p -122.81 160.21 26.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.884 HD11 ' HG2' ' A' ' 396' ' ' PRO . 9.1 tp -56.55 -60.33 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -48.0 -37.1 13.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -30.12 68.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.745 HD12 HD11 ' A' ' 400' ' ' ILE . 63.2 mt -85.39 -31.34 22.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.95 -35.14 66.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.44 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 23.3 t0 -80.63 -20.56 42.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.828 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -92.65 -51.61 5.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.891 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.3 m-85 -61.11 -21.48 63.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.44 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 8.4 ptpt -75.79 -13.34 60.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -47.21 -54.53 10.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 21.6 t -57.34 -70.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -131.84 -124.22 2.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.508 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 96.3 t -124.55 136.67 59.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.392 . . . . 0.0 111.08 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 96.3 t -92.17 129.26 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.143 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -51.05 107.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 62.7 mmm -103.89 124.64 49.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.791 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.405 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 11.4 t-20 -47.44 145.48 2.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -94.69 -18.32 21.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 19.2 tpp85 -99.74 -45.26 5.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.863 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.405 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 23.6 p -91.85 -24.28 19.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.216 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 68.55 29.0 72.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.537 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.76 153.07 47.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.536 0.684 . . . . 0.0 110.961 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.884 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.2 Cg_endo -69.83 144.95 55.28 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.625 2.216 . . . . 0.0 112.326 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.449 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 12.5 mmt -81.37 41.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.471 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.5 mt -97.81 142.79 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.151 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -122.22 139.62 53.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.745 HD11 HD12 ' A' ' 377' ' ' LEU . 64.3 mt -133.31 94.6 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.191 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -61.23 122.32 14.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 409' ' ' PRO . 33.3 mt -107.12 135.06 49.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 407' ' ' GLY . 9.9 t0 -55.51 121.54 9.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -1.16 8.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -89.08 -37.64 14.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 43.1 p -125.19 -35.67 2.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.109 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.36 1.7 38.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.467 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -87.12 152.58 53.27 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.561 0.696 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.517 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.6 Cg_endo -69.72 93.06 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.701 2.267 . . . . 0.0 112.317 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 409' ' ' PRO . 6.5 ptmt -32.76 -52.93 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.884 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 153.95 -16.08 0.61 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.494 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -87.68 155.49 19.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.848 0.356 . . . . 0.0 110.84 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.46 168.59 11.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.9 p -136.7 139.85 42.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.765 HG21 ' CD2' ' A' ' 381' ' ' PHE . 31.9 t -124.81 116.62 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' SER . . . . . 0.449 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 22.9 m -92.06 110.76 22.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.869 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.505 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 51.9 m-85 -86.79 161.89 18.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -57.94 -63.54 1.22 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.511 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 1.2 m-20 -118.59 157.13 50.51 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.576 0.703 . . . . 0.0 110.84 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.51 -43.0 55.12 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.648 2.232 . . . . 0.0 112.383 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 56.9 Cg_exo -49.48 -26.43 12.23 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.641 2.227 . . . . 0.0 112.397 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 98.8 m -91.33 -41.13 11.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.04 -51.0 71.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.448 ' HG2' HD11 ' A' ' 444' ' ' LEU . 27.2 mtpp -58.63 -39.05 79.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -72.62 -32.18 65.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.104 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.87 72.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.073 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 423' ' ' ALA . 94.6 t -54.39 -61.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.187 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -66.25 -13.03 59.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.533 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.3 t-105 -80.46 -50.84 9.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.878 ' HB2' HG21 ' A' ' 442' ' ' VAL . 82.3 m-85 -92.88 -13.09 29.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.0 OUTLIER -59.51 92.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.97 -13.64 19.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.433 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 9.8 mmtm -45.68 166.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.749 0.309 . . . . 0.0 110.916 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 4.4 p-10 -115.1 112.24 22.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.501 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.2 t80 -111.76 108.6 18.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 61.64 31.06 18.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 91.49 -15.96 60.16 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.563 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.2 t -91.11 159.05 16.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.382 . . . . 0.0 110.898 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -96.23 134.52 39.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 435' ' ' PHE . 8.6 mt -100.01 140.05 34.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -117.36 100.13 7.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.878 HG21 ' HB2' ' A' ' 430' ' ' PHE . 12.5 t -97.67 133.08 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 6.1 p -156.49 128.43 7.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.825 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.448 HD11 ' HG2' ' A' ' 424' ' ' LYS . 18.8 mt -39.76 130.13 1.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -67.23 148.12 52.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 63.16 28.99 16.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.814 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -135.59 168.59 18.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' LYS . . . . . 0.477 ' CG ' ' HD2' ' A' ' 449' ' ' PRO . 20.5 ttpt -84.11 139.78 39.61 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.55 0.69 . . . . 0.0 110.942 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 448' ' ' LYS . 53.8 Cg_endo -69.75 159.77 52.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.682 2.255 . . . . 0.0 112.351 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 123.31 9.97 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.704 2.269 . . . . 0.0 112.314 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 18.7 ptm -63.72 176.01 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.863 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -57.27 -54.81 42.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 5.7 t -160.33 156.11 25.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.809 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -150.96 81.9 0.18 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.485 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -12.61 33.27 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.707 2.271 . . . . 0.0 112.324 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 2.2 t -104.79 92.07 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 7.1 t -57.47 -51.89 67.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.5 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.388 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 58.7 m -102.55 177.06 4.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.867 0.365 . . . . 0.0 110.844 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 26.6 p -130.98 -53.67 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.889 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 138.5 -153.06 22.31 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.478 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 3.1 t -78.34 91.53 4.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.914 0.387 . . . . 0.0 110.843 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 80.0 p -112.29 93.54 4.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.915 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 54.33 -89.6 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.552 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.18 153.45 46.72 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.631 0.729 . . . . 0.0 110.853 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 156.66 62.9 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.774 2.316 . . . . 0.0 112.375 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.79 43.4 1.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -68.1 100.15 0.97 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.893 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -131.17 126.85 36.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 34.2 t -159.3 149.34 18.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -115.8 152.64 32.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -75.2 80.35 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.887 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.6 m -104.49 36.83 2.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.841 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -139.05 166.98 23.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.069 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.632 HD12 ' CG1' ' A' ' 442' ' ' VAL . 33.7 pt -137.71 143.78 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -102.32 114.31 28.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 1.029 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 15.6 t -97.72 141.31 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.177 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -147.89 121.05 8.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.49 20.72 1.36 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.438 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.486 HD13 HD11 ' A' ' 377' ' ' LEU . 65.8 mt -81.28 153.4 27.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.766 0.317 . . . . 0.0 110.979 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' ASN . . . . . 0.406 ' H ' ' ND2' ' A' ' 369' ' ' ASN . 3.8 p30 -75.71 -177.21 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.25 7.59 40.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.8 t -123.2 14.11 9.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 10.8 p -75.57 132.9 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 58.6 p -114.53 159.68 20.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.203 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.756 HD11 ' HG2' ' A' ' 396' ' ' PRO . 13.1 tp -58.95 -61.29 2.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -48.74 -32.74 9.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.97 -31.09 65.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.579 HD12 HD11 ' A' ' 400' ' ' ILE . 38.6 mt -86.21 -30.03 22.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.87 -33.26 65.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.67 -20.97 35.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.428 ' CE2' ' CD1' ' A' ' 430' ' ' PHE . 63.6 t80 -92.32 -49.5 6.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 1.029 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.1 m-85 -59.9 -26.38 65.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -75.89 -4.39 40.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -55.43 -48.88 73.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 39.3 t -63.71 -57.87 8.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -142.22 -123.19 1.83 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.488 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 71.9 t -124.84 135.98 62.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 85.9 t -92.04 128.35 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -53.18 108.96 0.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 40.1 mmm -105.87 127.53 53.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.431 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 14.4 t-20 -50.23 146.17 5.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -94.86 -13.39 25.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -100.47 -48.27 4.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.431 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 30.4 p -92.49 -19.62 21.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.473 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 66.12 26.65 72.49 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.472 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -112.59 153.28 45.03 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.654 0.74 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.756 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.9 Cg_endo -69.67 146.61 61.32 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.722 2.281 . . . . 0.0 112.379 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.44 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.2 mmt -81.49 40.69 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.52 HG12 HG22 ' A' ' 415' ' ' VAL . 97.1 mt -98.05 138.76 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -118.3 137.16 53.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.579 HD11 HD12 ' A' ' 377' ' ' LEU . 73.6 mt -130.8 95.54 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.157 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -63.16 126.15 26.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 409' ' ' PRO . 35.8 mt -110.96 135.49 51.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.913 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.7 t0 -56.58 121.46 9.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.416 ' HD3' ' C ' ' A' ' 404' ' ' LYS . 0.0 OUTLIER -70.12 -1.05 8.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -89.04 -37.27 15.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.0 p -124.18 -36.01 2.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.098 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 107.56 -2.87 34.39 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.45 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -85.15 152.82 59.09 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.515 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.6 Cg_endo -69.76 95.79 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.707 2.271 . . . . 0.0 112.292 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 409' ' ' PRO . 6.4 ptmt -33.39 -52.37 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.99 -12.8 0.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.51 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -91.39 152.03 20.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -165.26 170.6 14.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.4 p -139.1 142.12 38.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.924 HG21 ' CD2' ' A' ' 381' ' ' PHE . 48.1 t -128.99 116.28 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' SER . . . . . 0.44 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 14.5 m -90.76 115.54 27.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.537 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 56.6 m-85 -88.36 163.98 15.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -62.17 -63.61 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.509 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 1.6 m-20 -116.01 156.29 46.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.634 0.731 . . . . 0.0 110.87 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.26 -43.02 56.44 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.745 2.297 . . . . 0.0 112.36 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 56.7 Cg_exo -49.31 -26.71 11.99 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.658 2.238 . . . . 0.0 112.373 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 93.4 m -91.89 -41.46 10.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.719 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.28 -47.36 85.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.126 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -63.26 -37.41 87.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.86 -32.33 61.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.041 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.453 ' HB1' ' OH ' ' A' ' 417' ' ' TYR . . . -69.36 -33.85 73.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.027 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 423' ' ' ALA . 85.2 t -56.15 -64.42 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.127 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.59 -13.67 44.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.53 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.3 t-105 -79.21 -54.39 6.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.888 ' HB2' HG21 ' A' ' 442' ' ' VAL . 79.8 m-85 -90.61 -11.67 39.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 3.0 t70 -61.4 98.38 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 106.38 -7.93 40.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.511 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.444 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 30.8 mmtt -53.82 165.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 110.876 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -112.67 116.18 29.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.622 ' HB2' HD11 ' A' ' 440' ' ' LEU . 6.4 t80 -113.82 109.71 18.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 61.13 28.77 18.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 94.1 -14.83 64.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.512 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 19.7 m -91.81 160.59 15.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 0.0 110.834 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -97.39 134.46 40.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.937 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' A' ' 435' ' ' PHE . 9.6 mt -102.84 144.9 30.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -122.77 99.51 6.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.888 HG21 ' HB2' ' A' ' 430' ' ' PHE . 16.9 t -96.2 131.37 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 5.4 m -151.8 129.43 11.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.491 ' HG ' HG21 ' A' ' 427' ' ' VAL . 21.5 mt -44.33 112.84 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.938 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -50.13 104.28 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.173 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 27.7 ttt-85 -107.09 152.53 23.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.91 158.88 30.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.943 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 448' ' ' LYS . . . . . 0.457 ' CG ' ' HD2' ' A' ' 449' ' ' PRO . 26.5 tttt -76.7 139.32 66.65 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.642 0.735 . . . . 0.0 110.851 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.457 ' HD2' ' CG ' ' A' ' 448' ' ' LYS . 53.9 Cg_endo -69.77 125.63 12.36 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.711 2.274 . . . . 0.0 112.372 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.69 10.23 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.686 2.257 . . . . 0.0 112.378 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.1 150.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.861 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 452' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 454' ' ' GLY . 7.9 t30 -123.96 122.49 38.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.908 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 1.9 m -64.68 85.68 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' GLY . . . . . 0.418 ' O ' ' ND2' ' A' ' 452' ' ' ASN . . . 69.46 147.54 0.26 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.524 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 455' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 456' ' ' SER . 53.3 Cg_endo -69.77 2.68 3.32 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.702 2.268 . . . . 0.0 112.411 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 456' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 455' ' ' PRO . 6.1 m -34.76 134.44 0.23 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.3 t -40.43 155.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.848 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.497 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 47.6 t -113.1 140.06 48.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 110.848 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 63.7 m 48.65 42.87 20.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 350' ' ' SER . . . -117.44 72.54 0.29 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.504 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 349' ' ' GLY . 4.2 m -36.05 -50.29 0.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.908 0.385 . . . . 0.0 110.885 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 71.3 p -44.84 118.41 1.61 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -134.41 -90.2 0.36 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.523 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -139.44 153.54 70.79 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.563 0.696 . . . . 0.0 110.906 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.72 163.77 36.98 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.719 2.279 . . . . 0.0 112.367 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -110.19 97.65 7.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.817 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -89.12 39.94 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -86.67 148.91 25.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 4.7 t -134.34 -54.13 0.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.25 46.07 1.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.841 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -130.36 82.37 2.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.938 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 6.8 m -93.63 42.39 1.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -141.52 165.65 26.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.146 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.477 ' HB ' ' CG1' ' A' ' 442' ' ' VAL . 17.1 pt -137.66 139.29 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.081 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -99.45 113.49 25.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 1.052 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 23.2 t -96.93 143.31 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.132 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -149.95 120.57 7.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.82 20.76 1.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.498 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.512 HD23 HD22 ' A' ' 440' ' ' LEU . 44.2 mt -83.58 156.01 22.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -78.62 -176.3 4.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.58 10.06 29.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.5 t -122.91 10.04 9.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.5 HG21 HD21 ' A' ' 377' ' ' LEU . 7.4 p -73.79 128.95 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 74.8 p -111.35 162.86 14.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.122 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.752 HD11 ' HG2' ' A' ' 396' ' ' PRO . 13.8 tp -58.74 -63.77 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -46.69 -38.24 9.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.869 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -67.09 -29.99 69.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.577 HD12 HD11 ' A' ' 400' ' ' ILE . 47.6 mt -87.33 -29.81 21.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.934 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.92 -41.04 64.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.431 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 30.7 t0 -76.17 -19.39 58.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -92.61 -45.58 8.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.943 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 1.052 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 15.0 m-85 -67.46 -19.36 65.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.838 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.431 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 5.7 ptmm? -77.14 -6.04 51.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -53.24 -53.08 55.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 13.2 t -59.2 -68.18 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.07 -122.39 2.31 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.483 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 71.7 t -126.98 135.22 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.882 0.372 . . . . 0.0 111.16 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.48 130.93 36.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.158 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -55.09 104.51 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' MET . . . . . 0.499 ' SD ' ' N ' ' A' ' 396' ' ' PRO . 59.4 mmm -101.5 118.71 37.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -46.82 150.38 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -95.09 -23.6 17.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' ARG . . . . . 0.415 ' CD ' HG23 ' A' ' 393' ' ' THR . 0.0 OUTLIER -93.64 -46.51 7.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.821 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.415 HG23 ' CD ' ' A' ' 392' ' ' ARG . 41.4 p -90.93 -14.1 32.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.16 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.45 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 55.32 30.41 55.12 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.529 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -118.67 153.18 52.14 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.556 0.693 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.752 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.1 Cg_endo -69.8 147.95 63.76 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.682 2.255 . . . . 0.0 112.345 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.46 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 19.7 mmt -81.84 40.58 0.61 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.829 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.525 HG12 HG22 ' A' ' 415' ' ' VAL . 96.2 mt -96.71 143.66 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.144 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -123.66 138.11 54.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.577 HD11 HD12 ' A' ' 377' ' ' LEU . 60.3 mt -131.73 96.23 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.136 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -63.75 124.46 21.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 409' ' ' PRO . 24.7 mt -109.84 136.16 49.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.935 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.5 t70 -56.72 134.67 55.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.806 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -5.82 55.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -97.31 -26.37 14.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.43 ' OG1' ' CG ' ' A' ' 408' ' ' LYS . 65.2 p -123.1 -36.16 2.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.074 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 95.17 -6.61 68.99 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.461 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' LYS . . . . . 0.43 ' CG ' ' OG1' ' A' ' 406' ' ' THR . 3.7 ptpt -86.97 159.42 51.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.592 0.711 . . . . 0.0 110.858 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.524 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.0 Cg_endo -69.76 92.57 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.61 2.207 . . . . 0.0 112.404 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -32.39 -51.98 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 153.77 -13.96 0.59 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -90.43 157.08 17.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.903 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -170.17 169.63 7.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.056 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.6 p -140.05 139.15 35.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.138 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.975 HG21 ' CD2' ' A' ' 381' ' ' PHE . 60.5 t -125.66 120.85 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' SER . . . . . 0.46 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 4.8 m -95.46 116.42 28.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.827 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.434 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 60.4 m-85 -89.29 163.6 15.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.898 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -58.49 -66.35 0.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.831 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.5 m-20 -112.31 156.44 42.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.663 0.744 . . . . 0.0 110.793 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.37 -42.99 56.12 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.7 2.267 . . . . 0.0 112.349 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.3 Cg_exo -50.21 -32.63 33.17 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.638 2.225 . . . . 0.0 112.345 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 89.1 m -81.75 -38.57 25.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -62.33 -50.64 70.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.181 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.664 ' HG2' HD11 ' A' ' 444' ' ' LEU . 39.3 mtmt -58.94 -35.61 73.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.64 -32.05 57.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.25 -33.38 71.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.069 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.614 HG21 ' HG ' ' A' ' 444' ' ' LEU . 97.2 t -55.91 -63.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.13 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -65.73 -9.74 30.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.534 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.2 t-105 -83.77 -55.09 4.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.938 ' HB2' HG21 ' A' ' 442' ' ' VAL . 93.2 m-85 -87.29 -18.52 30.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.856 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.8 t70 -55.81 98.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 103.92 12.22 30.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.518 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.444 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 16.2 mmtm -71.05 175.03 5.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.766 0.317 . . . . 0.0 110.894 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 438' ' ' SER . 1.2 m-20 -121.72 127.94 51.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.576 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.1 t80 -123.92 100.74 6.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 62.17 36.85 14.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 93.3 -21.36 40.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.47 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 434' ' ' ASP . 24.4 p -85.53 166.84 15.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.96 0.41 . . . . 0.0 110.842 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' LYS . . . . . 0.426 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.7 tmmm? -112.43 137.02 51.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.576 HD11 ' HB2' ' A' ' 435' ' ' PHE . 1.4 mt -108.71 151.19 26.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -125.31 106.78 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.938 HG21 ' HB2' ' A' ' 430' ' ' PHE . 15.0 t -96.74 138.95 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 47.7 m -157.51 126.1 5.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.664 HD11 ' HG2' ' A' ' 424' ' ' LYS . 19.7 mt -38.74 106.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 444' ' ' LEU . . . -37.33 100.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -69.9 -40.2 75.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -48.34 150.72 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.948 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' LYS . . . . . 0.469 ' CG ' ' HD2' ' A' ' 449' ' ' PRO . 21.2 tttp -128.51 139.43 35.51 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.532 0.682 . . . . 0.0 110.929 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' A' ' 448' ' ' LYS . 53.9 Cg_endo -69.72 164.23 35.28 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.757 2.305 . . . . 0.0 112.311 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 450' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 452' ' ' ASN . 54.0 Cg_endo -69.75 2.59 3.38 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.674 2.249 . . . . 0.0 112.314 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 10.7 tpt -46.12 89.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.855 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 450' ' ' PRO . 0.0 OUTLIER -172.02 159.64 5.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 3.1 t -174.75 165.91 3.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.825 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -156.47 -174.28 26.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.429 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.66 120.92 7.65 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.718 2.279 . . . . 0.0 112.407 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 33.3 t -87.43 -55.04 3.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.856 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 22.7 t -59.65 123.83 18.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.485 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 13.0 t -151.02 110.93 4.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.903 0.382 . . . . 0.0 110.832 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 59.6 p -39.21 -35.41 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -99.47 -148.81 23.5 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.441 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.9 m 38.27 42.09 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.873 0.368 . . . . 0.0 110.839 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 77.5 p -149.76 146.36 27.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 79.01 96.17 0.27 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.533 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -129.86 144.17 51.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.52 0.676 . . . . 0.0 110.867 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -175.61 1.22 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.727 2.285 . . . . 0.0 112.345 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -80.62 116.83 20.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -99.14 175.18 5.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.836 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -122.04 -46.03 2.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.816 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 3.3 m -41.35 -46.8 3.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.31 35.77 23.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -87.75 100.93 13.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.6 p -85.62 23.96 1.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -126.52 158.96 34.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.112 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.688 HD12 ' CG1' ' A' ' 442' ' ' VAL . 38.2 pt -130.76 143.3 41.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.154 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -102.57 110.9 22.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.99 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 12.0 t -95.13 142.23 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.149 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -146.66 121.09 9.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.88 14.49 2.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.519 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.498 HD13 HD11 ' A' ' 377' ' ' LEU . 96.7 mt -73.47 154.85 39.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -77.11 178.79 6.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.99 6.25 40.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.9 t -121.91 13.57 10.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.858 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.471 HG21 HD21 ' A' ' 377' ' ' LEU . 11.7 p -74.31 138.02 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.156 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 35.4 p -122.45 158.7 29.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.825 HD11 ' HG2' ' A' ' 396' ' ' PRO . 17.6 tp -54.81 -60.4 3.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -50.9 -29.74 12.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -75.8 -34.24 60.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.641 HD12 HD11 ' A' ' 400' ' ' ILE . 53.0 mt -82.63 -27.96 31.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -74.26 -37.87 63.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.074 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.438 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 13.5 t70 -76.08 -21.58 56.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.848 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -92.53 -49.32 6.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.935 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.99 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.6 m-85 -63.82 -11.6 28.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.438 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 13.5 ptmt -88.63 -5.13 58.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -54.54 -54.04 46.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.51 -67.36 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -130.71 -127.43 2.89 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.514 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 78.3 t -125.86 130.78 72.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 111.195 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 56.0 t -82.0 128.58 38.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -50.03 105.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 82.7 mmm -100.57 124.08 45.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.404 ' CB ' ' OG1' ' A' ' 393' ' ' THR . 8.0 t-20 -50.38 144.78 7.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -94.46 -18.83 21.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -99.93 -44.1 6.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.404 ' OG1' ' CB ' ' A' ' 390' ' ' ASN . 25.6 p -92.18 -22.14 19.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.185 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 65.89 29.95 76.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -120.03 153.11 55.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.86 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.825 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.0 Cg_endo -69.83 145.72 57.6 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.721 2.281 . . . . 0.0 112.298 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.42 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 11.8 mmt -81.33 41.21 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.458 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 98.6 mt -98.76 140.86 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -121.05 140.25 52.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.641 HD11 HD12 ' A' ' 377' ' ' LEU . 61.3 mt -132.64 99.86 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -68.12 131.61 45.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 409' ' ' PRO . 26.0 mt -115.51 138.28 51.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.921 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 407' ' ' GLY . 6.0 t0 -59.53 124.52 20.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -71.34 -1.17 12.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -89.5 -39.66 13.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 82.8 p -121.72 -33.42 3.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 103.9 -4.49 45.84 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.523 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -82.54 152.86 67.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.6 0.714 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.561 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.1 Cg_endo -69.76 95.64 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.689 2.26 . . . . 0.0 112.336 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 409' ' ' PRO . 8.7 ptmt -32.76 -54.62 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.51 -13.87 0.52 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.2 p-10 -87.73 157.21 19.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.743 0.306 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.38 169.4 9.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.052 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 2.3 p -137.84 139.69 40.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.192 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.881 HG21 ' CD2' ' A' ' 381' ' ' PHE . 48.6 t -127.15 114.78 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 416' ' ' SER . . . . . 0.42 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 2.8 m -91.11 112.17 23.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.841 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 68.8 m-85 -86.84 160.93 18.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.88 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -55.18 -67.44 0.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.83 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.517 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.4 m-20 -107.41 156.21 38.15 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.517 0.675 . . . . 0.0 110.942 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.34 -42.94 56.76 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.712 2.275 . . . . 0.0 112.324 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 53.0 Cg_exo -50.03 -46.82 26.35 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.733 2.289 . . . . 0.0 112.253 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 28.6 m -64.45 -43.77 93.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.17 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.727 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -58.85 -45.8 89.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.093 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.605 ' HG2' HD11 ' A' ' 444' ' ' LEU . 68.1 mttt -64.49 -35.33 80.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.03 -33.53 57.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.078 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -69.38 -33.87 73.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.075 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 423' ' ' ALA . 77.1 t -54.71 -61.43 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.55 -15.03 63.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.535 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.3 t-105 -78.14 -52.39 8.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.903 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.748 ' HB2' HG21 ' A' ' 442' ' ' VAL . 89.1 m-85 -88.92 -16.68 31.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.869 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.0 t70 -59.9 97.04 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 111.57 1.26 27.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.547 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 19.5 mmtm -67.36 168.34 10.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.803 0.335 . . . . 0.0 110.956 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 1.4 p-10 -115.78 111.55 20.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.657 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -111.27 106.55 15.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 61.42 37.73 16.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 74.6 23.61 74.79 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.415 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 36.5 m -132.35 128.78 38.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.919 0.39 . . . . 0.0 110.832 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.17 133.75 48.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.925 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.657 HD11 ' HB2' ' A' ' 435' ' ' PHE . 17.1 mt -101.05 156.81 17.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.96 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -129.74 100.58 5.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.886 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.748 HG21 ' HB2' ' A' ' 430' ' ' PHE . 14.2 t -100.58 131.89 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.171 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 443' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 444' ' ' LEU . 13.3 m -157.37 124.27 5.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.605 HD11 ' HG2' ' A' ' 424' ' ' LYS . 34.9 mt -35.05 128.22 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -68.76 138.16 54.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.156 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -93.55 146.97 23.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -93.65 171.38 8.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' LYS . . . . . 0.476 ' CD ' ' HD2' ' A' ' 449' ' ' PRO . 6.1 tppt? -118.83 138.65 26.24 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.542 0.687 . . . . 0.0 110.936 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.476 ' HD2' ' CD ' ' A' ' 448' ' ' LYS . 53.3 Cg_endo -69.78 162.2 43.0 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.647 2.232 . . . . 0.0 112.379 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -36.96 9.86 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.685 2.257 . . . . 0.0 112.346 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 22.2 mmt -42.51 163.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -67.86 159.41 30.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 1.3 t -100.09 115.29 29.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -40.3 140.33 1.02 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.557 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 124.41 11.06 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.681 2.254 . . . . 0.0 112.371 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 95.6 p -116.27 162.91 16.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.838 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 8.7 t -67.84 83.63 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.438 179.969 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 17.2 m -107.45 -59.96 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.372 . . . . 0.0 110.853 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 3.0 t -76.64 -55.78 5.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.873 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -64.92 138.19 39.36 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.465 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 14.4 t -101.53 43.46 1.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.797 0.332 . . . . 0.0 110.815 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 96.3 p -109.43 148.45 31.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 74.35 -175.65 48.59 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.479 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.417 ' CG ' ' HD2' ' A' ' 354' ' ' PRO . 8.5 t70 -124.35 139.76 33.61 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.529 0.681 . . . . 0.0 110.866 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' A' ' 353' ' ' ASP . 53.8 Cg_endo -69.77 2.24 3.72 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.709 2.272 . . . . 0.0 112.321 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.69 -176.57 3.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.861 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -113.66 97.08 6.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -65.3 121.94 15.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.893 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 5.7 t -60.54 163.74 5.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.855 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.67 56.93 3.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.848 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -85.92 80.75 8.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.93 39.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -142.85 161.65 37.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.091 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.554 HD12 ' CG1' ' A' ' 442' ' ' VAL . 38.9 pt -135.52 141.14 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.113 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -100.03 122.04 42.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.897 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 8.1 t -107.5 141.75 21.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.076 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -145.62 123.59 12.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 126.54 16.33 2.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.458 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 93.9 mt -73.84 152.89 40.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 372' ' ' VAL . 6.1 p30 -73.96 -176.53 2.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.96 3.6 54.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.8 m -120.79 17.7 11.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.423 ' N ' ' OD1' ' A' ' 369' ' ' ASN . 11.5 p -79.31 143.23 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.181 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 82.2 p -126.82 155.51 42.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.183 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.708 HD11 ' HG2' ' A' ' 396' ' ' PRO . 16.5 tp -49.64 -62.05 1.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -48.74 -37.85 20.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.83 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -66.53 -27.43 67.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 400' ' ' ILE . 89.6 mt -91.09 -30.06 16.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.66 -37.53 67.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.089 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.436 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 27.7 t70 -78.39 -19.63 52.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.895 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -92.61 -51.9 4.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.897 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 19.1 m-85 -60.34 -24.87 65.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.436 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 8.8 ptmt -70.87 -10.48 59.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.934 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -51.71 -57.4 9.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.3 t -53.93 -66.82 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -136.59 -122.67 2.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 75.4 t -126.01 130.66 72.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.92 0.39 . . . . 0.0 111.115 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.61 131.15 34.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -54.54 107.76 0.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' MET . . . . . 0.467 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 64.0 mmm -104.35 122.76 46.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.449 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 14.4 t-20 -48.8 148.98 1.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -94.91 -22.38 18.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.85 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -93.98 -48.39 6.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.842 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.449 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 41.1 p -88.42 -24.07 23.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.098 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.467 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 68.0 25.88 74.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.433 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -114.94 153.22 47.05 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.571 0.7 . . . . 0.0 110.965 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.708 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.4 Cg_endo -69.78 147.03 61.86 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.7 2.267 . . . . 0.0 112.339 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.471 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 15.0 mmt -81.27 41.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.638 HG12 HG22 ' A' ' 415' ' ' VAL . 96.2 mt -98.04 136.52 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.182 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -117.47 142.19 47.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.765 HD11 HD12 ' A' ' 377' ' ' LEU . 61.4 mt -134.81 94.08 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -61.17 121.84 13.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' A' ' 409' ' ' PRO . 31.3 mt -108.88 135.37 50.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.931 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 407' ' ' GLY . 11.7 t0 -55.33 122.36 10.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -69.89 -0.9 8.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.772 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -91.35 -41.21 11.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.6 p -118.78 -34.39 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 101.7 5.06 51.71 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.46 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -91.09 153.15 44.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.552 0.692 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.554 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.4 Cg_endo -69.76 91.89 0.51 Allowed 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.652 2.235 . . . . 0.0 112.372 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 409' ' ' PRO . 9.2 ptmt -31.67 -52.41 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.33 -17.13 0.59 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -87.63 157.22 19.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.856 0.36 . . . . 0.0 110.872 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.4 174.17 6.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 2.2 p -143.61 141.32 30.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.113 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.879 HG21 ' CD2' ' A' ' 381' ' ' PHE . 95.8 t -129.41 115.23 34.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' SER . . . . . 0.471 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 1.9 m -90.67 114.76 27.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 51.8 m-85 -87.94 161.1 17.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -54.34 -66.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.835 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.517 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 7.1 m-20 -116.34 158.35 43.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.632 0.729 . . . . 0.0 110.878 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.8 Cg_exo -57.44 -43.23 53.44 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.71 2.273 . . . . 0.0 112.332 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 53.1 Cg_exo -49.99 -27.44 16.48 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.65 2.234 . . . . 0.0 112.374 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 40.4 m -89.61 -41.78 11.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.117 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.64 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.84 -48.89 79.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -59.7 -38.96 83.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.82 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -72.84 -32.99 65.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -69.09 -35.07 76.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 423' ' ' ALA . 94.7 t -55.27 -62.52 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -66.9 -11.11 55.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.551 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.1 t-105 -81.02 -55.39 4.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.925 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.847 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.0 m-85 -87.34 -19.65 27.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.859 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.1 t70 -51.65 96.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.854 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 103.93 20.8 10.19 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.485 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.453 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 16.1 mmtm -76.81 170.99 15.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.769 0.319 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' ASP . . . . . 0.426 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 1.7 p30 -115.04 109.29 17.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.841 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.623 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.0 t80 -112.79 108.07 16.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 62.08 33.72 16.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 89.2 -16.38 55.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.448 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 3.1 m -92.66 164.04 13.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.964 0.411 . . . . 0.0 110.836 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -101.62 138.38 38.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 435' ' ' PHE . 12.4 mt -106.89 144.86 32.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -118.94 107.93 14.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.847 HG21 ' HB2' ' A' ' 430' ' ' PHE . 9.1 t -100.85 131.99 47.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.12 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 10.3 p -152.12 128.81 10.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.885 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 33.2 mt -40.41 111.81 0.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -48.65 170.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.04 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -110.52 100.03 8.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.51 116.4 31.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.851 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.87 132.22 86.63 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.605 0.717 . . . . 0.0 110.884 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 146.31 59.86 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.702 2.268 . . . . 0.0 112.337 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' PRO . . . . . 0.405 ' C ' ' SD ' ' A' ' 451' ' ' MET . 54.1 Cg_endo -69.66 -172.52 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.62 2.213 . . . . 0.0 112.37 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 451' ' ' MET . . . . . 0.405 ' SD ' ' C ' ' A' ' 450' ' ' PRO . 0.5 OUTLIER -125.92 89.61 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.937 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -82.3 39.89 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 10.6 t 64.67 35.88 8.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -87.53 -69.06 1.3 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 2.11 3.88 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.662 2.242 . . . . 0.0 112.312 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 6.2 t 73.35 50.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 2.7 t -80.4 -32.47 37.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.863 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 2.3 m -104.13 42.88 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.0 110.85 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 13.2 t -108.67 147.42 31.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 160.55 -171.75 36.78 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.551 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 93.6 p -144.64 127.76 16.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.346 . . . . 0.0 110.849 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 2.2 t -97.35 85.58 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.813 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -155.84 124.38 1.47 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.503 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -109.12 79.47 1.17 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.592 0.71 . . . . 0.0 110.869 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 2.64 3.35 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.65 2.234 . . . . 0.0 112.313 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 73.95 48.57 0.13 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.789 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -150.62 114.22 4.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.79 48.67 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 93.9 p -85.91 76.37 9.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.863 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -164.5 -179.77 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.7 82.37 2.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 361' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 423' ' ' ALA . 3.8 p -96.8 6.75 48.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -108.86 158.71 17.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.468 ' CG1' ' HB ' ' A' ' 415' ' ' VAL . 28.9 pt -125.84 142.33 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -103.09 116.32 32.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.957 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 9.3 t -101.73 144.21 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.123 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -149.06 120.13 7.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.01 20.25 1.33 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.454 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.454 HD13 HD11 ' A' ' 377' ' ' LEU . 90.9 mt -79.94 154.53 28.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.808 0.337 . . . . 0.0 110.965 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -77.61 -178.53 5.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.69 3.5 52.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.405 ' HB3' HE22 ' A' ' 436' ' ' GLN . 3.0 t -118.83 15.72 13.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.859 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.524 HG23 ' CE2' ' A' ' 435' ' ' PHE . 9.3 p -77.13 136.15 25.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 34.0 p -121.48 157.16 31.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.14 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.704 HD11 ' HG2' ' A' ' 396' ' ' PRO . 21.8 tp -53.75 -65.99 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -45.47 -32.75 2.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.21 -32.34 64.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.749 HD12 HD11 ' A' ' 400' ' ' ILE . 27.8 mt -82.59 -31.11 29.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.918 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -71.03 -44.93 64.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.107 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -72.57 -18.63 61.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -92.62 -41.6 10.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.957 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.3 m-85 -73.6 -25.01 60.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -67.06 -6.84 18.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.982 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -56.04 -60.19 3.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 35.2 t -49.46 -64.45 0.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.907 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -143.98 -122.55 1.64 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.451 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 69.0 t -121.79 122.04 65.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 0.0 111.131 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 81.8 t -77.53 127.75 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.226 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.472 ' CD ' ' HA ' ' A' ' 418' ' ' GLU . 33.2 tptt -46.09 103.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 73.0 mmm -103.32 126.33 50.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -51.43 145.7 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.92 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -94.59 -20.81 19.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -97.38 -45.47 6.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 25.0 p -90.72 -25.26 20.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 68.98 29.47 72.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -117.9 153.76 51.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.644 0.735 . . . . 0.0 110.927 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.704 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.0 Cg_endo -69.72 144.11 53.17 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.68 2.253 . . . . 0.0 112.379 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.435 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 15.2 mmt -82.1 40.26 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.625 HG12 HG22 ' A' ' 415' ' ' VAL . 96.4 mt -96.06 141.42 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.158 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -122.03 139.48 53.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.749 HD11 HD12 ' A' ' 377' ' ' LEU . 61.2 mt -132.08 94.48 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.126 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -61.29 130.11 44.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 409' ' ' PRO . 35.8 mt -114.36 136.82 52.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.861 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 407' ' ' GLY . 6.4 t0 -56.83 126.52 27.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.812 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.57 -1.15 17.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -92.02 -36.74 13.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 31.2 p -123.57 -33.6 3.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 101.64 -1.52 52.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.524 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -84.27 152.93 62.15 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.612 0.72 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.583 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.2 Cg_endo -69.76 92.42 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.306 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.48 ' C ' ' O ' ' A' ' 409' ' ' PRO . 8.1 ptmt -31.82 -51.99 0.23 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.86 -15.6 0.8 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.531 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -88.23 151.64 22.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -164.29 172.04 14.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.1 p -140.21 141.3 35.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.12 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.824 HG21 ' CD2' ' A' ' 381' ' ' PHE . 58.0 t -128.29 113.63 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.076 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' SER . . . . . 0.435 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 2.1 m -87.48 119.25 27.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.558 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 37.2 m-85 -91.55 159.02 16.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.959 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 418' ' ' GLU . . . . . 0.472 ' HA ' ' CD ' ' A' ' 388' ' ' LYS . 15.9 mm-40 -58.2 -60.88 3.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.524 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.2 m-20 -113.69 156.9 42.96 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.568 0.699 . . . . 0.0 110.899 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.4 Cg_exo -57.01 -42.89 59.36 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.626 2.217 . . . . 0.0 112.323 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.5 Cg_exo -52.46 -41.99 64.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.727 2.285 . . . . 0.0 112.351 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 39.3 m -67.36 -40.82 85.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.167 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -62.18 -49.8 74.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.06 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.578 ' HG2' HD11 ' A' ' 444' ' ' LEU . 43.3 mtpt -60.15 -36.14 76.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.55 -33.05 58.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.115 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 417' ' ' TYR . . . -72.43 -33.24 66.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 423' ' ' ALA . 86.1 t -57.33 -62.06 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.179 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -68.12 -11.35 58.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.549 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.62 -54.81 5.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.846 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.7 m-85 -87.76 -19.6 27.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.4 t0 -54.15 89.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 116.46 13.99 7.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.533 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.472 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 2.4 mmmp? -79.44 176.2 9.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 0.0 110.903 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -121.36 126.9 50.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.781 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.2 t80 -126.24 105.53 8.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' GLN . . . . . 0.405 HE22 ' HB3' ' A' ' 371' ' ' SER . 28.4 mt-30 62.58 31.01 17.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 83.94 18.38 63.38 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.527 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 19.4 m -128.6 126.67 40.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.969 0.414 . . . . 0.0 110.862 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.9 138.07 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.781 HD11 ' HB2' ' A' ' 435' ' ' PHE . 10.0 mt -108.89 147.49 32.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -119.37 108.5 14.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.846 HG21 ' HB2' ' A' ' 430' ' ' PHE . 13.0 t -100.85 132.2 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 9.5 p -151.7 127.54 10.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.806 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.719 ' HG ' HG21 ' A' ' 427' ' ' VAL . 16.4 mt -45.76 113.9 0.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.891 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.41 109.38 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.053 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 446' ' ' ARG . 21.7 ttm105 -110.79 -56.03 2.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 22.3 tttm 56.89 31.6 19.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 38.9 tttt -129.76 134.79 26.59 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.607 0.718 . . . . 0.0 110.886 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 148.41 65.05 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.697 2.265 . . . . 0.0 112.334 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 175.38 8.16 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.701 2.267 . . . . 0.0 112.343 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.59 -176.66 3.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.933 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -109.81 109.5 20.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.916 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 21.2 m -161.12 122.97 3.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -89.63 151.54 21.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.412 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.73 -10.34 28.34 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.642 2.228 . . . . 0.0 112.352 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 37.1 m -71.79 168.5 17.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.849 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 2.7 m -56.81 103.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.793 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.257 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.456 179.984 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 347' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 346' ' ' GLY . 3.8 m -36.4 123.06 0.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.906 0.384 . . . . 0.0 110.84 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 93.4 p -127.76 106.5 9.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.834 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 142.49 -146.5 17.46 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.464 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 29.0 t -109.79 109.28 19.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.006 0.431 . . . . 0.0 110.886 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 3.8 m -51.46 -56.04 15.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.848 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 162.17 -50.54 0.33 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.47 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -110.25 80.91 2.04 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.707 . . . . 0.0 110.868 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.66 1.16 4.62 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.737 2.291 . . . . 0.0 112.327 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.86 94.1 1.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.825 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -50.9 108.58 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -100.88 -43.54 6.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 30.2 p -107.27 90.06 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -104.26 104.75 14.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -145.0 114.81 7.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.857 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 417' ' ' TYR . 8.5 p -121.97 44.17 2.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -146.99 169.24 19.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.068 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.693 HD12 ' CG1' ' A' ' 442' ' ' VAL . 37.0 pt -144.96 142.68 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -101.1 113.11 25.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.979 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 19.3 t -96.19 144.22 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.123 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -150.23 119.55 6.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.4 23.38 1.01 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.574 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 71.6 mt -83.72 152.71 24.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 0.0 110.887 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' ASN . . . . . 0.505 ' ND2' ' CD ' ' A' ' 436' ' ' GLN . 5.0 p30 -74.61 179.34 4.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.41 1.08 52.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 14.3 m -117.29 13.65 14.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.845 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.37 133.59 31.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.129 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 81.6 p -117.56 163.98 15.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.149 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.766 HD11 ' HG2' ' A' ' 396' ' ' PRO . 16.3 tp -58.9 -62.77 1.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.08 -38.37 7.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.92 -31.8 73.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.55 HD12 HD11 ' A' ' 400' ' ' ILE . 84.5 mt -86.97 -30.32 21.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.959 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.17 -33.76 65.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.081 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.425 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 8.4 t70 -84.6 -19.4 33.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -91.92 -50.89 5.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.979 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 20.0 m-85 -61.72 -23.6 66.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.876 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.425 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 30.3 pttt -72.65 -6.95 47.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.865 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -55.11 -51.91 64.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 7.3 t -62.79 -64.75 0.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -134.82 -129.87 2.93 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.49 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 50.3 t -122.07 129.11 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.808 0.337 . . . . 0.0 111.178 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.85 128.43 38.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -52.42 105.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.845 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 73.9 mmm -101.22 123.75 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.409 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 11.5 t-20 -50.1 147.27 4.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.844 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -94.71 -18.28 21.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' ARG . . . . . 0.456 ' HG3' HG23 ' A' ' 393' ' ' THR . 19.6 ptt180 -99.71 -44.22 6.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.456 HG23 ' HG3' ' A' ' 392' ' ' ARG . 67.0 p -93.53 -17.12 23.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 60.69 26.67 65.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.514 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -115.37 153.04 47.53 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.581 0.705 . . . . 0.0 110.942 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.766 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.5 Cg_endo -69.7 146.66 61.21 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.696 2.264 . . . . 0.0 112.362 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.407 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 6.8 mmt -81.37 41.15 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.926 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.466 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 90.6 mt -98.96 135.02 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.137 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -114.77 138.08 51.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.55 HD11 HD12 ' A' ' 377' ' ' LEU . 60.7 mt -130.79 94.2 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.163 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -61.78 123.82 19.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.545 HD23 ' HA ' ' A' ' 409' ' ' PRO . 45.3 mt -110.19 135.93 50.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 407' ' ' GLY . 11.1 t70 -55.42 124.37 16.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.932 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -73.09 -1.05 15.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -95.08 -35.12 12.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 37.2 p -121.24 -36.13 3.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.079 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 103.21 -6.99 51.21 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.551 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -82.55 153.04 67.87 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.592 0.71 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.545 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.8 Cg_endo -69.69 94.51 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.7 2.267 . . . . 0.0 112.372 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -32.58 -50.15 0.24 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.817 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 150.14 -15.3 1.01 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.468 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -88.15 154.99 20.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.777 0.322 . . . . 0.0 110.927 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.05 170.93 10.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.121 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 2.5 p -137.91 142.04 40.62 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.167 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.852 HG21 ' CD2' ' A' ' 381' ' ' PHE . 47.3 t -127.81 115.25 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' SER . . . . . 0.407 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 1.9 m -92.65 114.97 27.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.493 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 54.2 m-85 -89.05 163.39 15.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.974 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -56.24 -65.49 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.517 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 4.7 m-20 -115.78 156.56 46.24 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.731 . . . . 0.0 110.842 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.2 Cg_exo -57.37 -42.89 57.11 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.636 2.224 . . . . 0.0 112.366 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.0 Cg_exo -50.69 -26.98 18.49 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.625 2.217 . . . . 0.0 112.361 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 52.9 m -89.05 -43.17 11.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.71 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -58.87 -48.13 82.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.522 ' HG2' HD11 ' A' ' 444' ' ' LEU . 7.9 mtmp? -59.86 -38.47 82.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.888 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.0 -32.83 63.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.079 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.73 -31.95 68.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 423' ' ' ALA . 90.5 t -56.32 -60.69 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.082 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -67.06 -12.45 59.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.554 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.53 -54.6 5.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.826 ' HB2' HG21 ' A' ' 442' ' ' VAL . 88.9 m-85 -88.26 -14.56 38.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.88 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.7 OUTLIER -58.49 93.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 108.1 14.72 16.06 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.466 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.413 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 15.7 mmtm -73.92 169.67 16.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.76 0.315 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -112.28 112.92 24.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.566 ' HB3' HD21 ' A' ' 440' ' ' LEU . 4.4 t80 -115.47 106.48 14.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' GLN . . . . . 0.505 ' CD ' ' ND2' ' A' ' 369' ' ' ASN . 20.4 mt-30 61.59 38.56 15.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.968 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 84.49 -14.53 45.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.5 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 6.1 m -94.25 168.92 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.815 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -106.62 135.95 47.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 435' ' ' PHE . 9.4 mt -102.69 145.05 30.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -119.78 107.39 13.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.832 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.826 HG21 ' HB2' ' A' ' 430' ' ' PHE . 6.3 t -103.08 136.26 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.1 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 443' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 444' ' ' LEU . 22.0 m -157.3 126.38 5.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.522 HD11 ' HG2' ' A' ' 424' ' ' LYS . 19.4 mt -35.03 123.75 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -61.79 129.69 42.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.067 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 46.5 mmt-85 61.64 42.01 11.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -76.21 148.45 37.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' LYS . . . . . 0.484 ' CD ' ' HD2' ' A' ' 449' ' ' PRO . 1.9 tppp? -68.69 136.38 90.31 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 0.0 110.886 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.484 ' HD2' ' CD ' ' A' ' 448' ' ' LYS . 53.8 Cg_endo -69.7 129.51 17.78 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.745 2.297 . . . . 0.0 112.326 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -170.44 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.709 2.273 . . . . 0.0 112.343 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 72.6 mmm -114.22 96.38 5.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -57.21 98.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 8.3 t -111.99 145.3 39.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -135.34 -94.76 0.46 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.549 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 108.73 2.14 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.623 2.215 . . . . 0.0 112.377 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 73.9 m -95.46 119.69 34.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.833 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.4 t -80.34 115.62 19.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.466 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.25 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 53.4 m -138.39 135.32 35.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.901 0.381 . . . . 0.0 110.935 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 90.1 p -159.42 162.66 35.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -79.5 104.2 2.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.535 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 32.0 t -149.05 105.87 3.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.865 0.364 . . . . 0.0 110.872 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 78.9 p -94.91 -46.23 6.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 145.71 98.58 0.24 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.483 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.57 150.36 97.88 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.631 0.729 . . . . 0.0 110.847 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 138.57 38.1 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.708 2.272 . . . . 0.0 112.397 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -70.39 98.19 1.38 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -48.35 158.51 0.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -54.49 -53.48 53.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 99.2 p -129.87 156.48 44.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.793 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.7 44.29 1.78 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.865 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -51.86 99.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.951 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.7 m -93.95 42.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.863 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -145.68 156.73 43.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.105 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.468 ' HB ' ' CG1' ' A' ' 442' ' ' VAL . 44.8 pt -128.67 140.12 50.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -98.75 111.36 23.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.918 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 13.0 t -95.19 140.09 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.148 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -147.39 122.4 10.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 131.81 6.07 3.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.517 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.487 HD13 HD11 ' A' ' 377' ' ' LEU . 19.8 mt -71.99 156.42 39.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.871 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' ASN . . . . . 0.603 ' H ' ' ND2' ' A' ' 369' ' ' ASN . 0.3 OUTLIER -83.88 175.37 9.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -83.61 7.45 17.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.5 t -116.92 3.51 12.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.405 HG21 HD22 ' A' ' 368' ' ' LEU . 5.0 p -75.05 134.61 29.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.083 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 41.1 p -113.59 170.69 8.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.155 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.709 HD11 ' HG2' ' A' ' 396' ' ' PRO . 12.0 tp -65.93 -65.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -45.59 -26.58 0.62 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -73.41 -36.39 65.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.828 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.487 HD11 HD13 ' A' ' 368' ' ' LEU . 81.1 mt -87.32 -25.48 23.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.6 -35.3 72.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -89.15 -15.04 34.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -92.53 -42.58 9.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.918 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 20.3 m-85 -72.49 -22.19 61.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 2.7 ptmm? -68.87 -5.05 18.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -56.13 -59.99 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 4.1 t -52.8 -64.26 0.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -139.05 -123.43 2.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.445 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 92.8 t -125.53 131.41 72.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 111.099 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 64.7 t -82.52 122.36 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -47.06 110.39 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' MET . . . . . 0.478 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 27.9 mtp -107.94 128.75 54.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.879 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -54.83 147.6 14.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 391' ' ' LYS . 0.0 OUTLIER -94.63 -14.25 25.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 392' ' ' ARG . . . . . 0.445 ' HG3' HG23 ' A' ' 393' ' ' THR . 14.9 ptm180 -101.09 -46.5 5.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.836 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.445 HG23 ' HG3' ' A' ' 392' ' ' ARG . 67.3 p -91.76 -19.28 22.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.118 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.478 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 64.89 19.9 66.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.464 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -107.64 152.65 41.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 0.0 110.917 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.709 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.7 Cg_endo -69.81 147.41 62.47 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.66 2.24 . . . . 0.0 112.38 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 11.0 mmt -81.36 41.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.477 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 91.8 mt -98.63 135.97 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' HIS . . . . . 0.42 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 7.3 t60 -115.59 138.07 51.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.827 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 67.0 mt -134.41 94.0 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.095 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -59.63 122.34 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.931 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' A' ' 409' ' ' PRO . 49.0 mt -106.76 136.35 46.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.939 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 407' ' ' GLY . 1.5 t70 -55.14 125.93 22.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -73.1 -1.24 16.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.441 ' CG ' ' OD1' ' A' ' 403' ' ' ASP . 3.4 mm-40 -96.48 -36.59 10.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 34.6 p -119.74 -35.22 3.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 100.25 -1.02 56.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.507 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -86.8 155.95 55.7 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.597 0.713 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.53 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.9 Cg_endo -69.75 91.3 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.72 2.28 . . . . 0.0 112.272 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.482 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -31.49 -48.45 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.864 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 148.95 -10.63 1.03 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -95.35 154.53 17.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 0.0 110.828 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -168.39 171.47 9.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.13 128.63 20.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.896 HG21 ' CD2' ' A' ' 381' ' ' PHE . 62.5 t -112.3 118.38 57.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 3.2 m -92.59 116.08 28.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.849 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.541 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 52.9 m-85 -89.74 160.3 16.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -57.5 -63.97 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.509 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.7 m-20 -115.59 156.66 45.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.625 0.726 . . . . 0.0 110.845 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.8 Cg_exo -57.4 -43.02 55.66 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.705 2.27 . . . . 0.0 112.3 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 61.7 Cg_exo -48.68 -29.43 14.44 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 90.7 m -88.58 -39.45 14.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.133 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.58 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -61.5 -50.23 73.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -60.08 -38.5 83.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.98 -31.29 61.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.104 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.421 ' CB ' ' CE2' ' A' ' 417' ' ' TYR . . . -70.04 -33.81 72.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.156 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 423' ' ' ALA . 76.3 t -55.85 -64.11 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.157 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -64.99 -12.58 51.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.534 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.3 t-105 -80.16 -54.64 5.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.77 ' HB2' HG21 ' A' ' 442' ' ' VAL . 90.9 m-85 -89.47 -14.1 36.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.7 t0 -58.15 99.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.768 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 99.79 22.85 11.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.53 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.447 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 19.9 mmtt -78.72 167.92 20.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.794 0.33 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 4.3 p-10 -110.7 108.29 18.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.792 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.738 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.6 t80 -115.42 108.33 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.82 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 61.28 36.94 17.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 75.2 21.17 78.44 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.555 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 72.1 m -130.85 129.69 42.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.908 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -70.27 136.56 49.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.738 HD11 ' HB2' ' A' ' 435' ' ' PHE . 8.0 mt -104.66 157.41 17.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.894 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -130.39 106.01 8.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.77 HG21 ' HB2' ' A' ' 430' ' ' PHE . 10.2 t -103.1 133.06 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.106 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 84.7 p -150.04 132.21 15.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.441 ' HG ' HG21 ' A' ' 427' ' ' VAL . 24.3 mt -44.42 116.46 1.04 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.902 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -50.36 115.65 1.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.193 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 22.5 ttt-85 -129.27 106.28 8.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.46 24.57 5.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -107.56 136.79 19.59 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.535 0.683 . . . . 0.0 110.91 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' PRO . . . . . 0.453 ' HA ' ' HD2' ' A' ' 450' ' ' PRO . 53.7 Cg_endo -69.87 110.35 2.56 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.643 2.229 . . . . 0.0 112.333 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 450' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 449' ' ' PRO . 53.9 Cg_endo -69.72 -22.13 32.68 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.666 2.244 . . . . 0.0 112.358 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -134.62 134.02 40.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -82.36 -48.64 10.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 94.7 p -126.55 -43.16 1.76 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.776 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -165.89 179.83 39.89 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.504 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -7.84 22.07 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.666 2.244 . . . . 0.0 112.383 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 3.2 m -65.5 128.96 38.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 4.6 t -118.92 120.76 38.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.505 -179.973 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 8.4 t -82.38 101.41 10.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.372 . . . . 0.0 110.844 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 96.9 p -107.29 118.07 35.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.919 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -156.89 82.11 0.16 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.2 t -89.2 106.07 18.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.906 0.384 . . . . 0.0 110.836 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 95.0 p -105.85 -34.37 7.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.863 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 78.11 178.55 49.32 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -154.1 120.52 2.82 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.649 0.737 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -30.42 22.12 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.691 2.261 . . . . 0.0 112.358 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -94.24 122.83 37.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.833 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.99 -9.36 22.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.892 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.26 171.94 12.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 73.5 m 61.39 44.99 8.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.757 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -38.81 102.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.11 72.54 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.4 m -89.0 38.45 0.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.858 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -140.25 155.83 46.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.102 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.768 HD12 ' CG1' ' A' ' 442' ' ' VAL . 31.4 pt -128.85 143.48 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.102 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.69 123.35 44.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.943 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 11.3 t -107.45 139.34 29.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.135 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -145.79 122.87 11.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 128.63 11.11 3.06 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.518 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.423 HD22 HG21 ' A' ' 372' ' ' VAL . 30.6 mt -70.98 155.84 40.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.798 0.332 . . . . 0.0 110.921 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 369' ' ' ASN . . . . . 0.402 ' CG ' ' CD ' ' A' ' 436' ' ' GLN . 6.6 p30 -78.2 174.46 11.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.68 14.53 5.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.4 t -131.71 19.57 4.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.831 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.423 HG21 HD22 ' A' ' 368' ' ' LEU . 8.2 p -82.69 130.15 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.133 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 58.8 p -110.44 156.69 20.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.141 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.978 HD11 ' HG2' ' A' ' 396' ' ' PRO . 9.1 tp -54.46 -54.16 44.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -54.57 -35.13 62.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -69.88 -28.49 65.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.754 HD12 HD11 ' A' ' 400' ' ' ILE . 60.2 mt -89.42 -29.06 19.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -71.67 -38.48 70.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.436 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 8.9 t70 -82.56 -17.37 45.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -92.67 -41.73 10.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.943 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 15.2 m-85 -71.95 -16.91 62.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.436 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 9.5 ptpt -77.79 -6.59 54.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -55.74 -50.28 70.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.0 t -62.14 -60.84 3.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.91 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -142.65 -126.46 2.08 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.82 128.81 75.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 0.0 111.195 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 84.2 t -84.9 130.05 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.099 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -54.8 113.29 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' MET . . . . . 0.501 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 43.7 mmm -109.74 123.63 49.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -49.55 144.15 6.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -94.75 -8.39 37.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -101.9 -46.82 4.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 35.0 p -97.42 -16.63 20.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.101 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.501 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 65.6 26.66 72.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.568 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -112.43 152.95 44.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.557 0.694 . . . . 0.0 110.967 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.978 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.6 Cg_endo -69.69 149.12 66.91 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.74 2.293 . . . . 0.0 112.333 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 7.0 mmt -82.69 38.09 0.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.469 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 91.8 mt -95.98 140.97 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.158 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' HIS . . . . . 0.408 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 5.5 t60 -121.5 138.01 54.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.754 HD11 HD12 ' A' ' 377' ' ' LEU . 61.6 mt -131.1 93.83 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.076 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -59.44 124.4 19.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.965 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 409' ' ' PRO . 35.1 mt -107.9 137.16 46.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.891 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 407' ' ' GLY . 8.1 t0 -55.46 123.92 15.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -71.2 -1.12 11.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -96.08 -39.1 9.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 33.0 p -117.31 -35.43 4.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 101.23 -1.65 54.35 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.446 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -85.94 155.55 58.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.646 0.736 . . . . 0.0 110.856 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.533 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.1 Cg_endo -69.76 90.95 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.702 2.268 . . . . 0.0 112.279 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.482 ' C ' ' O ' ' A' ' 409' ' ' PRO . 2.3 ptmt -31.73 -53.89 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 155.01 -15.96 0.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.507 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -88.9 156.99 18.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.769 0.319 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -168.93 175.23 5.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.14 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.56 132.71 23.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.147 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.92 HG21 ' CD2' ' A' ' 381' ' ' PHE . 38.8 t -118.87 113.3 41.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.168 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 2.6 m -89.54 116.78 27.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.487 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 57.7 m-85 -93.04 164.18 13.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -56.84 -66.46 0.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.939 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.52 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.4 m-20 -114.54 156.97 43.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.614 0.721 . . . . 0.0 110.83 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.34 -42.97 56.48 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.634 2.223 . . . . 0.0 112.355 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.1 Cg_exo -50.53 -27.19 18.35 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.652 2.235 . . . . 0.0 112.412 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 29.4 m -87.91 -42.36 12.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.843 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -60.44 -41.42 93.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.113 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.469 ' HG2' HD11 ' A' ' 444' ' ' LEU . 35.9 mtpt -65.77 -38.36 88.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.38 -30.89 62.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.138 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -72.1 -30.78 65.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 423' ' ' ALA . 64.0 t -58.74 -63.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.144 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -64.23 -13.21 47.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.523 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.3 t-105 -80.08 -54.65 5.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.919 ' HB2' HG21 ' A' ' 442' ' ' VAL . 79.3 m-85 -87.56 -14.06 41.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.4 t70 -61.51 95.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 117.8 -19.05 11.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.496 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.422 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 2.5 mmmp? -47.88 176.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.764 0.316 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -124.53 130.4 52.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.811 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.631 ' HB2' HD11 ' A' ' 440' ' ' LEU . 1.1 t80 -129.75 107.27 9.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' GLN . . . . . 0.402 ' CD ' ' CG ' ' A' ' 369' ' ' ASN . 26.8 mt-30 61.8 32.53 18.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 81.12 19.53 66.89 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.465 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 12.2 m -128.11 129.31 46.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.911 0.386 . . . . 0.0 110.844 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -68.67 134.52 49.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 435' ' ' PHE . 22.1 mt -100.81 143.07 31.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -119.37 101.81 8.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.919 HG21 ' HB2' ' A' ' 430' ' ' PHE . 14.0 t -99.27 129.8 49.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.143 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.5 m -154.21 128.46 9.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.866 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.469 HD11 ' HG2' ' A' ' 424' ' ' LYS . 28.6 mt -40.41 132.06 2.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.967 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -76.23 109.89 10.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.071 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -146.69 109.64 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -155.48 111.6 3.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -127.51 150.45 72.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.554 0.692 . . . . 0.0 110.856 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.88 167.2 25.28 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.637 2.225 . . . . 0.0 112.267 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 451' ' ' MET . 54.1 Cg_endo -69.79 2.94 3.09 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.683 2.255 . . . . 0.0 112.276 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 451' ' ' MET . . . . . 0.449 ' C ' ' O ' ' A' ' 450' ' ' PRO . 7.5 mmt -34.44 -47.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.933 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -104.78 137.77 42.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.818 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 7.6 t -137.72 129.63 28.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -148.72 -94.45 0.13 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.498 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 129.3 17.36 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.671 2.247 . . . . 0.0 112.34 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 38.4 m -120.36 148.21 44.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.785 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 91.8 p -125.88 -43.16 1.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.813 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.525 -179.942 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 1.6 t -148.24 115.92 6.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.907 0.384 . . . . 0.0 110.926 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 20.1 t -54.47 147.89 13.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.914 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -176.45 40.47 0.1 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.507 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 76.4 p -59.53 160.66 6.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.858 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 28.2 p -117.46 -56.31 2.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.858 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 83.07 148.54 7.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.491 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -111.5 85.21 5.64 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.634 0.731 . . . . 0.0 110.919 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.61 62.88 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.663 2.242 . . . . 0.0 112.373 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -144.48 162.94 35.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -43.49 141.08 1.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 49.75 41.81 22.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.813 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 20.3 t -44.33 110.35 0.21 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -91.84 111.84 23.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -133.15 102.35 5.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.3 m -90.2 37.68 0.9 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -137.39 164.78 27.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.485 HD12 ' CG1' ' A' ' 442' ' ' VAL . 36.7 pt -138.32 142.22 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.11 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -102.52 115.25 30.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.977 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.938 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 12.1 t -101.35 142.59 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -150.55 122.29 8.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 133.16 6.82 2.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.455 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.46 HD23 HD22 ' A' ' 440' ' ' LEU . 28.2 mt -72.82 156.4 38.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.812 0.339 . . . . 0.0 110.954 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.62 179.86 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.81 6.1 33.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.78 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 10.9 t -114.23 4.21 15.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.839 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.486 HG21 HD21 ' A' ' 377' ' ' LEU . 6.2 p -76.1 139.06 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.107 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 68.9 p -122.21 173.88 7.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.755 HD11 ' HG2' ' A' ' 396' ' ' PRO . 14.9 tp -67.29 -63.3 1.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -47.64 -28.63 2.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.909 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.07 -32.6 56.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.523 HD12 HD11 ' A' ' 400' ' ' ILE . 48.4 mt -84.78 -27.94 26.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.872 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.77 -37.29 65.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.431 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 21.7 t0 -78.75 -20.25 50.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -92.69 -51.31 5.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.938 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 15.9 m-85 -60.01 -24.64 64.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.431 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -71.27 -15.08 62.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.894 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -45.35 -53.58 8.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 38.3 t -59.23 -69.0 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.14 -124.99 2.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.47 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 67.1 t -124.73 135.25 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.921 0.391 . . . . 0.0 111.113 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.16 131.57 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -55.8 111.74 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.955 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' MET . . . . . 0.434 ' SD ' ' CA ' ' A' ' 396' ' ' PRO . 64.7 mmm -106.8 121.72 44.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -48.3 148.15 2.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -94.77 -19.16 20.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -96.78 -46.67 6.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.816 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 37.1 p -91.09 -21.7 21.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 65.6 27.93 73.1 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.507 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -117.18 153.24 49.77 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.532 0.682 . . . . 0.0 110.932 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.755 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.2 Cg_endo -69.79 146.99 61.64 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.694 2.262 . . . . 0.0 112.293 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.419 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.5 mmt -81.17 41.47 0.6 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.466 HG12 HG22 ' A' ' 415' ' ' VAL . 96.7 mt -99.27 135.93 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.18 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 399' ' ' HIS . . . . . 0.434 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 6.0 t60 -115.5 141.03 48.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.523 HD11 HD12 ' A' ' 377' ' ' LEU . 67.6 mt -134.12 93.72 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -59.71 122.35 13.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.539 HD23 ' HA ' ' A' ' 409' ' ' PRO . 45.0 mt -107.57 136.4 47.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.889 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 407' ' ' GLY . 2.0 t70 -55.19 133.63 49.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.09 -6.54 57.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -97.46 -22.88 16.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 69.5 p -128.17 -36.06 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 94.8 0.54 64.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.507 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -90.7 156.93 44.6 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.615 0.721 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.539 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.3 Cg_endo -69.73 89.38 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 0.0 112.392 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.489 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.1 OUTLIER -30.54 -54.74 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 156.77 -15.27 0.36 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.482 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -91.22 153.53 19.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.909 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -166.87 174.85 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.083 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 3.0 p -141.78 143.37 33.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.154 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.827 HG21 ' CD2' ' A' ' 381' ' ' PHE . 45.3 t -130.69 119.87 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' SER . . . . . 0.419 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 2.1 m -94.66 114.01 25.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 50.4 m-85 -86.8 162.32 17.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.41 -65.5 0.6 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.522 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 4.5 m-20 -115.5 157.72 43.44 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.669 0.747 . . . . 0.0 110.843 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.2 Cg_exo -57.16 -43.11 56.2 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.617 2.212 . . . . 0.0 112.371 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.4 Cg_exo -50.81 -29.37 26.13 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.648 2.232 . . . . 0.0 112.369 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 40.9 m -86.26 -39.27 16.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.185 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.504 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -62.3 -53.95 47.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.093 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.641 ' HG2' HD11 ' A' ' 444' ' ' LEU . 32.6 mtmt -56.51 -33.94 66.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.81 -32.07 52.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.063 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -72.1 -33.81 68.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.084 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.515 HG21 ' HG ' ' A' ' 444' ' ' LEU . 77.8 t -55.17 -61.58 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -66.59 -12.79 59.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.548 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.76 -54.31 5.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.851 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.3 m-85 -88.75 -18.01 28.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.835 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.6 t70 -52.93 97.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 100.95 23.56 9.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.503 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.451 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 25.0 mmtt -76.5 175.87 8.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.32 . . . . 0.0 110.906 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.39 112.33 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.684 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -108.12 98.61 8.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.886 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 61.04 35.25 18.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 96.37 -21.55 44.87 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.45 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.2 p -82.55 152.77 25.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.976 0.417 . . . . 0.0 110.834 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' LYS . . . . . 0.495 ' C ' HD23 ' A' ' 440' ' ' LEU . 25.8 ttpt -99.72 130.75 45.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.684 HD11 ' HB2' ' A' ' 435' ' ' PHE . 1.1 mt -105.81 144.39 32.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.954 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -122.02 107.7 12.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.851 HG21 ' HB2' ' A' ' 430' ' ' PHE . 7.1 t -100.23 135.52 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 10.0 p -155.99 130.72 9.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.816 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.641 HD11 ' HG2' ' A' ' 424' ' ' LYS . 19.2 mt -43.99 111.37 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.887 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 444' ' ' LEU . . . -35.34 -65.6 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -61.5 113.95 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -86.18 123.72 31.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.967 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -106.82 134.12 19.98 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.595 0.712 . . . . 0.0 110.921 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 164.87 32.94 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.68 2.253 . . . . 0.0 112.383 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -6.54 18.85 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.628 2.219 . . . . 0.0 112.357 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 2.0 ttt -47.51 99.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.801 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -150.51 143.28 24.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.942 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 28.7 t -161.59 153.23 18.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.856 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -162.31 -94.81 0.1 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.551 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 107.98 1.99 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.628 2.219 . . . . 0.0 112.396 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 91.3 p -88.88 -47.27 8.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.822 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 10.0 m -58.01 112.43 1.51 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.45 -179.945 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 1.2 t -126.2 -59.25 1.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 110.919 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 44.6 m -98.76 147.27 25.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -156.87 127.18 1.9 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.449 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 53.8 p -74.53 154.4 38.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.881 0.372 . . . . 0.0 110.887 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 37.0 p -132.74 158.8 41.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.927 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -123.61 -40.62 0.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.539 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.71 132.0 78.24 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.651 0.739 . . . . 0.0 110.917 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 170.46 16.49 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.713 2.275 . . . . 0.0 112.33 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -95.66 122.67 38.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.946 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -98.06 86.2 3.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.847 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 45.45 41.64 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.834 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 69.5 m -116.76 90.67 3.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -102.32 88.69 3.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -125.16 79.02 1.76 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 4.1 p -87.19 23.73 1.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -123.39 156.7 34.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.153 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.43 ' CG1' ' HB ' ' A' ' 415' ' ' VAL . 29.4 pt -126.08 142.74 41.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.085 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -104.5 111.68 24.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.994 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 1.033 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 8.5 t -95.7 141.09 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.148 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -145.67 120.3 9.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.1 19.95 1.51 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.479 HD13 HD11 ' A' ' 377' ' ' LEU . 90.3 mt -78.68 151.74 32.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.768 0.318 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -74.68 -176.36 2.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.23 4.62 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.5 t -120.32 17.67 12.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.3 p -80.64 136.72 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.178 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 77.5 p -121.3 162.47 20.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.134 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.876 HD11 ' HG2' ' A' ' 396' ' ' PRO . 17.8 tp -57.28 -66.1 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -45.98 -30.19 1.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.95 -34.04 66.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.83 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.551 HD12 HD11 ' A' ' 400' ' ' ILE . 54.1 mt -85.5 -28.99 24.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.853 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.64 -28.88 62.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.414 ' HA ' ' NZ ' ' A' ' 382' ' ' LYS . 10.4 t70 -84.99 -22.34 29.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.437 ' CE2' ' CD1' ' A' ' 430' ' ' PHE . 68.0 t80 -92.63 -48.14 6.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 1.033 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 17.7 m-85 -62.57 -21.02 65.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.414 ' NZ ' ' HA ' ' A' ' 379' ' ' ASP . 2.0 ptpp? -78.19 -4.57 48.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -56.05 -57.92 10.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.947 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' CYS . . . . . 0.567 ' SG ' ' CE3' ' A' ' 429' ' ' TRP . 1.9 t -56.38 -64.63 0.8 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.68 -127.22 2.74 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.409 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 77.3 t -125.87 131.51 71.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.897 0.38 . . . . 0.0 111.183 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 57.3 t -84.55 128.44 38.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -51.04 105.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' A' ' 396' ' ' PRO . 64.1 mmm -101.55 122.13 43.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -46.52 145.65 1.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -94.39 -21.58 18.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -96.25 -46.93 6.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 30.2 p -88.94 -26.63 21.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 70.25 32.08 68.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.477 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -121.07 153.66 57.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.586 0.707 . . . . 0.0 110.95 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.876 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.3 Cg_endo -69.8 145.15 56.05 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.677 2.251 . . . . 0.0 112.276 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.448 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 7.0 mmt -81.52 41.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.827 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.548 HG12 HG22 ' A' ' 415' ' ' VAL . 94.4 mt -97.97 142.75 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.156 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -120.98 141.34 50.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.551 HD11 HD12 ' A' ' 377' ' ' LEU . 60.1 mt -134.91 94.73 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.189 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -62.44 127.41 31.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 409' ' ' PRO . 37.0 mt -112.11 134.56 53.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.878 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 407' ' ' GLY . 13.1 t0 -55.43 120.21 6.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.856 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -1.98 8.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -88.0 -39.67 14.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 33.4 p -121.88 -35.92 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 107.27 -0.87 35.07 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.47 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -86.53 152.56 54.87 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.53 0.681 . . . . 0.0 110.935 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.49 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.8 Cg_endo -69.71 94.82 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.748 2.299 . . . . 0.0 112.321 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 409' ' ' PRO . 8.4 ptmt -33.19 -52.02 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.883 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.65 -14.39 0.8 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -89.88 149.01 22.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.785 0.326 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -162.09 170.17 19.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.067 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.4 p -138.96 143.29 38.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.184 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.853 HG21 ' CD2' ' A' ' 381' ' ' PHE . 59.4 t -129.01 118.58 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.17 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' SER . . . . . 0.448 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 17.3 m -92.67 114.03 26.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.552 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 43.6 m-85 -86.82 165.68 15.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -61.4 -64.28 1.0 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.846 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.518 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.9 m-20 -112.63 156.68 42.04 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.672 0.749 . . . . 0.0 110.789 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.3 Cg_exo -57.11 -43.0 57.48 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.654 2.236 . . . . 0.0 112.339 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.5 Cg_exo -50.96 -43.15 49.2 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.708 2.272 . . . . 0.0 112.361 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 52.3 m -67.8 -43.22 80.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.111 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.552 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -57.2 -57.61 11.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.1 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.786 ' HG2' HD11 ' A' ' 444' ' ' LEU . 23.2 mtmm -51.89 -36.96 50.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.85 64.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.482 ' CB ' ' CE2' ' A' ' 417' ' ' TYR . . . -69.51 -30.8 68.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.052 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.568 HG21 ' HG ' ' A' ' 444' ' ' LEU . 85.0 t -58.66 -62.14 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.159 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -67.5 -9.71 44.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.567 ' CE3' ' SG ' ' A' ' 384' ' ' CYS . 1.2 t-105 -82.44 -54.16 5.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.972 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.854 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.2 m-85 -89.05 -20.96 23.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.491 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.0 OUTLIER -49.7 94.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.823 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.15 20.29 9.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.535 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.469 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 14.3 mmtm -78.11 161.47 27.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.842 0.353 . . . . 0.0 110.851 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -107.08 106.45 16.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.667 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -107.17 110.11 22.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 58.22 35.26 24.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 89.76 -18.94 44.18 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.519 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.4 m -90.35 164.21 14.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.4 . . . . 0.0 110.886 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.86 140.53 33.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 435' ' ' PHE . 11.4 mt -108.06 139.66 42.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -115.82 103.93 11.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.854 HG21 ' HB2' ' A' ' 430' ' ' PHE . 19.2 t -99.34 132.37 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.077 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 9.5 p -151.6 132.35 14.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.824 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.786 HD11 ' HG2' ' A' ' 424' ' ' LYS . 12.5 mt -48.84 105.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.868 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -40.74 132.44 2.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.104 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -113.77 81.12 1.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 4.0 ptmm? -77.65 172.91 12.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -165.37 149.69 7.63 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.597 0.713 . . . . 0.0 110.921 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 135.05 29.49 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.693 2.262 . . . . 0.0 112.33 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 165.57 30.49 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.714 2.276 . . . . 0.0 112.356 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 29.1 tpp -170.22 105.84 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -160.9 155.61 23.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 51.0 m -107.77 103.27 12.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.819 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -107.5 137.15 13.85 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.45 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -24.06 30.2 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.688 2.259 . . . . 0.0 112.398 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 20.7 m -45.57 140.66 3.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.881 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 35.8 p -88.86 172.05 9.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.803 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.487 -179.99 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.562 -0.215 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 3.8 m -121.02 -65.03 1.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 0.0 110.825 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 56.6 p -76.99 120.81 22.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -73.22 -93.3 0.11 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.511 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 20.5 m -146.62 109.69 4.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.92 0.39 . . . . 0.0 110.881 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 60.2 p -92.22 160.65 15.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -113.1 -168.61 17.14 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.483 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -142.56 141.65 21.14 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.588 0.709 . . . . 0.0 110.93 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 172.17 13.19 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.649 2.233 . . . . 0.0 112.308 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.11 149.77 21.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -119.23 40.83 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -114.45 41.47 2.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.864 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 38.2 p -166.89 133.24 2.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.22 98.38 9.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.864 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -144.62 111.79 5.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.3 m -87.2 25.05 1.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.842 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -130.92 166.68 20.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.077 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.756 HD12 HG11 ' A' ' 442' ' ' VAL . 39.8 pt -134.7 142.49 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -99.31 115.02 28.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 4.5 t -103.06 142.31 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.128 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -149.12 124.84 10.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.27 12.59 2.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.489 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.521 HD13 HD11 ' A' ' 377' ' ' LEU . 30.2 mt -77.84 156.38 30.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.9 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 369' ' ' ASN . . . . . 0.496 ' H ' ' ND2' ' A' ' 369' ' ' ASN . 0.2 OUTLIER -81.72 -179.32 7.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.945 179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.92 -2.02 58.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 39.4 t -106.14 3.14 27.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.782 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.46 ' HB ' ' ND2' ' A' ' 369' ' ' ASN . 12.2 p -69.46 144.77 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 80.7 p -127.85 170.6 12.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.16 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.853 HD11 ' HG2' ' A' ' 396' ' ' PRO . 12.1 tp -68.26 -49.69 58.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -59.74 -34.46 72.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.841 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.37 -31.41 68.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.659 HD12 HD11 ' A' ' 400' ' ' ILE . 60.0 mt -87.96 -28.09 21.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.932 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.41 -35.83 68.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.431 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 12.5 t70 -85.36 -17.92 35.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -92.31 -43.94 9.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.944 ' CD2' HG21 ' A' ' 415' ' ' VAL . 15.8 m-85 -69.9 -21.85 63.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.861 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.431 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -72.9 -9.49 58.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.947 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -50.08 -54.65 19.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 3.5 t -58.88 -65.9 0.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -135.19 -126.34 2.6 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.462 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 93.2 t -124.44 131.29 72.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.837 0.351 . . . . 0.0 111.177 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 57.0 t -82.44 126.03 39.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -49.22 107.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' MET . . . . . 0.468 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 19.5 mtp -104.47 122.3 45.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -50.73 147.07 5.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -94.59 -18.41 21.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -95.22 -47.89 6.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 37.8 p -90.36 -26.85 19.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.202 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.468 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 73.39 20.32 79.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -108.97 152.81 42.63 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.546 0.688 . . . . 0.0 110.978 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.853 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.0 Cg_endo -69.81 147.73 63.18 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.636 2.224 . . . . 0.0 112.345 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 9.5 mmt -81.52 40.96 0.6 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.469 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.1 mt -98.82 136.36 30.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -115.71 136.17 53.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.659 HD11 HD12 ' A' ' 377' ' ' LEU . 67.7 mt -132.33 93.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -59.17 124.54 20.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.522 HD23 ' HA ' ' A' ' 409' ' ' PRO . 35.1 mt -109.34 135.14 50.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.9 t0 -55.37 128.1 32.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -75.11 -1.0 21.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -93.66 -31.24 14.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.9 p -128.32 -35.89 1.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.089 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 100.57 9.92 45.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.501 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -95.7 155.62 38.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.533 0.682 . . . . 0.0 110.944 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.522 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.6 Cg_endo -69.78 89.47 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.629 2.219 . . . . 0.0 112.381 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 409' ' ' PRO . 5.1 ptmt -31.58 -53.23 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 155.64 -14.68 0.44 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -90.64 155.07 19.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.5 169.47 10.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.3 p -141.79 124.16 15.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.173 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.944 HG21 ' CD2' ' A' ' 381' ' ' PHE . 59.3 t -109.33 121.35 62.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 2.2 m -95.96 114.08 25.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.914 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.529 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 67.2 m-85 -87.1 162.85 17.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -57.63 -67.12 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.52 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 5.7 m-20 -111.6 157.55 38.99 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.626 0.727 . . . . 0.0 110.858 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.16 -43.0 57.28 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.696 2.264 . . . . 0.0 112.319 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.3 Cg_exo -50.81 -31.24 32.5 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.672 2.248 . . . . 0.0 112.299 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 23.6 m -84.26 -37.72 21.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.105 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.622 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -64.55 -47.86 77.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.074 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.606 ' HG2' HD11 ' A' ' 444' ' ' LEU . 65.4 mttt -62.4 -36.56 82.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.01 -31.24 58.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.407 ' CB ' ' CZ ' ' A' ' 417' ' ' TYR . . . -70.39 -31.88 69.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.649 HG21 ' HG ' ' A' ' 444' ' ' LEU . 94.2 t -57.18 -64.02 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.196 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.0 -11.55 29.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.526 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.3 t-105 -81.3 -54.33 5.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.753 ' HB2' HG21 ' A' ' 442' ' ' VAL . 89.7 m-85 -89.79 -13.39 36.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.2 t0 -60.23 95.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 108.29 -0.03 33.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.465 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.454 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 18.7 mmtt -61.13 173.75 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.773 0.32 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -121.18 120.61 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.909 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.782 ' HB2' HD11 ' A' ' 440' ' ' LEU . 5.4 t80 -117.85 105.12 11.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 62.36 26.09 15.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.903 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 97.27 -16.47 60.69 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.539 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 75.5 m -96.8 127.02 42.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.949 0.404 . . . . 0.0 110.817 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -71.12 140.22 50.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.782 HD11 ' HB2' ' A' ' 435' ' ' PHE . 10.6 mt -108.87 151.65 25.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.953 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -122.63 108.16 12.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.912 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.756 HG11 HD12 ' A' ' 363' ' ' ILE . 10.4 t -104.36 135.49 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.197 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.4 m -154.86 127.49 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.891 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.649 ' HG ' HG21 ' A' ' 427' ' ' VAL . 24.6 mt -40.86 122.57 1.74 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.912 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.0 126.99 29.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.12 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 29.9 mtm-85 -99.67 95.51 7.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.823 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 6.8 ptmm? -100.45 29.15 4.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.859 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -121.96 134.89 24.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.556 0.693 . . . . 0.0 110.842 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 152.37 69.19 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.717 2.278 . . . . 0.0 112.354 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 -9.07 25.22 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.653 2.235 . . . . 0.0 112.349 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 14.2 tpp -95.06 123.13 38.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -118.65 -57.56 2.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.934 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 17.4 t -90.36 110.51 21.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -122.4 -95.07 1.26 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.512 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 80.75 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.64 2.227 . . . . 0.0 112.361 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 6.8 m -128.87 114.61 16.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 2.6 m 51.94 48.21 23.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.827 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.467 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.223 0 N-CA-C 112.417 -0.273 . . . . 0.0 112.417 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 57.2 p -122.66 -57.9 1.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.358 . . . . 0.0 110.789 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 22.4 t -63.05 134.67 56.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.845 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 167.53 -111.97 0.47 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.474 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 45.2 m -109.31 171.2 7.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.857 0.36 . . . . 0.0 110.867 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 15.0 m -39.86 -61.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 90.68 -136.22 13.28 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.478 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.443 ' N ' ' CD ' ' A' ' 354' ' ' PRO . 0.9 OUTLIER 48.54 54.7 16.4 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.59 0.71 . . . . 0.0 110.831 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 353' ' ' ASP . 53.1 Cg_endo -69.88 -170.03 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.711 2.274 . . . . 0.0 112.236 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -97.48 41.66 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.802 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 357' ' ' ASP . 22.2 tt0 -64.48 146.44 54.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.894 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 356' ' ' GLU . 16.4 t70 35.51 40.7 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 8.2 t -118.2 141.34 48.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -133.87 152.34 51.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.79 81.27 1.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 6.3 p -100.81 19.51 17.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.833 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.99 159.13 22.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.074 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.698 HD12 ' CG1' ' A' ' 442' ' ' VAL . 38.6 pt -131.8 142.28 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -98.72 117.38 33.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.879 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 15.7 t -102.34 141.94 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.137 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -148.83 122.58 9.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.43 18.82 1.59 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.418 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.536 HD13 HD11 ' A' ' 377' ' ' LEU . 64.6 mt -80.87 154.4 27.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' ASN . . . . . 0.423 ' H ' ' ND2' ' A' ' 369' ' ' ASN . 2.6 p30 -81.44 171.01 15.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.84 6.59 10.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 31.7 m -119.67 14.43 12.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.404 HG21 HD22 ' A' ' 368' ' ' LEU . 6.5 p -79.58 137.33 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.148 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 74.8 p -119.93 156.82 30.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.174 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.942 HD11 ' HG2' ' A' ' 396' ' ' PRO . 11.6 tp -53.24 -60.69 2.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -51.76 -33.58 35.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.796 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.47 -29.74 68.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.536 HD11 HD13 ' A' ' 368' ' ' LEU . 49.1 mt -89.9 -29.5 18.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.78 72.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.086 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' ASP . . . . . 0.43 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 21.1 t70 -80.38 -18.91 47.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -92.47 -52.93 4.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.879 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 28.3 m-85 -59.58 -21.66 60.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.43 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 2.6 ptmm? -75.38 -6.1 48.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -58.62 -56.25 24.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 28.3 t -57.57 -63.09 1.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.839 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -136.02 -126.54 2.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.463 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 76.2 t -125.46 133.92 68.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 111.124 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 68.4 t -87.14 129.97 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.163 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -56.62 106.85 0.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' MET . . . . . 0.5 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 47.6 mmm -103.34 125.94 50.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.869 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.402 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 15.5 t-20 -51.14 148.88 4.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -94.88 -17.99 21.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.944 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -97.28 -48.32 5.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.402 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 38.2 p -90.63 -17.95 25.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.173 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.5 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 62.16 27.47 69.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.436 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -114.63 153.19 46.78 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.608 0.718 . . . . 0.0 110.922 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.942 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.7 Cg_endo -69.68 146.64 61.28 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.67 2.247 . . . . 0.0 112.366 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.45 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.8 mmt -81.25 41.26 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.846 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.473 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.1 mt -98.64 136.4 29.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.124 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 399' ' ' HIS . . . . . 0.528 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 9.2 t60 -115.64 142.24 47.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.402 HD11 HD12 ' A' ' 377' ' ' LEU . 66.9 mt -134.86 94.03 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.084 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -59.7 125.28 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 409' ' ' PRO . 50.0 mt -109.13 136.7 48.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.971 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.4 t0 -55.24 132.33 47.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -79.74 -5.58 55.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -97.3 -24.05 15.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 70.4 p -128.15 -36.09 1.97 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.135 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 97.4 -4.49 62.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.565 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -85.69 156.05 58.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.56 0.695 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.484 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.2 Cg_endo -69.78 91.37 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.738 2.292 . . . . 0.0 112.305 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.48 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.1 OUTLIER -31.67 -51.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.873 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.46 -12.0 0.76 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -93.68 152.79 18.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.83 0.348 . . . . 0.0 110.846 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -165.68 173.4 10.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 p -138.81 140.63 38.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.172 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.758 HG21 ' CD2' ' A' ' 381' ' ' PHE . 46.0 t -124.77 116.93 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.144 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 416' ' ' SER . . . . . 0.45 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 13.4 m -92.85 112.16 24.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 417' ' ' TYR . . . . . 0.51 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 59.0 m-85 -86.84 161.41 18.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.897 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.86 -66.51 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.953 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.4 m-20 -115.17 156.72 45.12 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.617 0.723 . . . . 0.0 110.848 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.591 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.31 -42.97 56.64 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.659 2.239 . . . . 0.0 112.373 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.8 Cg_exo -50.42 -26.85 17.05 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.743 2.295 . . . . 0.0 112.323 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 56.0 m -89.09 -41.07 12.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -60.23 -47.31 86.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.077 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.431 ' HG2' HD11 ' A' ' 444' ' ' LEU . 80.7 mttt -60.92 -38.11 84.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.24 -34.59 63.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.029 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.99 -32.62 72.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 423' ' ' ALA . 70.1 t -56.04 -60.02 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.061 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -67.62 -13.89 62.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' TRP . . . . . 0.551 ' C ' ' CD1' ' A' ' 429' ' ' TRP . 1.1 t-105 -78.75 -55.14 5.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.861 ' HB2' HG21 ' A' ' 442' ' ' VAL . 82.8 m-85 -87.41 -14.81 39.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 431' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.6 OUTLIER -55.74 93.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.875 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.8 21.54 8.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.505 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 433' ' ' LYS . . . . . 0.459 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 15.5 mmtm -77.3 176.78 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.7 124.82 44.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.803 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.763 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.0 t80 -128.16 100.44 5.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 62.52 34.52 15.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.902 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 82.4 19.96 63.25 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.468 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 19.7 p -126.36 130.09 50.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 110.868 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' LYS . . . . . 0.413 ' C ' HD23 ' A' ' 440' ' ' LEU . 19.8 ttpt -75.95 131.37 39.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.861 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.763 HD11 ' HB2' ' A' ' 435' ' ' PHE . 5.8 mt -105.49 133.83 49.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.59 113.71 27.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.861 HG21 ' HB2' ' A' ' 430' ' ' PHE . 9.2 t -107.8 131.19 58.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.096 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 2.7 m -156.89 130.98 8.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.772 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.431 HD11 ' HG2' ' A' ' 424' ' ' LYS . 26.5 mt -39.15 133.86 1.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -73.37 143.9 46.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.085 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? 60.35 35.02 20.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -142.35 124.24 15.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 13.0 ttpp -165.25 135.43 2.93 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.632 0.73 . . . . 0.0 110.912 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.62 122.83 9.54 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.729 2.286 . . . . 0.0 112.383 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 -17.34 37.38 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.731 2.287 . . . . 0.0 112.331 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -128.7 149.35 50.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -172.14 157.16 4.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 48.9 m -49.29 -46.32 46.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -177.25 -156.66 16.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.469 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 456' ' ' SER . 53.9 Cg_endo -69.76 106.93 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.259 . . . . 0.0 112.348 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 456' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 455' ' ' PRO . 46.9 t -35.94 -63.96 0.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.821 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 33.4 p -86.72 152.84 22.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.517 -179.968 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.929 0.395 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -112.75 160.81 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.605 HD12 ' CG1' ' A' ' 442' ' ' VAL . 31.3 pt -131.89 144.48 37.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -103.44 111.47 23.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 1.039 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 8.2 t -96.42 140.12 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.098 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -145.91 122.44 11.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.26 17.97 1.72 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.489 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.557 HD13 HD11 ' A' ' 377' ' ' LEU . 87.0 mt -78.2 153.09 32.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.873 0.368 . . . . 0.0 110.861 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -76.17 -179.52 5.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.85 3.54 50.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 12.5 m -119.27 15.81 13.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . 0.481 HG21 HD22 ' A' ' 368' ' ' LEU . 8.7 p -80.61 134.02 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.152 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 70.2 p -117.87 160.22 21.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.158 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.848 HD11 ' HG2' ' A' ' 396' ' ' PRO . 12.3 tp -53.11 -64.17 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.95 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -46.1 -38.75 8.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.55 -32.69 74.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.631 HD12 HD11 ' A' ' 400' ' ' ILE . 75.7 mt -87.09 -28.08 22.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.8 -39.56 66.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.015 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.433 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 40.0 t0 -76.51 -20.82 56.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.497 ' CE1' ' NE2' ' A' ' 383' ' ' GLN . 40.6 t80 -91.6 -53.84 4.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 1.039 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.6 m-85 -57.56 -23.67 51.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.433 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 13.9 ptmt -74.44 -12.16 60.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.925 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . 0.497 ' NE2' ' CE1' ' A' ' 380' ' ' PHE . 6.8 mt-30 -48.68 -53.4 18.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 2.3 t -59.74 -65.17 0.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -136.82 -124.3 2.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.459 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 95.1 t -125.51 128.82 72.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.841 0.353 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 58.2 t -82.53 124.79 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.101 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -45.85 107.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.975 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . 0.471 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 20.4 mtp -102.91 127.28 50.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.894 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -53.7 146.01 14.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.75 -13.69 25.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . 0.463 ' HG3' HG23 ' A' ' 393' ' ' THR . 15.9 ptt180 -102.52 -42.09 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.463 HG23 ' HG3' ' A' ' 392' ' ' ARG . 66.8 p -96.93 -19.57 18.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.157 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . 0.471 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 66.04 18.44 66.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.442 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -107.14 152.75 41.2 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.554 0.692 . . . . 0.0 110.934 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.848 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.6 Cg_endo -69.77 147.62 63.2 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.684 2.256 . . . . 0.0 112.349 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.439 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 11.3 mmt -81.61 40.76 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.846 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.53 HG12 HG22 ' A' ' 415' ' ' VAL . 97.7 mt -99.33 137.68 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.171 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -118.5 143.56 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.808 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.631 HD11 HD12 ' A' ' 377' ' ' LEU . 58.6 mt -134.59 93.9 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -59.77 125.23 22.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.844 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 409' ' ' PRO . 36.5 mt -109.38 134.57 51.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.9 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 407' ' ' GLY . 11.1 t0 -55.67 121.25 8.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -69.23 -1.29 7.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -88.5 -38.5 14.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 70.1 p -124.74 -35.05 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.85 -1.47 35.96 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.475 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 12.0 pttp -84.37 152.62 61.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.483 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.8 Cg_endo -69.75 94.69 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.68 2.253 . . . . 0.0 112.341 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -33.55 -52.75 0.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 153.19 -15.85 0.67 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.487 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . 0.416 ' CG ' ' HE3' ' A' ' 410' ' ' LYS . 49.5 p-10 -87.74 157.24 19.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -170.15 171.67 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.096 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.4 142.91 37.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.183 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.879 HG21 ' CD2' ' A' ' 381' ' ' PHE . 57.0 t -130.13 111.94 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . 0.439 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 9.1 m -87.35 114.39 23.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.429 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 47.3 m-85 -88.07 164.41 15.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.77 -63.29 1.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.508 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.4 m-20 -115.9 156.05 47.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.604 0.716 . . . . 0.0 110.84 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.602 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.39 -43.01 55.77 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.644 2.23 . . . . 0.0 112.356 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.7 Cg_exo -50.06 -29.57 22.3 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.686 2.257 . . . . 0.0 112.286 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 70.0 m -85.8 -40.07 16.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.159 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.682 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -61.93 -51.5 67.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.131 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.574 ' HG2' HD11 ' A' ' 444' ' ' LEU . 33.2 mtmt -58.93 -35.58 73.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.849 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.29 -31.69 54.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.041 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.23 68.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.147 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 423' ' ' ALA . 92.6 t -54.68 -60.83 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -66.7 -14.65 62.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.55 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -77.85 -52.04 9.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.975 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.901 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.2 m-85 -90.37 -17.37 27.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 3.8 t70 -57.12 100.28 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 101.5 13.78 31.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.458 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 18.7 mmtp -71.7 -178.75 2.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.748 0.309 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.79 102.87 6.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.776 ' HB2' HD11 ' A' ' 440' ' ' LEU . 5.0 t80 -102.76 113.1 26.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 59.01 27.16 15.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 96.02 -16.66 60.72 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.431 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 24.3 m -90.62 150.46 21.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.965 0.412 . . . . 0.0 110.819 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . 0.431 ' C ' HD23 ' A' ' 440' ' ' LEU . 13.9 ttmt -87.61 133.74 33.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 435' ' ' PHE . 6.0 mt -102.66 143.09 32.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.932 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.03 101.42 7.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.983 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.901 HG21 ' HB2' ' A' ' 430' ' ' PHE . 20.5 t -96.98 132.6 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.079 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.5 m -154.24 128.73 9.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.574 HD11 ' HG2' ' A' ' 424' ' ' LYS . 22.4 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.804 0.335 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -141.82 156.15 45.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.474 HG22 HG22 ' A' ' 427' ' ' VAL . 18.8 pt -128.8 141.88 45.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.121 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -103.5 112.02 24.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 1.07 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 9.1 t -97.96 138.99 21.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -145.03 120.66 10.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.64 16.51 1.83 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.503 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.509 HD13 HD11 ' A' ' 377' ' ' LEU . 97.7 mt -74.51 155.39 38.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.821 0.343 . . . . 0.0 110.861 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -75.12 -178.88 4.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.55 3.69 53.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.2 t -121.05 16.58 11.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 8.5 p -76.89 133.99 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 81.8 p -118.28 154.8 31.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.919 HD11 ' HG2' ' A' ' 396' ' ' PRO . 11.1 tp -50.75 -62.82 1.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -46.72 -38.15 9.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.864 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.26 -29.59 68.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.825 HD12 HD11 ' A' ' 400' ' ' ILE . 45.5 mt -87.08 -28.52 22.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.16 62.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.146 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -75.11 -18.48 60.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -92.63 -47.17 7.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 1.07 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 15.7 m-85 -66.98 -26.44 66.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -9.13 57.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -51.58 -51.75 52.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 42.4 t -61.02 -65.45 0.69 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -134.55 -126.74 2.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.508 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.441 ' CG1' ' OE2' ' A' ' 418' ' ' GLU . 91.0 t -123.53 128.47 74.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.83 0.347 . . . . 0.0 111.127 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 84.5 t -83.64 123.1 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.076 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -47.55 108.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . 0.427 ' HE2' ' O ' ' A' ' 394' ' ' GLY . 23.8 mtp -105.41 124.18 49.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.896 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -50.9 143.94 9.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -94.72 -8.41 37.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -102.47 -45.55 5.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.967 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 20.5 p -95.82 -22.16 17.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.157 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . 0.427 ' O ' ' HE2' ' A' ' 389' ' ' MET . . . 71.1 23.29 78.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.503 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -112.09 152.49 44.39 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.523 0.678 . . . . 0.0 110.929 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.919 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.9 Cg_endo -69.67 149.41 67.4 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.693 2.262 . . . . 0.0 112.352 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.412 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 11.1 mmt -82.19 40.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.794 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.46 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 93.6 mt -97.52 137.4 25.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.148 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -116.78 138.75 51.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.825 HD11 HD12 ' A' ' 377' ' ' LEU . 58.0 mt -132.41 94.99 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -62.47 127.6 32.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 409' ' ' PRO . 36.2 mt -112.06 135.48 52.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 407' ' ' GLY . 6.6 t70 -56.14 122.25 11.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -1.05 9.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -89.04 -38.46 14.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.809 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 59.0 p -123.65 -34.73 3.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.3 -3.28 37.51 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.481 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -83.61 152.69 63.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.505 0.669 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.543 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.4 Cg_endo -69.74 95.17 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.673 2.248 . . . . 0.0 112.356 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 409' ' ' PRO . 9.2 ptmt -33.33 -52.01 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.882 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 152.2 -15.61 0.77 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.519 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -87.68 154.51 20.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 110.825 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -167.68 170.51 10.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.23 142.4 37.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.107 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 381' ' ' PHE . 39.2 t -128.23 112.88 28.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.123 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . 0.412 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 9.6 m -87.82 114.03 24.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.556 ' CE2' ' CB ' ' A' ' 426' ' ' ALA . 38.5 m-85 -87.06 167.21 14.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.965 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . 0.441 ' OE2' ' CG1' ' A' ' 386' ' ' VAL . 4.0 mt-10 -65.5 -61.96 1.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.513 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.8 m-20 -116.43 156.28 47.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.552 0.692 . . . . 0.0 110.884 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.3 -43.01 56.27 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.773 2.316 . . . . 0.0 112.335 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.8 Cg_exo -50.7 -27.36 19.62 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.7 2.267 . . . . 0.0 112.354 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 55.4 m -87.35 -40.72 14.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.154 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -60.17 -54.66 43.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.532 ' HG2' HD11 ' A' ' 444' ' ' LEU . 37.5 mtpt -55.63 -35.39 65.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.29 -33.09 55.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.159 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . 0.556 ' CB ' ' CE2' ' A' ' 417' ' ' TYR . . . -70.51 -31.83 69.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.101 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 423' ' ' ALA . 72.9 t -58.16 -64.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.151 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -65.11 -10.92 34.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.546 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.2 t-105 -80.3 -56.22 4.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.985 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.913 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.2 m-85 -88.09 -18.19 29.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.485 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.2 t70 -54.66 96.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.38 17.3 13.95 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.515 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.429 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 17.1 mmtm -76.87 170.7 16.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.721 0.296 . . . . 0.0 110.913 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 434' ' ' ASP . 2.8 p-10 -115.83 110.49 19.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.563 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.7 t80 -113.42 106.87 15.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 62.15 25.91 15.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.919 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 93.29 -5.92 75.09 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.51 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.4 m -104.87 129.39 53.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.877 0.37 . . . . 0.0 110.878 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -70.83 137.83 49.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 435' ' ' PHE . 12.4 mt -103.66 150.89 23.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -123.81 100.04 6.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.913 HG21 ' HB2' ' A' ' 430' ' ' PHE . 17.8 t -95.13 128.22 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.103 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 89.7 p -146.42 125.44 12.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.562 ' HG ' HG21 ' A' ' 427' ' ' VAL . 19.8 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.915 0.388 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -129.65 162.67 27.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.138 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.659 HD12 ' CG1' ' A' ' 442' ' ' VAL . 34.3 pt -133.34 144.55 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -102.15 115.09 29.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.888 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 13.5 t -100.31 136.34 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.142 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -143.64 120.74 11.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 128.96 20.18 1.5 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.441 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 88.0 mt -79.25 155.34 28.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 110.944 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . 0.487 ' OD1' ' NE2' ' A' ' 436' ' ' GLN . 4.2 p30 -75.07 178.07 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.844 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -91.31 13.4 17.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.857 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.1 m -130.13 13.22 5.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.69 141.93 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 72.2 p -121.59 160.42 24.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.126 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.877 HD11 ' HG2' ' A' ' 396' ' ' PRO . 10.6 tp -56.22 -58.1 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -50.61 -38.17 44.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.823 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -66.71 -27.77 67.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.847 HD12 HD11 ' A' ' 400' ' ' ILE . 51.6 mt -89.03 -32.02 17.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.12 -33.78 65.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.427 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 15.8 t0 -82.93 -20.24 35.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -92.69 -48.43 6.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.888 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 18.7 m-85 -63.75 -19.08 64.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.427 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -76.27 -6.69 52.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.916 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -54.31 -56.86 14.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.6 t -56.56 -65.54 0.59 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -135.67 -126.01 2.55 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.448 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 44.5 t -125.06 132.59 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 111.111 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 60.3 t -87.25 128.62 39.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.206 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 49.6 tttt -50.31 108.32 0.22 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 396' ' ' PRO . 73.6 mmm -104.05 122.79 45.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -47.66 143.18 4.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -93.38 -18.64 22.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 37.5 ttt85 -99.01 -46.6 5.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 30.1 p -89.72 -24.96 21.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.047 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 69.24 31.92 72.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.513 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -121.85 153.62 60.4 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.619 0.723 . . . . 0.0 110.899 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.877 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.6 Cg_endo -69.55 146.17 60.67 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.736 2.29 . . . . 0.0 112.432 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 9.1 mmt -82.12 40.32 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.825 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.531 HG12 HG22 ' A' ' 415' ' ' VAL . 94.3 mt -96.53 145.84 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . 0.409 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 6.3 t60 -126.04 136.11 52.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.847 HD11 HD12 ' A' ' 377' ' ' LEU . 59.5 mt -131.04 94.79 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -61.6 127.78 33.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.898 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 409' ' ' PRO . 33.5 mt -112.24 135.56 52.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.953 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 407' ' ' GLY . 8.1 t0 -55.44 122.78 11.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -1.18 12.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -90.03 -36.03 15.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 37.7 p -125.21 -35.63 2.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.73 -3.66 36.42 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.487 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -83.33 152.59 64.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.679 0.752 . . . . 0.0 110.814 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.524 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.2 Cg_endo -69.74 94.99 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.726 2.284 . . . . 0.0 112.281 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -33.37 -50.56 0.32 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.955 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 150.6 -16.4 0.96 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.489 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -87.79 156.09 19.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 110.856 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -169.48 173.14 6.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.081 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.06 142.13 32.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.168 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.848 HG21 ' CD2' ' A' ' 381' ' ' PHE . 57.4 t -128.74 117.68 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 24.0 m -92.73 112.86 24.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.493 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 51.9 m-85 -87.17 163.29 17.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.947 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -58.01 -65.3 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.511 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.5 m-20 -114.11 155.89 44.88 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.603 0.716 . . . . 0.0 110.903 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.42 -42.84 57.36 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.677 2.251 . . . . 0.0 112.334 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 54.3 Cg_exo -49.58 -28.81 17.47 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.719 2.279 . . . . 0.0 112.373 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 48.6 m -86.94 -42.98 12.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.77 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.7 -48.34 82.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.188 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.599 ' HG2' HD11 ' A' ' 444' ' ' LEU . 72.8 mttt -61.5 -39.62 91.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.45 -32.84 62.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.094 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.29 -32.91 70.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 423' ' ' ALA . 84.1 t -55.85 -60.85 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.164 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.12 -13.0 61.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.561 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.0 OUTLIER -79.49 -52.27 8.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.827 ' HB2' HG21 ' A' ' 442' ' ' VAL . 89.5 m-85 -88.5 -16.68 32.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.871 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.5 OUTLIER -60.4 93.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.22 16.79 7.55 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.401 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 2.6 mmmp? -82.37 163.91 21.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 110.862 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -110.24 108.54 18.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.931 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.647 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.2 t80 -109.12 108.65 19.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . 0.487 ' NE2' ' OD1' ' A' ' 369' ' ' ASN . 62.2 mt-30 61.32 26.56 16.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.972 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 94.38 -13.71 66.74 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.526 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.6 m -100.67 128.9 46.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 110.864 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -70.41 138.77 51.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.647 HD11 ' HB2' ' A' ' 435' ' ' PHE . 12.8 mt -104.05 152.95 21.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -126.26 106.08 9.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.827 HG21 ' HB2' ' A' ' 430' ' ' PHE . 14.2 t -99.41 138.56 23.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 3.6 p -161.12 130.17 4.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.825 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 424' ' ' LYS . 45.7 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.83 0.347 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -131.85 166.18 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.065 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.723 HD12 ' CG1' ' A' ' 442' ' ' VAL . 27.4 pt -140.38 144.47 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -100.05 124.53 45.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.98 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.928 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 21.8 t -108.68 143.33 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -149.73 121.11 7.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.48 19.86 1.46 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.506 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.503 ' HB3' HG11 ' A' ' 372' ' ' VAL . 97.4 mt -78.76 154.35 30.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.885 0.374 . . . . 0.0 110.926 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . 0.432 ' ND2' ' CD ' ' A' ' 436' ' ' GLN . 9.4 p30 -76.37 179.32 5.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.4 1.87 53.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.2 m -119.85 18.73 12.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 368' ' ' LEU . 8.1 p -82.38 133.05 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.131 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 69.4 p -115.99 163.46 15.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.06 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.962 HD11 ' HG2' ' A' ' 396' ' ' PRO . 12.2 tp -54.64 -59.92 4.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.17 -47.38 23.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -53.15 -38.48 62.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.715 HD12 HD11 ' A' ' 400' ' ' ILE . 81.5 mt -82.82 -30.04 29.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.957 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -71.99 -25.64 61.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.074 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.408 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 17.9 t70 -93.27 -19.96 20.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -91.9 -52.34 4.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.928 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 21.2 m-85 -59.83 -23.47 63.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.408 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 5.4 ptmt -72.35 -10.98 60.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -49.9 -58.03 6.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 37.7 t -56.45 -69.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -130.56 -124.24 2.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 71.0 t -126.87 131.41 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.104 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 85.7 t -83.81 123.42 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.146 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -46.72 105.05 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.917 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . 0.445 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 26.7 mtp -102.85 128.17 49.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -53.97 147.09 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -94.61 -16.13 23.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 15.8 ttm105 -96.43 -49.65 5.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 46.9 p -90.45 -22.11 21.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . 0.445 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 69.49 23.66 76.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.438 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -110.93 153.02 43.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.571 0.7 . . . . 0.0 110.951 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.962 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.7 Cg_endo -69.82 148.13 64.0 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.652 2.235 . . . . 0.0 112.3 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.428 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 7.6 mmt -81.74 40.68 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.427 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.3 mt -98.53 138.86 21.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.204 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -116.97 141.78 47.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.715 HD11 HD12 ' A' ' 377' ' ' LEU . 75.0 mt -134.7 95.4 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.222 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -62.69 124.94 22.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' A' ' 409' ' ' PRO . 44.1 mt -110.67 135.37 51.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 407' ' ' GLY . 9.0 t70 -55.49 126.36 24.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -75.16 -1.07 21.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -93.47 -30.29 15.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 43.4 p -127.97 -36.09 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 104.3 -5.89 45.6 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.474 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 8.8 pttm -82.94 152.8 66.38 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.569 0.699 . . . . 0.0 110.845 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.554 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.1 Cg_endo -69.73 95.29 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.66 2.24 . . . . 0.0 112.343 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 409' ' ' PRO . 9.4 ptmt -32.88 -51.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.866 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.15 -12.34 0.8 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.491 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -90.93 157.95 17.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.777 0.322 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.53 172.65 6.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.079 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.88 136.59 30.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.174 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.757 HG21 ' CD2' ' A' ' 381' ' ' PHE . 40.6 t -120.89 127.69 75.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.133 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . 0.428 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 3.3 m -102.46 111.17 23.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.509 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 62.9 m-85 -87.4 157.68 19.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.944 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -53.46 -65.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.9 m-20 -113.31 155.81 44.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.644 0.735 . . . . 0.0 110.838 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.589 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.1 -42.96 58.0 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.689 2.259 . . . . 0.0 112.32 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.0 Cg_exo -50.34 -27.37 17.98 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.377 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 44.9 m -88.89 -34.3 17.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.582 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -64.76 -50.61 66.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.116 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.95 ' HG2' HD11 ' A' ' 444' ' ' LEU . 23.1 mttp -61.05 -40.01 92.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -69.56 -35.27 75.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.087 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.41 -34.68 76.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.043 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 423' ' ' ALA . 72.6 t -54.75 -61.73 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.74 -12.89 60.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.551 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.82 -54.21 6.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.899 ' HB2' HG21 ' A' ' 442' ' ' VAL . 84.5 m-85 -87.63 -20.12 26.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.2 t70 -54.74 99.93 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 104.42 11.72 30.6 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.539 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -74.44 176.16 7.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.757 0.313 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -122.27 112.59 18.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.926 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.579 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -113.4 112.59 23.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . 0.432 ' CD ' ' ND2' ' A' ' 369' ' ' ASN . 53.6 mt-30 58.44 36.89 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 85.9 -15.76 46.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.1 t -92.69 165.8 12.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.845 0.355 . . . . 0.0 110.901 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -102.95 134.09 46.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.921 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.579 HD11 ' HB2' ' A' ' 435' ' ' PHE . 11.7 mt -102.05 143.97 31.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -119.75 104.57 10.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.899 HG21 ' HB2' ' A' ' 430' ' ' PHE . 6.2 t -99.95 140.91 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.146 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 20.0 m -162.47 125.73 2.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.808 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.95 HD11 ' HG2' ' A' ' 424' ' ' LYS . 17.4 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.864 0.364 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -135.02 165.07 26.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.089 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.699 HD12 ' CG1' ' A' ' 442' ' ' VAL . 41.6 pt -135.26 145.79 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -103.89 112.94 26.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 1.05 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 20.5 t -97.04 142.34 14.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.133 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -148.16 122.78 9.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.59 17.05 1.77 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.47 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.521 HD13 HD11 ' A' ' 377' ' ' LEU . 87.5 mt -76.23 155.97 33.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.842 0.353 . . . . 0.0 110.907 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -79.37 -174.99 4.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.82 1.57 56.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.7 m -118.74 20.56 12.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . 0.51 HG23 ' CE2' ' A' ' 435' ' ' PHE . 6.2 p -87.15 137.29 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.083 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 59.2 p -120.22 163.46 17.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.197 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.792 HD11 ' HG2' ' A' ' 396' ' ' PRO . 10.0 tp -57.35 -63.35 1.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -44.87 -30.78 1.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.838 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -74.21 -34.19 63.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.828 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.521 HD11 HD13 ' A' ' 368' ' ' LEU . 61.0 mt -86.26 -23.53 26.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -75.86 -32.53 59.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.111 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.426 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 19.6 t0 -87.47 -18.01 30.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.825 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -92.07 -50.72 5.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 1.05 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.3 m-85 -62.03 -22.13 65.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.826 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.426 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 12.7 ptmt -75.55 -10.62 59.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -51.14 -53.96 29.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 34.4 t -58.93 -66.0 0.57 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.24 -124.76 2.55 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.454 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.32 130.71 71.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.878 0.371 . . . . 0.0 111.103 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.56 129.27 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.188 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -54.41 108.14 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . 0.443 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 67.4 mmm -103.75 122.04 44.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.436 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 17.6 t-20 -48.51 149.06 1.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.839 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -94.87 -18.86 20.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.875 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -97.77 -47.32 5.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.436 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 49.0 p -90.68 -18.95 24.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.181 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . 0.443 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 62.13 27.53 69.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.448 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -114.77 153.5 46.88 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.611 0.719 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.792 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.5 Cg_endo -69.75 146.07 59.15 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.69 2.26 . . . . 0.0 112.282 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.45 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 16.6 mmt -81.17 41.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.462 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 95.7 mt -99.44 135.87 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.094 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -116.39 141.55 48.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 71.4 mt -133.65 93.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -60.69 124.41 20.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 409' ' ' PRO . 33.7 mt -108.98 136.71 48.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.94 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 407' ' ' GLY . 3.1 t70 -55.42 127.23 28.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.837 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.0 pttm -74.29 -1.03 18.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -97.18 -34.89 10.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 37.5 p -121.09 -34.97 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.154 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 99.59 -1.06 56.87 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.533 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -86.94 155.95 55.3 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.512 0.673 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.7 Cg_endo -69.82 91.36 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.697 2.265 . . . . 0.0 112.307 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.482 ' C ' ' O ' ' A' ' 409' ' ' PRO . 10.2 ptmt -31.75 -53.14 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.892 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.9 -14.78 0.51 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.501 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -88.45 156.81 18.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.868 0.366 . . . . 0.0 110.803 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.99 167.75 10.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.106 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.9 p -136.76 140.17 42.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.905 HG21 ' CD2' ' A' ' 381' ' ' PHE . 37.0 t -127.1 112.26 28.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.121 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . 0.45 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 6.0 m -89.39 113.75 25.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.475 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 69.1 m-85 -88.8 164.97 14.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -57.27 -68.86 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.518 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 4.0 m-20 -112.68 156.97 41.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.605 0.717 . . . . 0.0 110.886 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.32 -43.06 55.79 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.704 2.269 . . . . 0.0 112.329 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.2 Cg_exo -50.25 -26.64 15.87 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.651 2.234 . . . . 0.0 112.326 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 35.2 m -90.0 -39.87 12.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.538 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -60.37 -51.31 70.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.065 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.463 ' HG2' HD11 ' A' ' 444' ' ' LEU . 4.3 mtpm? -57.52 -39.31 76.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.09 70.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.046 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.68 71.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.08 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 423' ' ' ALA . 85.6 t -56.89 -64.15 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.58 -11.44 24.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.537 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -82.09 -55.29 4.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.889 ' HB2' HG21 ' A' ' 442' ' ' VAL . 89.1 m-85 -88.3 -13.88 39.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.831 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.8 t0 -58.64 96.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 112.26 -16.07 24.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.529 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -49.7 165.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.737 0.303 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -122.33 110.37 15.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.793 ' HB2' HD11 ' A' ' 440' ' ' LEU . 5.6 t80 -97.78 105.43 17.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 62.98 34.37 14.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 83.58 19.66 61.51 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.503 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 22.2 p -125.19 128.66 48.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.952 0.406 . . . . 0.0 110.828 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . 0.407 ' C ' HD23 ' A' ' 440' ' ' LEU . 0.5 OUTLIER -71.65 133.1 45.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 435' ' ' PHE . 8.6 mt -107.2 160.59 15.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -133.41 101.04 5.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.889 HG21 ' HB2' ' A' ' 430' ' ' PHE . 13.8 t -98.26 131.99 44.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.17 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.3 m -153.2 128.98 10.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.463 HD11 ' HG2' ' A' ' 424' ' ' LYS . 39.5 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.909 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 417' ' ' TYR . 3.3 p . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.896 0.379 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -144.25 166.98 23.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.084 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.731 HD12 ' CG1' ' A' ' 442' ' ' VAL . 37.7 pt -142.49 142.73 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -100.79 114.36 28.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.981 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.971 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 9.4 t -97.52 142.19 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.176 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -147.79 120.06 8.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.43 20.55 1.39 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.424 HD13 HD11 ' A' ' 377' ' ' LEU . 96.6 mt -79.48 154.43 28.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.865 0.364 . . . . 0.0 110.85 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -74.04 -177.95 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.24 0.42 57.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 20.1 m -118.68 16.9 13.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.837 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . 0.441 HG23 ' CE2' ' A' ' 435' ' ' PHE . 7.6 p -76.48 135.18 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.131 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 75.5 p -117.26 158.82 23.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.195 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.755 HD11 ' HG2' ' A' ' 396' ' ' PRO . 10.7 tp -56.99 -60.03 4.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.871 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -48.13 -40.12 22.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -28.8 68.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.769 HD12 HD11 ' A' ' 400' ' ' ILE . 47.6 mt -86.44 -31.44 21.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.38 -33.73 67.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.101 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.437 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 9.3 t70 -81.79 -20.16 39.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -92.45 -46.55 7.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.971 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 17.4 m-85 -65.76 -19.11 65.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.437 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -78.65 -4.28 48.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.914 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -56.74 -54.0 51.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.5 t -59.44 -65.92 0.59 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -134.41 -125.6 2.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.48 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 50.9 t -124.21 136.61 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.946 0.403 . . . . 0.0 111.105 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.22 132.26 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.089 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -57.18 106.87 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . 0.49 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 73.4 mmm -102.44 121.08 41.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.78 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -46.79 150.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.72 -23.06 17.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.931 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . 0.598 ' HG3' HG23 ' A' ' 393' ' ' THR . 35.0 ptt180 -96.37 -47.11 6.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.598 HG23 ' HG3' ' A' ' 392' ' ' ARG . 61.9 p -89.46 -16.34 31.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . 0.49 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 58.59 24.09 56.07 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.478 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -111.45 153.34 44.2 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.638 0.733 . . . . 0.0 110.883 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.755 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.7 Cg_endo -69.8 146.67 60.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.667 2.245 . . . . 0.0 112.362 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.426 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.6 mmt -81.79 40.83 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.569 HG12 HG22 ' A' ' 415' ' ' VAL . 95.6 mt -98.8 136.22 30.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.122 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . 0.41 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 8.6 t60 -116.3 141.09 48.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.769 HD11 HD12 ' A' ' 377' ' ' LEU . 76.9 mt -134.67 94.13 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -60.65 124.41 20.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 409' ' ' PRO . 36.3 mt -109.82 135.17 51.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 407' ' ' GLY . 7.7 t0 -55.57 123.42 13.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.819 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -70.75 -2.03 13.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -89.28 -38.93 13.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 27.4 p -122.7 -34.74 3.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.177 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 104.79 -1.45 41.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.537 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -84.55 152.69 60.8 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.523 0.678 . . . . 0.0 110.915 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.486 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.2 Cg_endo -69.8 94.0 0.53 Allowed 'Trans proline' 0 N--CA 1.466 -0.132 0 C-N-CA 122.689 2.259 . . . . 0.0 112.354 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 409' ' ' PRO . 7.9 ptmt -32.94 -49.57 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 149.72 -13.58 1.02 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -90.53 155.83 18.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.84 0.353 . . . . 0.0 110.876 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -168.46 170.51 9.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.1 p -139.73 132.83 29.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.882 HG21 ' CD2' ' A' ' 381' ' ' PHE . 99.7 t -118.25 122.8 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . 0.426 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 1.8 m -98.42 113.12 24.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.487 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 58.4 m-85 -86.74 169.85 12.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -63.44 -66.28 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.9 m-20 -114.53 156.25 44.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.708 . . . . 0.0 110.895 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.15 -43.01 57.2 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.706 2.271 . . . . 0.0 112.381 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.0 Cg_exo -50.42 -27.03 17.42 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.769 2.312 . . . . 0.0 112.348 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 90.2 m -90.4 -41.17 11.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.196 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.604 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.34 -49.6 77.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.077 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.522 ' HG2' HD11 ' A' ' 444' ' ' LEU . 47.4 mtpt -59.34 -40.24 85.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.94 -33.98 71.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.037 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.5 -33.94 75.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 423' ' ' ALA . 97.6 t -55.38 -60.88 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.97 -12.7 60.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.942 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.549 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -80.16 -55.19 5.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.918 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.853 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.2 m-85 -86.73 -17.68 33.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.6 OUTLIER -54.16 94.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.861 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.2 20.26 9.89 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.464 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.453 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 15.2 mmtm -78.16 170.4 16.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.877 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -114.36 112.93 23.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.605 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.7 t80 -120.96 105.21 10.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 62.25 38.08 13.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.937 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 73.97 23.38 76.41 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 71.3 m -132.38 131.05 41.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 0.0 110.868 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -72.51 136.06 45.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' A' ' 435' ' ' PHE . 8.5 mt -104.15 143.27 33.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -117.45 104.23 10.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.853 HG21 ' HB2' ' A' ' 430' ' ' PHE . 7.5 t -101.11 133.86 43.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.128 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 3.8 m -156.07 132.09 9.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.522 HD11 ' HG2' ' A' ' 424' ' ' LYS . 18.5 mt . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 7.6 m . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.888 0.375 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -136.95 166.04 24.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.071 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.428 HD12 HG13 ' A' ' 442' ' ' VAL . 12.5 pt -137.69 142.14 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.139 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -100.44 117.91 35.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.986 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 40.4 t -101.78 144.41 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.033 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -150.31 118.06 6.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.38 23.11 1.03 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.447 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.497 HD13 HD11 ' A' ' 377' ' ' LEU . 93.9 mt -81.36 156.37 25.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.817 0.341 . . . . 0.0 110.895 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' A' ' 436' ' ' GLN . 8.5 p30 -79.9 179.94 7.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.87 1.5 53.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.844 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.9 m -117.31 16.0 14.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.83 136.59 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.098 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 73.4 p -123.05 156.21 35.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.136 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.955 HD11 ' HG2' ' A' ' 396' ' ' PRO . 10.6 tp -52.56 -65.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -46.61 -36.94 7.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -69.15 -31.56 70.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 400' ' ' ILE . 43.4 mt -84.93 -28.45 25.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.93 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.8 -40.38 63.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.438 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 23.2 t0 -73.14 -21.39 60.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -92.58 -49.42 6.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.986 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 14.8 m-85 -62.51 -22.65 66.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.438 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -74.67 -12.77 60.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.881 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -48.47 -56.11 9.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 32.6 t -55.74 -69.58 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -132.46 -123.4 2.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.439 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 55.8 t -125.5 133.52 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 111.165 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.38 131.21 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.167 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -54.95 109.28 0.5 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . 0.402 ' SD ' ' CA ' ' A' ' 396' ' ' PRO . 65.0 mmm -104.29 123.16 46.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -50.51 145.51 6.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.867 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -94.85 -8.81 36.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 392' ' ' ARG . 3.8 ptp180 -102.98 -49.46 3.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.887 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.407 HG23 ' HG3' ' A' ' 392' ' ' ARG . 41.1 p -94.11 -14.92 25.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.179 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 62.53 30.19 75.8 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.469 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -116.52 153.28 48.91 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.6 0.714 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.955 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.6 Cg_endo -69.82 147.61 62.87 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.415 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 12.5 mmt -81.36 41.23 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.47 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.0 mt -97.79 135.67 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.074 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -116.09 139.99 49.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.765 HD11 HD12 ' A' ' 377' ' ' LEU . 60.7 mt -133.34 94.29 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.187 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -59.83 129.83 43.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.557 HD23 ' HA ' ' A' ' 409' ' ' PRO . 27.0 mt -114.09 137.12 52.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 407' ' ' GLY . 5.0 t70 -55.43 128.95 36.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -76.15 -1.62 27.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -97.46 -30.18 13.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.883 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 52.5 p -124.38 -36.17 2.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 97.62 7.84 56.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.452 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.8 156.66 37.06 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.584 0.707 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.557 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.0 Cg_endo -69.68 89.08 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.644 2.229 . . . . 0.0 112.382 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 409' ' ' PRO . 6.7 ptmt -31.22 -55.45 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 157.67 -15.93 0.31 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.484 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -88.76 158.0 18.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.349 . . . . 0.0 110.842 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -170.55 173.57 5.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.139 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.4 p -141.91 137.63 31.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.157 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.873 HG21 ' CD2' ' A' ' 381' ' ' PHE . 45.9 t -123.55 111.63 30.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.127 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . 0.415 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 3.6 m -87.67 113.9 23.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.518 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 55.5 m-85 -87.72 166.91 14.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.859 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -61.33 -66.24 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.524 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.3 m-20 -110.73 156.63 40.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.636 0.731 . . . . 0.0 110.831 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.04 -42.91 58.88 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.674 2.249 . . . . 0.0 112.38 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.0 Cg_exo -50.86 -46.0 32.87 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.713 2.276 . . . . 0.0 112.394 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 86.2 m -68.36 -39.22 81.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.166 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -61.82 -48.13 81.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.116 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -61.33 -39.38 90.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.59 -34.93 72.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.152 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -67.7 -34.16 76.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.053 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 423' ' ' ALA . 94.3 t -54.93 -62.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -66.48 -10.83 48.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.548 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.2 t-105 -82.01 -55.63 4.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.918 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.819 ' HB2' HG21 ' A' ' 442' ' ' VAL . 90.7 m-85 -86.14 -21.43 27.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.5 t70 -52.62 97.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 103.42 21.37 9.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.494 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.426 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 19.5 mmtt -81.46 176.02 10.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.853 0.358 . . . . 0.0 110.845 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 1.6 p-10 -119.9 114.91 22.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.728 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -121.69 104.08 9.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . 0.419 ' HB2' ' ND2' ' A' ' 369' ' ' ASN . 41.9 mt-30 62.69 40.61 9.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.829 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 71.79 25.56 74.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.5 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 67.8 m -134.79 127.69 31.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.902 0.382 . . . . 0.0 110.891 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -68.95 136.77 53.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.9 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.728 HD11 ' HB2' ' A' ' 435' ' ' PHE . 12.4 mt -106.37 140.05 39.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -116.06 106.26 13.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.819 HG21 ' HB2' ' A' ' 430' ' ' PHE . 11.5 t -100.6 135.77 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.093 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 12.6 p -156.13 127.41 7.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 25.0 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.978 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.83 0.348 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -115.29 163.1 16.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.066 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.664 HD12 ' CG1' ' A' ' 442' ' ' VAL . 37.7 pt -137.06 141.99 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -100.93 114.67 28.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.935 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.891 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 5.1 t -101.2 141.9 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.105 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -147.4 123.67 10.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 128.66 14.26 2.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.521 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.09 152.61 41.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 372' ' ' VAL . 6.1 p30 -72.94 -176.41 2.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.95 -0.15 57.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.827 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.0 t -117.02 17.8 14.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . 0.4 ' N ' ' OD1' ' A' ' 369' ' ' ASN . 9.0 p -79.04 139.71 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.089 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 72.7 p -122.81 160.21 26.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.884 HD11 ' HG2' ' A' ' 396' ' ' PRO . 9.1 tp -56.55 -60.33 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -48.0 -37.1 13.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -30.12 68.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.745 HD12 HD11 ' A' ' 400' ' ' ILE . 63.2 mt -85.39 -31.34 22.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.95 -35.14 66.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.44 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 23.3 t0 -80.63 -20.56 42.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.828 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -92.65 -51.61 5.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.891 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.3 m-85 -61.11 -21.48 63.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.44 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 8.4 ptpt -75.79 -13.34 60.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -47.21 -54.53 10.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 21.6 t -57.34 -70.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -131.84 -124.22 2.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.508 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 96.3 t -124.55 136.67 59.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.392 . . . . 0.0 111.08 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 96.3 t -92.17 129.26 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.143 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -51.05 107.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 62.7 mmm -103.89 124.64 49.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.791 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.405 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 11.4 t-20 -47.44 145.48 2.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -94.69 -18.32 21.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 19.2 tpp85 -99.74 -45.26 5.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.863 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.405 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 23.6 p -91.85 -24.28 19.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.216 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 68.55 29.0 72.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.537 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.76 153.07 47.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.536 0.684 . . . . 0.0 110.961 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.884 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.2 Cg_endo -69.83 144.95 55.28 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.625 2.216 . . . . 0.0 112.326 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.449 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 12.5 mmt -81.37 41.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.471 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.5 mt -97.81 142.79 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.151 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -122.22 139.62 53.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.745 HD11 HD12 ' A' ' 377' ' ' LEU . 64.3 mt -133.31 94.6 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.191 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -61.23 122.32 14.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 409' ' ' PRO . 33.3 mt -107.12 135.06 49.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 407' ' ' GLY . 9.9 t0 -55.51 121.54 9.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -1.16 8.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -89.08 -37.64 14.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 43.1 p -125.19 -35.67 2.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.109 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.36 1.7 38.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.467 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -87.12 152.58 53.27 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.561 0.696 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.517 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.6 Cg_endo -69.72 93.06 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.701 2.267 . . . . 0.0 112.317 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 409' ' ' PRO . 6.5 ptmt -32.76 -52.93 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.884 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 153.95 -16.08 0.61 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.494 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -87.68 155.49 19.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.848 0.356 . . . . 0.0 110.84 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.46 168.59 11.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.9 p -136.7 139.85 42.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.765 HG21 ' CD2' ' A' ' 381' ' ' PHE . 31.9 t -124.81 116.62 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . 0.449 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 22.9 m -92.06 110.76 22.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.869 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.505 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 51.9 m-85 -86.79 161.89 18.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -57.94 -63.54 1.22 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.511 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 1.2 m-20 -118.59 157.13 50.51 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.576 0.703 . . . . 0.0 110.84 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.51 -43.0 55.12 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.648 2.232 . . . . 0.0 112.383 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 56.9 Cg_exo -49.48 -26.43 12.23 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.641 2.227 . . . . 0.0 112.397 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 98.8 m -91.33 -41.13 11.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.04 -51.0 71.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.448 ' HG2' HD11 ' A' ' 444' ' ' LEU . 27.2 mtpp -58.63 -39.05 79.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -72.62 -32.18 65.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.104 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.87 72.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.073 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 423' ' ' ALA . 94.6 t -54.39 -61.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.187 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -66.25 -13.03 59.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.533 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -80.46 -50.84 9.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.878 ' HB2' HG21 ' A' ' 442' ' ' VAL . 82.3 m-85 -92.88 -13.09 29.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.0 OUTLIER -59.51 92.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.97 -13.64 19.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.433 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 9.8 mmtm -45.68 166.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.749 0.309 . . . . 0.0 110.916 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 4.4 p-10 -115.1 112.24 22.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.501 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.2 t80 -111.76 108.6 18.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 61.64 31.06 18.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 91.49 -15.96 60.16 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.563 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.2 t -91.11 159.05 16.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.382 . . . . 0.0 110.898 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -96.23 134.52 39.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 435' ' ' PHE . 8.6 mt -100.01 140.05 34.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -117.36 100.13 7.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.878 HG21 ' HB2' ' A' ' 430' ' ' PHE . 12.5 t -97.67 133.08 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 6.1 p -156.49 128.43 7.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.825 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.448 HD11 ' HG2' ' A' ' 424' ' ' LYS . 18.8 mt . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.829 0.347 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -139.05 166.98 23.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.069 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.632 HD12 ' CG1' ' A' ' 442' ' ' VAL . 33.7 pt -137.71 143.78 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -102.32 114.31 28.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 1.029 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 15.6 t -97.72 141.31 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.177 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -147.89 121.05 8.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.49 20.72 1.36 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.438 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.486 HD13 HD11 ' A' ' 377' ' ' LEU . 65.8 mt -81.28 153.4 27.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.766 0.317 . . . . 0.0 110.979 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . 0.406 ' H ' ' ND2' ' A' ' 369' ' ' ASN . 3.8 p30 -75.71 -177.21 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.25 7.59 40.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.8 t -123.2 14.11 9.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 10.8 p -75.57 132.9 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 58.6 p -114.53 159.68 20.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.203 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.756 HD11 ' HG2' ' A' ' 396' ' ' PRO . 13.1 tp -58.95 -61.29 2.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -48.74 -32.74 9.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.97 -31.09 65.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.579 HD12 HD11 ' A' ' 400' ' ' ILE . 38.6 mt -86.21 -30.03 22.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.87 -33.26 65.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.67 -20.97 35.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.428 ' CE2' ' CD1' ' A' ' 430' ' ' PHE . 63.6 t80 -92.32 -49.5 6.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 1.029 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.1 m-85 -59.9 -26.38 65.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -75.89 -4.39 40.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -55.43 -48.88 73.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 39.3 t -63.71 -57.87 8.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -142.22 -123.19 1.83 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.488 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 71.9 t -124.84 135.98 62.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 85.9 t -92.04 128.35 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -53.18 108.96 0.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 40.1 mmm -105.87 127.53 53.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.431 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 14.4 t-20 -50.23 146.17 5.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -94.86 -13.39 25.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -100.47 -48.27 4.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.431 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 30.4 p -92.49 -19.62 21.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . 0.473 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 66.12 26.65 72.49 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.472 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -112.59 153.28 45.03 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.654 0.74 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.756 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.9 Cg_endo -69.67 146.61 61.32 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.722 2.281 . . . . 0.0 112.379 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.44 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.2 mmt -81.49 40.69 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.52 HG12 HG22 ' A' ' 415' ' ' VAL . 97.1 mt -98.05 138.76 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -118.3 137.16 53.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.579 HD11 HD12 ' A' ' 377' ' ' LEU . 73.6 mt -130.8 95.54 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.157 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -63.16 126.15 26.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 409' ' ' PRO . 35.8 mt -110.96 135.49 51.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.913 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.7 t0 -56.58 121.46 9.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.416 ' C ' ' HD3' ' A' ' 404' ' ' LYS . 0.0 OUTLIER -70.12 -1.05 8.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -89.04 -37.27 15.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.0 p -124.18 -36.01 2.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.098 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 107.56 -2.87 34.39 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.45 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -85.15 152.82 59.09 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.515 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.6 Cg_endo -69.76 95.79 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.707 2.271 . . . . 0.0 112.292 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 409' ' ' PRO . 6.4 ptmt -33.39 -52.37 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.99 -12.8 0.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.51 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -91.39 152.03 20.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -165.26 170.6 14.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.4 p -139.1 142.12 38.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.924 HG21 ' CD2' ' A' ' 381' ' ' PHE . 48.1 t -128.99 116.28 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . 0.44 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 14.5 m -90.76 115.54 27.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.537 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 56.6 m-85 -88.36 163.98 15.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -62.17 -63.61 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.509 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 1.6 m-20 -116.01 156.29 46.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.634 0.731 . . . . 0.0 110.87 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.26 -43.02 56.44 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.745 2.297 . . . . 0.0 112.36 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 56.7 Cg_exo -49.31 -26.71 11.99 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.658 2.238 . . . . 0.0 112.373 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 93.4 m -91.89 -41.46 10.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.719 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.28 -47.36 85.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.126 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -63.26 -37.41 87.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.86 -32.33 61.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.041 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . 0.453 ' HB1' ' OH ' ' A' ' 417' ' ' TYR . . . -69.36 -33.85 73.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.027 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 423' ' ' ALA . 85.2 t -56.15 -64.42 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.127 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.59 -13.67 44.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.53 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -79.21 -54.39 6.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.888 ' HB2' HG21 ' A' ' 442' ' ' VAL . 79.8 m-85 -90.61 -11.67 39.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 3.0 t70 -61.4 98.38 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 106.38 -7.93 40.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.511 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.444 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 30.8 mmtt -53.82 165.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 110.876 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -112.67 116.18 29.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.622 ' HB2' HD11 ' A' ' 440' ' ' LEU . 6.4 t80 -113.82 109.71 18.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 61.13 28.77 18.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 94.1 -14.83 64.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.512 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 19.7 m -91.81 160.59 15.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 0.0 110.834 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -97.39 134.46 40.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.937 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' A' ' 435' ' ' PHE . 9.6 mt -102.84 144.9 30.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -122.77 99.51 6.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.888 HG21 ' HB2' ' A' ' 430' ' ' PHE . 16.9 t -96.2 131.37 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 5.4 m -151.8 129.43 11.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.491 ' HG ' HG21 ' A' ' 427' ' ' VAL . 21.5 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.938 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 6.8 m . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.871 0.367 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -141.52 165.65 26.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.146 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.477 ' HB ' ' CG1' ' A' ' 442' ' ' VAL . 17.1 pt -137.66 139.29 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.081 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -99.45 113.49 25.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 1.052 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 23.2 t -96.93 143.31 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.132 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -149.95 120.57 7.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.82 20.76 1.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.498 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.512 HD23 HD22 ' A' ' 440' ' ' LEU . 44.2 mt -83.58 156.01 22.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . 0.565 HD21 ' NE2' ' A' ' 436' ' ' GLN . 18.4 p30 -78.62 -176.3 4.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.58 10.06 29.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.5 t -122.91 10.04 9.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . 0.5 HG21 HD21 ' A' ' 377' ' ' LEU . 7.4 p -73.79 128.95 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 74.8 p -111.35 162.86 14.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.122 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.752 HD11 ' HG2' ' A' ' 396' ' ' PRO . 13.8 tp -58.74 -63.77 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -46.69 -38.24 9.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.869 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -67.09 -29.99 69.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.577 HD12 HD11 ' A' ' 400' ' ' ILE . 47.6 mt -87.33 -29.81 21.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.934 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.92 -41.04 64.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.431 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 30.7 t0 -76.17 -19.39 58.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -92.61 -45.58 8.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.943 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 1.052 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 15.0 m-85 -67.46 -19.36 65.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.838 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.431 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 5.7 ptmm? -77.14 -6.04 51.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -53.24 -53.08 55.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 13.2 t -59.2 -68.18 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.07 -122.39 2.31 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.483 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 71.7 t -126.98 135.22 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.882 0.372 . . . . 0.0 111.16 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.48 130.93 36.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.158 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -55.09 104.51 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . 0.499 ' SD ' ' N ' ' A' ' 396' ' ' PRO . 59.4 mmm -101.5 118.71 37.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -46.82 150.38 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -95.09 -23.6 17.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . 0.415 ' CD ' HG23 ' A' ' 393' ' ' THR . 0.0 OUTLIER -93.64 -46.51 7.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.821 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.415 HG23 ' CD ' ' A' ' 392' ' ' ARG . 41.4 p -90.93 -14.1 32.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.16 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . 0.45 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 55.32 30.41 55.12 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.529 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -118.67 153.18 52.14 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.556 0.693 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.752 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.1 Cg_endo -69.8 147.95 63.76 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.682 2.255 . . . . 0.0 112.345 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.46 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 19.7 mmt -81.84 40.58 0.61 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.829 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.525 HG12 HG22 ' A' ' 415' ' ' VAL . 96.2 mt -96.71 143.66 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.144 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -123.66 138.11 54.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.577 HD11 HD12 ' A' ' 377' ' ' LEU . 60.3 mt -131.73 96.23 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.136 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -63.75 124.46 21.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 409' ' ' PRO . 24.7 mt -109.84 136.16 49.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.935 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.5 t70 -56.72 134.67 55.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.806 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -5.82 55.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -97.31 -26.37 14.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.43 ' OG1' ' CG ' ' A' ' 408' ' ' LYS . 65.2 p -123.1 -36.16 2.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.074 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 95.17 -6.61 68.99 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.461 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . 0.43 ' CG ' ' OG1' ' A' ' 406' ' ' THR . 3.7 ptpt -86.97 159.42 51.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.592 0.711 . . . . 0.0 110.858 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.524 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.0 Cg_endo -69.76 92.57 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.61 2.207 . . . . 0.0 112.404 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -32.39 -51.98 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 153.77 -13.96 0.59 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -90.43 157.08 17.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.903 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -170.17 169.63 7.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.056 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.6 p -140.05 139.15 35.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.138 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.975 HG21 ' CD2' ' A' ' 381' ' ' PHE . 60.5 t -125.66 120.85 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . 0.46 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 4.8 m -95.46 116.42 28.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.827 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.434 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 60.4 m-85 -89.29 163.6 15.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.898 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -58.49 -66.35 0.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.831 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.5 m-20 -112.31 156.44 42.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.663 0.744 . . . . 0.0 110.793 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.37 -42.99 56.12 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.7 2.267 . . . . 0.0 112.349 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.3 Cg_exo -50.21 -32.63 33.17 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.638 2.225 . . . . 0.0 112.345 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 89.1 m -81.75 -38.57 25.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -62.33 -50.64 70.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.181 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.664 ' HG2' HD11 ' A' ' 444' ' ' LEU . 39.3 mtmt -58.94 -35.61 73.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.64 -32.05 57.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.25 -33.38 71.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.069 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.614 HG21 ' HG ' ' A' ' 444' ' ' LEU . 97.2 t -55.91 -63.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.13 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -65.73 -9.74 30.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.534 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.2 t-105 -83.77 -55.09 4.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.938 ' HB2' HG21 ' A' ' 442' ' ' VAL . 93.2 m-85 -87.29 -18.52 30.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.856 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.8 t70 -55.81 98.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 103.92 12.22 30.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.518 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.444 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 16.2 mmtm -71.05 175.03 5.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.766 0.317 . . . . 0.0 110.894 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 438' ' ' SER . 1.2 m-20 -121.72 127.94 51.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.576 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.1 t80 -123.92 100.74 6.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . 0.565 ' NE2' HD21 ' A' ' 369' ' ' ASN . 56.9 mt-30 62.17 36.85 14.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 93.3 -21.36 40.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.47 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 434' ' ' ASP . 24.4 p -85.53 166.84 15.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.96 0.41 . . . . 0.0 110.842 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . 0.426 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.7 tmmm? -112.43 137.02 51.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.576 HD11 ' HB2' ' A' ' 435' ' ' PHE . 1.4 mt -108.71 151.19 26.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -125.31 106.78 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.938 HG21 ' HB2' ' A' ' 430' ' ' PHE . 15.0 t -96.74 138.95 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 47.7 m -157.51 126.1 5.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.664 HD11 ' HG2' ' A' ' 424' ' ' LYS . 19.7 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.909 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.913 0.387 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -126.52 158.96 34.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.112 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.688 HD12 ' CG1' ' A' ' 442' ' ' VAL . 38.2 pt -130.76 143.3 41.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.154 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -102.57 110.9 22.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.99 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 12.0 t -95.13 142.23 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.149 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -146.66 121.09 9.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.88 14.49 2.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.519 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.498 HD13 HD11 ' A' ' 377' ' ' LEU . 96.7 mt -73.47 154.85 39.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -77.11 178.79 6.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.99 6.25 40.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.9 t -121.91 13.57 10.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.858 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . 0.471 HG21 HD21 ' A' ' 377' ' ' LEU . 11.7 p -74.31 138.02 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.156 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 35.4 p -122.45 158.7 29.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.825 HD11 ' HG2' ' A' ' 396' ' ' PRO . 17.6 tp -54.81 -60.4 3.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -50.9 -29.74 12.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -75.8 -34.24 60.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.641 HD12 HD11 ' A' ' 400' ' ' ILE . 53.0 mt -82.63 -27.96 31.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -74.26 -37.87 63.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.074 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.438 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 13.5 t70 -76.08 -21.58 56.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.848 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -92.53 -49.32 6.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.935 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.99 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.6 m-85 -63.82 -11.6 28.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.438 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 13.5 ptmt -88.63 -5.13 58.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -54.54 -54.04 46.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.51 -67.36 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -130.71 -127.43 2.89 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.514 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 78.3 t -125.86 130.78 72.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 111.195 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 56.0 t -82.0 128.58 38.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -50.03 105.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 82.7 mmm -100.57 124.08 45.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.404 ' CB ' ' OG1' ' A' ' 393' ' ' THR . 8.0 t-20 -50.38 144.78 7.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -94.46 -18.83 21.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -99.93 -44.1 6.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.404 ' OG1' ' CB ' ' A' ' 390' ' ' ASN . 25.6 p -92.18 -22.14 19.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.185 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 65.89 29.95 76.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -120.03 153.11 55.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.86 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.825 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.0 Cg_endo -69.83 145.72 57.6 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.721 2.281 . . . . 0.0 112.298 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.42 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 11.8 mmt -81.33 41.21 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.458 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 98.6 mt -98.76 140.86 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -121.05 140.25 52.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.641 HD11 HD12 ' A' ' 377' ' ' LEU . 61.3 mt -132.64 99.86 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -68.12 131.61 45.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 409' ' ' PRO . 26.0 mt -115.51 138.28 51.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.921 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 407' ' ' GLY . 6.0 t0 -59.53 124.52 20.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -71.34 -1.17 12.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -89.5 -39.66 13.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 82.8 p -121.72 -33.42 3.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 103.9 -4.49 45.84 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.523 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -82.54 152.86 67.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.6 0.714 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.561 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.1 Cg_endo -69.76 95.64 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.689 2.26 . . . . 0.0 112.336 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 409' ' ' PRO . 8.7 ptmt -32.76 -54.62 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.51 -13.87 0.52 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.2 p-10 -87.73 157.21 19.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.743 0.306 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.38 169.4 9.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.052 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 2.3 p -137.84 139.69 40.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.192 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.881 HG21 ' CD2' ' A' ' 381' ' ' PHE . 48.6 t -127.15 114.78 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . 0.42 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 2.8 m -91.11 112.17 23.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.841 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 68.8 m-85 -86.84 160.93 18.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.88 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -55.18 -67.44 0.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.83 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.517 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.4 m-20 -107.41 156.21 38.15 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.517 0.675 . . . . 0.0 110.942 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.34 -42.94 56.76 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.712 2.275 . . . . 0.0 112.324 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 53.0 Cg_exo -50.03 -46.82 26.35 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.733 2.289 . . . . 0.0 112.253 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 28.6 m -64.45 -43.77 93.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.17 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.727 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -58.85 -45.8 89.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.093 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.605 ' HG2' HD11 ' A' ' 444' ' ' LEU . 68.1 mttt -64.49 -35.33 80.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.03 -33.53 57.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.078 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -69.38 -33.87 73.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.075 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 423' ' ' ALA . 77.1 t -54.71 -61.43 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.55 -15.03 63.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.535 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -78.14 -52.39 8.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.903 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.748 ' HB2' HG21 ' A' ' 442' ' ' VAL . 89.1 m-85 -88.92 -16.68 31.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.869 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.0 t70 -59.9 97.04 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 111.57 1.26 27.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.547 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 19.5 mmtm -67.36 168.34 10.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.803 0.335 . . . . 0.0 110.956 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 434' ' ' ASP . 1.4 p-10 -115.78 111.55 20.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.657 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -111.27 106.55 15.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 61.42 37.73 16.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 74.6 23.61 74.79 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.415 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 36.5 m -132.35 128.78 38.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.919 0.39 . . . . 0.0 110.832 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.17 133.75 48.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.925 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.657 HD11 ' HB2' ' A' ' 435' ' ' PHE . 17.1 mt -101.05 156.81 17.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.96 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -129.74 100.58 5.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.886 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.748 HG21 ' HB2' ' A' ' 430' ' ' PHE . 14.2 t -100.58 131.89 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.171 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 444' ' ' LEU . 13.3 m -157.37 124.27 5.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.605 HD11 ' HG2' ' A' ' 424' ' ' LYS . 34.9 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.858 0.361 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -142.85 161.65 37.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.091 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.554 HD12 ' CG1' ' A' ' 442' ' ' VAL . 38.9 pt -135.52 141.14 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.113 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -100.03 122.04 42.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.897 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 8.1 t -107.5 141.75 21.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.076 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -145.62 123.59 12.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 126.54 16.33 2.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.458 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 93.9 mt -73.84 152.89 40.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 372' ' ' VAL . 6.1 p30 -73.96 -176.53 2.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.96 3.6 54.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.8 m -120.79 17.7 11.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . 0.423 ' N ' ' OD1' ' A' ' 369' ' ' ASN . 11.5 p -79.31 143.23 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.181 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 82.2 p -126.82 155.51 42.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.183 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.708 HD11 ' HG2' ' A' ' 396' ' ' PRO . 16.5 tp -49.64 -62.05 1.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -48.74 -37.85 20.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.83 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -66.53 -27.43 67.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 400' ' ' ILE . 89.6 mt -91.09 -30.06 16.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.66 -37.53 67.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.089 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.436 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 27.7 t70 -78.39 -19.63 52.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.895 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -92.61 -51.9 4.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.897 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 19.1 m-85 -60.34 -24.87 65.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.436 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 8.8 ptmt -70.87 -10.48 59.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.934 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -51.71 -57.4 9.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.3 t -53.93 -66.82 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -136.59 -122.67 2.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 75.4 t -126.01 130.66 72.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.92 0.39 . . . . 0.0 111.115 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.61 131.15 34.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -54.54 107.76 0.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . 0.467 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 64.0 mmm -104.35 122.76 46.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.449 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 14.4 t-20 -48.8 148.98 1.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -94.91 -22.38 18.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.85 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -93.98 -48.39 6.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.842 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.449 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 41.1 p -88.42 -24.07 23.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.098 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . 0.467 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 68.0 25.88 74.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.433 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -114.94 153.22 47.05 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.571 0.7 . . . . 0.0 110.965 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.708 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.4 Cg_endo -69.78 147.03 61.86 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.7 2.267 . . . . 0.0 112.339 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.471 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 15.0 mmt -81.27 41.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.638 HG12 HG22 ' A' ' 415' ' ' VAL . 96.2 mt -98.04 136.52 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.182 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -117.47 142.19 47.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.765 HD11 HD12 ' A' ' 377' ' ' LEU . 61.4 mt -134.81 94.08 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -61.17 121.84 13.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' A' ' 409' ' ' PRO . 31.3 mt -108.88 135.37 50.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.931 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 407' ' ' GLY . 11.7 t0 -55.33 122.36 10.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -69.89 -0.9 8.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.772 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -91.35 -41.21 11.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.6 p -118.78 -34.39 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 101.7 5.06 51.71 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.46 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -91.09 153.15 44.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.552 0.692 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.554 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.4 Cg_endo -69.76 91.89 0.51 Allowed 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.652 2.235 . . . . 0.0 112.372 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 409' ' ' PRO . 9.2 ptmt -31.67 -52.41 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.33 -17.13 0.59 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -87.63 157.22 19.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.856 0.36 . . . . 0.0 110.872 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.4 174.17 6.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 2.2 p -143.61 141.32 30.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.113 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.879 HG21 ' CD2' ' A' ' 381' ' ' PHE . 95.8 t -129.41 115.23 34.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . 0.471 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 1.9 m -90.67 114.76 27.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 51.8 m-85 -87.94 161.1 17.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -54.34 -66.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.835 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.517 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 7.1 m-20 -116.34 158.35 43.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.632 0.729 . . . . 0.0 110.878 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.8 Cg_exo -57.44 -43.23 53.44 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.71 2.273 . . . . 0.0 112.332 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 53.1 Cg_exo -49.99 -27.44 16.48 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.65 2.234 . . . . 0.0 112.374 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 40.4 m -89.61 -41.78 11.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.117 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.64 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.84 -48.89 79.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -59.7 -38.96 83.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.82 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -72.84 -32.99 65.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -69.09 -35.07 76.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 423' ' ' ALA . 94.7 t -55.27 -62.52 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -66.9 -11.11 55.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.551 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -81.02 -55.39 4.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.925 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.847 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.0 m-85 -87.34 -19.65 27.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.859 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.1 t70 -51.65 96.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.854 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 103.93 20.8 10.19 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.485 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.453 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 16.1 mmtm -76.81 170.99 15.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.769 0.319 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . 0.426 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 1.7 p30 -115.04 109.29 17.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.841 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.623 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.0 t80 -112.79 108.07 16.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 62.08 33.72 16.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 89.2 -16.38 55.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.448 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 3.1 m -92.66 164.04 13.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.964 0.411 . . . . 0.0 110.836 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -101.62 138.38 38.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 435' ' ' PHE . 12.4 mt -106.89 144.86 32.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -118.94 107.93 14.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.847 HG21 ' HB2' ' A' ' 430' ' ' PHE . 9.1 t -100.85 131.99 47.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.12 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 10.3 p -152.12 128.81 10.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.885 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.972 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 423' ' ' ALA . 3.8 p . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.896 0.379 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -108.86 158.71 17.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.468 ' CG1' ' HB ' ' A' ' 415' ' ' VAL . 28.9 pt -125.84 142.33 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -103.09 116.32 32.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.957 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 9.3 t -101.73 144.21 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.123 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -149.06 120.13 7.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.01 20.25 1.33 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.454 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.454 HD13 HD11 ' A' ' 377' ' ' LEU . 90.9 mt -79.94 154.53 28.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.808 0.337 . . . . 0.0 110.965 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -77.61 -178.53 5.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.69 3.5 52.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.0 t -118.83 15.72 13.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.859 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . 0.524 HG23 ' CE2' ' A' ' 435' ' ' PHE . 9.3 p -77.13 136.15 25.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 34.0 p -121.48 157.16 31.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.14 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.704 HD11 ' HG2' ' A' ' 396' ' ' PRO . 21.8 tp -53.75 -65.99 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -45.47 -32.75 2.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.21 -32.34 64.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.749 HD12 HD11 ' A' ' 400' ' ' ILE . 27.8 mt -82.59 -31.11 29.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.918 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -71.03 -44.93 64.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.107 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -72.57 -18.63 61.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -92.62 -41.6 10.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.957 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.3 m-85 -73.6 -25.01 60.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -67.06 -6.84 18.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.982 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -56.04 -60.19 3.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 35.2 t -49.46 -64.45 0.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.907 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -143.98 -122.55 1.64 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.451 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 69.0 t -121.79 122.04 65.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 0.0 111.131 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 81.8 t -77.53 127.75 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.226 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.472 ' CD ' ' HA ' ' A' ' 418' ' ' GLU . 33.2 tptt -46.09 103.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 73.0 mmm -103.32 126.33 50.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -51.43 145.7 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.92 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -94.59 -20.81 19.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -97.38 -45.47 6.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 25.0 p -90.72 -25.26 20.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 68.98 29.47 72.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -117.9 153.76 51.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.644 0.735 . . . . 0.0 110.927 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.704 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.0 Cg_endo -69.72 144.11 53.17 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.68 2.253 . . . . 0.0 112.379 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.435 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 15.2 mmt -82.1 40.26 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.625 HG12 HG22 ' A' ' 415' ' ' VAL . 96.4 mt -96.06 141.42 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.158 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -122.03 139.48 53.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.749 HD11 HD12 ' A' ' 377' ' ' LEU . 61.2 mt -132.08 94.48 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.126 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -61.29 130.11 44.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 409' ' ' PRO . 35.8 mt -114.36 136.82 52.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.861 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 407' ' ' GLY . 6.4 t0 -56.83 126.52 27.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.812 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.57 -1.15 17.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -92.02 -36.74 13.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 31.2 p -123.57 -33.6 3.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 101.64 -1.52 52.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.524 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -84.27 152.93 62.15 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.612 0.72 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.583 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.2 Cg_endo -69.76 92.42 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.306 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.48 ' C ' ' O ' ' A' ' 409' ' ' PRO . 8.1 ptmt -31.82 -51.99 0.23 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.86 -15.6 0.8 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.531 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -88.23 151.64 22.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -164.29 172.04 14.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.1 p -140.21 141.3 35.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.12 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.824 HG21 ' CD2' ' A' ' 381' ' ' PHE . 58.0 t -128.29 113.63 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.076 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . 0.435 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 2.1 m -87.48 119.25 27.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.558 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 37.2 m-85 -91.55 159.02 16.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.959 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . 0.472 ' HA ' ' CD ' ' A' ' 388' ' ' LYS . 15.9 mm-40 -58.2 -60.88 3.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.524 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.2 m-20 -113.69 156.9 42.96 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.568 0.699 . . . . 0.0 110.899 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.4 Cg_exo -57.01 -42.89 59.36 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.626 2.217 . . . . 0.0 112.323 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.5 Cg_exo -52.46 -41.99 64.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.727 2.285 . . . . 0.0 112.351 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 39.3 m -67.36 -40.82 85.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.167 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -62.18 -49.8 74.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.06 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.578 ' HG2' HD11 ' A' ' 444' ' ' LEU . 43.3 mtpt -60.15 -36.14 76.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.55 -33.05 58.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.115 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 417' ' ' TYR . . . -72.43 -33.24 66.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 423' ' ' ALA . 86.1 t -57.33 -62.06 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.179 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -68.12 -11.35 58.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.549 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.62 -54.81 5.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.846 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.7 m-85 -87.76 -19.6 27.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.4 t0 -54.15 89.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 116.46 13.99 7.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.533 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.472 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 2.4 mmmp? -79.44 176.2 9.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 0.0 110.903 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -121.36 126.9 50.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.781 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.2 t80 -126.24 105.53 8.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 62.58 31.01 17.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.889 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 83.94 18.38 63.38 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.527 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 19.4 m -128.6 126.67 40.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.969 0.414 . . . . 0.0 110.862 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.9 138.07 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.781 HD11 ' HB2' ' A' ' 435' ' ' PHE . 10.0 mt -108.89 147.49 32.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -119.37 108.5 14.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.846 HG21 ' HB2' ' A' ' 430' ' ' PHE . 13.0 t -100.85 132.2 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 9.5 p -151.7 127.54 10.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.806 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.719 ' HG ' HG21 ' A' ' 427' ' ' VAL . 16.4 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 417' ' ' TYR . 8.5 p . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.866 0.365 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -146.99 169.24 19.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.068 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.693 HD12 ' CG1' ' A' ' 442' ' ' VAL . 37.0 pt -144.96 142.68 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -101.1 113.11 25.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.979 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 19.3 t -96.19 144.22 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.123 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -150.23 119.55 6.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.4 23.38 1.01 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.574 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 71.6 mt -83.72 152.71 24.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 0.0 110.887 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . 0.505 ' ND2' ' CD ' ' A' ' 436' ' ' GLN . 5.0 p30 -74.61 179.34 4.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.41 1.08 52.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 14.3 m -117.29 13.65 14.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.845 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.37 133.59 31.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.129 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 81.6 p -117.56 163.98 15.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.149 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.766 HD11 ' HG2' ' A' ' 396' ' ' PRO . 16.3 tp -58.9 -62.77 1.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.08 -38.37 7.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.92 -31.8 73.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.55 HD12 HD11 ' A' ' 400' ' ' ILE . 84.5 mt -86.97 -30.32 21.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.959 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.17 -33.76 65.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.081 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.425 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 8.4 t70 -84.6 -19.4 33.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.493 ' CE1' ' NE2' ' A' ' 383' ' ' GLN . 47.0 t80 -91.92 -50.89 5.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.979 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 20.0 m-85 -61.72 -23.6 66.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.876 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.425 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 30.3 pttt -72.65 -6.95 47.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.865 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . 0.493 ' NE2' ' CE1' ' A' ' 380' ' ' PHE . 12.5 mt-30 -55.11 -51.91 64.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 7.3 t -62.79 -64.75 0.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -134.82 -129.87 2.93 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.49 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 50.3 t -122.07 129.11 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.808 0.337 . . . . 0.0 111.178 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.85 128.43 38.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -52.42 105.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.845 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 73.9 mmm -101.22 123.75 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.409 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 11.5 t-20 -50.1 147.27 4.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.844 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -94.71 -18.28 21.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . 0.456 ' HG3' HG23 ' A' ' 393' ' ' THR . 19.6 ptt180 -99.71 -44.22 6.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.456 HG23 ' HG3' ' A' ' 392' ' ' ARG . 67.0 p -93.53 -17.12 23.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 60.69 26.67 65.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.514 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -115.37 153.04 47.53 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.581 0.705 . . . . 0.0 110.942 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.766 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.5 Cg_endo -69.7 146.66 61.21 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.696 2.264 . . . . 0.0 112.362 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.407 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 6.8 mmt -81.37 41.15 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.926 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.466 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 90.6 mt -98.96 135.02 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.137 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -114.77 138.08 51.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.55 HD11 HD12 ' A' ' 377' ' ' LEU . 60.7 mt -130.79 94.2 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.163 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -61.78 123.82 19.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.545 HD23 ' HA ' ' A' ' 409' ' ' PRO . 45.3 mt -110.19 135.93 50.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 407' ' ' GLY . 11.1 t70 -55.42 124.37 16.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.932 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -73.09 -1.05 15.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -95.08 -35.12 12.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 37.2 p -121.24 -36.13 3.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.079 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 103.21 -6.99 51.21 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.551 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -82.55 153.04 67.87 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.592 0.71 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.545 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.8 Cg_endo -69.69 94.51 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.7 2.267 . . . . 0.0 112.372 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -32.58 -50.15 0.24 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.817 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 150.14 -15.3 1.01 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.468 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -88.15 154.99 20.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.777 0.322 . . . . 0.0 110.927 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.05 170.93 10.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.121 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 2.5 p -137.91 142.04 40.62 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.167 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.852 HG21 ' CD2' ' A' ' 381' ' ' PHE . 47.3 t -127.81 115.25 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . 0.407 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 1.9 m -92.65 114.97 27.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.493 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 54.2 m-85 -89.05 163.39 15.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.974 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -56.24 -65.49 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.517 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 4.7 m-20 -115.78 156.56 46.24 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.731 . . . . 0.0 110.842 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.2 Cg_exo -57.37 -42.89 57.11 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.636 2.224 . . . . 0.0 112.366 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.0 Cg_exo -50.69 -26.98 18.49 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.625 2.217 . . . . 0.0 112.361 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 52.9 m -89.05 -43.17 11.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.71 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -58.87 -48.13 82.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.522 ' HG2' HD11 ' A' ' 444' ' ' LEU . 7.9 mtmp? -59.86 -38.47 82.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.888 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.0 -32.83 63.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.079 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.73 -31.95 68.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 423' ' ' ALA . 90.5 t -56.32 -60.69 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.082 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -67.06 -12.45 59.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.554 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.53 -54.6 5.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.826 ' HB2' HG21 ' A' ' 442' ' ' VAL . 88.9 m-85 -88.26 -14.56 38.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.88 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.7 OUTLIER -58.49 93.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 108.1 14.72 16.06 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.466 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.413 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 15.7 mmtm -73.92 169.67 16.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.76 0.315 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -112.28 112.92 24.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.566 ' HB3' HD21 ' A' ' 440' ' ' LEU . 4.4 t80 -115.47 106.48 14.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . 0.505 ' CD ' ' ND2' ' A' ' 369' ' ' ASN . 69.1 mt-30 61.59 38.56 15.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.968 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 84.49 -14.53 45.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.5 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 6.1 m -94.25 168.92 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.815 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -106.62 135.95 47.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 435' ' ' PHE . 9.4 mt -102.69 145.05 30.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -119.78 107.39 13.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.832 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.826 HG21 ' HB2' ' A' ' 430' ' ' PHE . 6.3 t -103.08 136.26 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.1 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 444' ' ' LEU . 22.0 m -157.3 126.38 5.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.522 HD11 ' HG2' ' A' ' 424' ' ' LYS . 19.4 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.891 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.866 0.365 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -145.68 156.73 43.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.105 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.468 ' HB ' ' CG1' ' A' ' 442' ' ' VAL . 44.8 pt -128.67 140.12 50.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -98.75 111.36 23.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.918 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 13.0 t -95.19 140.09 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.148 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -147.39 122.4 10.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 131.81 6.07 3.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.517 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.487 HD13 HD11 ' A' ' 377' ' ' LEU . 19.8 mt -71.99 156.42 39.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.871 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . 0.603 ' H ' ' ND2' ' A' ' 369' ' ' ASN . 0.3 OUTLIER -83.88 175.37 9.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -83.61 7.45 17.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.5 t -116.92 3.51 12.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . 0.405 HG21 HD22 ' A' ' 368' ' ' LEU . 5.0 p -75.05 134.61 29.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.083 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 41.1 p -113.59 170.69 8.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.155 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.709 HD11 ' HG2' ' A' ' 396' ' ' PRO . 12.0 tp -65.93 -65.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -45.59 -26.58 0.62 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -73.41 -36.39 65.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.828 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.487 HD11 HD13 ' A' ' 368' ' ' LEU . 81.1 mt -87.32 -25.48 23.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.6 -35.3 72.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -89.15 -15.04 34.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -92.53 -42.58 9.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.918 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 20.3 m-85 -72.49 -22.19 61.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 2.7 ptmm? -68.87 -5.05 18.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -56.13 -59.99 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 4.1 t -52.8 -64.26 0.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -139.05 -123.43 2.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.445 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 92.8 t -125.53 131.41 72.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 111.099 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 64.7 t -82.52 122.36 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -47.06 110.39 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . 0.478 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 27.9 mtp -107.94 128.75 54.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.879 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -54.83 147.6 14.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 391' ' ' LYS . 0.0 OUTLIER -94.63 -14.25 25.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . 0.445 ' HG3' HG23 ' A' ' 393' ' ' THR . 14.9 ptm180 -101.09 -46.5 5.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.836 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.445 HG23 ' HG3' ' A' ' 392' ' ' ARG . 67.3 p -91.76 -19.28 22.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.118 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . 0.478 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 64.89 19.9 66.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.464 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -107.64 152.65 41.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 0.0 110.917 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.709 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.7 Cg_endo -69.81 147.41 62.47 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.66 2.24 . . . . 0.0 112.38 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 11.0 mmt -81.36 41.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.477 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 91.8 mt -98.63 135.97 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . 0.42 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 7.3 t60 -115.59 138.07 51.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.827 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 67.0 mt -134.41 94.0 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.095 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -59.63 122.34 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.931 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' A' ' 409' ' ' PRO . 49.0 mt -106.76 136.35 46.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.939 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 407' ' ' GLY . 1.5 t70 -55.14 125.93 22.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -73.1 -1.24 16.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.441 ' CG ' ' OD1' ' A' ' 403' ' ' ASP . 3.4 mm-40 -96.48 -36.59 10.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 34.6 p -119.74 -35.22 3.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 100.25 -1.02 56.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.507 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -86.8 155.95 55.7 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.597 0.713 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.53 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.9 Cg_endo -69.75 91.3 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.72 2.28 . . . . 0.0 112.272 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.482 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -31.49 -48.45 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.864 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 148.95 -10.63 1.03 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -95.35 154.53 17.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 0.0 110.828 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -168.39 171.47 9.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.13 128.63 20.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.896 HG21 ' CD2' ' A' ' 381' ' ' PHE . 62.5 t -112.3 118.38 57.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 3.2 m -92.59 116.08 28.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.849 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.541 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 52.9 m-85 -89.74 160.3 16.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -57.5 -63.97 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.509 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.7 m-20 -115.59 156.66 45.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.625 0.726 . . . . 0.0 110.845 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.8 Cg_exo -57.4 -43.02 55.66 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.705 2.27 . . . . 0.0 112.3 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 61.7 Cg_exo -48.68 -29.43 14.44 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 90.7 m -88.58 -39.45 14.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.133 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.58 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -61.5 -50.23 73.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -60.08 -38.5 83.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.98 -31.29 61.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.104 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . 0.421 ' CB ' ' CE2' ' A' ' 417' ' ' TYR . . . -70.04 -33.81 72.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.156 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 423' ' ' ALA . 76.3 t -55.85 -64.11 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.157 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -64.99 -12.58 51.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.534 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -80.16 -54.64 5.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.77 ' HB2' HG21 ' A' ' 442' ' ' VAL . 90.9 m-85 -89.47 -14.1 36.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.7 t0 -58.15 99.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.768 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 99.79 22.85 11.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.53 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.447 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 19.9 mmtt -78.72 167.92 20.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.794 0.33 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 4.3 p-10 -110.7 108.29 18.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.792 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.738 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.6 t80 -115.42 108.33 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.82 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 61.28 36.94 17.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 75.2 21.17 78.44 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.555 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 72.1 m -130.85 129.69 42.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.908 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -70.27 136.56 49.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.738 HD11 ' HB2' ' A' ' 435' ' ' PHE . 8.0 mt -104.66 157.41 17.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.894 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -130.39 106.01 8.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.77 HG21 ' HB2' ' A' ' 430' ' ' PHE . 10.2 t -103.1 133.06 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.106 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 84.7 p -150.04 132.21 15.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.441 ' HG ' HG21 ' A' ' 427' ' ' VAL . 24.3 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.902 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.913 0.387 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -140.25 155.83 46.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.102 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.768 HD12 ' CG1' ' A' ' 442' ' ' VAL . 31.4 pt -128.85 143.48 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.102 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.69 123.35 44.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.943 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 11.3 t -107.45 139.34 29.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.135 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -145.79 122.87 11.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 128.63 11.11 3.06 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.518 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.423 HD22 HG21 ' A' ' 372' ' ' VAL . 30.6 mt -70.98 155.84 40.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.798 0.332 . . . . 0.0 110.921 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . 0.478 ' OD1' ' NE2' ' A' ' 436' ' ' GLN . 6.6 p30 -78.2 174.46 11.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.68 14.53 5.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.4 t -131.71 19.57 4.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.831 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . 0.423 HG21 HD22 ' A' ' 368' ' ' LEU . 8.2 p -82.69 130.15 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.133 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 58.8 p -110.44 156.69 20.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.141 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.978 HD11 ' HG2' ' A' ' 396' ' ' PRO . 9.1 tp -54.46 -54.16 44.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -54.57 -35.13 62.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -69.88 -28.49 65.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.754 HD12 HD11 ' A' ' 400' ' ' ILE . 60.2 mt -89.42 -29.06 19.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -71.67 -38.48 70.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.436 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 8.9 t70 -82.56 -17.37 45.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -92.67 -41.73 10.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.943 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 15.2 m-85 -71.95 -16.91 62.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.436 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 9.5 ptpt -77.79 -6.59 54.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -55.74 -50.28 70.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.0 t -62.14 -60.84 3.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.91 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -142.65 -126.46 2.08 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.82 128.81 75.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 0.0 111.195 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 84.2 t -84.9 130.05 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.099 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -54.8 113.29 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . 0.501 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 43.7 mmm -109.74 123.63 49.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -49.55 144.15 6.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -94.75 -8.39 37.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -101.9 -46.82 4.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 35.0 p -97.42 -16.63 20.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.101 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . 0.501 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 65.6 26.66 72.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.568 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -112.43 152.95 44.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.557 0.694 . . . . 0.0 110.967 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.978 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.6 Cg_endo -69.69 149.12 66.91 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.74 2.293 . . . . 0.0 112.333 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 7.0 mmt -82.69 38.09 0.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.469 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 91.8 mt -95.98 140.97 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.158 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . 0.408 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 5.5 t60 -121.5 138.01 54.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.754 HD11 HD12 ' A' ' 377' ' ' LEU . 61.6 mt -131.1 93.83 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.076 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -59.44 124.4 19.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.965 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 409' ' ' PRO . 35.1 mt -107.9 137.16 46.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.891 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 407' ' ' GLY . 8.1 t0 -55.46 123.92 15.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -71.2 -1.12 11.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -96.08 -39.1 9.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 33.0 p -117.31 -35.43 4.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 101.23 -1.65 54.35 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.446 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -85.94 155.55 58.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.646 0.736 . . . . 0.0 110.856 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.533 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.1 Cg_endo -69.76 90.95 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.702 2.268 . . . . 0.0 112.279 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.482 ' C ' ' O ' ' A' ' 409' ' ' PRO . 2.3 ptmt -31.73 -53.89 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 155.01 -15.96 0.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.507 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -88.9 156.99 18.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.769 0.319 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -168.93 175.23 5.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.14 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.56 132.71 23.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.147 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.92 HG21 ' CD2' ' A' ' 381' ' ' PHE . 38.8 t -118.87 113.3 41.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.168 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 2.6 m -89.54 116.78 27.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.487 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 57.7 m-85 -93.04 164.18 13.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -56.84 -66.46 0.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.939 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.52 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.4 m-20 -114.54 156.97 43.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.614 0.721 . . . . 0.0 110.83 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.34 -42.97 56.48 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.634 2.223 . . . . 0.0 112.355 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.1 Cg_exo -50.53 -27.19 18.35 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.652 2.235 . . . . 0.0 112.412 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 29.4 m -87.91 -42.36 12.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.843 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -60.44 -41.42 93.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.113 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.469 ' HG2' HD11 ' A' ' 444' ' ' LEU . 35.9 mtpt -65.77 -38.36 88.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.38 -30.89 62.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.138 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -72.1 -30.78 65.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 423' ' ' ALA . 64.0 t -58.74 -63.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.144 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -64.23 -13.21 47.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.523 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -80.08 -54.65 5.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.919 ' HB2' HG21 ' A' ' 442' ' ' VAL . 79.3 m-85 -87.56 -14.06 41.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.4 t70 -61.51 95.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 117.8 -19.05 11.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.496 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.422 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 2.5 mmmp? -47.88 176.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.764 0.316 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -124.53 130.4 52.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.811 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.631 ' HB2' HD11 ' A' ' 440' ' ' LEU . 1.1 t80 -129.75 107.27 9.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . 0.478 ' NE2' ' OD1' ' A' ' 369' ' ' ASN . 63.7 mt-30 61.8 32.53 18.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 81.12 19.53 66.89 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.465 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 12.2 m -128.11 129.31 46.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.911 0.386 . . . . 0.0 110.844 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -68.67 134.52 49.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 435' ' ' PHE . 22.1 mt -100.81 143.07 31.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -119.37 101.81 8.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.919 HG21 ' HB2' ' A' ' 430' ' ' PHE . 14.0 t -99.27 129.8 49.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.143 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.5 m -154.21 128.46 9.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.866 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.469 HD11 ' HG2' ' A' ' 424' ' ' LYS . 28.6 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.967 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.867 0.365 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -137.39 164.78 27.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.485 HD12 ' CG1' ' A' ' 442' ' ' VAL . 36.7 pt -138.32 142.22 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.11 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -102.52 115.25 30.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.977 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.938 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 12.1 t -101.35 142.59 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -150.55 122.29 8.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 133.16 6.82 2.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.455 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.46 HD23 HD22 ' A' ' 440' ' ' LEU . 28.2 mt -72.82 156.4 38.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.812 0.339 . . . . 0.0 110.954 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.62 179.86 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.81 6.1 33.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.78 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 10.9 t -114.23 4.21 15.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.839 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . 0.486 HG21 HD21 ' A' ' 377' ' ' LEU . 6.2 p -76.1 139.06 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.107 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 68.9 p -122.21 173.88 7.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.755 HD11 ' HG2' ' A' ' 396' ' ' PRO . 14.9 tp -67.29 -63.3 1.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -47.64 -28.63 2.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.909 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.07 -32.6 56.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.523 HD12 HD11 ' A' ' 400' ' ' ILE . 48.4 mt -84.78 -27.94 26.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.872 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.77 -37.29 65.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.431 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 21.7 t0 -78.75 -20.25 50.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -92.69 -51.31 5.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.938 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 15.9 m-85 -60.01 -24.64 64.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.431 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -71.27 -15.08 62.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.894 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -45.35 -53.58 8.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 38.3 t -59.23 -69.0 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.14 -124.99 2.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.47 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 67.1 t -124.73 135.25 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.921 0.391 . . . . 0.0 111.113 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.16 131.57 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -55.8 111.74 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.955 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . 0.434 ' SD ' ' CA ' ' A' ' 396' ' ' PRO . 64.7 mmm -106.8 121.72 44.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -48.3 148.15 2.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -94.77 -19.16 20.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -96.78 -46.67 6.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.816 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 37.1 p -91.09 -21.7 21.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 65.6 27.93 73.1 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.507 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -117.18 153.24 49.77 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.532 0.682 . . . . 0.0 110.932 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.755 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.2 Cg_endo -69.79 146.99 61.64 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.694 2.262 . . . . 0.0 112.293 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.419 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.5 mmt -81.17 41.47 0.6 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.466 HG12 HG22 ' A' ' 415' ' ' VAL . 96.7 mt -99.27 135.93 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.18 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . 0.434 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 6.0 t60 -115.5 141.03 48.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.523 HD11 HD12 ' A' ' 377' ' ' LEU . 67.6 mt -134.12 93.72 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -59.71 122.35 13.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.539 HD23 ' HA ' ' A' ' 409' ' ' PRO . 45.0 mt -107.57 136.4 47.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.889 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 407' ' ' GLY . 2.0 t70 -55.19 133.63 49.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.09 -6.54 57.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -97.46 -22.88 16.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 69.5 p -128.17 -36.06 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 94.8 0.54 64.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.507 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -90.7 156.93 44.6 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.615 0.721 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.539 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.3 Cg_endo -69.73 89.38 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 0.0 112.392 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.489 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.1 OUTLIER -30.54 -54.74 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 156.77 -15.27 0.36 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.482 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -91.22 153.53 19.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.909 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -166.87 174.85 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.083 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 3.0 p -141.78 143.37 33.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.154 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.827 HG21 ' CD2' ' A' ' 381' ' ' PHE . 45.3 t -130.69 119.87 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . 0.419 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 2.1 m -94.66 114.01 25.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 50.4 m-85 -86.8 162.32 17.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.41 -65.5 0.6 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.522 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 4.5 m-20 -115.5 157.72 43.44 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.669 0.747 . . . . 0.0 110.843 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.2 Cg_exo -57.16 -43.11 56.2 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.617 2.212 . . . . 0.0 112.371 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.4 Cg_exo -50.81 -29.37 26.13 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.648 2.232 . . . . 0.0 112.369 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 40.9 m -86.26 -39.27 16.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.185 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.504 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -62.3 -53.95 47.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.093 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.641 ' HG2' HD11 ' A' ' 444' ' ' LEU . 32.6 mtmt -56.51 -33.94 66.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.81 -32.07 52.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.063 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -72.1 -33.81 68.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.084 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.515 HG21 ' HG ' ' A' ' 444' ' ' LEU . 77.8 t -55.17 -61.58 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -66.59 -12.79 59.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.548 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.76 -54.31 5.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.851 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.3 m-85 -88.75 -18.01 28.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.835 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.6 t70 -52.93 97.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 100.95 23.56 9.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.503 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.451 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 25.0 mmtt -76.5 175.87 8.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.32 . . . . 0.0 110.906 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.39 112.33 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.684 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -108.12 98.61 8.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.886 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 61.04 35.25 18.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 96.37 -21.55 44.87 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.45 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.2 p -82.55 152.77 25.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.976 0.417 . . . . 0.0 110.834 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . 0.495 ' C ' HD23 ' A' ' 440' ' ' LEU . 25.8 ttpt -99.72 130.75 45.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.684 HD11 ' HB2' ' A' ' 435' ' ' PHE . 1.1 mt -105.81 144.39 32.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.954 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -122.02 107.7 12.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.851 HG21 ' HB2' ' A' ' 430' ' ' PHE . 7.1 t -100.23 135.52 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 10.0 p -155.99 130.72 9.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.816 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.641 HD11 ' HG2' ' A' ' 424' ' ' LYS . 19.2 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.78 0.324 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -123.39 156.7 34.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.153 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.43 ' CG1' ' HB ' ' A' ' 415' ' ' VAL . 29.4 pt -126.08 142.74 41.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.085 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -104.5 111.68 24.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.994 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 1.033 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 8.5 t -95.7 141.09 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.148 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -145.67 120.3 9.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.1 19.95 1.51 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.479 HD13 HD11 ' A' ' 377' ' ' LEU . 90.3 mt -78.68 151.74 32.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.768 0.318 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -74.68 -176.36 2.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.23 4.62 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.5 t -120.32 17.67 12.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.3 p -80.64 136.72 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.178 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 77.5 p -121.3 162.47 20.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.134 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.876 HD11 ' HG2' ' A' ' 396' ' ' PRO . 17.8 tp -57.28 -66.1 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -45.98 -30.19 1.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.95 -34.04 66.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.83 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.551 HD12 HD11 ' A' ' 400' ' ' ILE . 54.1 mt -85.5 -28.99 24.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.853 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.64 -28.88 62.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.414 ' HA ' ' NZ ' ' A' ' 382' ' ' LYS . 10.4 t70 -84.99 -22.34 29.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.437 ' CE2' ' CD1' ' A' ' 430' ' ' PHE . 68.0 t80 -92.63 -48.14 6.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 1.033 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 17.7 m-85 -62.57 -21.02 65.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.414 ' NZ ' ' HA ' ' A' ' 379' ' ' ASP . 2.0 ptpp? -78.19 -4.57 48.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -56.05 -57.92 10.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.947 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . 0.567 ' SG ' ' CE3' ' A' ' 429' ' ' TRP . 1.9 t -56.38 -64.63 0.8 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.68 -127.22 2.74 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.409 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 77.3 t -125.87 131.51 71.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.897 0.38 . . . . 0.0 111.183 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 57.3 t -84.55 128.44 38.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -51.04 105.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' A' ' 396' ' ' PRO . 64.1 mmm -101.55 122.13 43.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -46.52 145.65 1.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -94.39 -21.58 18.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -96.25 -46.93 6.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 30.2 p -88.94 -26.63 21.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 70.25 32.08 68.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.477 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -121.07 153.66 57.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.586 0.707 . . . . 0.0 110.95 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.876 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.3 Cg_endo -69.8 145.15 56.05 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.677 2.251 . . . . 0.0 112.276 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.448 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 7.0 mmt -81.52 41.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.827 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.548 HG12 HG22 ' A' ' 415' ' ' VAL . 94.4 mt -97.97 142.75 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.156 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -120.98 141.34 50.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.551 HD11 HD12 ' A' ' 377' ' ' LEU . 60.1 mt -134.91 94.73 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.189 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -62.44 127.41 31.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 409' ' ' PRO . 37.0 mt -112.11 134.56 53.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.878 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 407' ' ' GLY . 13.1 t0 -55.43 120.21 6.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.856 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -1.98 8.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -88.0 -39.67 14.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 33.4 p -121.88 -35.92 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 107.27 -0.87 35.07 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.47 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -86.53 152.56 54.87 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.53 0.681 . . . . 0.0 110.935 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.49 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.8 Cg_endo -69.71 94.82 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.748 2.299 . . . . 0.0 112.321 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 409' ' ' PRO . 8.4 ptmt -33.19 -52.02 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.883 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.65 -14.39 0.8 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -89.88 149.01 22.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.785 0.326 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -162.09 170.17 19.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.067 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.4 p -138.96 143.29 38.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.184 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.853 HG21 ' CD2' ' A' ' 381' ' ' PHE . 59.4 t -129.01 118.58 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.17 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . 0.448 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 17.3 m -92.67 114.03 26.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.552 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 43.6 m-85 -86.82 165.68 15.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -61.4 -64.28 1.0 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.846 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.518 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.9 m-20 -112.63 156.68 42.04 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.672 0.749 . . . . 0.0 110.789 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.3 Cg_exo -57.11 -43.0 57.48 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.654 2.236 . . . . 0.0 112.339 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.5 Cg_exo -50.96 -43.15 49.2 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.708 2.272 . . . . 0.0 112.361 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 52.3 m -67.8 -43.22 80.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.111 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.552 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -57.2 -57.61 11.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.1 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.786 ' HG2' HD11 ' A' ' 444' ' ' LEU . 23.2 mtmm -51.89 -36.96 50.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.85 64.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . 0.482 ' CB ' ' CE2' ' A' ' 417' ' ' TYR . . . -69.51 -30.8 68.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.052 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.568 HG21 ' HG ' ' A' ' 444' ' ' LEU . 85.0 t -58.66 -62.14 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.159 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -67.5 -9.71 44.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.567 ' CE3' ' SG ' ' A' ' 384' ' ' CYS . 1.2 t-105 -82.44 -54.16 5.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.972 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.854 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.2 m-85 -89.05 -20.96 23.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.491 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.0 OUTLIER -49.7 94.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.823 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.15 20.29 9.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.535 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.469 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 14.3 mmtm -78.11 161.47 27.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.842 0.353 . . . . 0.0 110.851 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -107.08 106.45 16.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.667 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -107.17 110.11 22.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 58.22 35.26 24.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 89.76 -18.94 44.18 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.519 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.4 m -90.35 164.21 14.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.4 . . . . 0.0 110.886 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.86 140.53 33.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 435' ' ' PHE . 11.4 mt -108.06 139.66 42.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -115.82 103.93 11.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.854 HG21 ' HB2' ' A' ' 430' ' ' PHE . 19.2 t -99.34 132.37 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.077 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 9.5 p -151.6 132.35 14.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.824 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.786 HD11 ' HG2' ' A' ' 424' ' ' LYS . 12.5 mt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.868 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.458 -0.047 0 CA-C-O 120.905 0.383 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -130.92 166.68 20.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.077 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.756 HD12 HG11 ' A' ' 442' ' ' VAL . 39.8 pt -134.7 142.49 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -99.31 115.02 28.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 4.5 t -103.06 142.31 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.128 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -149.12 124.84 10.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.27 12.59 2.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.489 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.521 HD13 HD11 ' A' ' 377' ' ' LEU . 30.2 mt -77.84 156.38 30.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.9 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.72 -179.32 7.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.945 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.92 -2.02 58.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 39.4 t -106.14 3.14 27.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.782 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 12.2 p -69.46 144.77 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 80.7 p -127.85 170.6 12.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.16 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.853 HD11 ' HG2' ' A' ' 396' ' ' PRO . 12.1 tp -68.26 -49.69 58.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -59.74 -34.46 72.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.841 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.37 -31.41 68.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.659 HD12 HD11 ' A' ' 400' ' ' ILE . 60.0 mt -87.96 -28.09 21.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.932 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.41 -35.83 68.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.431 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 12.5 t70 -85.36 -17.92 35.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -92.31 -43.94 9.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.944 ' CD2' HG21 ' A' ' 415' ' ' VAL . 15.8 m-85 -69.9 -21.85 63.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.861 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.431 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -72.9 -9.49 58.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.947 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -50.08 -54.65 19.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 3.5 t -58.88 -65.9 0.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -135.19 -126.34 2.6 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.462 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 93.2 t -124.44 131.29 72.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.837 0.351 . . . . 0.0 111.177 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 57.0 t -82.44 126.03 39.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -49.22 107.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . 0.468 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 19.5 mtp -104.47 122.3 45.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -50.73 147.07 5.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -94.59 -18.41 21.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -95.22 -47.89 6.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 37.8 p -90.36 -26.85 19.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.202 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . 0.468 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 73.39 20.32 79.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -108.97 152.81 42.63 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.546 0.688 . . . . 0.0 110.978 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.853 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.0 Cg_endo -69.81 147.73 63.18 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.636 2.224 . . . . 0.0 112.345 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 9.5 mmt -81.52 40.96 0.6 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.469 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.1 mt -98.82 136.36 30.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -115.71 136.17 53.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.659 HD11 HD12 ' A' ' 377' ' ' LEU . 67.7 mt -132.33 93.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -59.17 124.54 20.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.522 HD23 ' HA ' ' A' ' 409' ' ' PRO . 35.1 mt -109.34 135.14 50.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.9 t0 -55.37 128.1 32.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -75.11 -1.0 21.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -93.66 -31.24 14.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.9 p -128.32 -35.89 1.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.089 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 100.57 9.92 45.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.501 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -95.7 155.62 38.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.533 0.682 . . . . 0.0 110.944 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.522 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.6 Cg_endo -69.78 89.47 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.629 2.219 . . . . 0.0 112.381 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 409' ' ' PRO . 5.1 ptmt -31.58 -53.23 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 155.64 -14.68 0.44 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -90.64 155.07 19.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.5 169.47 10.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.3 p -141.79 124.16 15.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.173 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.944 HG21 ' CD2' ' A' ' 381' ' ' PHE . 59.3 t -109.33 121.35 62.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 2.2 m -95.96 114.08 25.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.914 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.529 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 67.2 m-85 -87.1 162.85 17.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -57.63 -67.12 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.52 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 5.7 m-20 -111.6 157.55 38.99 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.626 0.727 . . . . 0.0 110.858 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.16 -43.0 57.28 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.696 2.264 . . . . 0.0 112.319 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.3 Cg_exo -50.81 -31.24 32.5 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.672 2.248 . . . . 0.0 112.299 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 23.6 m -84.26 -37.72 21.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.105 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.622 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -64.55 -47.86 77.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.074 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.606 ' HG2' HD11 ' A' ' 444' ' ' LEU . 65.4 mttt -62.4 -36.56 82.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.01 -31.24 58.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . 0.407 ' CB ' ' CZ ' ' A' ' 417' ' ' TYR . . . -70.39 -31.88 69.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.649 HG21 ' HG ' ' A' ' 444' ' ' LEU . 94.2 t -57.18 -64.02 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.196 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.0 -11.55 29.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.526 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -81.3 -54.33 5.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.753 ' HB2' HG21 ' A' ' 442' ' ' VAL . 89.7 m-85 -89.79 -13.39 36.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.2 t0 -60.23 95.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 108.29 -0.03 33.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.465 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.454 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 18.7 mmtt -61.13 173.75 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.773 0.32 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -121.18 120.61 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.909 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.782 ' HB2' HD11 ' A' ' 440' ' ' LEU . 5.4 t80 -117.85 105.12 11.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 62.36 26.09 15.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.903 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 97.27 -16.47 60.69 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.539 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 75.5 m -96.8 127.02 42.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.949 0.404 . . . . 0.0 110.817 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -71.12 140.22 50.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.782 HD11 ' HB2' ' A' ' 435' ' ' PHE . 10.6 mt -108.87 151.65 25.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.953 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -122.63 108.16 12.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.912 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.756 HG11 HD12 ' A' ' 363' ' ' ILE . 10.4 t -104.36 135.49 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.197 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.4 m -154.86 127.49 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.891 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.649 ' HG ' HG21 ' A' ' 427' ' ' VAL . 24.6 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.827 0.346 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.99 159.13 22.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.074 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.698 HD12 ' CG1' ' A' ' 442' ' ' VAL . 38.6 pt -131.8 142.28 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -98.72 117.38 33.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.879 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 15.7 t -102.34 141.94 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.137 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -148.83 122.58 9.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.43 18.82 1.59 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.418 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.536 HD13 HD11 ' A' ' 377' ' ' LEU . 64.6 mt -80.87 154.4 27.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . 0.423 ' H ' ' ND2' ' A' ' 369' ' ' ASN . 2.6 p30 -81.44 171.01 15.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.84 6.59 10.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 31.7 m -119.67 14.43 12.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . 0.404 HG21 HD22 ' A' ' 368' ' ' LEU . 6.5 p -79.58 137.33 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.148 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 74.8 p -119.93 156.82 30.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.174 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.942 HD11 ' HG2' ' A' ' 396' ' ' PRO . 11.6 tp -53.24 -60.69 2.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -51.76 -33.58 35.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.796 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.47 -29.74 68.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.536 HD11 HD13 ' A' ' 368' ' ' LEU . 49.1 mt -89.9 -29.5 18.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.78 72.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.086 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' ASP . . . . . 0.43 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 21.1 t70 -80.38 -18.91 47.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -92.47 -52.93 4.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.879 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 28.3 m-85 -59.58 -21.66 60.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.43 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 2.6 ptmm? -75.38 -6.1 48.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -58.62 -56.25 24.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 28.3 t -57.57 -63.09 1.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.839 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -136.02 -126.54 2.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.463 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 76.2 t -125.46 133.92 68.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 111.124 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 68.4 t -87.14 129.97 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.163 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -56.62 106.85 0.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' MET . . . . . 0.5 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 47.6 mmm -103.34 125.94 50.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.869 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' ASN . . . . . 0.402 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 15.5 t-20 -51.14 148.88 4.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -94.88 -17.99 21.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.944 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -97.28 -48.32 5.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.402 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 38.2 p -90.63 -17.95 25.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.173 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . 0.5 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 62.16 27.47 69.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.436 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -114.63 153.19 46.78 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.608 0.718 . . . . 0.0 110.922 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.942 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.7 Cg_endo -69.68 146.64 61.28 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.67 2.247 . . . . 0.0 112.366 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.45 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.8 mmt -81.25 41.26 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.846 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.473 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.1 mt -98.64 136.4 29.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.124 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' HIS . . . . . 0.528 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 9.2 t60 -115.64 142.24 47.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.402 HD11 HD12 ' A' ' 377' ' ' LEU . 66.9 mt -134.86 94.03 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.084 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -59.7 125.28 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 409' ' ' PRO . 50.0 mt -109.13 136.7 48.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.971 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.4 t0 -55.24 132.33 47.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -79.74 -5.58 55.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -97.3 -24.05 15.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 70.4 p -128.15 -36.09 1.97 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.135 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 97.4 -4.49 62.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.565 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -85.69 156.05 58.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.56 0.695 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.484 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.2 Cg_endo -69.78 91.37 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.738 2.292 . . . . 0.0 112.305 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.48 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.1 OUTLIER -31.67 -51.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.873 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.46 -12.0 0.76 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -93.68 152.79 18.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.83 0.348 . . . . 0.0 110.846 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -165.68 173.4 10.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 p -138.81 140.63 38.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.172 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.758 HG21 ' CD2' ' A' ' 381' ' ' PHE . 46.0 t -124.77 116.93 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.144 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' SER . . . . . 0.45 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 13.4 m -92.85 112.16 24.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' TYR . . . . . 0.51 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 59.0 m-85 -86.84 161.41 18.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.897 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.86 -66.51 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.953 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.4 m-20 -115.17 156.72 45.12 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.617 0.723 . . . . 0.0 110.848 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.591 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.31 -42.97 56.64 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.659 2.239 . . . . 0.0 112.373 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.8 Cg_exo -50.42 -26.85 17.05 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.743 2.295 . . . . 0.0 112.323 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 56.0 m -89.09 -41.07 12.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -60.23 -47.31 86.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.077 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.431 ' HG2' HD11 ' A' ' 444' ' ' LEU . 80.7 mttt -60.92 -38.11 84.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.24 -34.59 63.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.029 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.99 -32.62 72.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 423' ' ' ALA . 70.1 t -56.04 -60.02 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.061 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -67.62 -13.89 62.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' TRP . . . . . 0.551 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -78.75 -55.14 5.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.861 ' HB2' HG21 ' A' ' 442' ' ' VAL . 82.8 m-85 -87.41 -14.81 39.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.6 OUTLIER -55.74 93.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.875 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.8 21.54 8.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.505 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' LYS . . . . . 0.459 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 15.5 mmtm -77.3 176.78 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.7 124.82 44.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.803 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.763 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.0 t80 -128.16 100.44 5.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 62.52 34.52 15.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.902 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 82.4 19.96 63.25 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.468 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 19.7 p -126.36 130.09 50.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 110.868 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' LYS . . . . . 0.413 ' C ' HD23 ' A' ' 440' ' ' LEU . 19.8 ttpt -75.95 131.37 39.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.861 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.763 HD11 ' HB2' ' A' ' 435' ' ' PHE . 5.8 mt -105.49 133.83 49.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.59 113.71 27.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.861 HG21 ' HB2' ' A' ' 430' ' ' PHE . 9.2 t -107.8 131.19 58.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.096 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 2.7 m -156.89 130.98 8.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.772 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.431 HD11 ' HG2' ' A' ' 424' ' ' LYS . 26.5 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 8.3 t -105.55 153.25 22.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.876 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 34.9 t -86.6 132.76 33.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.934 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 87.43 127.61 2.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 23.3 m -88.03 94.78 9.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.937 0.398 . . . . 0.0 110.834 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 47.7 t -98.29 82.77 2.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.819 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 68.21 132.17 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.51 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -107.18 147.2 34.72 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.618 0.723 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 154.29 68.05 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.705 2.27 . . . . 0.0 112.33 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -170.69 167.72 7.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -65.98 112.81 4.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -99.82 44.7 1.01 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.947 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 359' ' ' ASP . 20.1 m -79.4 70.41 5.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.854 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 358' ' ' SER . 3.9 m-20 -37.3 -37.75 0.2 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . 0.465 ' ND2' ' H ' ' A' ' 446' ' ' ARG . 10.0 t30 -45.36 112.13 0.41 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.949 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 6.3 p -107.35 15.8 24.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -112.75 160.81 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.605 HD12 ' CG1' ' A' ' 442' ' ' VAL . 31.3 pt -131.89 144.48 37.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -103.44 111.47 23.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 1.039 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 8.2 t -96.42 140.12 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.098 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -145.91 122.44 11.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.26 17.97 1.72 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.489 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.557 HD13 HD11 ' A' ' 377' ' ' LEU . 87.0 mt -78.2 153.09 32.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.873 0.368 . . . . 0.0 110.861 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -76.17 -179.52 5.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.85 3.54 50.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 12.5 m -119.27 15.81 13.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.481 HG21 HD22 ' A' ' 368' ' ' LEU . 8.7 p -80.61 134.02 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.152 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 70.2 p -117.87 160.22 21.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.158 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.848 HD11 ' HG2' ' A' ' 396' ' ' PRO . 12.3 tp -53.11 -64.17 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.95 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -46.1 -38.75 8.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.55 -32.69 74.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.631 HD12 HD11 ' A' ' 400' ' ' ILE . 75.7 mt -87.09 -28.08 22.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.8 -39.56 66.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.015 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.433 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 40.0 t0 -76.51 -20.82 56.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.497 ' CE1' ' NE2' ' A' ' 383' ' ' GLN . 40.6 t80 -91.6 -53.84 4.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 1.039 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.6 m-85 -57.56 -23.67 51.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.433 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 13.9 ptmt -74.44 -12.16 60.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.925 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . 0.497 ' NE2' ' CE1' ' A' ' 380' ' ' PHE . 6.8 mt-30 -48.68 -53.4 18.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 2.3 t -59.74 -65.17 0.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -136.82 -124.3 2.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.459 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 95.1 t -125.51 128.82 72.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.841 0.353 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 58.2 t -82.53 124.79 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.101 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -45.85 107.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.975 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . 0.471 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 20.4 mtp -102.91 127.28 50.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.894 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -53.7 146.01 14.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.75 -13.69 25.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . 0.463 ' HG3' HG23 ' A' ' 393' ' ' THR . 15.9 ptt180 -102.52 -42.09 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.463 HG23 ' HG3' ' A' ' 392' ' ' ARG . 66.8 p -96.93 -19.57 18.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.157 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.471 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 66.04 18.44 66.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.442 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -107.14 152.75 41.2 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.554 0.692 . . . . 0.0 110.934 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.848 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.6 Cg_endo -69.77 147.62 63.2 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.684 2.256 . . . . 0.0 112.349 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.439 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 11.3 mmt -81.61 40.76 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.846 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.53 HG12 HG22 ' A' ' 415' ' ' VAL . 97.7 mt -99.33 137.68 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.171 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -118.5 143.56 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.808 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.631 HD11 HD12 ' A' ' 377' ' ' LEU . 58.6 mt -134.59 93.9 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -59.77 125.23 22.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.844 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 409' ' ' PRO . 36.5 mt -109.38 134.57 51.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.9 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 407' ' ' GLY . 11.1 t0 -55.67 121.25 8.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -69.23 -1.29 7.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -88.5 -38.5 14.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 70.1 p -124.74 -35.05 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.85 -1.47 35.96 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.475 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 12.0 pttp -84.37 152.62 61.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.483 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.8 Cg_endo -69.75 94.69 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.68 2.253 . . . . 0.0 112.341 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -33.55 -52.75 0.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 153.19 -15.85 0.67 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.487 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . 0.416 ' CG ' ' HE3' ' A' ' 410' ' ' LYS . 49.5 p-10 -87.74 157.24 19.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -170.15 171.67 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.096 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.4 142.91 37.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.183 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.879 HG21 ' CD2' ' A' ' 381' ' ' PHE . 57.0 t -130.13 111.94 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . 0.439 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 9.1 m -87.35 114.39 23.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.429 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 47.3 m-85 -88.07 164.41 15.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.77 -63.29 1.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.508 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.4 m-20 -115.9 156.05 47.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.604 0.716 . . . . 0.0 110.84 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.602 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.39 -43.01 55.77 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.644 2.23 . . . . 0.0 112.356 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.7 Cg_exo -50.06 -29.57 22.3 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.686 2.257 . . . . 0.0 112.286 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 70.0 m -85.8 -40.07 16.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.159 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.682 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -61.93 -51.5 67.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.131 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.574 ' HG2' HD11 ' A' ' 444' ' ' LEU . 33.2 mtmt -58.93 -35.58 73.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.849 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.29 -31.69 54.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.041 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.23 68.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.147 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 423' ' ' ALA . 92.6 t -54.68 -60.83 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -66.7 -14.65 62.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.55 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -77.85 -52.04 9.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.975 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.901 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.2 m-85 -90.37 -17.37 27.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 3.8 t70 -57.12 100.28 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 101.5 13.78 31.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.458 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 18.7 mmtp -71.7 -178.75 2.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.748 0.309 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.79 102.87 6.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.776 ' HB2' HD11 ' A' ' 440' ' ' LEU . 5.0 t80 -102.76 113.1 26.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 59.01 27.16 15.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 96.02 -16.66 60.72 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.431 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 24.3 m -90.62 150.46 21.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.965 0.412 . . . . 0.0 110.819 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . 0.431 ' C ' HD23 ' A' ' 440' ' ' LEU . 13.9 ttmt -87.61 133.74 33.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 435' ' ' PHE . 6.0 mt -102.66 143.09 32.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.932 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.03 101.42 7.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.983 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.901 HG21 ' HB2' ' A' ' 430' ' ' PHE . 20.5 t -96.98 132.6 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.079 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.5 m -154.24 128.73 9.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.574 HD11 ' HG2' ' A' ' 424' ' ' LYS . 22.4 mt -43.76 109.8 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.849 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 444' ' ' LEU . . . -35.71 -55.96 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.465 ' H ' ' ND2' ' A' ' 360' ' ' ASN . 26.8 ttt180 -92.43 92.98 8.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -131.22 128.68 40.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . 0.459 ' CD ' ' HD2' ' A' ' 449' ' ' PRO . 35.7 tptt -162.68 137.06 4.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.535 0.683 . . . . 0.0 110.93 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.459 ' HD2' ' CD ' ' A' ' 448' ' ' LYS . 53.5 Cg_endo -69.8 149.54 66.78 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.638 2.226 . . . . 0.0 112.359 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -173.93 0.81 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.765 2.31 . . . . 0.0 112.307 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -94.07 -47.85 6.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.857 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -57.72 115.42 2.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 15.4 m 61.82 27.8 16.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -71.69 -79.8 0.39 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.515 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 145.08 56.28 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.705 2.27 . . . . 0.0 112.388 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 39.0 m -113.93 -50.32 2.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 57.9 p -158.78 178.38 10.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.844 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.46 -179.945 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 68.2 m -85.6 87.09 7.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.875 0.369 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 10.8 t -117.26 135.32 53.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 149.13 -51.83 0.54 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 3.7 t -101.24 -61.19 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 0.0 110.893 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 23.1 t -126.69 111.1 13.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.919 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -162.37 169.1 37.59 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.469 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.75 143.1 39.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.661 0.744 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 162.59 41.51 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.771 2.314 . . . . 0.0 112.327 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -141.36 162.38 35.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -132.22 141.93 49.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.86 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 357' ' ' ASP . 0.0 OUTLIER -104.08 -45.17 4.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 5.3 t -165.21 148.91 8.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -74.83 89.7 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.815 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -139.53 116.19 10.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.4 m -106.28 40.03 1.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.858 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -141.82 156.15 45.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.474 HG22 HG22 ' A' ' 427' ' ' VAL . 18.8 pt -128.8 141.88 45.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.121 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -103.5 112.02 24.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 1.07 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 9.1 t -97.96 138.99 21.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -145.03 120.66 10.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.913 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.64 16.51 1.83 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.503 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.509 HD13 HD11 ' A' ' 377' ' ' LEU . 97.7 mt -74.51 155.39 38.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.821 0.343 . . . . 0.0 110.861 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -75.12 -178.88 4.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.55 3.69 53.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.2 t -121.05 16.58 11.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 8.5 p -76.89 133.99 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 81.8 p -118.28 154.8 31.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.919 HD11 ' HG2' ' A' ' 396' ' ' PRO . 11.1 tp -50.75 -62.82 1.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -46.72 -38.15 9.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.864 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.26 -29.59 68.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.825 HD12 HD11 ' A' ' 400' ' ' ILE . 45.5 mt -87.08 -28.52 22.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.16 62.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.146 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -75.11 -18.48 60.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -92.63 -47.17 7.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 1.07 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 15.7 m-85 -66.98 -26.44 66.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -9.13 57.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -51.58 -51.75 52.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 42.4 t -61.02 -65.45 0.69 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -134.55 -126.74 2.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.508 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.441 ' CG1' ' OE2' ' A' ' 418' ' ' GLU . 91.0 t -123.53 128.47 74.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.83 0.347 . . . . 0.0 111.127 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 84.5 t -83.64 123.1 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.076 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -47.55 108.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . 0.427 ' HE2' ' O ' ' A' ' 394' ' ' GLY . 23.8 mtp -105.41 124.18 49.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.896 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -50.9 143.94 9.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -94.72 -8.41 37.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.822 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -102.47 -45.55 5.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.967 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 20.5 p -95.82 -22.16 17.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.157 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.427 ' O ' ' HE2' ' A' ' 389' ' ' MET . . . 71.1 23.29 78.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.503 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -112.09 152.49 44.39 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.523 0.678 . . . . 0.0 110.929 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.919 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.9 Cg_endo -69.67 149.41 67.4 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.693 2.262 . . . . 0.0 112.352 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.412 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 11.1 mmt -82.19 40.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.794 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.46 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 93.6 mt -97.52 137.4 25.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.148 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -116.78 138.75 51.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.825 HD11 HD12 ' A' ' 377' ' ' LEU . 58.0 mt -132.41 94.99 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -62.47 127.6 32.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 409' ' ' PRO . 36.2 mt -112.06 135.48 52.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 407' ' ' GLY . 6.6 t70 -56.14 122.25 11.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -1.05 9.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -89.04 -38.46 14.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.809 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 59.0 p -123.65 -34.73 3.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.3 -3.28 37.51 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.481 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -83.61 152.69 63.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.505 0.669 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.543 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.4 Cg_endo -69.74 95.17 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.673 2.248 . . . . 0.0 112.356 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 409' ' ' PRO . 9.2 ptmt -33.33 -52.01 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.882 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 152.2 -15.61 0.77 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.519 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -87.68 154.51 20.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 110.825 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -167.68 170.51 10.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.099 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.23 142.4 37.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.107 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.844 HG21 ' CD2' ' A' ' 381' ' ' PHE . 39.2 t -128.23 112.88 28.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.123 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . 0.412 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 9.6 m -87.82 114.03 24.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.556 ' CE2' ' CB ' ' A' ' 426' ' ' ALA . 38.5 m-85 -87.06 167.21 14.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.965 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . 0.441 ' OE2' ' CG1' ' A' ' 386' ' ' VAL . 4.0 mt-10 -65.5 -61.96 1.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.513 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.8 m-20 -116.43 156.28 47.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.552 0.692 . . . . 0.0 110.884 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.3 -43.01 56.27 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.773 2.316 . . . . 0.0 112.335 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.8 Cg_exo -50.7 -27.36 19.62 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.7 2.267 . . . . 0.0 112.354 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 55.4 m -87.35 -40.72 14.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.154 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -60.17 -54.66 43.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.532 ' HG2' HD11 ' A' ' 444' ' ' LEU . 37.5 mtpt -55.63 -35.39 65.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.29 -33.09 55.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.159 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.556 ' CB ' ' CE2' ' A' ' 417' ' ' TYR . . . -70.51 -31.83 69.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.101 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 423' ' ' ALA . 72.9 t -58.16 -64.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.151 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -65.11 -10.92 34.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.546 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.2 t-105 -80.3 -56.22 4.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.985 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.913 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.2 m-85 -88.09 -18.19 29.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.485 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.2 t70 -54.66 96.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.38 17.3 13.95 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.515 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.429 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 17.1 mmtm -76.87 170.7 16.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.721 0.296 . . . . 0.0 110.913 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 434' ' ' ASP . 2.8 p-10 -115.83 110.49 19.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.902 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.563 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.7 t80 -113.42 106.87 15.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 62.15 25.91 15.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.919 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 93.29 -5.92 75.09 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.51 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.4 m -104.87 129.39 53.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.877 0.37 . . . . 0.0 110.878 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -70.83 137.83 49.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 435' ' ' PHE . 12.4 mt -103.66 150.89 23.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -123.81 100.04 6.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.913 HG21 ' HB2' ' A' ' 430' ' ' PHE . 17.8 t -95.13 128.22 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.103 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 89.7 p -146.42 125.44 12.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.562 ' HG ' HG21 ' A' ' 427' ' ' VAL . 19.8 mt -38.58 102.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -45.3 127.84 7.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.143 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -118.32 121.58 40.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.864 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.0 -175.77 3.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.7 152.21 79.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.587 0.708 . . . . 0.0 110.871 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 149.22 66.39 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.676 2.25 . . . . 0.0 112.292 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -3.01 11.15 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.694 2.262 . . . . 0.0 112.339 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 62.9 mmm -133.19 147.26 52.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -65.4 136.66 56.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.934 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 29.2 t -112.03 85.29 2.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 143.13 82.68 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.505 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 136.6 33.33 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.605 2.203 . . . . 0.0 112.334 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 2.0 t -37.38 133.89 0.67 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 51.8 m -114.57 167.26 10.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.478 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 4.2 m -152.79 139.78 19.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.894 0.378 . . . . 0.0 110.804 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 96.4 p -57.92 -15.94 10.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.856 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 178.27 83.29 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.58 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 71.4 p -99.06 114.92 27.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 0.0 110.905 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 31.8 p -70.56 -43.71 68.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 130.93 -55.04 0.78 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.461 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' A' ' 354' ' ' PRO . 8.4 t70 -143.27 140.77 18.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.591 0.71 . . . . 0.0 110.818 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 353' ' ' ASP . 53.5 Cg_endo -69.76 79.68 0.93 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.684 2.256 . . . . 0.0 112.297 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -85.33 92.77 8.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.19 172.4 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.882 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.87 121.29 42.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 82.5 p -42.49 -41.42 2.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -95.95 155.84 16.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.863 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.76 82.68 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.3 m -99.44 28.26 4.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.875 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -129.65 162.67 27.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.138 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.659 HD12 ' CG1' ' A' ' 442' ' ' VAL . 34.3 pt -133.34 144.55 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -102.15 115.09 29.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.888 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 13.5 t -100.31 136.34 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.142 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -143.64 120.74 11.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 128.96 20.18 1.5 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.441 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 88.0 mt -79.25 155.34 28.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 110.944 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . 0.487 ' OD1' ' NE2' ' A' ' 436' ' ' GLN . 4.2 p30 -75.07 178.07 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.844 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -91.31 13.4 17.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.857 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.1 m -130.13 13.22 5.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.69 141.93 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 72.2 p -121.59 160.42 24.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.126 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.877 HD11 ' HG2' ' A' ' 396' ' ' PRO . 10.6 tp -56.22 -58.1 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -50.61 -38.17 44.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.823 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -66.71 -27.77 67.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.847 HD12 HD11 ' A' ' 400' ' ' ILE . 51.6 mt -89.03 -32.02 17.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.12 -33.78 65.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.427 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 15.8 t0 -82.93 -20.24 35.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -92.69 -48.43 6.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.888 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 18.7 m-85 -63.75 -19.08 64.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.427 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -76.27 -6.69 52.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.916 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -54.31 -56.86 14.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.6 t -56.56 -65.54 0.59 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -135.67 -126.01 2.55 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.448 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 44.5 t -125.06 132.59 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 111.111 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 60.3 t -87.25 128.62 39.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.206 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 49.6 tttt -50.31 108.32 0.22 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 396' ' ' PRO . 73.6 mmm -104.05 122.79 45.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -47.66 143.18 4.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -93.38 -18.64 22.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 37.5 ttt85 -99.01 -46.6 5.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 30.1 p -89.72 -24.96 21.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.047 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 69.24 31.92 72.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.513 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -121.85 153.62 60.4 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.619 0.723 . . . . 0.0 110.899 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.877 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.6 Cg_endo -69.55 146.17 60.67 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.736 2.29 . . . . 0.0 112.432 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 9.1 mmt -82.12 40.32 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.825 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.531 HG12 HG22 ' A' ' 415' ' ' VAL . 94.3 mt -96.53 145.84 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . 0.409 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 6.3 t60 -126.04 136.11 52.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.847 HD11 HD12 ' A' ' 377' ' ' LEU . 59.5 mt -131.04 94.79 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -61.6 127.78 33.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.898 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 409' ' ' PRO . 33.5 mt -112.24 135.56 52.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.953 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 407' ' ' GLY . 8.1 t0 -55.44 122.78 11.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -1.18 12.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -90.03 -36.03 15.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 37.7 p -125.21 -35.63 2.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.73 -3.66 36.42 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.487 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -83.33 152.59 64.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.679 0.752 . . . . 0.0 110.814 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.524 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.2 Cg_endo -69.74 94.99 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.726 2.284 . . . . 0.0 112.281 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -33.37 -50.56 0.32 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.955 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 150.6 -16.4 0.96 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.489 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -87.79 156.09 19.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 110.856 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -169.48 173.14 6.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.081 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.06 142.13 32.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.168 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.848 HG21 ' CD2' ' A' ' 381' ' ' PHE . 57.4 t -128.74 117.68 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 24.0 m -92.73 112.86 24.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.493 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 51.9 m-85 -87.17 163.29 17.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.947 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -58.01 -65.3 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.511 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.5 m-20 -114.11 155.89 44.88 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.603 0.716 . . . . 0.0 110.903 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.42 -42.84 57.36 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.677 2.251 . . . . 0.0 112.334 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 54.3 Cg_exo -49.58 -28.81 17.47 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.719 2.279 . . . . 0.0 112.373 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 48.6 m -86.94 -42.98 12.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.77 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.7 -48.34 82.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.188 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.599 ' HG2' HD11 ' A' ' 444' ' ' LEU . 72.8 mttt -61.5 -39.62 91.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.45 -32.84 62.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.094 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.29 -32.91 70.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 423' ' ' ALA . 84.1 t -55.85 -60.85 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.164 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.12 -13.0 61.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.561 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.0 OUTLIER -79.49 -52.27 8.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.827 ' HB2' HG21 ' A' ' 442' ' ' VAL . 89.5 m-85 -88.5 -16.68 32.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.871 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.5 OUTLIER -60.4 93.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.22 16.79 7.55 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.401 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 2.6 mmmp? -82.37 163.91 21.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 110.862 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -110.24 108.54 18.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.931 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.647 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.2 t80 -109.12 108.65 19.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . 0.487 ' NE2' ' OD1' ' A' ' 369' ' ' ASN . 62.2 mt-30 61.32 26.56 16.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.972 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 94.38 -13.71 66.74 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.526 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.6 m -100.67 128.9 46.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 110.864 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -70.41 138.77 51.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.647 HD11 ' HB2' ' A' ' 435' ' ' PHE . 12.8 mt -104.05 152.95 21.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -126.26 106.08 9.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.827 HG21 ' HB2' ' A' ' 430' ' ' PHE . 14.2 t -99.41 138.56 23.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 3.6 p -161.12 130.17 4.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.825 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 424' ' ' LYS . 45.7 mt -43.38 121.78 2.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.79 156.77 13.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.116 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? 66.03 29.68 9.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm -149.63 155.29 40.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.09 152.63 1.4 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.605 0.717 . . . . 0.0 110.889 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 162.03 43.68 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.713 2.275 . . . . 0.0 112.376 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 147.53 63.79 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.76 2.306 . . . . 0.0 112.333 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 9.7 ttt -123.3 160.09 27.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -83.99 104.59 14.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 14.1 m -144.06 122.84 12.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 147.17 -158.26 27.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.503 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 2.8 3.22 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.6 2.2 . . . . 0.0 112.359 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 88.4 p -136.57 130.23 32.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 43.5 t -104.56 95.48 5.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.515 179.986 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 30.6 t -106.87 122.05 45.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 0.0 110.859 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 35.3 m -111.31 42.04 1.74 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 132.15 -61.15 0.66 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.459 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 9.1 t -62.42 119.83 9.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.892 0.377 . . . . 0.0 110.807 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 17.5 t -81.39 -57.56 3.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.869 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 178.55 80.12 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.467 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.79 159.69 29.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.565 0.698 . . . . 0.0 110.813 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 175.71 7.69 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.691 2.261 . . . . 0.0 112.36 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -153.49 148.62 26.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -83.08 168.42 16.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -78.0 135.48 37.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.848 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 58.7 p -132.07 171.11 14.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.848 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.8 t0 66.34 38.01 4.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.824 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -96.05 76.19 3.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.944 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.2 m -88.73 29.59 1.0 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -131.85 166.18 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.065 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.723 HD12 ' CG1' ' A' ' 442' ' ' VAL . 27.4 pt -140.38 144.47 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -100.05 124.53 45.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.98 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.928 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 21.8 t -108.68 143.33 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -149.73 121.11 7.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.48 19.86 1.46 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.506 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.503 ' HB3' HG11 ' A' ' 372' ' ' VAL . 97.4 mt -78.76 154.35 30.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.885 0.374 . . . . 0.0 110.926 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . 0.432 ' ND2' ' CD ' ' A' ' 436' ' ' GLN . 9.4 p30 -76.37 179.32 5.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.4 1.87 53.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.2 m -119.85 18.73 12.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 368' ' ' LEU . 8.1 p -82.38 133.05 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.131 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 69.4 p -115.99 163.46 15.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.06 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.962 HD11 ' HG2' ' A' ' 396' ' ' PRO . 12.2 tp -54.64 -59.92 4.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.17 -47.38 23.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -53.15 -38.48 62.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.715 HD12 HD11 ' A' ' 400' ' ' ILE . 81.5 mt -82.82 -30.04 29.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.957 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -71.99 -25.64 61.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.074 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.408 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 17.9 t70 -93.27 -19.96 20.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -91.9 -52.34 4.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.928 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 21.2 m-85 -59.83 -23.47 63.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.408 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 5.4 ptmt -72.35 -10.98 60.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -49.9 -58.03 6.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 37.7 t -56.45 -69.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -130.56 -124.24 2.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 71.0 t -126.87 131.41 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.104 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 85.7 t -83.81 123.42 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.146 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -46.72 105.05 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.917 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . 0.445 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 26.7 mtp -102.85 128.17 49.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -53.97 147.09 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -94.61 -16.13 23.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 15.8 ttm105 -96.43 -49.65 5.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 46.9 p -90.45 -22.11 21.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.445 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 69.49 23.66 76.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.438 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -110.93 153.02 43.97 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.571 0.7 . . . . 0.0 110.951 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.962 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.7 Cg_endo -69.82 148.13 64.0 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.652 2.235 . . . . 0.0 112.3 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.428 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 7.6 mmt -81.74 40.68 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.427 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.3 mt -98.53 138.86 21.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.204 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -116.97 141.78 47.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.715 HD11 HD12 ' A' ' 377' ' ' LEU . 75.0 mt -134.7 95.4 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.222 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -62.69 124.94 22.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' A' ' 409' ' ' PRO . 44.1 mt -110.67 135.37 51.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 407' ' ' GLY . 9.0 t70 -55.49 126.36 24.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -75.16 -1.07 21.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -93.47 -30.29 15.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 43.4 p -127.97 -36.09 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 104.3 -5.89 45.6 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.474 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 8.8 pttm -82.94 152.8 66.38 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.569 0.699 . . . . 0.0 110.845 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.554 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.1 Cg_endo -69.73 95.29 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.66 2.24 . . . . 0.0 112.343 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 409' ' ' PRO . 9.4 ptmt -32.88 -51.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.866 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.15 -12.34 0.8 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.491 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -90.93 157.95 17.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.777 0.322 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.53 172.65 6.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.079 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.88 136.59 30.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.174 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.757 HG21 ' CD2' ' A' ' 381' ' ' PHE . 40.6 t -120.89 127.69 75.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.133 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . 0.428 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 3.3 m -102.46 111.17 23.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.509 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 62.9 m-85 -87.4 157.68 19.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.944 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -53.46 -65.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.9 m-20 -113.31 155.81 44.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.644 0.735 . . . . 0.0 110.838 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.589 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.1 -42.96 58.0 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.689 2.259 . . . . 0.0 112.32 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.0 Cg_exo -50.34 -27.37 17.98 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.377 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 44.9 m -88.89 -34.3 17.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.582 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -64.76 -50.61 66.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.116 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.95 ' HG2' HD11 ' A' ' 444' ' ' LEU . 23.1 mttp -61.05 -40.01 92.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -69.56 -35.27 75.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.087 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.41 -34.68 76.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.043 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 423' ' ' ALA . 72.6 t -54.75 -61.73 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.74 -12.89 60.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.551 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.82 -54.21 6.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.899 ' HB2' HG21 ' A' ' 442' ' ' VAL . 84.5 m-85 -87.63 -20.12 26.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.2 t70 -54.74 99.93 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 104.42 11.72 30.6 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.539 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -74.44 176.16 7.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.757 0.313 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -122.27 112.59 18.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.926 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.579 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -113.4 112.59 23.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . 0.432 ' CD ' ' ND2' ' A' ' 369' ' ' ASN . 53.6 mt-30 58.44 36.89 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 85.9 -15.76 46.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.1 t -92.69 165.8 12.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.845 0.355 . . . . 0.0 110.901 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -102.95 134.09 46.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.921 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.579 HD11 ' HB2' ' A' ' 435' ' ' PHE . 11.7 mt -102.05 143.97 31.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -119.75 104.57 10.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.899 HG21 ' HB2' ' A' ' 430' ' ' PHE . 6.2 t -99.95 140.91 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.146 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 20.0 m -162.47 125.73 2.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.808 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.95 HD11 ' HG2' ' A' ' 424' ' ' LYS . 17.4 mt -36.99 118.72 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.29 96.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.079 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -106.15 91.41 3.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.872 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.82 146.6 26.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . 0.427 ' CG ' ' HD2' ' A' ' 449' ' ' PRO . 38.5 tttp -141.76 140.16 19.59 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.544 0.688 . . . . 0.0 110.942 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.427 ' HD2' ' CG ' ' A' ' 448' ' ' LYS . 53.5 Cg_endo -69.83 157.79 59.06 Favored 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.728 2.285 . . . . 0.0 112.281 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 114.86 3.84 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.66 2.24 . . . . 0.0 112.359 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 12.2 mmt -118.14 -45.56 2.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.88 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 56.06 39.96 30.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 35.7 p -83.35 99.45 10.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -159.17 84.04 0.13 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.491 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 2.78 3.28 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.706 2.271 . . . . 0.0 112.305 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 77.3 p -104.55 -43.76 5.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 80.1 p -73.03 140.77 47.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.46 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 24.3 m -46.4 121.99 3.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.35 . . . . 0.0 110.913 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 78.4 p -65.75 -45.72 81.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 98.56 115.14 3.51 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.544 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 9.5 m -60.57 128.69 37.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.764 0.316 . . . . 0.0 110.87 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 83.8 p -154.61 158.53 39.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -100.16 117.72 5.96 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.505 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.7 147.38 34.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.599 0.714 . . . . 0.0 110.872 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 0.22 5.99 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.679 2.252 . . . . 0.0 112.337 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -151.98 150.5 30.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.851 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -53.09 -30.9 38.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -145.35 135.18 23.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 3.6 m -100.75 42.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -45.28 97.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.87 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -156.83 107.09 2.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.939 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.4 m -89.56 30.45 1.02 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -135.02 165.07 26.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.089 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.699 HD12 ' CG1' ' A' ' 442' ' ' VAL . 41.6 pt -135.26 145.79 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -103.89 112.94 26.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 1.05 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 20.5 t -97.04 142.34 14.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.133 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -148.16 122.78 9.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.59 17.05 1.77 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.47 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.521 HD13 HD11 ' A' ' 377' ' ' LEU . 87.5 mt -76.23 155.97 33.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.842 0.353 . . . . 0.0 110.907 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -79.37 -174.99 4.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.82 1.57 56.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.7 m -118.74 20.56 12.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.51 HG23 ' CE2' ' A' ' 435' ' ' PHE . 6.2 p -87.15 137.29 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.083 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 59.2 p -120.22 163.46 17.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.197 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.792 HD11 ' HG2' ' A' ' 396' ' ' PRO . 10.0 tp -57.35 -63.35 1.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -44.87 -30.78 1.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.838 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -74.21 -34.19 63.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.828 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.521 HD11 HD13 ' A' ' 368' ' ' LEU . 61.0 mt -86.26 -23.53 26.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -75.86 -32.53 59.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.111 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.426 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 19.6 t0 -87.47 -18.01 30.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.825 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -92.07 -50.72 5.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 1.05 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.3 m-85 -62.03 -22.13 65.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.826 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.426 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 12.7 ptmt -75.55 -10.62 59.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -51.14 -53.96 29.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 34.4 t -58.93 -66.0 0.57 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.24 -124.76 2.55 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.454 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.32 130.71 71.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.878 0.371 . . . . 0.0 111.103 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.56 129.27 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.188 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -54.41 108.14 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . 0.443 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 67.4 mmm -103.75 122.04 44.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.436 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 17.6 t-20 -48.51 149.06 1.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.839 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -94.87 -18.86 20.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.875 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -97.77 -47.32 5.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.436 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 49.0 p -90.68 -18.95 24.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.181 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.443 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 62.13 27.53 69.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.448 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -114.77 153.5 46.88 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.611 0.719 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.792 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.5 Cg_endo -69.75 146.07 59.15 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.69 2.26 . . . . 0.0 112.282 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.45 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 16.6 mmt -81.17 41.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.462 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 95.7 mt -99.44 135.87 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.094 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -116.39 141.55 48.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 71.4 mt -133.65 93.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -60.69 124.41 20.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 409' ' ' PRO . 33.7 mt -108.98 136.71 48.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.94 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 407' ' ' GLY . 3.1 t70 -55.42 127.23 28.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.837 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 10.0 pttm -74.29 -1.03 18.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -97.18 -34.89 10.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 37.5 p -121.09 -34.97 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.154 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 99.59 -1.06 56.87 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.533 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -86.94 155.95 55.3 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.512 0.673 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 410' ' ' LYS . 53.7 Cg_endo -69.82 91.36 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.697 2.265 . . . . 0.0 112.307 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.482 ' C ' ' O ' ' A' ' 409' ' ' PRO . 10.2 ptmt -31.75 -53.14 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.892 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.9 -14.78 0.51 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.501 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -88.45 156.81 18.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.868 0.366 . . . . 0.0 110.803 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.99 167.75 10.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.106 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.9 p -136.76 140.17 42.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.905 HG21 ' CD2' ' A' ' 381' ' ' PHE . 37.0 t -127.1 112.26 28.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.121 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . 0.45 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 6.0 m -89.39 113.75 25.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.475 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 69.1 m-85 -88.8 164.97 14.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -57.27 -68.86 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.518 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 4.0 m-20 -112.68 156.97 41.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.605 0.717 . . . . 0.0 110.886 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.32 -43.06 55.79 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.704 2.269 . . . . 0.0 112.329 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.2 Cg_exo -50.25 -26.64 15.87 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.651 2.234 . . . . 0.0 112.326 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 35.2 m -90.0 -39.87 12.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.538 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -60.37 -51.31 70.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.065 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.463 ' HG2' HD11 ' A' ' 444' ' ' LEU . 4.3 mtpm? -57.52 -39.31 76.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.09 70.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.046 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.68 71.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.08 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 423' ' ' ALA . 85.6 t -56.89 -64.15 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.58 -11.44 24.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.537 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -82.09 -55.29 4.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.889 ' HB2' HG21 ' A' ' 442' ' ' VAL . 89.1 m-85 -88.3 -13.88 39.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.831 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.8 t0 -58.64 96.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 112.26 -16.07 24.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.529 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -49.7 165.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.737 0.303 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -122.33 110.37 15.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.793 ' HB2' HD11 ' A' ' 440' ' ' LEU . 5.6 t80 -97.78 105.43 17.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 62.98 34.37 14.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 83.58 19.66 61.51 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.503 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 22.2 p -125.19 128.66 48.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.952 0.406 . . . . 0.0 110.828 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . 0.407 ' C ' HD23 ' A' ' 440' ' ' LEU . 0.5 OUTLIER -71.65 133.1 45.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 435' ' ' PHE . 8.6 mt -107.2 160.59 15.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -133.41 101.04 5.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.889 HG21 ' HB2' ' A' ' 430' ' ' PHE . 13.8 t -98.26 131.99 44.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.17 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.3 m -153.2 128.98 10.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.463 HD11 ' HG2' ' A' ' 424' ' ' LYS . 39.5 mt -37.96 136.18 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.909 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -81.83 162.13 22.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.84 159.07 6.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -139.03 115.49 10.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.42 148.01 62.31 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.574 0.702 . . . . 0.0 110.868 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 159.34 53.77 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.88 158.43 56.83 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.635 2.224 . . . . 0.0 112.304 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -87.53 160.75 18.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.9 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -174.46 137.04 0.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 37.2 p -97.85 175.39 6.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . 79.73 84.46 0.64 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.477 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 115.49 4.13 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.64 2.226 . . . . 0.0 112.342 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 54.2 p -153.49 145.48 23.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 3.1 t -77.66 92.46 4.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.477 179.996 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 15.6 t -79.36 154.38 29.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.892 0.377 . . . . 0.0 110.843 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 15.6 t -86.04 125.0 33.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.893 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 40.92 88.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.574 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 15.2 t -142.88 112.9 7.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.84 0.352 . . . . 0.0 110.871 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 7.6 m -72.2 136.0 46.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.811 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 147.32 42.63 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.471 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -120.3 140.43 30.12 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.584 0.707 . . . . 0.0 110.899 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -175.02 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.701 2.267 . . . . 0.0 112.349 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -133.24 171.44 14.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -52.19 115.47 1.74 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -144.96 154.06 42.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.842 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 52.9 p -79.39 165.2 23.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -42.92 118.67 1.31 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -161.19 123.16 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.938 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 417' ' ' TYR . 3.3 p -120.71 37.69 4.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -144.25 166.98 23.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.084 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.731 HD12 ' CG1' ' A' ' 442' ' ' VAL . 37.7 pt -142.49 142.73 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -100.79 114.36 28.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.981 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.971 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 9.4 t -97.52 142.19 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.176 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -147.79 120.06 8.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.43 20.55 1.39 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.424 HD13 HD11 ' A' ' 377' ' ' LEU . 96.6 mt -79.48 154.43 28.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.865 0.364 . . . . 0.0 110.85 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -74.04 -177.95 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.24 0.42 57.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 20.1 m -118.68 16.9 13.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.837 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.441 HG23 ' CE2' ' A' ' 435' ' ' PHE . 7.6 p -76.48 135.18 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.131 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 75.5 p -117.26 158.82 23.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.195 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.755 HD11 ' HG2' ' A' ' 396' ' ' PRO . 10.7 tp -56.99 -60.03 4.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.871 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -48.13 -40.12 22.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -28.8 68.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.769 HD12 HD11 ' A' ' 400' ' ' ILE . 47.6 mt -86.44 -31.44 21.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.38 -33.73 67.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.101 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.437 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 9.3 t70 -81.79 -20.16 39.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -92.45 -46.55 7.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.971 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 17.4 m-85 -65.76 -19.11 65.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.437 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -78.65 -4.28 48.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.914 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -56.74 -54.0 51.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.5 t -59.44 -65.92 0.59 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -134.41 -125.6 2.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.48 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 50.9 t -124.21 136.61 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.946 0.403 . . . . 0.0 111.105 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.22 132.26 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.089 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -57.18 106.87 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . 0.49 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 73.4 mmm -102.44 121.08 41.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.78 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -46.79 150.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.72 -23.06 17.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.931 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . 0.598 ' HG3' HG23 ' A' ' 393' ' ' THR . 35.0 ptt180 -96.37 -47.11 6.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.598 HG23 ' HG3' ' A' ' 392' ' ' ARG . 61.9 p -89.46 -16.34 31.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.49 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 58.59 24.09 56.07 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.478 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -111.45 153.34 44.2 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.638 0.733 . . . . 0.0 110.883 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.755 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.7 Cg_endo -69.8 146.67 60.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.667 2.245 . . . . 0.0 112.362 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.426 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.6 mmt -81.79 40.83 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.569 HG12 HG22 ' A' ' 415' ' ' VAL . 95.6 mt -98.8 136.22 30.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.122 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . 0.41 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 8.6 t60 -116.3 141.09 48.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.769 HD11 HD12 ' A' ' 377' ' ' LEU . 76.9 mt -134.67 94.13 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -60.65 124.41 20.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 409' ' ' PRO . 36.3 mt -109.82 135.17 51.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 407' ' ' GLY . 7.7 t0 -55.57 123.42 13.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.819 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -70.75 -2.03 13.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -89.28 -38.93 13.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 27.4 p -122.7 -34.74 3.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.177 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 104.79 -1.45 41.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.537 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -84.55 152.69 60.8 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.523 0.678 . . . . 0.0 110.915 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.486 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.2 Cg_endo -69.8 94.0 0.53 Allowed 'Trans proline' 0 N--CA 1.466 -0.132 0 C-N-CA 122.689 2.259 . . . . 0.0 112.354 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 409' ' ' PRO . 7.9 ptmt -32.94 -49.57 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 149.72 -13.58 1.02 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -90.53 155.83 18.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.84 0.353 . . . . 0.0 110.876 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -168.46 170.51 9.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.1 p -139.73 132.83 29.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.882 HG21 ' CD2' ' A' ' 381' ' ' PHE . 99.7 t -118.25 122.8 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . 0.426 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 1.8 m -98.42 113.12 24.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.487 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 58.4 m-85 -86.74 169.85 12.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -63.44 -66.28 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.9 m-20 -114.53 156.25 44.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.708 . . . . 0.0 110.895 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.15 -43.01 57.2 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.706 2.271 . . . . 0.0 112.381 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.0 Cg_exo -50.42 -27.03 17.42 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.769 2.312 . . . . 0.0 112.348 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 90.2 m -90.4 -41.17 11.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.196 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.604 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.34 -49.6 77.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.077 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.522 ' HG2' HD11 ' A' ' 444' ' ' LEU . 47.4 mtpt -59.34 -40.24 85.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.94 -33.98 71.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.037 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.5 -33.94 75.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 423' ' ' ALA . 97.6 t -55.38 -60.88 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.97 -12.7 60.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.942 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.549 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -80.16 -55.19 5.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.918 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.853 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.2 m-85 -86.73 -17.68 33.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.6 OUTLIER -54.16 94.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.861 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.2 20.26 9.89 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.464 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.453 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 15.2 mmtm -78.16 170.4 16.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.877 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -114.36 112.93 23.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.605 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.7 t80 -120.96 105.21 10.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 62.25 38.08 13.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.937 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 73.97 23.38 76.41 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 71.3 m -132.38 131.05 41.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 0.0 110.868 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -72.51 136.06 45.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' A' ' 435' ' ' PHE . 8.5 mt -104.15 143.27 33.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -117.45 104.23 10.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.853 HG21 ' HB2' ' A' ' 430' ' ' PHE . 7.5 t -101.11 133.86 43.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.128 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 3.8 m -156.07 132.09 9.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.522 HD11 ' HG2' ' A' ' 424' ' ' LYS . 18.5 mt -40.35 119.82 1.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.57 98.5 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -133.9 126.52 30.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.22 143.24 28.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -110.77 135.09 20.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.563 0.697 . . . . 0.0 110.907 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 162.43 42.09 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.619 2.213 . . . . 0.0 112.387 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -34.47 14.5 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.683 2.255 . . . . 0.0 112.369 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -75.11 148.47 39.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -142.77 111.99 6.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 54.5 p 38.39 35.15 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.798 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -56.0 169.78 2.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.475 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 89.8 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.665 2.243 . . . . 0.0 112.328 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 57.1 m -101.85 106.11 17.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.89 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.1 t -60.45 96.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.489 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 89.2 p -78.69 140.42 38.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.877 0.37 . . . . 0.0 110.858 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 54.4 p -125.58 174.65 8.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -149.35 -82.77 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.47 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 46.5 p -75.05 91.65 2.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.349 . . . . 0.0 110.829 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 8.0 m -109.56 128.43 55.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.897 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 170.52 -135.03 3.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.477 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -140.9 141.28 23.71 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.62 0.724 . . . . 0.0 110.855 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 164.95 32.61 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.768 2.312 . . . . 0.0 112.353 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -69.05 79.05 0.33 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.29 141.3 58.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.13 136.29 57.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.829 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 73.2 m -101.08 44.15 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -110.38 177.52 4.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -97.01 94.02 6.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.886 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 7.6 m -90.88 37.06 0.91 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.806 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -136.95 166.04 24.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.071 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.428 HD12 HG13 ' A' ' 442' ' ' VAL . 12.5 pt -137.69 142.14 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.139 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -100.44 117.91 35.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.986 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 40.4 t -101.78 144.41 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.033 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -150.31 118.06 6.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.38 23.11 1.03 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.447 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.497 HD13 HD11 ' A' ' 377' ' ' LEU . 93.9 mt -81.36 156.37 25.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.817 0.341 . . . . 0.0 110.895 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' A' ' 436' ' ' GLN . 8.5 p30 -79.9 179.94 7.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.87 1.5 53.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.844 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.9 m -117.31 16.0 14.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.83 136.59 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.098 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 73.4 p -123.05 156.21 35.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.136 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.955 HD11 ' HG2' ' A' ' 396' ' ' PRO . 10.6 tp -52.56 -65.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -46.61 -36.94 7.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -69.15 -31.56 70.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 400' ' ' ILE . 43.4 mt -84.93 -28.45 25.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.93 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.8 -40.38 63.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.438 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 23.2 t0 -73.14 -21.39 60.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -92.58 -49.42 6.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.986 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 14.8 m-85 -62.51 -22.65 66.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.438 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -74.67 -12.77 60.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.881 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -48.47 -56.11 9.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 32.6 t -55.74 -69.58 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -132.46 -123.4 2.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.439 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 55.8 t -125.5 133.52 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 111.165 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.38 131.21 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.167 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -54.95 109.28 0.5 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . 0.402 ' SD ' ' CA ' ' A' ' 396' ' ' PRO . 65.0 mmm -104.29 123.16 46.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -50.51 145.51 6.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.867 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -94.85 -8.81 36.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 392' ' ' ARG . 3.8 ptp180 -102.98 -49.46 3.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.887 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.407 HG23 ' HG3' ' A' ' 392' ' ' ARG . 41.1 p -94.11 -14.92 25.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.179 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 62.53 30.19 75.8 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.469 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -116.52 153.28 48.91 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.6 0.714 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.955 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.6 Cg_endo -69.82 147.61 62.87 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.415 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 12.5 mmt -81.36 41.23 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.47 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.0 mt -97.79 135.67 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.074 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -116.09 139.99 49.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.765 HD11 HD12 ' A' ' 377' ' ' LEU . 60.7 mt -133.34 94.29 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.187 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -59.83 129.83 43.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.557 HD23 ' HA ' ' A' ' 409' ' ' PRO . 27.0 mt -114.09 137.12 52.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 407' ' ' GLY . 5.0 t70 -55.43 128.95 36.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -76.15 -1.62 27.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -97.46 -30.18 13.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.883 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 52.5 p -124.38 -36.17 2.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 97.62 7.84 56.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.452 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.8 156.66 37.06 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.584 0.707 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.557 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.0 Cg_endo -69.68 89.08 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.644 2.229 . . . . 0.0 112.382 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 409' ' ' PRO . 6.7 ptmt -31.22 -55.45 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 157.67 -15.93 0.31 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.484 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -88.76 158.0 18.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.349 . . . . 0.0 110.842 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -170.55 173.57 5.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.139 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.4 p -141.91 137.63 31.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.157 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.873 HG21 ' CD2' ' A' ' 381' ' ' PHE . 45.9 t -123.55 111.63 30.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.127 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . 0.415 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 3.6 m -87.67 113.9 23.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.518 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 55.5 m-85 -87.72 166.91 14.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.859 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -61.33 -66.24 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.524 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.3 m-20 -110.73 156.63 40.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.636 0.731 . . . . 0.0 110.831 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.04 -42.91 58.88 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.674 2.249 . . . . 0.0 112.38 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.0 Cg_exo -50.86 -46.0 32.87 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.713 2.276 . . . . 0.0 112.394 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 86.2 m -68.36 -39.22 81.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.166 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -61.82 -48.13 81.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.116 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -61.33 -39.38 90.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.59 -34.93 72.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.152 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -67.7 -34.16 76.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.053 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 423' ' ' ALA . 94.3 t -54.93 -62.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -66.48 -10.83 48.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.548 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.2 t-105 -82.01 -55.63 4.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.918 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.819 ' HB2' HG21 ' A' ' 442' ' ' VAL . 90.7 m-85 -86.14 -21.43 27.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.5 t70 -52.62 97.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 103.42 21.37 9.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.494 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.426 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 19.5 mmtt -81.46 176.02 10.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.853 0.358 . . . . 0.0 110.845 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 1.6 p-10 -119.9 114.91 22.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.728 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -121.69 104.08 9.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . 0.419 ' HB2' ' ND2' ' A' ' 369' ' ' ASN . 41.9 mt-30 62.69 40.61 9.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.829 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 71.79 25.56 74.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.5 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 67.8 m -134.79 127.69 31.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.902 0.382 . . . . 0.0 110.891 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -68.95 136.77 53.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.9 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.728 HD11 ' HB2' ' A' ' 435' ' ' PHE . 12.4 mt -106.37 140.05 39.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -116.06 106.26 13.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.819 HG21 ' HB2' ' A' ' 430' ' ' PHE . 11.5 t -100.6 135.77 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.093 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 12.6 p -156.13 127.41 7.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 25.0 mt -38.87 112.63 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.978 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -50.18 132.3 23.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.086 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -75.15 142.52 43.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -173.3 135.17 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.79 150.42 39.41 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.619 0.723 . . . . 0.0 110.929 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 155.64 65.5 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.362 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.73 159.18 54.4 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.704 2.27 . . . . 0.0 112.339 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 34.8 ttm -101.07 118.69 37.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.829 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.56 131.15 52.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.881 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 38.9 t -163.9 116.15 1.4 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.808 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -115.51 171.02 13.51 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.419 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 -178.43 2.36 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.649 2.233 . . . . 0.0 112.397 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 43.6 t -54.7 147.8 13.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.812 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 78.0 p -116.93 -48.75 2.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.464 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 14.2 m -97.42 135.47 39.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.846 0.355 . . . . 0.0 110.89 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 8.2 t -101.34 170.02 8.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 62.94 107.76 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.464 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 6.3 t -113.06 40.9 2.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.871 0.367 . . . . 0.0 110.867 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 4.0 t -129.86 166.78 19.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 93.68 141.5 11.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.443 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 353' ' ' ASP . 0.3 OUTLIER -96.6 158.42 33.71 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 0.0 110.866 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 355' ' ' ASP . 53.5 Cg_endo -69.77 -7.94 22.34 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.61 2.207 . . . . 0.0 112.347 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 354' ' ' PRO . 24.5 t0 -36.24 118.74 0.55 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -102.01 143.92 31.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -103.24 -52.7 2.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 35.5 t -105.04 92.17 4.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.95 130.52 41.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.846 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -113.84 88.85 2.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 32.6 t -86.06 21.63 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -115.29 163.1 16.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.066 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.664 HD12 ' CG1' ' A' ' 442' ' ' VAL . 37.7 pt -137.06 141.99 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -100.93 114.67 28.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.935 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.891 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 5.1 t -101.2 141.9 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.105 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -147.4 123.67 10.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 128.66 14.26 2.37 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.521 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.09 152.61 41.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 372' ' ' VAL . 6.1 p30 -72.94 -176.41 2.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.95 -0.15 57.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.827 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.0 t -117.02 17.8 14.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.4 ' N ' ' OD1' ' A' ' 369' ' ' ASN . 9.0 p -79.04 139.71 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.089 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 72.7 p -122.81 160.21 26.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.884 HD11 ' HG2' ' A' ' 396' ' ' PRO . 9.1 tp -56.55 -60.33 3.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -48.0 -37.1 13.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -30.12 68.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.745 HD12 HD11 ' A' ' 400' ' ' ILE . 63.2 mt -85.39 -31.34 22.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.95 -35.14 66.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.44 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 23.3 t0 -80.63 -20.56 42.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.828 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -92.65 -51.61 5.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.891 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.3 m-85 -61.11 -21.48 63.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.44 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 8.4 ptpt -75.79 -13.34 60.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -47.21 -54.53 10.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 21.6 t -57.34 -70.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -131.84 -124.22 2.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.508 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 96.3 t -124.55 136.67 59.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.392 . . . . 0.0 111.08 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 96.3 t -92.17 129.26 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.143 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -51.05 107.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 62.7 mmm -103.89 124.64 49.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.791 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.405 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 11.4 t-20 -47.44 145.48 2.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -94.69 -18.32 21.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 19.2 tpp85 -99.74 -45.26 5.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.863 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.405 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 23.6 p -91.85 -24.28 19.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.216 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 68.55 29.0 72.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.537 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.76 153.07 47.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.536 0.684 . . . . 0.0 110.961 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.884 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.2 Cg_endo -69.83 144.95 55.28 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.625 2.216 . . . . 0.0 112.326 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.449 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 12.5 mmt -81.37 41.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.471 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.5 mt -97.81 142.79 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.151 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -122.22 139.62 53.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.745 HD11 HD12 ' A' ' 377' ' ' LEU . 64.3 mt -133.31 94.6 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.191 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -61.23 122.32 14.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 409' ' ' PRO . 33.3 mt -107.12 135.06 49.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 407' ' ' GLY . 9.9 t0 -55.51 121.54 9.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -1.16 8.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -89.08 -37.64 14.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 43.1 p -125.19 -35.67 2.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.109 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 106.36 1.7 38.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.467 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -87.12 152.58 53.27 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.561 0.696 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.517 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.6 Cg_endo -69.72 93.06 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.701 2.267 . . . . 0.0 112.317 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 409' ' ' PRO . 6.5 ptmt -32.76 -52.93 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.884 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 153.95 -16.08 0.61 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.494 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -87.68 155.49 19.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.848 0.356 . . . . 0.0 110.84 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.46 168.59 11.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.9 p -136.7 139.85 42.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.765 HG21 ' CD2' ' A' ' 381' ' ' PHE . 31.9 t -124.81 116.62 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . 0.449 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 22.9 m -92.06 110.76 22.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.869 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.505 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 51.9 m-85 -86.79 161.89 18.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -57.94 -63.54 1.22 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.511 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 1.2 m-20 -118.59 157.13 50.51 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.576 0.703 . . . . 0.0 110.84 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.51 -43.0 55.12 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.648 2.232 . . . . 0.0 112.383 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 56.9 Cg_exo -49.48 -26.43 12.23 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.641 2.227 . . . . 0.0 112.397 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 98.8 m -91.33 -41.13 11.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.209 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.04 -51.0 71.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.448 ' HG2' HD11 ' A' ' 444' ' ' LEU . 27.2 mtpp -58.63 -39.05 79.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -72.62 -32.18 65.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.104 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.87 72.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.073 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 423' ' ' ALA . 94.6 t -54.39 -61.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.187 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -66.25 -13.03 59.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.533 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -80.46 -50.84 9.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.878 ' HB2' HG21 ' A' ' 442' ' ' VAL . 82.3 m-85 -92.88 -13.09 29.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.0 OUTLIER -59.51 92.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 114.97 -13.64 19.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.433 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 9.8 mmtm -45.68 166.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.749 0.309 . . . . 0.0 110.916 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 4.4 p-10 -115.1 112.24 22.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.501 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.2 t80 -111.76 108.6 18.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 61.64 31.06 18.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 91.49 -15.96 60.16 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.563 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.2 t -91.11 159.05 16.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.901 0.382 . . . . 0.0 110.898 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -96.23 134.52 39.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 435' ' ' PHE . 8.6 mt -100.01 140.05 34.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -117.36 100.13 7.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.878 HG21 ' HB2' ' A' ' 430' ' ' PHE . 12.5 t -97.67 133.08 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 6.1 p -156.49 128.43 7.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.825 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.448 HD11 ' HG2' ' A' ' 424' ' ' LYS . 18.8 mt -39.76 130.13 1.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -67.23 148.12 52.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 63.16 28.99 16.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.814 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -135.59 168.59 18.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . 0.477 ' CG ' ' HD2' ' A' ' 449' ' ' PRO . 20.5 ttpt -84.11 139.78 39.61 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.55 0.69 . . . . 0.0 110.942 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 448' ' ' LYS . 53.8 Cg_endo -69.75 159.77 52.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.682 2.255 . . . . 0.0 112.351 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 123.31 9.97 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.704 2.269 . . . . 0.0 112.314 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 18.7 ptm -63.72 176.01 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.863 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -57.27 -54.81 42.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 5.7 t -160.33 156.11 25.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.809 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -150.96 81.9 0.18 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.485 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -12.61 33.27 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.707 2.271 . . . . 0.0 112.324 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 2.2 t -104.79 92.07 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 7.1 t -57.47 -51.89 67.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.5 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.388 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 58.7 m -102.55 177.06 4.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.867 0.365 . . . . 0.0 110.844 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 26.6 p -130.98 -53.67 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.889 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 138.5 -153.06 22.31 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.478 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 3.1 t -78.34 91.53 4.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.914 0.387 . . . . 0.0 110.843 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 80.0 p -112.29 93.54 4.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.915 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 54.33 -89.6 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.552 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.18 153.45 46.72 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.631 0.729 . . . . 0.0 110.853 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 156.66 62.9 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.774 2.316 . . . . 0.0 112.375 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.79 43.4 1.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -68.1 100.15 0.97 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.893 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -131.17 126.85 36.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 34.2 t -159.3 149.34 18.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -115.8 152.64 32.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -75.2 80.35 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.887 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.6 m -104.49 36.83 2.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.841 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -139.05 166.98 23.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.069 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.632 HD12 ' CG1' ' A' ' 442' ' ' VAL . 33.7 pt -137.71 143.78 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -102.32 114.31 28.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 1.029 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 15.6 t -97.72 141.31 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.177 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -147.89 121.05 8.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.49 20.72 1.36 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.438 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.486 HD13 HD11 ' A' ' 377' ' ' LEU . 65.8 mt -81.28 153.4 27.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.766 0.317 . . . . 0.0 110.979 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . 0.406 ' H ' ' ND2' ' A' ' 369' ' ' ASN . 3.8 p30 -75.71 -177.21 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.25 7.59 40.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.909 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.8 t -123.2 14.11 9.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 10.8 p -75.57 132.9 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 58.6 p -114.53 159.68 20.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.203 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.756 HD11 ' HG2' ' A' ' 396' ' ' PRO . 13.1 tp -58.95 -61.29 2.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -48.74 -32.74 9.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.97 -31.09 65.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.579 HD12 HD11 ' A' ' 400' ' ' ILE . 38.6 mt -86.21 -30.03 22.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.87 -33.26 65.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.67 -20.97 35.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.428 ' CE2' ' CD1' ' A' ' 430' ' ' PHE . 63.6 t80 -92.32 -49.5 6.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 1.029 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.1 m-85 -59.9 -26.38 65.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -75.89 -4.39 40.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -55.43 -48.88 73.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 39.3 t -63.71 -57.87 8.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -142.22 -123.19 1.83 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.488 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 71.9 t -124.84 135.98 62.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 85.9 t -92.04 128.35 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -53.18 108.96 0.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 40.1 mmm -105.87 127.53 53.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.431 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 14.4 t-20 -50.23 146.17 5.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -94.86 -13.39 25.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -100.47 -48.27 4.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.431 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 30.4 p -92.49 -19.62 21.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.473 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 66.12 26.65 72.49 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.472 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -112.59 153.28 45.03 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.654 0.74 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.756 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.9 Cg_endo -69.67 146.61 61.32 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.722 2.281 . . . . 0.0 112.379 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.44 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.2 mmt -81.49 40.69 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.52 HG12 HG22 ' A' ' 415' ' ' VAL . 97.1 mt -98.05 138.76 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -118.3 137.16 53.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.579 HD11 HD12 ' A' ' 377' ' ' LEU . 73.6 mt -130.8 95.54 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.157 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -63.16 126.15 26.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 409' ' ' PRO . 35.8 mt -110.96 135.49 51.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.913 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.7 t0 -56.58 121.46 9.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.416 ' C ' ' HD3' ' A' ' 404' ' ' LYS . 0.0 OUTLIER -70.12 -1.05 8.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -89.04 -37.27 15.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.0 p -124.18 -36.01 2.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.098 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 107.56 -2.87 34.39 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.45 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -85.15 152.82 59.09 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.515 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.6 Cg_endo -69.76 95.79 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.707 2.271 . . . . 0.0 112.292 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 409' ' ' PRO . 6.4 ptmt -33.39 -52.37 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.99 -12.8 0.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.51 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -91.39 152.03 20.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -165.26 170.6 14.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.4 p -139.1 142.12 38.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.924 HG21 ' CD2' ' A' ' 381' ' ' PHE . 48.1 t -128.99 116.28 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . 0.44 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 14.5 m -90.76 115.54 27.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.537 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 56.6 m-85 -88.36 163.98 15.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -62.17 -63.61 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.509 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 1.6 m-20 -116.01 156.29 46.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.634 0.731 . . . . 0.0 110.87 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.26 -43.02 56.44 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.745 2.297 . . . . 0.0 112.36 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 56.7 Cg_exo -49.31 -26.71 11.99 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.658 2.238 . . . . 0.0 112.373 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 93.4 m -91.89 -41.46 10.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.719 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.28 -47.36 85.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.126 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -63.26 -37.41 87.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.86 -32.33 61.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.041 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.453 ' HB1' ' OH ' ' A' ' 417' ' ' TYR . . . -69.36 -33.85 73.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.027 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 423' ' ' ALA . 85.2 t -56.15 -64.42 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.127 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.59 -13.67 44.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.53 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -79.21 -54.39 6.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.888 ' HB2' HG21 ' A' ' 442' ' ' VAL . 79.8 m-85 -90.61 -11.67 39.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 3.0 t70 -61.4 98.38 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 106.38 -7.93 40.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.511 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.444 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 30.8 mmtt -53.82 165.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 110.876 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -112.67 116.18 29.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.826 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.622 ' HB2' HD11 ' A' ' 440' ' ' LEU . 6.4 t80 -113.82 109.71 18.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 61.13 28.77 18.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 94.1 -14.83 64.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.512 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 19.7 m -91.81 160.59 15.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 0.0 110.834 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -97.39 134.46 40.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.937 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' A' ' 435' ' ' PHE . 9.6 mt -102.84 144.9 30.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -122.77 99.51 6.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.888 HG21 ' HB2' ' A' ' 430' ' ' PHE . 16.9 t -96.2 131.37 43.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 5.4 m -151.8 129.43 11.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.491 ' HG ' HG21 ' A' ' 427' ' ' VAL . 21.5 mt -44.33 112.84 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.938 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -50.13 104.28 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.173 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 27.7 ttt-85 -107.09 152.53 23.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.91 158.88 30.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.943 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . 0.457 ' CG ' ' HD2' ' A' ' 449' ' ' PRO . 26.5 tttt -76.7 139.32 66.65 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.642 0.735 . . . . 0.0 110.851 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.457 ' HD2' ' CG ' ' A' ' 448' ' ' LYS . 53.9 Cg_endo -69.77 125.63 12.36 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.711 2.274 . . . . 0.0 112.372 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.69 10.23 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.686 2.257 . . . . 0.0 112.378 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.1 150.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.861 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 454' ' ' GLY . 7.9 t30 -123.96 122.49 38.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.908 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 1.9 m -64.68 85.68 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . 0.418 ' O ' ' ND2' ' A' ' 452' ' ' ASN . . . 69.46 147.54 0.26 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.524 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 456' ' ' SER . 53.3 Cg_endo -69.77 2.68 3.32 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.702 2.268 . . . . 0.0 112.411 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 455' ' ' PRO . 6.1 m -34.76 134.44 0.23 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.3 t -40.43 155.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.848 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.497 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 47.6 t -113.1 140.06 48.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 110.848 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 63.7 m 48.65 42.87 20.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 350' ' ' SER . . . -117.44 72.54 0.29 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.504 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 349' ' ' GLY . 4.2 m -36.05 -50.29 0.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.908 0.385 . . . . 0.0 110.885 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 71.3 p -44.84 118.41 1.61 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -134.41 -90.2 0.36 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.523 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -139.44 153.54 70.79 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.563 0.696 . . . . 0.0 110.906 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.72 163.77 36.98 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.719 2.279 . . . . 0.0 112.367 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -110.19 97.65 7.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.817 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -89.12 39.94 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -86.67 148.91 25.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 4.7 t -134.34 -54.13 0.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.25 46.07 1.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.841 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -130.36 82.37 2.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.938 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 6.8 m -93.63 42.39 1.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -141.52 165.65 26.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.146 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.477 ' HB ' ' CG1' ' A' ' 442' ' ' VAL . 17.1 pt -137.66 139.29 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.081 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -99.45 113.49 25.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 1.052 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 23.2 t -96.93 143.31 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.132 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -149.95 120.57 7.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.82 20.76 1.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.498 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.512 HD23 HD22 ' A' ' 440' ' ' LEU . 44.2 mt -83.58 156.01 22.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . 0.565 HD21 ' NE2' ' A' ' 436' ' ' GLN . 18.4 p30 -78.62 -176.3 4.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.58 10.06 29.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.5 t -122.91 10.04 9.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.5 HG21 HD21 ' A' ' 377' ' ' LEU . 7.4 p -73.79 128.95 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 74.8 p -111.35 162.86 14.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.122 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.752 HD11 ' HG2' ' A' ' 396' ' ' PRO . 13.8 tp -58.74 -63.77 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -46.69 -38.24 9.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.869 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -67.09 -29.99 69.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.577 HD12 HD11 ' A' ' 400' ' ' ILE . 47.6 mt -87.33 -29.81 21.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.934 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.92 -41.04 64.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.431 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 30.7 t0 -76.17 -19.39 58.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -92.61 -45.58 8.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.943 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 1.052 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 15.0 m-85 -67.46 -19.36 65.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.838 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.431 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 5.7 ptmm? -77.14 -6.04 51.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -53.24 -53.08 55.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 13.2 t -59.2 -68.18 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.07 -122.39 2.31 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.483 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 71.7 t -126.98 135.22 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.882 0.372 . . . . 0.0 111.16 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.48 130.93 36.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.158 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -55.09 104.51 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . 0.499 ' SD ' ' N ' ' A' ' 396' ' ' PRO . 59.4 mmm -101.5 118.71 37.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -46.82 150.38 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -95.09 -23.6 17.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . 0.415 ' CD ' HG23 ' A' ' 393' ' ' THR . 0.0 OUTLIER -93.64 -46.51 7.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.821 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.415 HG23 ' CD ' ' A' ' 392' ' ' ARG . 41.4 p -90.93 -14.1 32.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.16 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.45 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 55.32 30.41 55.12 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.529 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -118.67 153.18 52.14 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.556 0.693 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.752 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.1 Cg_endo -69.8 147.95 63.76 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.682 2.255 . . . . 0.0 112.345 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.46 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 19.7 mmt -81.84 40.58 0.61 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.829 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.525 HG12 HG22 ' A' ' 415' ' ' VAL . 96.2 mt -96.71 143.66 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.144 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -123.66 138.11 54.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.577 HD11 HD12 ' A' ' 377' ' ' LEU . 60.3 mt -131.73 96.23 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.136 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -63.75 124.46 21.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 409' ' ' PRO . 24.7 mt -109.84 136.16 49.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.935 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.5 t70 -56.72 134.67 55.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.806 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -5.82 55.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -97.31 -26.37 14.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.43 ' OG1' ' CG ' ' A' ' 408' ' ' LYS . 65.2 p -123.1 -36.16 2.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.074 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 95.17 -6.61 68.99 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.461 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . 0.43 ' CG ' ' OG1' ' A' ' 406' ' ' THR . 3.7 ptpt -86.97 159.42 51.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.592 0.711 . . . . 0.0 110.858 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.524 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.0 Cg_endo -69.76 92.57 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.61 2.207 . . . . 0.0 112.404 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -32.39 -51.98 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 153.77 -13.96 0.59 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -90.43 157.08 17.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.903 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -170.17 169.63 7.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.056 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.6 p -140.05 139.15 35.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.138 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.975 HG21 ' CD2' ' A' ' 381' ' ' PHE . 60.5 t -125.66 120.85 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . 0.46 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 4.8 m -95.46 116.42 28.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.827 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.434 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 60.4 m-85 -89.29 163.6 15.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.898 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -58.49 -66.35 0.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.831 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.5 m-20 -112.31 156.44 42.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.663 0.744 . . . . 0.0 110.793 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.37 -42.99 56.12 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.7 2.267 . . . . 0.0 112.349 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 52.3 Cg_exo -50.21 -32.63 33.17 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.638 2.225 . . . . 0.0 112.345 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 89.1 m -81.75 -38.57 25.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -62.33 -50.64 70.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.181 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.664 ' HG2' HD11 ' A' ' 444' ' ' LEU . 39.3 mtmt -58.94 -35.61 73.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.64 -32.05 57.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.25 -33.38 71.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.069 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.614 HG21 ' HG ' ' A' ' 444' ' ' LEU . 97.2 t -55.91 -63.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.13 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -65.73 -9.74 30.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.534 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.2 t-105 -83.77 -55.09 4.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.938 ' HB2' HG21 ' A' ' 442' ' ' VAL . 93.2 m-85 -87.29 -18.52 30.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.856 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.8 t70 -55.81 98.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 103.92 12.22 30.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.518 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.444 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 16.2 mmtm -71.05 175.03 5.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.766 0.317 . . . . 0.0 110.894 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 438' ' ' SER . 1.2 m-20 -121.72 127.94 51.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.576 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.1 t80 -123.92 100.74 6.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . 0.565 ' NE2' HD21 ' A' ' 369' ' ' ASN . 56.9 mt-30 62.17 36.85 14.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 93.3 -21.36 40.85 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.47 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 434' ' ' ASP . 24.4 p -85.53 166.84 15.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.96 0.41 . . . . 0.0 110.842 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . 0.426 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.7 tmmm? -112.43 137.02 51.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.576 HD11 ' HB2' ' A' ' 435' ' ' PHE . 1.4 mt -108.71 151.19 26.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -125.31 106.78 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.938 HG21 ' HB2' ' A' ' 430' ' ' PHE . 15.0 t -96.74 138.95 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 47.7 m -157.51 126.1 5.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.664 HD11 ' HG2' ' A' ' 424' ' ' LYS . 19.7 mt -38.74 106.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.909 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 444' ' ' LEU . . . -37.33 100.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -69.9 -40.2 75.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -48.34 150.72 1.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.948 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . 0.469 ' CG ' ' HD2' ' A' ' 449' ' ' PRO . 21.2 tttp -128.51 139.43 35.51 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.532 0.682 . . . . 0.0 110.929 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' A' ' 448' ' ' LYS . 53.9 Cg_endo -69.72 164.23 35.28 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.757 2.305 . . . . 0.0 112.311 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 452' ' ' ASN . 54.0 Cg_endo -69.75 2.59 3.38 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.674 2.249 . . . . 0.0 112.314 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 10.7 tpt -46.12 89.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.855 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 450' ' ' PRO . 1.2 p-10 -172.02 159.64 5.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 3.1 t -174.75 165.91 3.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.825 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -156.47 -174.28 26.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.429 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.66 120.92 7.65 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.718 2.279 . . . . 0.0 112.407 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 33.3 t -87.43 -55.04 3.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.856 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 22.7 t -59.65 123.83 18.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.485 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 13.0 t -151.02 110.93 4.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.903 0.382 . . . . 0.0 110.832 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 59.6 p -39.21 -35.41 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -99.47 -148.81 23.5 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.441 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.9 m 38.27 42.09 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.873 0.368 . . . . 0.0 110.839 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 77.5 p -149.76 146.36 27.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 79.01 96.17 0.27 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.533 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -129.86 144.17 51.95 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.52 0.676 . . . . 0.0 110.867 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -175.61 1.22 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.727 2.285 . . . . 0.0 112.345 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -80.62 116.83 20.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -99.14 175.18 5.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.836 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -122.04 -46.03 2.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.816 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 3.3 m -41.35 -46.8 3.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.31 35.77 23.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.834 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . 0.804 HD21 ' HB3' ' A' ' 445' ' ' ALA . 6.4 t30 -87.75 100.93 13.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.6 p -85.62 23.96 1.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -126.52 158.96 34.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.112 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.688 HD12 ' CG1' ' A' ' 442' ' ' VAL . 38.2 pt -130.76 143.3 41.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.154 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -102.57 110.9 22.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.99 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 12.0 t -95.13 142.23 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.149 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -146.66 121.09 9.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.88 14.49 2.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.519 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.498 HD13 HD11 ' A' ' 377' ' ' LEU . 96.7 mt -73.47 154.85 39.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -77.11 178.79 6.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.99 6.25 40.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.9 t -121.91 13.57 10.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.858 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.471 HG21 HD21 ' A' ' 377' ' ' LEU . 11.7 p -74.31 138.02 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.156 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 35.4 p -122.45 158.7 29.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.825 HD11 ' HG2' ' A' ' 396' ' ' PRO . 17.6 tp -54.81 -60.4 3.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -50.9 -29.74 12.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -75.8 -34.24 60.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.641 HD12 HD11 ' A' ' 400' ' ' ILE . 53.0 mt -82.63 -27.96 31.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -74.26 -37.87 63.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.074 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.438 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 13.5 t70 -76.08 -21.58 56.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.848 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -92.53 -49.32 6.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.935 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.99 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.6 m-85 -63.82 -11.6 28.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.438 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 13.5 ptmt -88.63 -5.13 58.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -54.54 -54.04 46.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 6.1 t -60.51 -67.36 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -130.71 -127.43 2.89 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.514 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 78.3 t -125.86 130.78 72.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 111.195 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 56.0 t -82.0 128.58 38.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -50.03 105.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 82.7 mmm -100.57 124.08 45.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.404 ' CB ' ' OG1' ' A' ' 393' ' ' THR . 8.0 t-20 -50.38 144.78 7.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -94.46 -18.83 21.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -99.93 -44.1 6.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.404 ' OG1' ' CB ' ' A' ' 390' ' ' ASN . 25.6 p -92.18 -22.14 19.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.185 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 65.89 29.95 76.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -120.03 153.11 55.06 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.86 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.825 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.0 Cg_endo -69.83 145.72 57.6 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.721 2.281 . . . . 0.0 112.298 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.42 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 11.8 mmt -81.33 41.21 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.458 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 98.6 mt -98.76 140.86 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -121.05 140.25 52.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.641 HD11 HD12 ' A' ' 377' ' ' LEU . 61.3 mt -132.64 99.86 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -68.12 131.61 45.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 409' ' ' PRO . 26.0 mt -115.51 138.28 51.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.921 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 407' ' ' GLY . 6.0 t0 -59.53 124.52 20.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -71.34 -1.17 12.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -89.5 -39.66 13.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 82.8 p -121.72 -33.42 3.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 103.9 -4.49 45.84 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.523 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -82.54 152.86 67.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.6 0.714 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.561 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.1 Cg_endo -69.76 95.64 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.689 2.26 . . . . 0.0 112.336 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 409' ' ' PRO . 8.7 ptmt -32.76 -54.62 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.51 -13.87 0.52 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.479 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.2 p-10 -87.73 157.21 19.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.743 0.306 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.38 169.4 9.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.052 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 2.3 p -137.84 139.69 40.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.192 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.881 HG21 ' CD2' ' A' ' 381' ' ' PHE . 48.6 t -127.15 114.78 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.161 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . 0.42 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 2.8 m -91.11 112.17 23.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.841 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 68.8 m-85 -86.84 160.93 18.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.88 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -55.18 -67.44 0.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.83 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.517 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.4 m-20 -107.41 156.21 38.15 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.517 0.675 . . . . 0.0 110.942 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.0 Cg_exo -57.34 -42.94 56.76 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.712 2.275 . . . . 0.0 112.324 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 53.0 Cg_exo -50.03 -46.82 26.35 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.733 2.289 . . . . 0.0 112.253 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 28.6 m -64.45 -43.77 93.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.17 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.727 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -58.85 -45.8 89.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.093 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.605 ' HG2' HD11 ' A' ' 444' ' ' LEU . 68.1 mttt -64.49 -35.33 80.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.03 -33.53 57.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.078 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -69.38 -33.87 73.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.075 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 423' ' ' ALA . 77.1 t -54.71 -61.43 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.55 -15.03 63.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.535 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -78.14 -52.39 8.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.903 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.748 ' HB2' HG21 ' A' ' 442' ' ' VAL . 89.1 m-85 -88.92 -16.68 31.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.869 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.0 t70 -59.9 97.04 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 111.57 1.26 27.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.547 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . . . . . . . . . 19.5 mmtm -67.36 168.34 10.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.803 0.335 . . . . 0.0 110.956 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 434' ' ' ASP . 1.4 p-10 -115.78 111.55 20.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.657 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -111.27 106.55 15.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 61.42 37.73 16.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 74.6 23.61 74.79 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.415 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 36.5 m -132.35 128.78 38.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.919 0.39 . . . . 0.0 110.832 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.17 133.75 48.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.925 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.657 HD11 ' HB2' ' A' ' 435' ' ' PHE . 17.1 mt -101.05 156.81 17.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.96 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -129.74 100.58 5.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.886 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.748 HG21 ' HB2' ' A' ' 430' ' ' PHE . 14.2 t -100.58 131.89 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.171 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 444' ' ' LEU . 13.3 m -157.37 124.27 5.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.605 HD11 ' HG2' ' A' ' 424' ' ' LYS . 34.9 mt -35.05 128.22 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.804 ' HB3' HD21 ' A' ' 360' ' ' ASN . . . -68.76 138.16 54.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.156 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -93.55 146.97 23.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -93.65 171.38 8.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . 0.476 ' CD ' ' HD2' ' A' ' 449' ' ' PRO . 6.1 tppt? -118.83 138.65 26.24 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.542 0.687 . . . . 0.0 110.936 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.476 ' HD2' ' CD ' ' A' ' 448' ' ' LYS . 53.3 Cg_endo -69.78 162.2 43.0 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.647 2.232 . . . . 0.0 112.379 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -36.96 9.86 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.685 2.257 . . . . 0.0 112.346 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 22.2 mmt -42.51 163.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.86 159.41 30.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 1.3 t -100.09 115.29 29.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -40.3 140.33 1.02 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.557 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 124.41 11.06 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.681 2.254 . . . . 0.0 112.371 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 95.6 p -116.27 162.91 16.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.838 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 8.7 t -67.84 83.63 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.438 179.969 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 17.2 m -107.45 -59.96 1.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.372 . . . . 0.0 110.853 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 3.0 t -76.64 -55.78 5.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.873 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -64.92 138.19 39.36 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.465 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 14.4 t -101.53 43.46 1.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.797 0.332 . . . . 0.0 110.815 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 96.3 p -109.43 148.45 31.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 74.35 -175.65 48.59 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.479 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.417 ' CG ' ' HD2' ' A' ' 354' ' ' PRO . 8.5 t70 -124.35 139.76 33.61 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.529 0.681 . . . . 0.0 110.866 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' A' ' 353' ' ' ASP . 53.8 Cg_endo -69.77 2.24 3.72 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.709 2.272 . . . . 0.0 112.321 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.69 -176.57 3.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.861 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -113.66 97.08 6.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -65.3 121.94 15.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.893 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 5.7 t -60.54 163.74 5.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.855 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.67 56.93 3.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.848 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -85.92 80.75 8.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.93 39.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -142.85 161.65 37.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.091 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.554 HD12 ' CG1' ' A' ' 442' ' ' VAL . 38.9 pt -135.52 141.14 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.113 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -100.03 122.04 42.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.897 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 8.1 t -107.5 141.75 21.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.076 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -145.62 123.59 12.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 126.54 16.33 2.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.458 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 93.9 mt -73.84 152.89 40.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 372' ' ' VAL . 6.1 p30 -73.96 -176.53 2.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.96 3.6 54.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.8 m -120.79 17.7 11.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.423 ' N ' ' OD1' ' A' ' 369' ' ' ASN . 11.5 p -79.31 143.23 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.181 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 82.2 p -126.82 155.51 42.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.183 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.708 HD11 ' HG2' ' A' ' 396' ' ' PRO . 16.5 tp -49.64 -62.05 1.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -48.74 -37.85 20.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.83 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -66.53 -27.43 67.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 400' ' ' ILE . 89.6 mt -91.09 -30.06 16.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.66 -37.53 67.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.089 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.436 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 27.7 t70 -78.39 -19.63 52.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.895 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -92.61 -51.9 4.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.897 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 19.1 m-85 -60.34 -24.87 65.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.436 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 8.8 ptmt -70.87 -10.48 59.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.934 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -51.71 -57.4 9.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.865 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.3 t -53.93 -66.82 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -136.59 -122.67 2.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 75.4 t -126.01 130.66 72.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.92 0.39 . . . . 0.0 111.115 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.61 131.15 34.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -54.54 107.76 0.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . 0.467 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 64.0 mmm -104.35 122.76 46.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.449 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 14.4 t-20 -48.8 148.98 1.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -94.91 -22.38 18.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.85 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -93.98 -48.39 6.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.842 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.449 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 41.1 p -88.42 -24.07 23.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.098 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.467 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 68.0 25.88 74.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.433 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -114.94 153.22 47.05 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.571 0.7 . . . . 0.0 110.965 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.708 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.4 Cg_endo -69.78 147.03 61.86 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.7 2.267 . . . . 0.0 112.339 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.471 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 15.0 mmt -81.27 41.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.638 HG12 HG22 ' A' ' 415' ' ' VAL . 96.2 mt -98.04 136.52 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.182 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -117.47 142.19 47.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.765 HD11 HD12 ' A' ' 377' ' ' LEU . 61.4 mt -134.81 94.08 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -61.17 121.84 13.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' A' ' 409' ' ' PRO . 31.3 mt -108.88 135.37 50.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.931 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 407' ' ' GLY . 11.7 t0 -55.33 122.36 10.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -69.89 -0.9 8.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.772 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -91.35 -41.21 11.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.6 p -118.78 -34.39 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 101.7 5.06 51.71 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.46 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -91.09 153.15 44.75 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.552 0.692 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.554 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.4 Cg_endo -69.76 91.89 0.51 Allowed 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.652 2.235 . . . . 0.0 112.372 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 409' ' ' PRO . 9.2 ptmt -31.67 -52.41 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.33 -17.13 0.59 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -87.63 157.22 19.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.856 0.36 . . . . 0.0 110.872 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -169.4 174.17 6.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 2.2 p -143.61 141.32 30.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.113 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.879 HG21 ' CD2' ' A' ' 381' ' ' PHE . 95.8 t -129.41 115.23 34.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . 0.471 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 1.9 m -90.67 114.76 27.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 51.8 m-85 -87.94 161.1 17.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -54.34 -66.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.835 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.517 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 7.1 m-20 -116.34 158.35 43.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.632 0.729 . . . . 0.0 110.878 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.8 Cg_exo -57.44 -43.23 53.44 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.71 2.273 . . . . 0.0 112.332 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 53.1 Cg_exo -49.99 -27.44 16.48 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.65 2.234 . . . . 0.0 112.374 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 40.4 m -89.61 -41.78 11.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.117 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.64 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -59.84 -48.89 79.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.096 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -59.7 -38.96 83.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.82 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -72.84 -32.99 65.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -69.09 -35.07 76.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 423' ' ' ALA . 94.7 t -55.27 -62.52 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -66.9 -11.11 55.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.551 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -81.02 -55.39 4.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.925 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.847 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.0 m-85 -87.34 -19.65 27.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.859 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.1 t70 -51.65 96.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.854 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 103.93 20.8 10.19 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.485 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.453 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 16.1 mmtm -76.81 170.99 15.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.769 0.319 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . 0.426 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 1.7 p30 -115.04 109.29 17.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.841 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.623 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.0 t80 -112.79 108.07 16.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 62.08 33.72 16.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 89.2 -16.38 55.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.448 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 3.1 m -92.66 164.04 13.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.964 0.411 . . . . 0.0 110.836 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -101.62 138.38 38.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.903 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 435' ' ' PHE . 12.4 mt -106.89 144.86 32.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -118.94 107.93 14.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.847 HG21 ' HB2' ' A' ' 430' ' ' PHE . 9.1 t -100.85 131.99 47.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.12 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 10.3 p -152.12 128.81 10.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.885 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 33.2 mt -40.41 111.81 0.23 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -48.65 170.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.04 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -110.52 100.03 8.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.51 116.4 31.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.851 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.87 132.22 86.63 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.605 0.717 . . . . 0.0 110.884 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 146.31 59.86 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.702 2.268 . . . . 0.0 112.337 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . 0.405 ' C ' ' SD ' ' A' ' 451' ' ' MET . 54.1 Cg_endo -69.66 -172.52 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.62 2.213 . . . . 0.0 112.37 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . 0.405 ' SD ' ' C ' ' A' ' 450' ' ' PRO . 0.5 OUTLIER -125.92 89.61 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.937 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -82.3 39.89 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 10.6 t 64.67 35.88 8.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -87.53 -69.06 1.3 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 2.11 3.88 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.662 2.242 . . . . 0.0 112.312 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 6.2 t 73.35 50.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 2.7 t -80.4 -32.47 37.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.863 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 2.3 m -104.13 42.88 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.0 110.85 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 13.2 t -108.67 147.42 31.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 160.55 -171.75 36.78 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.551 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 93.6 p -144.64 127.76 16.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.346 . . . . 0.0 110.849 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 2.2 t -97.35 85.58 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.813 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -155.84 124.38 1.47 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.503 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -109.12 79.47 1.17 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.592 0.71 . . . . 0.0 110.869 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 2.64 3.35 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.65 2.234 . . . . 0.0 112.313 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 73.95 48.57 0.13 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.789 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -150.62 114.22 4.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.79 48.67 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 93.9 p -85.91 76.37 9.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.863 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -164.5 -179.77 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.7 82.37 2.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 423' ' ' ALA . 3.8 p -96.8 6.75 48.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -108.86 158.71 17.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.468 ' CG1' ' HB ' ' A' ' 415' ' ' VAL . 28.9 pt -125.84 142.33 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -103.09 116.32 32.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.957 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 9.3 t -101.73 144.21 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.123 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -149.06 120.13 7.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.01 20.25 1.33 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.454 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.454 HD13 HD11 ' A' ' 377' ' ' LEU . 90.9 mt -79.94 154.53 28.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.808 0.337 . . . . 0.0 110.965 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -77.61 -178.53 5.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.69 3.5 52.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.0 t -118.83 15.72 13.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.859 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.524 HG23 ' CE2' ' A' ' 435' ' ' PHE . 9.3 p -77.13 136.15 25.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 34.0 p -121.48 157.16 31.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.14 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.704 HD11 ' HG2' ' A' ' 396' ' ' PRO . 21.8 tp -53.75 -65.99 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -45.47 -32.75 2.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.21 -32.34 64.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.749 HD12 HD11 ' A' ' 400' ' ' ILE . 27.8 mt -82.59 -31.11 29.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.918 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -71.03 -44.93 64.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.107 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -72.57 -18.63 61.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -92.62 -41.6 10.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.957 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 16.3 m-85 -73.6 -25.01 60.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -67.06 -6.84 18.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.982 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -56.04 -60.19 3.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 35.2 t -49.46 -64.45 0.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.907 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -143.98 -122.55 1.64 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.451 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 69.0 t -121.79 122.04 65.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 0.0 111.131 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 81.8 t -77.53 127.75 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.226 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.472 ' CD ' ' HA ' ' A' ' 418' ' ' GLU . 33.2 tptt -46.09 103.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 73.0 mmm -103.32 126.33 50.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -51.43 145.7 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.92 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -94.59 -20.81 19.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -97.38 -45.47 6.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 25.0 p -90.72 -25.26 20.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 68.98 29.47 72.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -117.9 153.76 51.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.644 0.735 . . . . 0.0 110.927 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.704 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.0 Cg_endo -69.72 144.11 53.17 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.68 2.253 . . . . 0.0 112.379 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.435 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 15.2 mmt -82.1 40.26 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.625 HG12 HG22 ' A' ' 415' ' ' VAL . 96.4 mt -96.06 141.42 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.158 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -122.03 139.48 53.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.749 HD11 HD12 ' A' ' 377' ' ' LEU . 61.2 mt -132.08 94.48 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.126 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -61.29 130.11 44.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 409' ' ' PRO . 35.8 mt -114.36 136.82 52.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.861 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 407' ' ' GLY . 6.4 t0 -56.83 126.52 27.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.812 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.57 -1.15 17.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -92.02 -36.74 13.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 31.2 p -123.57 -33.6 3.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 101.64 -1.52 52.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.524 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -84.27 152.93 62.15 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.612 0.72 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.583 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.2 Cg_endo -69.76 92.42 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.306 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.48 ' C ' ' O ' ' A' ' 409' ' ' PRO . 8.1 ptmt -31.82 -51.99 0.23 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.86 -15.6 0.8 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.531 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -88.23 151.64 22.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -164.29 172.04 14.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.1 p -140.21 141.3 35.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.12 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.824 HG21 ' CD2' ' A' ' 381' ' ' PHE . 58.0 t -128.29 113.63 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.076 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . 0.435 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 2.1 m -87.48 119.25 27.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.558 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 37.2 m-85 -91.55 159.02 16.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.959 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . 0.472 ' HA ' ' CD ' ' A' ' 388' ' ' LYS . 15.9 mm-40 -58.2 -60.88 3.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.524 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.2 m-20 -113.69 156.9 42.96 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.568 0.699 . . . . 0.0 110.899 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.4 Cg_exo -57.01 -42.89 59.36 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.626 2.217 . . . . 0.0 112.323 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.5 Cg_exo -52.46 -41.99 64.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.727 2.285 . . . . 0.0 112.351 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 39.3 m -67.36 -40.82 85.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.167 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -62.18 -49.8 74.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.06 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.578 ' HG2' HD11 ' A' ' 444' ' ' LEU . 43.3 mtpt -60.15 -36.14 76.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.55 -33.05 58.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.115 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 417' ' ' TYR . . . -72.43 -33.24 66.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 423' ' ' ALA . 86.1 t -57.33 -62.06 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.179 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -68.12 -11.35 58.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.549 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.62 -54.81 5.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.846 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.7 m-85 -87.76 -19.6 27.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.92 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.4 t0 -54.15 89.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 116.46 13.99 7.82 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.533 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.472 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 2.4 mmmp? -79.44 176.2 9.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 0.0 110.903 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -121.36 126.9 50.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.781 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.2 t80 -126.24 105.53 8.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 62.58 31.01 17.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.889 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 83.94 18.38 63.38 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.527 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 19.4 m -128.6 126.67 40.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.969 0.414 . . . . 0.0 110.862 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.9 138.07 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.781 HD11 ' HB2' ' A' ' 435' ' ' PHE . 10.0 mt -108.89 147.49 32.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -119.37 108.5 14.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.846 HG21 ' HB2' ' A' ' 430' ' ' PHE . 13.0 t -100.85 132.2 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 9.5 p -151.7 127.54 10.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.806 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.719 ' HG ' HG21 ' A' ' 427' ' ' VAL . 16.4 mt -45.76 113.9 0.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.891 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.41 109.38 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.053 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 446' ' ' ARG . 21.7 ttm105 -110.79 -56.03 2.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 22.3 tttm 56.89 31.6 19.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 38.9 tttt -129.76 134.79 26.59 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.607 0.718 . . . . 0.0 110.886 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 148.41 65.05 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.697 2.265 . . . . 0.0 112.334 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 175.38 8.16 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.701 2.267 . . . . 0.0 112.343 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.59 -176.66 3.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.933 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -109.81 109.5 20.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.916 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 21.2 m -161.12 122.97 3.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -89.63 151.54 21.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.412 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.73 -10.34 28.34 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.642 2.228 . . . . 0.0 112.352 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 37.1 m -71.79 168.5 17.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.849 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 2.7 m -56.81 103.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.793 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.257 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.456 179.984 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 347' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 346' ' ' GLY . 3.8 m -36.4 123.06 0.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.906 0.384 . . . . 0.0 110.84 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 93.4 p -127.76 106.5 9.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.834 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 142.49 -146.5 17.46 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.464 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 29.0 t -109.79 109.28 19.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.006 0.431 . . . . 0.0 110.886 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 3.8 m -51.46 -56.04 15.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.848 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 162.17 -50.54 0.33 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.47 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -110.25 80.91 2.04 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.707 . . . . 0.0 110.868 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.66 1.16 4.62 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.737 2.291 . . . . 0.0 112.327 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.86 94.1 1.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.825 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -50.9 108.58 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -100.88 -43.54 6.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 30.2 p -107.27 90.06 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -104.26 104.75 14.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -145.0 114.81 7.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.857 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 417' ' ' TYR . 8.5 p -121.97 44.17 2.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -146.99 169.24 19.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.068 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.693 HD12 ' CG1' ' A' ' 442' ' ' VAL . 37.0 pt -144.96 142.68 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -101.1 113.11 25.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.979 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 19.3 t -96.19 144.22 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.123 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -150.23 119.55 6.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.4 23.38 1.01 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.574 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 71.6 mt -83.72 152.71 24.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 0.0 110.887 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . 0.505 ' ND2' ' CD ' ' A' ' 436' ' ' GLN . 5.0 p30 -74.61 179.34 4.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.41 1.08 52.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 14.3 m -117.29 13.65 14.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.845 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.37 133.59 31.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.129 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 81.6 p -117.56 163.98 15.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.149 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.766 HD11 ' HG2' ' A' ' 396' ' ' PRO . 16.3 tp -58.9 -62.77 1.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.925 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.08 -38.37 7.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.92 -31.8 73.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.55 HD12 HD11 ' A' ' 400' ' ' ILE . 84.5 mt -86.97 -30.32 21.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.959 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.17 -33.76 65.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.081 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.425 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 8.4 t70 -84.6 -19.4 33.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.493 ' CE1' ' NE2' ' A' ' 383' ' ' GLN . 47.0 t80 -91.92 -50.89 5.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.979 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 20.0 m-85 -61.72 -23.6 66.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.876 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.425 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 30.3 pttt -72.65 -6.95 47.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.865 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . 0.493 ' NE2' ' CE1' ' A' ' 380' ' ' PHE . 12.5 mt-30 -55.11 -51.91 64.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 7.3 t -62.79 -64.75 0.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -134.82 -129.87 2.93 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.49 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 50.3 t -122.07 129.11 75.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.808 0.337 . . . . 0.0 111.178 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.85 128.43 38.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -52.42 105.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.845 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . . . . . . . . . 73.9 mmm -101.22 123.75 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.409 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 11.5 t-20 -50.1 147.27 4.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.844 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -94.71 -18.28 21.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . 0.456 ' HG3' HG23 ' A' ' 393' ' ' THR . 19.6 ptt180 -99.71 -44.22 6.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.456 HG23 ' HG3' ' A' ' 392' ' ' ARG . 67.0 p -93.53 -17.12 23.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 60.69 26.67 65.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.514 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -115.37 153.04 47.53 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.581 0.705 . . . . 0.0 110.942 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.766 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.5 Cg_endo -69.7 146.66 61.21 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.696 2.264 . . . . 0.0 112.362 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.407 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 6.8 mmt -81.37 41.15 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.926 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.466 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 90.6 mt -98.96 135.02 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.137 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -114.77 138.08 51.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.55 HD11 HD12 ' A' ' 377' ' ' LEU . 60.7 mt -130.79 94.2 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.163 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -61.78 123.82 19.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.545 HD23 ' HA ' ' A' ' 409' ' ' PRO . 45.3 mt -110.19 135.93 50.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 407' ' ' GLY . 11.1 t70 -55.42 124.37 16.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.932 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -73.09 -1.05 15.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -95.08 -35.12 12.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 37.2 p -121.24 -36.13 3.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.079 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 103.21 -6.99 51.21 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.551 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -82.55 153.04 67.87 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.592 0.71 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.545 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.8 Cg_endo -69.69 94.51 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.7 2.267 . . . . 0.0 112.372 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -32.58 -50.15 0.24 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.817 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 150.14 -15.3 1.01 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.468 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -88.15 154.99 20.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.777 0.322 . . . . 0.0 110.927 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.05 170.93 10.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.121 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 2.5 p -137.91 142.04 40.62 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.167 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.852 HG21 ' CD2' ' A' ' 381' ' ' PHE . 47.3 t -127.81 115.25 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . 0.407 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 1.9 m -92.65 114.97 27.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.493 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 54.2 m-85 -89.05 163.39 15.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.974 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -56.24 -65.49 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.517 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 4.7 m-20 -115.78 156.56 46.24 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.731 . . . . 0.0 110.842 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.2 Cg_exo -57.37 -42.89 57.11 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.636 2.224 . . . . 0.0 112.366 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.0 Cg_exo -50.69 -26.98 18.49 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.625 2.217 . . . . 0.0 112.361 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 52.9 m -89.05 -43.17 11.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.71 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -58.87 -48.13 82.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.522 ' HG2' HD11 ' A' ' 444' ' ' LEU . 7.9 mtmp? -59.86 -38.47 82.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.888 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.0 -32.83 63.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.079 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -70.73 -31.95 68.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 423' ' ' ALA . 90.5 t -56.32 -60.69 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.082 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -67.06 -12.45 59.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.554 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.53 -54.6 5.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.826 ' HB2' HG21 ' A' ' 442' ' ' VAL . 88.9 m-85 -88.26 -14.56 38.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.88 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.7 OUTLIER -58.49 93.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 108.1 14.72 16.06 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.466 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.413 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 15.7 mmtm -73.92 169.67 16.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.76 0.315 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -112.28 112.92 24.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.566 ' HB3' HD21 ' A' ' 440' ' ' LEU . 4.4 t80 -115.47 106.48 14.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . 0.505 ' CD ' ' ND2' ' A' ' 369' ' ' ASN . 69.1 mt-30 61.59 38.56 15.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.968 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 84.49 -14.53 45.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.5 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 6.1 m -94.25 168.92 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.815 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -106.62 135.95 47.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 435' ' ' PHE . 9.4 mt -102.69 145.05 30.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -119.78 107.39 13.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.832 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.826 HG21 ' HB2' ' A' ' 430' ' ' PHE . 6.3 t -103.08 136.26 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.1 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 444' ' ' LEU . 22.0 m -157.3 126.38 5.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.522 HD11 ' HG2' ' A' ' 424' ' ' LYS . 19.4 mt -35.03 123.75 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -61.79 129.69 42.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.067 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 46.5 mmt-85 61.64 42.01 11.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -76.21 148.45 37.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . 0.484 ' CD ' ' HD2' ' A' ' 449' ' ' PRO . 1.9 tppp? -68.69 136.38 90.31 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.579 0.704 . . . . 0.0 110.886 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.484 ' HD2' ' CD ' ' A' ' 448' ' ' LYS . 53.8 Cg_endo -69.7 129.51 17.78 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.745 2.297 . . . . 0.0 112.326 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -170.44 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.709 2.273 . . . . 0.0 112.343 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 72.6 mmm -114.22 96.38 5.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -57.21 98.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 8.3 t -111.99 145.3 39.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -135.34 -94.76 0.46 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.549 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 108.73 2.14 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.623 2.215 . . . . 0.0 112.377 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 73.9 m -95.46 119.69 34.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.833 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.4 t -80.34 115.62 19.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.466 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.25 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 53.4 m -138.39 135.32 35.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.901 0.381 . . . . 0.0 110.935 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 90.1 p -159.42 162.66 35.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -79.5 104.2 2.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.535 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 32.0 t -149.05 105.87 3.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.865 0.364 . . . . 0.0 110.872 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 78.9 p -94.91 -46.23 6.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 145.71 98.58 0.24 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.483 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.57 150.36 97.88 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.631 0.729 . . . . 0.0 110.847 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 138.57 38.1 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.708 2.272 . . . . 0.0 112.397 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -70.39 98.19 1.38 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -48.35 158.51 0.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -54.49 -53.48 53.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 99.2 p -129.87 156.48 44.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.793 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.7 44.29 1.78 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.865 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . 0.647 HD21 ' HB3' ' A' ' 445' ' ' ALA . 2.1 t30 -51.86 99.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.951 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.7 m -93.95 42.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.863 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -145.68 156.73 43.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.105 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.468 ' HB ' ' CG1' ' A' ' 442' ' ' VAL . 44.8 pt -128.67 140.12 50.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -98.75 111.36 23.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.918 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 13.0 t -95.19 140.09 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.148 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -147.39 122.4 10.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 131.81 6.07 3.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.517 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.487 HD13 HD11 ' A' ' 377' ' ' LEU . 19.8 mt -71.99 156.42 39.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.871 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . 0.603 ' H ' ' ND2' ' A' ' 369' ' ' ASN . 0.3 OUTLIER -83.88 175.37 9.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -83.61 7.45 17.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.5 t -116.92 3.51 12.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.405 HG21 HD22 ' A' ' 368' ' ' LEU . 5.0 p -75.05 134.61 29.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.083 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 41.1 p -113.59 170.69 8.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.155 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.709 HD11 ' HG2' ' A' ' 396' ' ' PRO . 12.0 tp -65.93 -65.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -45.59 -26.58 0.62 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -73.41 -36.39 65.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.828 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.487 HD11 HD13 ' A' ' 368' ' ' LEU . 81.1 mt -87.32 -25.48 23.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.6 -35.3 72.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -89.15 -15.04 34.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -92.53 -42.58 9.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.918 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 20.3 m-85 -72.49 -22.19 61.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 2.7 ptmm? -68.87 -5.05 18.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -56.13 -59.99 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.875 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 4.1 t -52.8 -64.26 0.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -139.05 -123.43 2.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.445 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 92.8 t -125.53 131.41 72.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 111.099 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 64.7 t -82.52 122.36 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -47.06 110.39 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . 0.478 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 27.9 mtp -107.94 128.75 54.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.879 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -54.83 147.6 14.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 391' ' ' LYS . 0.0 OUTLIER -94.63 -14.25 25.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . 0.445 ' HG3' HG23 ' A' ' 393' ' ' THR . 14.9 ptm180 -101.09 -46.5 5.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.836 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.445 HG23 ' HG3' ' A' ' 392' ' ' ARG . 67.3 p -91.76 -19.28 22.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.118 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.478 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 64.89 19.9 66.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.464 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -107.64 152.65 41.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 0.0 110.917 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.709 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.7 Cg_endo -69.81 147.41 62.47 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.66 2.24 . . . . 0.0 112.38 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 11.0 mmt -81.36 41.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.477 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 91.8 mt -98.63 135.97 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . 0.42 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 7.3 t60 -115.59 138.07 51.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.827 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 67.0 mt -134.41 94.0 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.095 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -59.63 122.34 13.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.931 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' A' ' 409' ' ' PRO . 49.0 mt -106.76 136.35 46.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.939 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 407' ' ' GLY . 1.5 t70 -55.14 125.93 22.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -73.1 -1.24 16.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.441 ' CG ' ' OD1' ' A' ' 403' ' ' ASP . 3.4 mm-40 -96.48 -36.59 10.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 34.6 p -119.74 -35.22 3.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 100.25 -1.02 56.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.507 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -86.8 155.95 55.7 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.597 0.713 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.53 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.9 Cg_endo -69.75 91.3 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.72 2.28 . . . . 0.0 112.272 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.482 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.0 OUTLIER -31.49 -48.45 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.864 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 148.95 -10.63 1.03 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -95.35 154.53 17.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 0.0 110.828 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -168.39 171.47 9.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.13 128.63 20.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.896 HG21 ' CD2' ' A' ' 381' ' ' PHE . 62.5 t -112.3 118.38 57.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 3.2 m -92.59 116.08 28.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.849 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.541 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 52.9 m-85 -89.74 160.3 16.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -57.5 -63.97 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.509 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.7 m-20 -115.59 156.66 45.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.625 0.726 . . . . 0.0 110.845 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.8 Cg_exo -57.4 -43.02 55.66 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.705 2.27 . . . . 0.0 112.3 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 61.7 Cg_exo -48.68 -29.43 14.44 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.714 2.276 . . . . 0.0 112.345 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 90.7 m -88.58 -39.45 14.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.133 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.58 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -61.5 -50.23 73.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -60.08 -38.5 83.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.98 -31.29 61.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.104 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.421 ' CB ' ' CE2' ' A' ' 417' ' ' TYR . . . -70.04 -33.81 72.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.156 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 423' ' ' ALA . 76.3 t -55.85 -64.11 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.157 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -64.99 -12.58 51.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.534 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -80.16 -54.64 5.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.77 ' HB2' HG21 ' A' ' 442' ' ' VAL . 90.9 m-85 -89.47 -14.1 36.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 2.7 t0 -58.15 99.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.768 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 99.79 22.85 11.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.53 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.447 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 19.9 mmtt -78.72 167.92 20.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.794 0.33 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 434' ' ' ASP . 4.3 p-10 -110.7 108.29 18.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.792 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.738 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.6 t80 -115.42 108.33 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.82 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 61.28 36.94 17.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 75.2 21.17 78.44 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.555 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 72.1 m -130.85 129.69 42.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.908 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -70.27 136.56 49.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.738 HD11 ' HB2' ' A' ' 435' ' ' PHE . 8.0 mt -104.66 157.41 17.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.894 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -130.39 106.01 8.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.77 HG21 ' HB2' ' A' ' 430' ' ' PHE . 10.2 t -103.1 133.06 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.106 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 84.7 p -150.04 132.21 15.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.441 ' HG ' HG21 ' A' ' 427' ' ' VAL . 24.3 mt -44.42 116.46 1.04 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.902 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.647 ' HB3' HD21 ' A' ' 360' ' ' ASN . . . -50.36 115.65 1.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.193 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 22.5 ttt-85 -129.27 106.28 8.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.46 24.57 5.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -107.56 136.79 19.59 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.535 0.683 . . . . 0.0 110.91 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . 0.453 ' HA ' ' HD2' ' A' ' 450' ' ' PRO . 53.7 Cg_endo -69.87 110.35 2.56 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.643 2.229 . . . . 0.0 112.333 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 449' ' ' PRO . 53.9 Cg_endo -69.72 -22.13 32.68 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.666 2.244 . . . . 0.0 112.358 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -134.62 134.02 40.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -82.36 -48.64 10.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 94.7 p -126.55 -43.16 1.76 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.776 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -165.89 179.83 39.89 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.504 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -7.84 22.07 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.666 2.244 . . . . 0.0 112.383 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 3.2 m -65.5 128.96 38.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 4.6 t -118.92 120.76 38.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.505 -179.973 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 8.4 t -82.38 101.41 10.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.372 . . . . 0.0 110.844 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 96.9 p -107.29 118.07 35.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.919 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -156.89 82.11 0.16 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.478 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.2 t -89.2 106.07 18.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.906 0.384 . . . . 0.0 110.836 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 95.0 p -105.85 -34.37 7.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.863 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 78.11 178.55 49.32 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -154.1 120.52 2.82 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.649 0.737 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -30.42 22.12 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.691 2.261 . . . . 0.0 112.358 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -94.24 122.83 37.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.833 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.99 -9.36 22.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.892 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.26 171.94 12.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 73.5 m 61.39 44.99 8.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.757 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -38.81 102.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.11 72.54 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.4 m -89.0 38.45 0.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.858 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -140.25 155.83 46.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.102 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.768 HD12 ' CG1' ' A' ' 442' ' ' VAL . 31.4 pt -128.85 143.48 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.102 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.69 123.35 44.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.943 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 11.3 t -107.45 139.34 29.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.135 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -145.79 122.87 11.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 128.63 11.11 3.06 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.518 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.423 HD22 HG21 ' A' ' 372' ' ' VAL . 30.6 mt -70.98 155.84 40.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.798 0.332 . . . . 0.0 110.921 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . 0.478 ' OD1' ' NE2' ' A' ' 436' ' ' GLN . 6.6 p30 -78.2 174.46 11.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.68 14.53 5.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.4 t -131.71 19.57 4.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.831 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.423 HG21 HD22 ' A' ' 368' ' ' LEU . 8.2 p -82.69 130.15 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.133 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 58.8 p -110.44 156.69 20.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.141 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.978 HD11 ' HG2' ' A' ' 396' ' ' PRO . 9.1 tp -54.46 -54.16 44.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -54.57 -35.13 62.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -69.88 -28.49 65.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.754 HD12 HD11 ' A' ' 400' ' ' ILE . 60.2 mt -89.42 -29.06 19.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -71.67 -38.48 70.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.436 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 8.9 t70 -82.56 -17.37 45.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -92.67 -41.73 10.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.943 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 15.2 m-85 -71.95 -16.91 62.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.436 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 9.5 ptpt -77.79 -6.59 54.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -55.74 -50.28 70.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 36.0 t -62.14 -60.84 3.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.91 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -142.65 -126.46 2.08 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.82 128.81 75.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 0.0 111.195 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 84.2 t -84.9 130.05 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.099 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -54.8 113.29 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . 0.501 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 43.7 mmm -109.74 123.63 49.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -49.55 144.15 6.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -94.75 -8.39 37.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -101.9 -46.82 4.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 35.0 p -97.42 -16.63 20.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.101 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.501 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 65.6 26.66 72.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.568 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -112.43 152.95 44.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.557 0.694 . . . . 0.0 110.967 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.978 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.6 Cg_endo -69.69 149.12 66.91 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.74 2.293 . . . . 0.0 112.333 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 7.0 mmt -82.69 38.09 0.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.469 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 91.8 mt -95.98 140.97 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.158 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . 0.408 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 5.5 t60 -121.5 138.01 54.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.754 HD11 HD12 ' A' ' 377' ' ' LEU . 61.6 mt -131.1 93.83 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.076 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -59.44 124.4 19.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.965 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 409' ' ' PRO . 35.1 mt -107.9 137.16 46.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.891 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 407' ' ' GLY . 8.1 t0 -55.46 123.92 15.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -71.2 -1.12 11.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -96.08 -39.1 9.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 33.0 p -117.31 -35.43 4.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 101.23 -1.65 54.35 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.446 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -85.94 155.55 58.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.646 0.736 . . . . 0.0 110.856 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.533 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.1 Cg_endo -69.76 90.95 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.702 2.268 . . . . 0.0 112.279 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.482 ' C ' ' O ' ' A' ' 409' ' ' PRO . 2.3 ptmt -31.73 -53.89 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 155.01 -15.96 0.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.507 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -88.9 156.99 18.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.769 0.319 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -168.93 175.23 5.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.14 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.56 132.71 23.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.147 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.92 HG21 ' CD2' ' A' ' 381' ' ' PHE . 38.8 t -118.87 113.3 41.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.168 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 2.6 m -89.54 116.78 27.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.487 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 57.7 m-85 -93.04 164.18 13.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -56.84 -66.46 0.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.939 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.52 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.4 m-20 -114.54 156.97 43.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.614 0.721 . . . . 0.0 110.83 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.34 -42.97 56.48 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.634 2.223 . . . . 0.0 112.355 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.1 Cg_exo -50.53 -27.19 18.35 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.652 2.235 . . . . 0.0 112.412 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 29.4 m -87.91 -42.36 12.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.843 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -60.44 -41.42 93.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.113 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.469 ' HG2' HD11 ' A' ' 444' ' ' LEU . 35.9 mtpt -65.77 -38.36 88.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.887 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.38 -30.89 62.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.138 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -72.1 -30.78 65.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 423' ' ' ALA . 64.0 t -58.74 -63.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.144 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -64.23 -13.21 47.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.523 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -80.08 -54.65 5.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.919 ' HB2' HG21 ' A' ' 442' ' ' VAL . 79.3 m-85 -87.56 -14.06 41.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.4 t70 -61.51 95.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 117.8 -19.05 11.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.496 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.422 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 2.5 mmmp? -47.88 176.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.764 0.316 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -124.53 130.4 52.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.811 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.631 ' HB2' HD11 ' A' ' 440' ' ' LEU . 1.1 t80 -129.75 107.27 9.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . 0.478 ' NE2' ' OD1' ' A' ' 369' ' ' ASN . 63.7 mt-30 61.8 32.53 18.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 81.12 19.53 66.89 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.465 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 12.2 m -128.11 129.31 46.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.911 0.386 . . . . 0.0 110.844 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -68.67 134.52 49.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 435' ' ' PHE . 22.1 mt -100.81 143.07 31.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -119.37 101.81 8.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.919 HG21 ' HB2' ' A' ' 430' ' ' PHE . 14.0 t -99.27 129.8 49.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.143 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.5 m -154.21 128.46 9.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.866 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.469 HD11 ' HG2' ' A' ' 424' ' ' LYS . 28.6 mt -40.41 132.06 2.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.967 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -76.23 109.89 10.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.071 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -146.69 109.64 4.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -155.48 111.6 3.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -127.51 150.45 72.85 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.554 0.692 . . . . 0.0 110.856 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.88 167.2 25.28 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.637 2.225 . . . . 0.0 112.267 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 451' ' ' MET . 54.1 Cg_endo -69.79 2.94 3.09 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.683 2.255 . . . . 0.0 112.276 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . 0.449 ' C ' ' O ' ' A' ' 450' ' ' PRO . 7.5 mmt -34.44 -47.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.933 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -104.78 137.77 42.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.818 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 7.6 t -137.72 129.63 28.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -148.72 -94.45 0.13 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.498 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 129.3 17.36 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.671 2.247 . . . . 0.0 112.34 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 38.4 m -120.36 148.21 44.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.785 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 91.8 p -125.88 -43.16 1.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.813 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.525 -179.942 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 1.6 t -148.24 115.92 6.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.907 0.384 . . . . 0.0 110.926 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 20.1 t -54.47 147.89 13.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.914 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -176.45 40.47 0.1 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.507 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 76.4 p -59.53 160.66 6.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.858 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 28.2 p -117.46 -56.31 2.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.858 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 83.07 148.54 7.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.491 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -111.5 85.21 5.64 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.634 0.731 . . . . 0.0 110.919 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.61 62.88 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.663 2.242 . . . . 0.0 112.373 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -144.48 162.94 35.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -43.49 141.08 1.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 49.75 41.81 22.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.813 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 20.3 t -44.33 110.35 0.21 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -91.84 111.84 23.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -133.15 102.35 5.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.3 m -90.2 37.68 0.9 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -137.39 164.78 27.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.485 HD12 ' CG1' ' A' ' 442' ' ' VAL . 36.7 pt -138.32 142.22 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.11 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -102.52 115.25 30.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.977 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.938 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 12.1 t -101.35 142.59 15.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -150.55 122.29 8.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 133.16 6.82 2.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.455 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.46 HD23 HD22 ' A' ' 440' ' ' LEU . 28.2 mt -72.82 156.4 38.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.812 0.339 . . . . 0.0 110.954 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.62 179.86 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.81 6.1 33.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.78 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 10.9 t -114.23 4.21 15.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.839 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.486 HG21 HD21 ' A' ' 377' ' ' LEU . 6.2 p -76.1 139.06 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.107 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 68.9 p -122.21 173.88 7.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.755 HD11 ' HG2' ' A' ' 396' ' ' PRO . 14.9 tp -67.29 -63.3 1.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -47.64 -28.63 2.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.909 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.07 -32.6 56.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.523 HD12 HD11 ' A' ' 400' ' ' ILE . 48.4 mt -84.78 -27.94 26.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.872 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.77 -37.29 65.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.077 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.431 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 21.7 t0 -78.75 -20.25 50.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -92.69 -51.31 5.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.938 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 15.9 m-85 -60.01 -24.64 64.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.431 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -71.27 -15.08 62.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.894 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -45.35 -53.58 8.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 38.3 t -59.23 -69.0 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.14 -124.99 2.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.47 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 67.1 t -124.73 135.25 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.921 0.391 . . . . 0.0 111.113 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.16 131.57 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 38.6 tttm -55.8 111.74 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.955 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . 0.434 ' SD ' ' CA ' ' A' ' 396' ' ' PRO . 64.7 mmm -106.8 121.72 44.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -48.3 148.15 2.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -94.77 -19.16 20.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -96.78 -46.67 6.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.816 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 37.1 p -91.09 -21.7 21.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 65.6 27.93 73.1 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.507 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -117.18 153.24 49.77 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.532 0.682 . . . . 0.0 110.932 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.755 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.2 Cg_endo -69.79 146.99 61.64 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.694 2.262 . . . . 0.0 112.293 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.419 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.5 mmt -81.17 41.47 0.6 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.466 HG12 HG22 ' A' ' 415' ' ' VAL . 96.7 mt -99.27 135.93 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.18 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . 0.434 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 6.0 t60 -115.5 141.03 48.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.523 HD11 HD12 ' A' ' 377' ' ' LEU . 67.6 mt -134.12 93.72 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -59.71 122.35 13.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.539 HD23 ' HA ' ' A' ' 409' ' ' PRO . 45.0 mt -107.57 136.4 47.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.889 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 407' ' ' GLY . 2.0 t70 -55.19 133.63 49.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.09 -6.54 57.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -97.46 -22.88 16.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 69.5 p -128.17 -36.06 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 94.8 0.54 64.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.507 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -90.7 156.93 44.6 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.615 0.721 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.539 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.3 Cg_endo -69.73 89.38 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 0.0 112.392 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.489 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.1 OUTLIER -30.54 -54.74 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 156.77 -15.27 0.36 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.482 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -91.22 153.53 19.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.909 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -166.87 174.85 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.083 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 3.0 p -141.78 143.37 33.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.154 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.827 HG21 ' CD2' ' A' ' 381' ' ' PHE . 45.3 t -130.69 119.87 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . 0.419 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 2.1 m -94.66 114.01 25.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 50.4 m-85 -86.8 162.32 17.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.41 -65.5 0.6 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.522 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 4.5 m-20 -115.5 157.72 43.44 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.669 0.747 . . . . 0.0 110.843 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.2 Cg_exo -57.16 -43.11 56.2 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.617 2.212 . . . . 0.0 112.371 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.4 Cg_exo -50.81 -29.37 26.13 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.648 2.232 . . . . 0.0 112.369 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 40.9 m -86.26 -39.27 16.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.185 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.504 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -62.3 -53.95 47.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.093 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.641 ' HG2' HD11 ' A' ' 444' ' ' LEU . 32.6 mtmt -56.51 -33.94 66.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.81 -32.07 52.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.063 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -72.1 -33.81 68.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.084 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.515 HG21 ' HG ' ' A' ' 444' ' ' LEU . 77.8 t -55.17 -61.58 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -66.59 -12.79 59.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.548 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -79.76 -54.31 5.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.851 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.3 m-85 -88.75 -18.01 28.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.835 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.6 t70 -52.93 97.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 100.95 23.56 9.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.503 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.451 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 25.0 mmtt -76.5 175.87 8.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.32 . . . . 0.0 110.906 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.39 112.33 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.684 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -108.12 98.61 8.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.886 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 61.04 35.25 18.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 96.37 -21.55 44.87 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.45 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.2 p -82.55 152.77 25.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.976 0.417 . . . . 0.0 110.834 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . 0.495 ' C ' HD23 ' A' ' 440' ' ' LEU . 25.8 ttpt -99.72 130.75 45.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.684 HD11 ' HB2' ' A' ' 435' ' ' PHE . 1.1 mt -105.81 144.39 32.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.954 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -122.02 107.7 12.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.917 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.851 HG21 ' HB2' ' A' ' 430' ' ' PHE . 7.1 t -100.23 135.52 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 10.0 p -155.99 130.72 9.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.816 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.641 HD11 ' HG2' ' A' ' 424' ' ' LYS . 19.2 mt -43.99 111.37 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.887 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 444' ' ' LEU . . . -35.34 -65.6 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.098 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -61.5 113.95 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -86.18 123.72 31.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.967 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -106.82 134.12 19.98 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.595 0.712 . . . . 0.0 110.921 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 164.87 32.94 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.68 2.253 . . . . 0.0 112.383 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -6.54 18.85 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.628 2.219 . . . . 0.0 112.357 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 2.0 ttt -47.51 99.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.801 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -150.51 143.28 24.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.942 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 28.7 t -161.59 153.23 18.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.856 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -162.31 -94.81 0.1 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.551 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 107.98 1.99 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.628 2.219 . . . . 0.0 112.396 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 91.3 p -88.88 -47.27 8.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.822 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 10.0 m -58.01 112.43 1.51 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.45 -179.945 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 1.2 t -126.2 -59.25 1.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 110.919 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 44.6 m -98.76 147.27 25.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -156.87 127.18 1.9 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.449 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 53.8 p -74.53 154.4 38.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.881 0.372 . . . . 0.0 110.887 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 37.0 p -132.74 158.8 41.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.927 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -123.61 -40.62 0.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.539 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.71 132.0 78.24 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.651 0.739 . . . . 0.0 110.917 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 170.46 16.49 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.713 2.275 . . . . 0.0 112.33 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -95.66 122.67 38.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.946 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -98.06 86.2 3.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.847 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 45.45 41.64 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.834 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 69.5 m -116.76 90.67 3.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -102.32 88.69 3.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -125.16 79.02 1.76 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 4.1 p -87.19 23.73 1.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -123.39 156.7 34.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.153 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.43 ' CG1' ' HB ' ' A' ' 415' ' ' VAL . 29.4 pt -126.08 142.74 41.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.085 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -104.5 111.68 24.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.994 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 1.033 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 8.5 t -95.7 141.09 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.148 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -145.67 120.3 9.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.1 19.95 1.51 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.479 HD13 HD11 ' A' ' 377' ' ' LEU . 90.3 mt -78.68 151.74 32.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.768 0.318 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -74.68 -176.36 2.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.23 4.62 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.5 t -120.32 17.67 12.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 11.3 p -80.64 136.72 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.178 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 77.5 p -121.3 162.47 20.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.134 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.876 HD11 ' HG2' ' A' ' 396' ' ' PRO . 17.8 tp -57.28 -66.1 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -45.98 -30.19 1.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.95 -34.04 66.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.83 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.551 HD12 HD11 ' A' ' 400' ' ' ILE . 54.1 mt -85.5 -28.99 24.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.853 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.64 -28.88 62.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.414 ' HA ' ' NZ ' ' A' ' 382' ' ' LYS . 10.4 t70 -84.99 -22.34 29.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.437 ' CE2' ' CD1' ' A' ' 430' ' ' PHE . 68.0 t80 -92.63 -48.14 6.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 1.033 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 17.7 m-85 -62.57 -21.02 65.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.414 ' NZ ' ' HA ' ' A' ' 379' ' ' ASP . 2.0 ptpp? -78.19 -4.57 48.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -56.05 -57.92 10.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.947 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . 0.567 ' SG ' ' CE3' ' A' ' 429' ' ' TRP . 1.9 t -56.38 -64.63 0.8 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -133.68 -127.22 2.74 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.409 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 77.3 t -125.87 131.51 71.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.897 0.38 . . . . 0.0 111.183 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 57.3 t -84.55 128.44 38.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -51.04 105.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' A' ' 396' ' ' PRO . 64.1 mmm -101.55 122.13 43.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -46.52 145.65 1.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -94.39 -21.58 18.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -96.25 -46.93 6.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 30.2 p -88.94 -26.63 21.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 70.25 32.08 68.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.477 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -121.07 153.66 57.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.586 0.707 . . . . 0.0 110.95 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.876 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.3 Cg_endo -69.8 145.15 56.05 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.677 2.251 . . . . 0.0 112.276 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.448 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 7.0 mmt -81.52 41.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.827 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.548 HG12 HG22 ' A' ' 415' ' ' VAL . 94.4 mt -97.97 142.75 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.156 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -120.98 141.34 50.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.551 HD11 HD12 ' A' ' 377' ' ' LEU . 60.1 mt -134.91 94.73 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.189 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -62.44 127.41 31.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 409' ' ' PRO . 37.0 mt -112.11 134.56 53.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.878 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 407' ' ' GLY . 13.1 t0 -55.43 120.21 6.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.856 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -1.98 8.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -88.0 -39.67 14.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 33.4 p -121.88 -35.92 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.177 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 107.27 -0.87 35.07 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.47 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -86.53 152.56 54.87 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.53 0.681 . . . . 0.0 110.935 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.49 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.8 Cg_endo -69.71 94.82 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.748 2.299 . . . . 0.0 112.321 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 409' ' ' PRO . 8.4 ptmt -33.19 -52.02 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.883 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.65 -14.39 0.8 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -89.88 149.01 22.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.785 0.326 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -162.09 170.17 19.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.067 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.4 p -138.96 143.29 38.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.184 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.853 HG21 ' CD2' ' A' ' 381' ' ' PHE . 59.4 t -129.01 118.58 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.17 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . 0.448 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 17.3 m -92.67 114.03 26.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.552 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 43.6 m-85 -86.82 165.68 15.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -61.4 -64.28 1.0 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.846 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.518 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 2.9 m-20 -112.63 156.68 42.04 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.672 0.749 . . . . 0.0 110.789 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.3 Cg_exo -57.11 -43.0 57.48 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.654 2.236 . . . . 0.0 112.339 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 50.5 Cg_exo -50.96 -43.15 49.2 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.708 2.272 . . . . 0.0 112.361 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 52.3 m -67.8 -43.22 80.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.111 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.552 ' HA ' ' CD2' ' A' ' 417' ' ' TYR . . . -57.2 -57.61 11.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.1 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.786 ' HG2' HD11 ' A' ' 444' ' ' LEU . 23.2 mtmm -51.89 -36.96 50.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.85 64.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.482 ' CB ' ' CE2' ' A' ' 417' ' ' TYR . . . -69.51 -30.8 68.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.052 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.568 HG21 ' HG ' ' A' ' 444' ' ' LEU . 85.0 t -58.66 -62.14 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.159 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -67.5 -9.71 44.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.567 ' CE3' ' SG ' ' A' ' 384' ' ' CYS . 1.2 t-105 -82.44 -54.16 5.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.972 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.854 ' HB2' HG21 ' A' ' 442' ' ' VAL . 91.2 m-85 -89.05 -20.96 23.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.491 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.0 OUTLIER -49.7 94.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.823 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.15 20.29 9.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.535 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.469 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 14.3 mmtm -78.11 161.47 27.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.842 0.353 . . . . 0.0 110.851 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -107.08 106.45 16.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.667 ' HB2' HD11 ' A' ' 440' ' ' LEU . 4.3 t80 -107.17 110.11 22.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 58.22 35.26 24.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 89.76 -18.94 44.18 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.519 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.4 m -90.35 164.21 14.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.4 . . . . 0.0 110.886 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.86 140.53 33.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 435' ' ' PHE . 11.4 mt -108.06 139.66 42.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -115.82 103.93 11.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.854 HG21 ' HB2' ' A' ' 430' ' ' PHE . 19.2 t -99.34 132.37 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.077 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 9.5 p -151.6 132.35 14.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.824 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.786 HD11 ' HG2' ' A' ' 424' ' ' LYS . 12.5 mt -48.84 105.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.868 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -40.74 132.44 2.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.104 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -113.77 81.12 1.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 4.0 ptmm? -77.65 172.91 12.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -165.37 149.69 7.63 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.597 0.713 . . . . 0.0 110.921 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 135.05 29.49 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.693 2.262 . . . . 0.0 112.33 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 165.57 30.49 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.714 2.276 . . . . 0.0 112.356 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 29.1 tpp -170.22 105.84 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -160.9 155.61 23.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 51.0 m -107.77 103.27 12.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.819 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -107.5 137.15 13.85 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.45 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -24.06 30.2 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.688 2.259 . . . . 0.0 112.398 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 20.7 m -45.57 140.66 3.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.881 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 35.8 p -88.86 172.05 9.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.803 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.487 -179.99 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.562 -0.215 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 3.8 m -121.02 -65.03 1.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 0.0 110.825 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 56.6 p -76.99 120.81 22.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -73.22 -93.3 0.11 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.511 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 20.5 m -146.62 109.69 4.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.92 0.39 . . . . 0.0 110.881 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 60.2 p -92.22 160.65 15.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -113.1 -168.61 17.14 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.483 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -142.56 141.65 21.14 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.588 0.709 . . . . 0.0 110.93 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 172.17 13.19 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.649 2.233 . . . . 0.0 112.308 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.11 149.77 21.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -119.23 40.83 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -114.45 41.47 2.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.864 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 38.2 p -166.89 133.24 2.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.22 98.38 9.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.864 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -144.62 111.79 5.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.3 m -87.2 25.05 1.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.842 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -130.92 166.68 20.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.077 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.756 HD12 HG11 ' A' ' 442' ' ' VAL . 39.8 pt -134.7 142.49 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -99.31 115.02 28.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 4.5 t -103.06 142.31 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.128 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -149.12 124.84 10.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 130.27 12.59 2.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.489 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.521 HD13 HD11 ' A' ' 377' ' ' LEU . 30.2 mt -77.84 156.38 30.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.9 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.72 -179.32 7.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.945 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.92 -2.02 58.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 39.4 t -106.14 3.14 27.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.782 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 12.2 p -69.46 144.77 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 80.7 p -127.85 170.6 12.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.16 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.853 HD11 ' HG2' ' A' ' 396' ' ' PRO . 12.1 tp -68.26 -49.69 58.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -59.74 -34.46 72.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.841 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.37 -31.41 68.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.659 HD12 HD11 ' A' ' 400' ' ' ILE . 60.0 mt -87.96 -28.09 21.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.932 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -72.41 -35.83 68.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.431 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 12.5 t70 -85.36 -17.92 35.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.861 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -92.31 -43.94 9.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.944 ' CD2' HG21 ' A' ' 415' ' ' VAL . 15.8 m-85 -69.9 -21.85 63.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.861 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.431 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 0.0 OUTLIER -72.9 -9.49 58.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.947 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -50.08 -54.65 19.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 3.5 t -58.88 -65.9 0.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -135.19 -126.34 2.6 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.462 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 93.2 t -124.44 131.29 72.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.837 0.351 . . . . 0.0 111.177 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 57.0 t -82.44 126.03 39.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -49.22 107.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . 0.468 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 19.5 mtp -104.47 122.3 45.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -50.73 147.07 5.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -94.59 -18.41 21.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -95.22 -47.89 6.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 37.8 p -90.36 -26.85 19.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.202 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.468 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 73.39 20.32 79.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -108.97 152.81 42.63 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.546 0.688 . . . . 0.0 110.978 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.853 ' HG2' HD11 ' A' ' 374' ' ' LEU . 54.0 Cg_endo -69.81 147.73 63.18 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.636 2.224 . . . . 0.0 112.345 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 9.5 mmt -81.52 40.96 0.6 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.469 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.1 mt -98.82 136.36 30.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -115.71 136.17 53.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.659 HD11 HD12 ' A' ' 377' ' ' LEU . 67.7 mt -132.33 93.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -59.17 124.54 20.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.522 HD23 ' HA ' ' A' ' 409' ' ' PRO . 35.1 mt -109.34 135.14 50.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.9 t0 -55.37 128.1 32.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -75.11 -1.0 21.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -93.66 -31.24 14.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 81.9 p -128.32 -35.89 1.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.089 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 100.57 9.92 45.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.501 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -95.7 155.62 38.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.533 0.682 . . . . 0.0 110.944 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.522 ' HA ' HD23 ' A' ' 402' ' ' LEU . 53.6 Cg_endo -69.78 89.47 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.629 2.219 . . . . 0.0 112.381 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 409' ' ' PRO . 5.1 ptmt -31.58 -53.23 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 155.64 -14.68 0.44 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -90.64 155.07 19.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -168.5 169.47 10.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.3 p -141.79 124.16 15.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.173 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.944 HG21 ' CD2' ' A' ' 381' ' ' PHE . 59.3 t -109.33 121.35 62.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 2.2 m -95.96 114.08 25.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.914 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.529 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 67.2 m-85 -87.1 162.85 17.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -57.63 -67.12 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.52 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 5.7 m-20 -111.6 157.55 38.99 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.626 0.727 . . . . 0.0 110.858 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 32.1 Cg_exo -57.16 -43.0 57.28 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.696 2.264 . . . . 0.0 112.319 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.3 Cg_exo -50.81 -31.24 32.5 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.672 2.248 . . . . 0.0 112.299 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 23.6 m -84.26 -37.72 21.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.105 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.622 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -64.55 -47.86 77.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.074 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.606 ' HG2' HD11 ' A' ' 444' ' ' LEU . 65.4 mttt -62.4 -36.56 82.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.01 -31.24 58.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.407 ' CB ' ' CZ ' ' A' ' 417' ' ' TYR . . . -70.39 -31.88 69.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.649 HG21 ' HG ' ' A' ' 444' ' ' LEU . 94.2 t -57.18 -64.02 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.196 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.0 -11.55 29.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.526 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.3 t-105 -81.3 -54.33 5.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.753 ' HB2' HG21 ' A' ' 442' ' ' VAL . 89.7 m-85 -89.79 -13.39 36.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 1.2 t0 -60.23 95.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 108.29 -0.03 33.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.465 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.454 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 18.7 mmtt -61.13 173.75 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.773 0.32 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -121.18 120.61 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.909 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.782 ' HB2' HD11 ' A' ' 440' ' ' LEU . 5.4 t80 -117.85 105.12 11.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 62.36 26.09 15.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.903 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 97.27 -16.47 60.69 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.539 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 75.5 m -96.8 127.02 42.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.949 0.404 . . . . 0.0 110.817 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -71.12 140.22 50.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.782 HD11 ' HB2' ' A' ' 435' ' ' PHE . 10.6 mt -108.87 151.65 25.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.953 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -122.63 108.16 12.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.912 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.756 HG11 HD12 ' A' ' 363' ' ' ILE . 10.4 t -104.36 135.49 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.197 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 15.4 m -154.86 127.49 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.891 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.649 ' HG ' HG21 ' A' ' 427' ' ' VAL . 24.6 mt -40.86 122.57 1.74 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.912 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.0 126.99 29.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.12 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 29.9 mtm-85 -99.67 95.51 7.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.823 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 6.8 ptmm? -100.45 29.15 4.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.859 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -121.96 134.89 24.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.556 0.693 . . . . 0.0 110.842 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 152.37 69.19 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.717 2.278 . . . . 0.0 112.354 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 -9.07 25.22 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.653 2.235 . . . . 0.0 112.349 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 14.2 tpp -95.06 123.13 38.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -118.65 -57.56 2.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.934 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 17.4 t -90.36 110.51 21.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -122.4 -95.07 1.26 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.512 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 80.75 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.64 2.227 . . . . 0.0 112.361 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 6.8 m -128.87 114.61 16.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 2.6 m 51.94 48.21 23.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.827 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.467 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.223 0 N-CA-C 112.417 -0.273 . . . . 0.0 112.417 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 57.2 p -122.66 -57.9 1.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.358 . . . . 0.0 110.789 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 22.4 t -63.05 134.67 56.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.845 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 167.53 -111.97 0.47 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.474 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 45.2 m -109.31 171.2 7.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.857 0.36 . . . . 0.0 110.867 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 15.0 m -39.86 -61.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 90.68 -136.22 13.28 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.478 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.443 ' N ' ' CD ' ' A' ' 354' ' ' PRO . 0.9 OUTLIER 48.54 54.7 16.4 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.59 0.71 . . . . 0.0 110.831 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 353' ' ' ASP . 53.1 Cg_endo -69.88 -170.03 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.711 2.274 . . . . 0.0 112.236 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -97.48 41.66 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.802 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 357' ' ' ASP . 22.2 tt0 -64.48 146.44 54.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.894 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 356' ' ' GLU . 16.4 t70 35.51 40.7 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' SER . . . . . . . . . . . . . 8.2 t -118.2 141.34 48.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -133.87 152.34 51.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.79 81.27 1.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 6.3 p -100.81 19.51 17.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.833 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.99 159.13 22.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.074 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.698 HD12 ' CG1' ' A' ' 442' ' ' VAL . 38.6 pt -131.8 142.28 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -98.72 117.38 33.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.879 HG21 ' CZ ' ' A' ' 381' ' ' PHE . 15.7 t -102.34 141.94 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.137 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -148.83 122.58 9.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 129.43 18.82 1.59 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.418 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.536 HD13 HD11 ' A' ' 377' ' ' LEU . 64.6 mt -80.87 154.4 27.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . 0.423 ' H ' ' ND2' ' A' ' 369' ' ' ASN . 2.6 p30 -81.44 171.01 15.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.84 6.59 10.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 31.7 m -119.67 14.43 12.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.404 HG21 HD22 ' A' ' 368' ' ' LEU . 6.5 p -79.58 137.33 21.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.148 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 74.8 p -119.93 156.82 30.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.174 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.942 HD11 ' HG2' ' A' ' 396' ' ' PRO . 11.6 tp -53.24 -60.69 2.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -51.76 -33.58 35.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.796 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.47 -29.74 68.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.536 HD11 HD13 ' A' ' 368' ' ' LEU . 49.1 mt -89.9 -29.5 18.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.78 72.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.086 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' ASP . . . . . 0.43 ' C ' ' HG2' ' A' ' 382' ' ' LYS . 21.1 t70 -80.38 -18.91 47.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -92.47 -52.93 4.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.879 ' CZ ' HG21 ' A' ' 365' ' ' VAL . 28.3 m-85 -59.58 -21.66 60.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.43 ' HG2' ' C ' ' A' ' 379' ' ' ASP . 2.6 ptmm? -75.38 -6.1 48.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -58.62 -56.25 24.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' CYS . . . . . . . . . . . . . 28.3 t -57.57 -63.09 1.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.839 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -136.02 -126.54 2.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.463 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 76.2 t -125.46 133.92 68.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 111.124 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 68.4 t -87.14 129.97 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.163 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -56.62 106.85 0.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' MET . . . . . 0.5 ' CE ' ' O ' ' A' ' 394' ' ' GLY . 47.6 mmm -103.34 125.94 50.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.869 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.402 ' ND2' ' OG1' ' A' ' 393' ' ' THR . 15.5 t-20 -51.14 148.88 4.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -94.88 -17.99 21.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.944 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -97.28 -48.32 5.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.402 ' OG1' ' ND2' ' A' ' 390' ' ' ASN . 38.2 p -90.63 -17.95 25.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.173 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.5 ' O ' ' CE ' ' A' ' 389' ' ' MET . . . 62.16 27.47 69.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.436 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -114.63 153.19 46.78 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.608 0.718 . . . . 0.0 110.922 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.942 ' HG2' HD11 ' A' ' 374' ' ' LEU . 53.7 Cg_endo -69.68 146.64 61.28 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.67 2.247 . . . . 0.0 112.366 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.45 ' CB ' ' HB2' ' A' ' 416' ' ' SER . 8.8 mmt -81.25 41.26 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.846 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.473 ' HB ' ' CD1' ' A' ' 374' ' ' LEU . 96.1 mt -98.64 136.4 29.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.124 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' HIS . . . . . 0.528 ' O ' ' HB1' ' A' ' 413' ' ' ALA . 9.2 t60 -115.64 142.24 47.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.402 HD11 HD12 ' A' ' 377' ' ' LEU . 66.9 mt -134.86 94.03 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.084 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -59.7 125.28 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 409' ' ' PRO . 50.0 mt -109.13 136.7 48.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.971 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 407' ' ' GLY . 4.4 t0 -55.24 132.33 47.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -79.74 -5.58 55.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.866 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -97.3 -24.05 15.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 70.4 p -128.15 -36.09 1.97 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.135 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 403' ' ' ASP . . . 97.4 -4.49 62.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.565 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -85.69 156.05 58.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.56 0.695 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.484 ' HA ' HD23 ' A' ' 402' ' ' LEU . 54.2 Cg_endo -69.78 91.37 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.738 2.292 . . . . 0.0 112.305 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.48 ' C ' ' O ' ' A' ' 409' ' ' PRO . 0.1 OUTLIER -31.67 -51.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.873 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.46 -12.0 0.76 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.508 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -93.68 152.79 18.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.83 0.348 . . . . 0.0 110.846 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' A' ' 399' ' ' HIS . . . -165.68 173.4 10.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . . . . . . . . . 1.2 p -138.81 140.63 38.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.172 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.758 HG21 ' CD2' ' A' ' 381' ' ' PHE . 46.0 t -124.77 116.93 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.144 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . 0.45 ' HB2' ' CB ' ' A' ' 397' ' ' MET . 13.4 m -92.85 112.16 24.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' TYR . . . . . 0.51 ' CD2' ' HA ' ' A' ' 423' ' ' ALA . 59.0 m-85 -86.84 161.41 18.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.897 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.86 -66.51 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.953 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.514 ' CB ' ' HD2' ' A' ' 421' ' ' PRO . 3.4 m-20 -115.17 156.72 45.12 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.617 0.723 . . . . 0.0 110.848 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.591 ' N ' ' CD ' ' A' ' 421' ' ' PRO . 31.9 Cg_exo -57.31 -42.97 56.64 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.659 2.239 . . . . 0.0 112.373 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 420' ' ' PRO . 51.8 Cg_exo -50.42 -26.85 17.05 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.743 2.295 . . . . 0.0 112.323 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 56.0 m -89.09 -41.07 12.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 427' ' ' VAL . . . -60.23 -47.31 86.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.077 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.431 ' HG2' HD11 ' A' ' 444' ' ' LEU . 80.7 mttt -60.92 -38.11 84.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.24 -34.59 63.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.029 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -68.99 -32.62 72.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 423' ' ' ALA . 70.1 t -56.04 -60.02 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.061 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -67.62 -13.89 62.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' TRP . . . . . 0.551 ' CD1' ' C ' ' A' ' 429' ' ' TRP . 1.1 t-105 -78.75 -55.14 5.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.861 ' HB2' HG21 ' A' ' 442' ' ' VAL . 82.8 m-85 -87.41 -14.81 39.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 427' ' ' VAL . 0.6 OUTLIER -55.74 93.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.875 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 105.8 21.54 8.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.505 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' LYS . . . . . 0.459 ' CG ' ' HA ' ' A' ' 430' ' ' PHE . 15.5 mmtm -77.3 176.78 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.7 124.82 44.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.803 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.763 ' HB2' HD11 ' A' ' 440' ' ' LEU . 2.0 t80 -128.16 100.44 5.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 62.52 34.52 15.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.902 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' GLY . . . . . . . . . . . . . . . 82.4 19.96 63.25 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.468 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 19.7 p -126.36 130.09 50.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 110.868 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' LYS . . . . . 0.413 ' C ' HD23 ' A' ' 440' ' ' LEU . 19.8 ttpt -75.95 131.37 39.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.861 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.763 HD11 ' HB2' ' A' ' 435' ' ' PHE . 5.8 mt -105.49 133.83 49.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.59 113.71 27.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.861 HG21 ' HB2' ' A' ' 430' ' ' PHE . 9.2 t -107.8 131.19 58.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.096 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 2.7 m -156.89 130.98 8.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.772 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.431 HD11 ' HG2' ' A' ' 424' ' ' LYS . 26.5 mt -39.15 133.86 1.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -73.37 143.9 46.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.085 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? 60.35 35.02 20.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -142.35 124.24 15.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 13.0 ttpp -165.25 135.43 2.93 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.632 0.73 . . . . 0.0 110.912 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.62 122.83 9.54 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.729 2.286 . . . . 0.0 112.383 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 -17.34 37.38 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.731 2.287 . . . . 0.0 112.331 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -128.7 149.35 50.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -172.14 157.16 4.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 48.9 m -49.29 -46.32 46.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' GLY . . . . . . . . . . . . . . . -177.25 -156.66 16.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.469 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 456' ' ' SER . 53.9 Cg_endo -69.76 106.93 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.259 . . . . 0.0 112.348 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 455' ' ' PRO . 46.9 t -35.94 -63.96 0.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.821 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 33.4 p -86.72 152.84 22.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.517 -179.968 . . . . . . . . 0 0 . 1 stop_ save_